Province, Autonomous City and Community of hospitalization	Main diagnosis (ICD-9-CM) reduced list	Sex	Total
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	4.746.651
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.244.928
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	2.501.723
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	108.095
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	59.825
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	48.270
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	16.738
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	8.712
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	8.026
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Both sexes	8.721
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Men	4.326
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Women	4.395
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Both sexes	3.725
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Men	2.373
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Women	1.352
TOTAL NATIONAL	Group 0104 Septicaemia  038	Both sexes	43.749
TOTAL NATIONAL	Group 0104 Septicaemia  038	Men	23.652
TOTAL NATIONAL	Group 0104 Septicaemia  038	Women	20.097
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	2.959
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2.234
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	725
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	32.203
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	18.528
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	13.675
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Both sexes	454.891
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Men	240.207
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Women	214.684
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	46.736
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	28.270
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	18.466
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	35.029
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	27.360
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7.669
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	8.323
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	4.813
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	3.510
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	34.220
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Men	283
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Women	33.937
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	9.261
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	9.261
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	4.972
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Men	..
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Women	4.972
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Both sexes	17.121
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Men	17.121
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Women	..
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Both sexes	42.301
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Men	35.384
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Women	6.917
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	161.465
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	94.166
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	67.299
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Both sexes	7.433
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Men	2.899
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Women	4.534
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	5.495
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	3.317
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	2.177
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Both sexes	21.306
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Men	..
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Women	21.306
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	61.229
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	26.593
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	34.636
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	42.492
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	20.760
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	21.732
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Both sexes	25.630
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Men	12.231
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Women	13.400
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	16.862
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	8.530
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	8.332
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	85.273
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	34.570
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	50.703
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Both sexes	26.481
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Men	15.482
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Women	10.998
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	58.792
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	19.088
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	39.704
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Both sexes	116.445
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Men	60.643
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Women	55.802
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	4.434
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	1.979
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	2.455
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	8.466
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	6.294
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	2.172
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	7.144
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	5.263
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1.880
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	33.568
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	20.509
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	13.060
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	26.465
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	10.418
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	16.047
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	36.368
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	16.180
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	20.188
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	104.277
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	52.422
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	51.855
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Both sexes	3.693
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Men	1.316
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Women	2.377
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Both sexes	2.303
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Men	734
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Women	1.568
TOTAL NATIONAL	Group 0603 Epilepsy  345	Both sexes	17.878
TOTAL NATIONAL	Group 0603 Epilepsy  345	Men	9.592
TOTAL NATIONAL	Group 0603 Epilepsy  345	Women	8.286
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Both sexes	14.940
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Men	7.632
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Women	7.309
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	65.462
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	33.147
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	32.315
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	27.624
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	14.255
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	13.369
TOTAL NATIONAL	Grupo 0701 Cataract  366	Both sexes	4.840
TOTAL NATIONAL	Grupo 0701 Cataract  366	Men	2.344
TOTAL NATIONAL	Grupo 0701 Cataract  366	Women	2.496
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	22.784
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	11.911
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	10.874
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	23.194
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Men	11.309
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Women	11.885
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	613.148
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	343.744
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	269.404
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Both sexes	31.589
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Men	13.729
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Women	17.861
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Both sexes	25.175
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Men	15.710
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Women	9.465
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Both sexes	54.090
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Men	38.340
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Women	15.751
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	41.068
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	31.512
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	9.556
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	20.164
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Men	9.116
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Women	11.048
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	78.991
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	42.862
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	36.129
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Both sexes	127.382
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Men	59.737
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Women	67.644
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	104.413
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	56.113
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	48.300
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Both sexes	21.102
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Men	15.705
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Women	5.398
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Both sexes	14.259
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Men	5.135
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Women	9.124
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	94.914
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	55.785
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	39.129
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	573.208
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	321.649
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	251.559
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	26.183
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	13.672
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	12.511
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Both sexes	128.975
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Men	74.598
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Women	54.377
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	56.629
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Men	26.963
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Women	29.666
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	25.168
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	13.346
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	11.822
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	41.567
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	25.591
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	15.976
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	90.176
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	67.844
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	22.332
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	23.094
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Men	6.999
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Women	16.096
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	181.416
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	92.637
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	88.779
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Both sexes	572.587
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Men	317.370
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Women	255.217
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	9.469
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	4.371
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	5.098
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	8.125
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	4.465
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	3.661
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Both sexes	10.979
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Men	6.606
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Women	4.374
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Both sexes	10.825
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Men	7.349
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Women	3.476
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	14.035
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	6.826
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	7.208
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Both sexes	48.489
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Men	27.387
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Women	21.102
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Both sexes	56.897
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Men	50.330
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Women	6.567
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Both sexes	47.577
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Men	22.444
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Women	25.132
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	11.142
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	5.688
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	5.454
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	33.148
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	15.456
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	17.692
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Both sexes	26.850
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Men	13.711
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Women	13.139
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Both sexes	24.843
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Men	12.267
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Women	12.576
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	32.955
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	21.210
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	11.744
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	19.230
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	8.773
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	10.457
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	10.270
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Men	8.613
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Women	1.657
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	20.125
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Men	12.164
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Women	7.961
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Both sexes	103.090
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Men	43.235
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Women	59.854
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	28.382
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	15.464
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	12.919
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Both sexes	31.712
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Men	17.677
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Women	14.034
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	24.444
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	13.333
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	11.111
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	48.339
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	25.805
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	22.534
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	30.158
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	17.424
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	12.733
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	2.130
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	1.066
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	1.064
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	16.052
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	7.315
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	8.737
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	346.416
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	165.083
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	181.333
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Both sexes	45.891
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Men	30.921
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Women	14.970
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	128.819
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	55.070
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	73.749
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	6.317
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	2.272
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	4.045
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	17.559
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	8.570
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	8.989
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	32.328
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	17.031
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	15.297
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	8.887
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	3.982
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	4.905
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	51.818
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	26.834
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	24.985
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	54.796
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	20.403
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	34.393
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	317.891
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	147.271
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	170.620
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	31.664
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	11.304
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	20.361
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	29.297
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Men	16.879
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Women	12.418
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	42.509
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Men	25.398
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Women	17.111
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	88.236
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	42.712
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	45.524
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Both sexes	26.433
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Men	26.433
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Women	..
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	22.186
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Men	22.186
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Women	..
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Both sexes	21.735
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Men	1.668
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Women	20.067
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	8.149
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	8.149
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	3.737
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	3.737
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	43.944
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	692
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	43.253
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	480.528
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	480.528
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Both sexes	2.013
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Men	..
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Women	2.013
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	24.950
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	24.950
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	290.779
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	290.779
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	83.396
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	83.396
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Both sexes	29.203
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Men	..
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Women	29.203
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Both sexes	13.947
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Men	..
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Women	13.947
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Both sexes	3.902
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Men	..
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Women	3.902
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	32.338
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	32.338
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	61.711
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Men	33.962
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Women	27.749
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	16.839
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	8.967
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	7.872
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	44.872
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	24.995
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	19.877
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Both sexes	37.234
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Men	20.786
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Women	16.448
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	212.140
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	113.872
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	98.268
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	24.515
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Men	13.888
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Women	10.627
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Both sexes	23.921
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Men	9.305
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Women	14.616
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	16.997
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	8.775
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	8.222
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	146.707
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	81.905
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	64.803
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Both sexes	424.014
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Men	214.698
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Women	209.315
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	23.935
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	13.553
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	10.382
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	11.249
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	7.916
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3.333
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Both sexes	25.880
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Men	11.980
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Women	13.900
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Both sexes	71.414
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Men	20.212
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Women	51.202
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	30.937
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Men	15.299
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Women	15.637
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	121.784
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	72.341
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	49.443
TOTAL NATIONAL	Group 1907 Burns  940-949	Both sexes	3.257
TOTAL NATIONAL	Group 1907 Burns  940-949	Men	2.027
TOTAL NATIONAL	Group 1907 Burns  940-949	Women	1.230
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	11.367
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	5.023
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	6.344
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	110.009
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	58.911
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	51.098
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1.199
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	731
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	469
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	12.983
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	6.706
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	6.277
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	97.144
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	46.695
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	50.449
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	3.832
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	2.171
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1.661
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Both sexes	1.398
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Men	104
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Women	1.294
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	32.133
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	19.208
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	12.925
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	59.781
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	25.211
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	34.570
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	696.093
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	313.556
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	382.538
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	17.868
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	9.922
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	7.946
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	2.133
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.184
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	949
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Both sexes	1.918
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Men	970
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Women	949
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Both sexes	591
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Men	377
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Women	214
ANDALUC═A	Group 0104 Septicaemia  038	Both sexes	7.541
ANDALUC═A	Group 0104 Septicaemia  038	Men	4.010
ANDALUC═A	Group 0104 Septicaemia  038	Women	3.530
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	510
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	385
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	125
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	5.175
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.996
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	2.179
ANDALUC═A	Group 0200 Neoplasms  140-239	Both sexes	64.660
ANDALUC═A	Group 0200 Neoplasms  140-239	Men	33.473
ANDALUC═A	Group 0200 Neoplasms  140-239	Women	31.188
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	6.606
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.940
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.666
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.741
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.901
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	840
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.486
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	873
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	612
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.335
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Men	53
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Women	5.282
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.394
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.394
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	816
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Women	816
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.750
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Men	1.750
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Women	..
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Both sexes	6.139
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Men	5.181
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Women	958
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	22.407
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	13.232
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	9.175
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Both sexes	766
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Men	259
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Women	507
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	552
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	328
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	224
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.588
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Men	..
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Women	3.588
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	9.082
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.955
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	5.127
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.365
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	3.077
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.288
ANDALUC═A	Group 0301 Anaemias 280-285	Both sexes	3.611
ANDALUC═A	Group 0301 Anaemias 280-285	Men	1.790
ANDALUC═A	Group 0301 Anaemias 280-285	Women	1.820
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.754
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.287
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.468
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	12.129
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	5.005
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	7.124
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Both sexes	3.758
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Men	2.280
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Women	1.478
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	8.371
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.725
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	5.646
ANDALUC═A	Group 0500 Mental disorders  290-319	Both sexes	13.068
ANDALUC═A	Group 0500 Mental disorders  290-319	Men	7.248
ANDALUC═A	Group 0500 Mental disorders  290-319	Women	5.819
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	260
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	115
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	146
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	527
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	425
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	102
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	798
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	626
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	173
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	4.190
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	2.795
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.395
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	3.114
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	1.331
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.783
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	4.178
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	1.958
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	2.220
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	13.561
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	6.802
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	6.759
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Both sexes	250
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Men	102
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Women	147
ANDALUC═A	Group 0602 Multiple sclerosis 340	Both sexes	361
ANDALUC═A	Group 0602 Multiple sclerosis 340	Men	111
ANDALUC═A	Group 0602 Multiple sclerosis 340	Women	250
ANDALUC═A	Group 0603 Epilepsy  345	Both sexes	2.251
ANDALUC═A	Group 0603 Epilepsy  345	Men	1.204
ANDALUC═A	Group 0603 Epilepsy  345	Women	1.047
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Both sexes	2.383
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Men	1.269
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Women	1.114
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	8.317
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	4.116
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	4.200
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	4.837
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.657
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.180
ANDALUC═A	Grupo 0701 Cataract  366	Both sexes	702
ANDALUC═A	Grupo 0701 Cataract  366	Men	408
ANDALUC═A	Grupo 0701 Cataract  366	Women	294
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	4.135
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	2.249
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.886
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.229
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.596
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.633
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	92.863
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	52.791
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	40.073
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Both sexes	6.352
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Men	2.712
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Women	3.640
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Both sexes	5.344
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Men	3.271
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Women	2.073
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Both sexes	10.029
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Men	6.932
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Women	3.097
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	7.185
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	5.409
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.775
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.467
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Men	1.142
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Women	1.325
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	11.397
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	6.116
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	5.282
ANDALUC═A	Grupo 0907 Heart failure  428	Both sexes	15.629
ANDALUC═A	Grupo 0907 Heart failure  428	Men	7.464
ANDALUC═A	Grupo 0907 Heart failure  428	Women	8.166
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	16.279
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	9.007
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	7.273
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Both sexes	3.130
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Men	2.382
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Women	748
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.659
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Men	611
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Women	1.047
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	13.391
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	7.745
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	5.647
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	68.822
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	39.320
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	29.502
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.394
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.752
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.641
ANDALUC═A	Group 1002 Pneumonia 480-486	Both sexes	15.670
ANDALUC═A	Group 1002 Pneumonia 480-486	Men	9.006
ANDALUC═A	Group 1002 Pneumonia 480-486	Women	6.663
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	7.631
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Men	3.946
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Women	3.685
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.886
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.446
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.440
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	5.983
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.655
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.328
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	8.060
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	6.310
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.750
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	2.124
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Men	639
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Women	1.485
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	23.075
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	12.565
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	10.510
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Both sexes	86.834
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Men	46.919
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Women	39.914
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.333
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	656
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	676
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.300
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	689
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	611
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Both sexes	1.957
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Men	1.143
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Women	814
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Both sexes	1.787
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Men	1.242
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Women	545
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	2.362
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	1.097
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	1.266
ANDALUC═A	Group 1106 Appendicitis  540-543	Both sexes	7.749
ANDALUC═A	Group 1106 Appendicitis  540-543	Men	4.374
ANDALUC═A	Group 1106 Appendicitis  540-543	Women	3.375
ANDALUC═A	Group 1107 Inguinal hernia  550	Both sexes	6.853
ANDALUC═A	Group 1107 Inguinal hernia  550	Men	5.878
ANDALUC═A	Group 1107 Inguinal hernia  550	Women	975
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Both sexes	6.911
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Men	2.995
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Women	3.917
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	2.142
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	1.121
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	1.021
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.717
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	2.141
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.576
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.579
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Men	1.807
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Women	1.772
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Both sexes	3.374
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Men	1.733
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Women	1.642
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	5.328
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.462
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.865
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.470
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.142
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.329
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.645
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.423
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Women	222
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	3.081
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Men	1.920
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Women	1.161
ANDALUC═A	Group 1117 Cholelithiasis  574	Both sexes	16.728
ANDALUC═A	Group 1117 Cholelithiasis  574	Men	6.767
ANDALUC═A	Group 1117 Cholelithiasis  574	Women	9.961
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.883
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.095
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.788
ANDALUC═A	Group 1119 Pancreatic diseases 577	Both sexes	5.982
ANDALUC═A	Group 1119 Pancreatic diseases 577	Men	3.241
ANDALUC═A	Group 1119 Pancreatic diseases 577	Women	2.742
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.652
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.995
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.656
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	6.332
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.465
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	2.867
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.850
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	2.320
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.530
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	269
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	146
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	124
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.212
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	999
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.213
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	43.639
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	20.053
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	23.586
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ANDALUC═A	Group 1303 Internal derangement of knee 717	Both sexes	4.505
ANDALUC═A	Group 1303 Internal derangement of knee 717	Men	2.988
ANDALUC═A	Group 1303 Internal derangement of knee 717	Women	1.517
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	17.883
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	7.287
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	10.596
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	946
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	339
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	606
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.376
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.177
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.200
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	4.414
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2.225
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.189
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.254
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	510
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	744
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	5.737
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	2.888
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	2.849
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	6.523
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	2.639
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	3.884
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	44.611
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	19.019
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	25.592
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	4.882
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.836
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	3.046
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	4.877
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Men	2.847
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Women	2.030
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	6.319
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Men	3.490
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Women	2.830
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	9.296
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	4.636
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	4.660
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Both sexes	2.960
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Men	2.960
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Women	..
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	2.846
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Men	2.846
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ANDALUC═A	Group 1407 Disorders of breast  610-612	Both sexes	4.232
ANDALUC═A	Group 1407 Disorders of breast  610-612	Men	318
ANDALUC═A	Group 1407 Disorders of breast  610-612	Women	3.913
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.340
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.340
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	755
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	755
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	7.104
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	86
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	7.018
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	95.708
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	95.708
ANDALUC═A	Group 1501 Legally induced abortion  635	Both sexes	166
ANDALUC═A	Group 1501 Legally induced abortion  635	Men	..
ANDALUC═A	Group 1501 Legally induced abortion  635	Women	166
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	5.268
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	5.268
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	60.986
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	60.986
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	13.310
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	13.310
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Both sexes	6.077
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Men	..
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Women	6.077
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Both sexes	3.464
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Men	..
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Women	3.464
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Both sexes	694
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Men	..
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Women	694
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	5.744
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	5.744
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	9.652
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Men	5.284
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Women	4.368
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	3.343
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.736
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.608
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	6.308
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	3.548
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.760
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.220
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Men	3.413
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Women	2.807
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	32.735
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	17.268
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	15.467
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	4.663
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Men	2.581
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Women	2.082
ANDALUC═A	Group 1802 Abdominal pain   7890	Both sexes	4.485
ANDALUC═A	Group 1802 Abdominal pain   7890	Men	1.735
ANDALUC═A	Group 1802 Abdominal pain   7890	Women	2.750
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.905
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1.016
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	889
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	21.682
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	11.936
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	9.745
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Both sexes	61.427
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Men	31.085
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Women	30.341
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.937
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.773
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.164
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.798
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.302
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	496
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Both sexes	4.556
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Men	2.165
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Women	2.391
ANDALUC═A	Group 1904 Femur fracture  820-821	Both sexes	10.518
ANDALUC═A	Group 1904 Femur fracture  820-821	Men	3.134
ANDALUC═A	Group 1904 Femur fracture  820-821	Women	7.384
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	5.263
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Men	2.717
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Women	2.546
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	16.527
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	9.511
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	7.017
ANDALUC═A	Group 1907 Burns  940-949	Both sexes	530
ANDALUC═A	Group 1907 Burns  940-949	Men	303
ANDALUC═A	Group 1907 Burns  940-949	Women	227
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.881
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	916
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	966
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	15.837
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	8.385
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	7.453
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	290
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	170
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	120
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.289
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	710
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	578
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	11.535
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	5.158
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	6.377
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	558
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	323
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	235
ANDALUC═A	Group 2102 Contraceptive management  V25	Both sexes	142
ANDALUC═A	Group 2102 Contraceptive management  V25	Men	22
ANDALUC═A	Group 2102 Contraceptive management  V25	Women	120
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	4.039
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.502
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.537
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	6.796
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	2.311
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	4.486
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	53.840
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	23.986
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	29.854
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.481
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	866
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	615
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	219
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	119
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	100
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Both sexes	237
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Men	121
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Women	116
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Both sexes	91
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Men	66
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Women	25
AlmerÝa	Group 0104 Septicaemia  038	Both sexes	468
AlmerÝa	Group 0104 Septicaemia  038	Men	254
AlmerÝa	Group 0104 Septicaemia  038	Women	214
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	51
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	38
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	13
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	415
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	268
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	147
AlmerÝa	Group 0200 Neoplasms  140-239	Both sexes	4.183
AlmerÝa	Group 0200 Neoplasms  140-239	Men	2.175
AlmerÝa	Group 0200 Neoplasms  140-239	Women	2.008
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	461
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	272
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	189
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	380
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	329
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	51
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	46
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	33
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	13
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	334
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Men	5
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Women	329
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	98
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	98
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	60
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Men	..
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Women	60
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Both sexes	116
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Men	116
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Women	..
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Both sexes	428
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Men	381
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Women	47
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.348
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	758
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	590
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Both sexes	30
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Men	5
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Women	25
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	32
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	18
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	14
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Both sexes	295
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Men	..
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Women	295
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	555
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	258
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	297
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	479
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	238
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	241
AlmerÝa	Group 0301 Anaemias 280-285	Both sexes	262
AlmerÝa	Group 0301 Anaemias 280-285	Men	142
AlmerÝa	Group 0301 Anaemias 280-285	Women	120
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	217
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	96
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	121
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	938
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	445
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	493
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Both sexes	338
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Men	218
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Women	120
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	600
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	227
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	373
AlmerÝa	Group 0500 Mental disorders  290-319	Both sexes	949
AlmerÝa	Group 0500 Mental disorders  290-319	Men	555
AlmerÝa	Group 0500 Mental disorders  290-319	Women	394
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	14
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	11
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	20
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	18
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	2
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	41
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	28
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	13
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	408
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	266
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	142
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	157
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	92
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	65
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	309
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	140
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	169
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	882
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	446
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	436
AlmerÝa	Group 0601 Alzheimer's disease  3310	Both sexes	38
AlmerÝa	Group 0601 Alzheimer's disease  3310	Men	18
AlmerÝa	Group 0601 Alzheimer's disease  3310	Women	20
AlmerÝa	Group 0602 Multiple sclerosis 340	Both sexes	16
AlmerÝa	Group 0602 Multiple sclerosis 340	Men	2
AlmerÝa	Group 0602 Multiple sclerosis 340	Women	14
AlmerÝa	Group 0603 Epilepsy  345	Both sexes	119
AlmerÝa	Group 0603 Epilepsy  345	Men	66
AlmerÝa	Group 0603 Epilepsy  345	Women	53
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Both sexes	215
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Men	111
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Women	104
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	494
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	249
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	245
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	343
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	200
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	143
AlmerÝa	Grupo 0701 Cataract  366	Both sexes	27
AlmerÝa	Grupo 0701 Cataract  366	Men	19
AlmerÝa	Grupo 0701 Cataract  366	Women	8
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	316
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	181
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	135
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	266
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Men	120
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Women	146
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.863
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.489
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.374
AlmerÝa	Group 0901 Hypertensive disease  401-405	Both sexes	302
AlmerÝa	Group 0901 Hypertensive disease  401-405	Men	116
AlmerÝa	Group 0901 Hypertensive disease  401-405	Women	186
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Both sexes	251
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Men	164
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Women	87
AlmerÝa	Group 0903 Acute myocardial infarction  410	Both sexes	813
AlmerÝa	Group 0903 Acute myocardial infarction  410	Men	601
AlmerÝa	Group 0903 Acute myocardial infarction  410	Women	212
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	408
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	310
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	98
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	188
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Men	93
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Women	95
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	679
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	381
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	298
AlmerÝa	Grupo 0907 Heart failure  428	Both sexes	1.115
AlmerÝa	Grupo 0907 Heart failure  428	Men	538
AlmerÝa	Grupo 0907 Heart failure  428	Women	577
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.216
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	681
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	535
AlmerÝa	Grupo 0909 Atherosclerosis  440	Both sexes	243
AlmerÝa	Grupo 0909 Atherosclerosis  440	Men	197
AlmerÝa	Grupo 0909 Atherosclerosis  440	Women	46
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Both sexes	4
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Men	1
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Women	3
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	644
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	407
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	237
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.671
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.865
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.806
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	301
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	170
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	131
AlmerÝa	Group 1002 Pneumonia 480-486	Both sexes	1.612
AlmerÝa	Group 1002 Pneumonia 480-486	Men	961
AlmerÝa	Group 1002 Pneumonia 480-486	Women	651
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.102
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Men	516
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Women	586
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	223
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	118
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	105
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	393
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	271
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	122
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	968
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	825
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	143
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	282
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Men	107
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Women	175
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.790
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	897
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	893
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.530
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Men	3.604
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Women	2.926
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	107
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	58
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	49
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	160
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	95
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	65
AlmerÝa	Group 1103 Diseases of the esophagus 530	Both sexes	131
AlmerÝa	Group 1103 Diseases of the esophagus 530	Men	75
AlmerÝa	Group 1103 Diseases of the esophagus 530	Women	56
AlmerÝa	Group 1104 Peptic ulcer 531-534	Both sexes	143
AlmerÝa	Group 1104 Peptic ulcer 531-534	Men	116
AlmerÝa	Group 1104 Peptic ulcer 531-534	Women	27
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	171
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	72
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	99
AlmerÝa	Group 1106 Appendicitis  540-543	Both sexes	712
AlmerÝa	Group 1106 Appendicitis  540-543	Men	440
AlmerÝa	Group 1106 Appendicitis  540-543	Women	272
AlmerÝa	Group 1107 Inguinal hernia  550	Both sexes	351
AlmerÝa	Group 1107 Inguinal hernia  550	Men	308
AlmerÝa	Group 1107 Inguinal hernia  550	Women	43
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Both sexes	344
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Men	168
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Women	176
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	177
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	90
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	87
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	361
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	155
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	206
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Both sexes	279
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Men	150
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Women	129
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Both sexes	290
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Men	155
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Women	135
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	391
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	262
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	129
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	184
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	77
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	107
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	140
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Men	119
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Women	21
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	192
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Men	117
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Women	75
AlmerÝa	Group 1117 Cholelithiasis  574	Both sexes	1.301
AlmerÝa	Group 1117 Cholelithiasis  574	Men	541
AlmerÝa	Group 1117 Cholelithiasis  574	Women	760
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	320
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	172
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	148
AlmerÝa	Group 1119 Pancreatic diseases 577	Both sexes	535
AlmerÝa	Group 1119 Pancreatic diseases 577	Men	304
AlmerÝa	Group 1119 Pancreatic diseases 577	Women	231
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	241
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	130
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	111
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	456
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	263
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	193
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	319
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	202
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	117
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	16
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	9
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	121
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	54
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	67
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.349
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.614
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.735
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
AlmerÝa	Group 1303 Internal derangement of knee 717	Both sexes	397
AlmerÝa	Group 1303 Internal derangement of knee 717	Men	262
AlmerÝa	Group 1303 Internal derangement of knee 717	Women	135
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.288
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	523
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	765
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	86
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	41
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	45
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	153
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	92
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	61
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	277
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	146
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	131
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	68
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	32
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	36
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	549
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	274
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	275
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	531
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	244
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	287
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.438
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.477
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.961
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	435
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	181
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	254
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	363
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Men	215
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Women	148
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	379
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Men	215
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Women	164
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	968
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	475
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	493
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Both sexes	220
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Men	220
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Women	..
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	148
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Men	148
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Women	..
AlmerÝa	Group 1407 Disorders of breast  610-612	Both sexes	252
AlmerÝa	Group 1407 Disorders of breast  610-612	Men	21
AlmerÝa	Group 1407 Disorders of breast  610-612	Women	231
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	112
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	112
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	38
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	38
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	523
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	521
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.599
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.599
AlmerÝa	Group 1501 Legally induced abortion  635	Both sexes	23
AlmerÝa	Group 1501 Legally induced abortion  635	Men	..
AlmerÝa	Group 1501 Legally induced abortion  635	Women	23
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	614
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	614
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.441
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.441
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.048
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.048
AlmerÝa	Group 1505 Single spontaneous delivery  650	Both sexes	462
AlmerÝa	Group 1505 Single spontaneous delivery  650	Men	..
AlmerÝa	Group 1505 Single spontaneous delivery  650	Women	462
AlmerÝa	Group 1506 Other deliveries  6695-6697	Both sexes	287
AlmerÝa	Group 1506 Other deliveries  6695-6697	Men	..
AlmerÝa	Group 1506 Other deliveries  6695-6697	Women	287
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Both sexes	34
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Men	..
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Women	34
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	690
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	690
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	836
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Men	480
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Women	356
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	291
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	151
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	140
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	545
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	329
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	216
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Both sexes	408
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Men	241
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Women	167
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.186
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.179
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.007
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	270
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Men	145
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Women	125
AlmerÝa	Group 1802 Abdominal pain   7890	Both sexes	289
AlmerÝa	Group 1802 Abdominal pain   7890	Men	117
AlmerÝa	Group 1802 Abdominal pain   7890	Women	172
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	108
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	57
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	51
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.519
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	860
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	659
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Both sexes	4.371
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Men	2.381
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Women	1.990
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	207
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	135
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	72
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	146
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	113
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	33
AlmerÝa	Group 1903 Radius and ulna fracture 813	Both sexes	388
AlmerÝa	Group 1903 Radius and ulna fracture 813	Men	217
AlmerÝa	Group 1903 Radius and ulna fracture 813	Women	171
AlmerÝa	Group 1904 Femur fracture  820-821	Both sexes	784
AlmerÝa	Group 1904 Femur fracture  820-821	Men	242
AlmerÝa	Group 1904 Femur fracture  820-821	Women	542
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	407
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Men	221
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Women	186
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.187
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	802
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	385
AlmerÝa	Group 1907 Burns  940-949	Both sexes	38
AlmerÝa	Group 1907 Burns  940-949	Men	20
AlmerÝa	Group 1907 Burns  940-949	Women	18
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	142
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	75
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	67
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	954
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	496
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	458
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	7
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	5
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	111
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	55
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	56
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	612
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	348
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	264
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	12
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	7
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
AlmerÝa	Group 2102 Contraceptive management  V25	Both sexes	6
AlmerÝa	Group 2102 Contraceptive management  V25	Men	2
AlmerÝa	Group 2102 Contraceptive management  V25	Women	4
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	347
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	205
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	142
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	247
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	134
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	113
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	104.518
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	47.918
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	56.600
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.015
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.220
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.795
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	308
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	164
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	144
Cßdiz	Group 0102 Imprecise intestinal infections 009	Both sexes	613
Cßdiz	Group 0102 Imprecise intestinal infections 009	Men	336
Cßdiz	Group 0102 Imprecise intestinal infections 009	Women	277
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Both sexes	83
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Men	55
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Women	28
Cßdiz	Group 0104 Septicaemia  038	Both sexes	1.999
Cßdiz	Group 0104 Septicaemia  038	Men	1.079
Cßdiz	Group 0104 Septicaemia  038	Women	920
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	87
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	62
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	25
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	925
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	524
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	400
Cßdiz	Group 0200 Neoplasms  140-239	Both sexes	8.824
Cßdiz	Group 0200 Neoplasms  140-239	Men	4.713
Cßdiz	Group 0200 Neoplasms  140-239	Women	4.111
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	886
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	513
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	373
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	728
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	610
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	118
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	174
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	99
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	75
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	758
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Women	755
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	180
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	180
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	103
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Women	103
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Both sexes	216
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Men	216
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Both sexes	880
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Men	754
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Women	126
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.123
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.887
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.237
Cßdiz	Group 0210 Carcinoma in situ  230-234	Both sexes	169
Cßdiz	Group 0210 Carcinoma in situ  230-234	Men	97
Cßdiz	Group 0210 Carcinoma in situ  230-234	Women	72
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	72
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	47
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	25
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Both sexes	453
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Women	453
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.083
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	489
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	594
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.108
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	513
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	594
Cßdiz	Group 0301 Anaemias 280-285	Both sexes	666
Cßdiz	Group 0301 Anaemias 280-285	Men	323
Cßdiz	Group 0301 Anaemias 280-285	Women	342
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	442
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	190
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	252
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.846
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	805
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.041
Cßdiz	Group 0401 Diabetes mellitus  249-250	Both sexes	646
Cßdiz	Group 0401 Diabetes mellitus  249-250	Men	383
Cßdiz	Group 0401 Diabetes mellitus  249-250	Women	263
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.200
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	422
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	778
Cßdiz	Group 0500 Mental disorders  290-319	Both sexes	1.703
Cßdiz	Group 0500 Mental disorders  290-319	Men	973
Cßdiz	Group 0500 Mental disorders  290-319	Women	730
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	62
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	28
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	34
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	93
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	72
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	21
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	133
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	102
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	31
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	492
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	346
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	145
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	360
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	165
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	195
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	563
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	260
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	303
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.239
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.131
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.109
Cßdiz	Group 0601 Alzheimer's disease  3310	Both sexes	39
Cßdiz	Group 0601 Alzheimer's disease  3310	Men	12
Cßdiz	Group 0601 Alzheimer's disease  3310	Women	26
Cßdiz	Group 0602 Multiple sclerosis 340	Both sexes	72
Cßdiz	Group 0602 Multiple sclerosis 340	Men	26
Cßdiz	Group 0602 Multiple sclerosis 340	Women	46
Cßdiz	Group 0603 Epilepsy  345	Both sexes	333
Cßdiz	Group 0603 Epilepsy  345	Men	183
Cßdiz	Group 0603 Epilepsy  345	Women	150
Cßdiz	Group 0604 Transient cerebral ischemia 435	Both sexes	497
Cßdiz	Group 0604 Transient cerebral ischemia 435	Men	264
Cßdiz	Group 0604 Transient cerebral ischemia 435	Women	233
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.299
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	645
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	653
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	540
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	256
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	284
Cßdiz	Grupo 0701 Cataract  366	Both sexes	98
Cßdiz	Grupo 0701 Cataract  366	Men	48
Cßdiz	Grupo 0701 Cataract  366	Women	50
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	443
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	208
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	235
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	411
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Men	195
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Women	216
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	14.310
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.006
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.304
Cßdiz	Group 0901 Hypertensive disease  401-405	Both sexes	777
Cßdiz	Group 0901 Hypertensive disease  401-405	Men	346
Cßdiz	Group 0901 Hypertensive disease  401-405	Women	431
Cßdiz	Group 0902 Angina pectoris  4111, 413	Both sexes	980
Cßdiz	Group 0902 Angina pectoris  4111, 413	Men	568
Cßdiz	Group 0902 Angina pectoris  4111, 413	Women	412
Cßdiz	Group 0903 Acute myocardial infarction  410	Both sexes	1.422
Cßdiz	Group 0903 Acute myocardial infarction  410	Men	1.005
Cßdiz	Group 0903 Acute myocardial infarction  410	Women	417
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.364
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	977
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	386
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	274
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Men	130
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Women	144
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.884
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	991
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	893
Cßdiz	Grupo 0907 Heart failure  428	Both sexes	2.529
Cßdiz	Grupo 0907 Heart failure  428	Men	1.123
Cßdiz	Grupo 0907 Heart failure  428	Women	1.406
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.564
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.383
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.181
Cßdiz	Grupo 0909 Atherosclerosis  440	Both sexes	475
Cßdiz	Grupo 0909 Atherosclerosis  440	Men	358
Cßdiz	Grupo 0909 Atherosclerosis  440	Women	117
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Both sexes	145
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Men	53
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Women	92
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.897
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.073
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	824
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.763
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	6.045
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.717
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	568
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	283
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	284
Cßdiz	Group 1002 Pneumonia 480-486	Both sexes	2.255
Cßdiz	Group 1002 Pneumonia 480-486	Men	1.244
Cßdiz	Group 1002 Pneumonia 480-486	Women	1.012
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.733
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Men	886
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Women	847
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	375
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	181
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	194
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	909
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	588
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	321
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.178
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	899
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	278
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	304
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Men	107
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Women	197
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.440
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.857
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.583
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.013
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Men	7.212
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Women	5.801
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	140
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	70
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	70
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	169
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	94
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	74
Cßdiz	Group 1103 Diseases of the esophagus 530	Both sexes	198
Cßdiz	Group 1103 Diseases of the esophagus 530	Men	130
Cßdiz	Group 1103 Diseases of the esophagus 530	Women	68
Cßdiz	Group 1104 Peptic ulcer 531-534	Both sexes	264
Cßdiz	Group 1104 Peptic ulcer 531-534	Men	177
Cßdiz	Group 1104 Peptic ulcer 531-534	Women	87
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	496
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	228
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	268
Cßdiz	Group 1106 Appendicitis  540-543	Both sexes	1.065
Cßdiz	Group 1106 Appendicitis  540-543	Men	609
Cßdiz	Group 1106 Appendicitis  540-543	Women	456
Cßdiz	Group 1107 Inguinal hernia  550	Both sexes	1.285
Cßdiz	Group 1107 Inguinal hernia  550	Men	1.146
Cßdiz	Group 1107 Inguinal hernia  550	Women	139
Cßdiz	Group 1108 Other abdominal hernia  551-553	Both sexes	973
Cßdiz	Group 1108 Other abdominal hernia  551-553	Men	446
Cßdiz	Group 1108 Other abdominal hernia  551-553	Women	527
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	376
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	187
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	189
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	808
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	340
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	467
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Both sexes	528
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Men	285
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Women	243
Cßdiz	Group 1112 Intestinal diverticulosis 562	Both sexes	484
Cßdiz	Group 1112 Intestinal diverticulosis 562	Men	256
Cßdiz	Group 1112 Intestinal diverticulosis 562	Women	228
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	745
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	457
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	288
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	392
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	179
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	213
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	306
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Men	261
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Women	45
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	518
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Men	334
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Women	184
Cßdiz	Group 1117 Cholelithiasis  574	Both sexes	2.288
Cßdiz	Group 1117 Cholelithiasis  574	Men	901
Cßdiz	Group 1117 Cholelithiasis  574	Women	1.387
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	602
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	327
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	274
Cßdiz	Group 1119 Pancreatic diseases 577	Both sexes	822
Cßdiz	Group 1119 Pancreatic diseases 577	Men	469
Cßdiz	Group 1119 Pancreatic diseases 577	Women	353
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	555
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	315
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	240
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.167
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	641
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	526
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	701
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	426
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	275
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	62
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	35
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	27
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	404
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	181
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	224
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.307
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.454
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.853
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cßdiz	Group 1303 Internal derangement of knee 717	Both sexes	613
Cßdiz	Group 1303 Internal derangement of knee 717	Men	417
Cßdiz	Group 1303 Internal derangement of knee 717	Women	196
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.205
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	921
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.284
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	129
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	46
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	83
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	240
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	130
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	110
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	462
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	247
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	215
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	289
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	120
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	169
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	501
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	260
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	241
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	868
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	313
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	555
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.898
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.322
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.576
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	841
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	309
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	532
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	744
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Men	417
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Women	327
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.279
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Men	683
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Women	596
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.010
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	978
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.031
Cßdiz	Group 1405 Prostatic hyperplasia  600	Both sexes	367
Cßdiz	Group 1405 Prostatic hyperplasia  600	Men	367
Cßdiz	Group 1405 Prostatic hyperplasia  600	Women	..
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	518
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Men	518
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cßdiz	Group 1407 Disorders of breast  610-612	Both sexes	586
Cßdiz	Group 1407 Disorders of breast  610-612	Men	46
Cßdiz	Group 1407 Disorders of breast  610-612	Women	540
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	191
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	191
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	266
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	266
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.096
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	5
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.091
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	13.212
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	13.212
Cßdiz	Group 1501 Legally induced abortion  635	Both sexes	39
Cßdiz	Group 1501 Legally induced abortion  635	Men	..
Cßdiz	Group 1501 Legally induced abortion  635	Women	39
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	771
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	771
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	7.605
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	7.605
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.616
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.616
Cßdiz	Group 1505 Single spontaneous delivery  650	Both sexes	1.442
Cßdiz	Group 1505 Single spontaneous delivery  650	Men	..
Cßdiz	Group 1505 Single spontaneous delivery  650	Women	1.442
Cßdiz	Group 1506 Other deliveries  6695-6697	Both sexes	1.106
Cßdiz	Group 1506 Other deliveries  6695-6697	Men	..
Cßdiz	Group 1506 Other deliveries  6695-6697	Women	1.106
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Both sexes	52
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Men	..
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Women	52
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	582
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	582
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.697
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Men	893
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Women	804
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	488
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	220
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	268
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.209
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	673
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	536
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Both sexes	792
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Men	465
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Women	326
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.595
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.489
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.106
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	792
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Men	453
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Women	338
Cßdiz	Group 1802 Abdominal pain   7890	Both sexes	1.203
Cßdiz	Group 1802 Abdominal pain   7890	Men	509
Cßdiz	Group 1802 Abdominal pain   7890	Women	694
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	214
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	135
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	79
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.387
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.391
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.995
Cßdiz	Group 1900 Injuries and poisoning  800-999	Both sexes	7.691
Cßdiz	Group 1900 Injuries and poisoning  800-999	Men	3.952
Cßdiz	Group 1900 Injuries and poisoning  800-999	Women	3.739
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	537
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	303
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	235
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	246
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	184
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	62
Cßdiz	Group 1903 Radius and ulna fracture 813	Both sexes	511
Cßdiz	Group 1903 Radius and ulna fracture 813	Men	268
Cßdiz	Group 1903 Radius and ulna fracture 813	Women	243
Cßdiz	Group 1904 Femur fracture  820-821	Both sexes	1.335
Cßdiz	Group 1904 Femur fracture  820-821	Men	428
Cßdiz	Group 1904 Femur fracture  820-821	Women	907
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	647
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Men	329
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Women	318
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.956
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.130
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	826
Cßdiz	Group 1907 Burns  940-949	Both sexes	26
Cßdiz	Group 1907 Burns  940-949	Men	17
Cßdiz	Group 1907 Burns  940-949	Women	9
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	258
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	142
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	116
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.904
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	990
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	914
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	70
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	39
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	31
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	200
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	123
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	77
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.385
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	631
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	754
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	43
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	17
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	25
Cßdiz	Group 2102 Contraceptive management  V25	Both sexes	31
Cßdiz	Group 2102 Contraceptive management  V25	Men	7
Cßdiz	Group 2102 Contraceptive management  V25	Women	24
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	513
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	348
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	166
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	798
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	259
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	539
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	71.406
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.449
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	37.957
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.192
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	640
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	552
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	183
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	100
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	83
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Both sexes	58
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Men	24
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Women	34
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Both sexes	52
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Men	32
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Women	20
C¾rdoba	Group 0104 Septicaemia  038	Both sexes	388
C¾rdoba	Group 0104 Septicaemia  038	Men	183
C¾rdoba	Group 0104 Septicaemia  038	Women	205
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	44
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	34
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	10
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	467
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	267
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	200
C¾rdoba	Group 0200 Neoplasms  140-239	Both sexes	7.166
C¾rdoba	Group 0200 Neoplasms  140-239	Men	3.751
C¾rdoba	Group 0200 Neoplasms  140-239	Women	3.415
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	702
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	419
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	283
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	452
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	379
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	73
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	223
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	134
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	89
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	529
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Men	4
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Women	525
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	169
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	169
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	85
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Men	..
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Women	85
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Both sexes	224
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Men	224
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Women	..
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Both sexes	680
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Men	562
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Women	118
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.405
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.377
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.028
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Both sexes	67
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Men	10
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Women	57
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	71
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	38
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	33
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Both sexes	193
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Men	..
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Women	193
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.366
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	604
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	762
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	701
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	330
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	371
C¾rdoba	Group 0301 Anaemias 280-285	Both sexes	435
C¾rdoba	Group 0301 Anaemias 280-285	Men	206
C¾rdoba	Group 0301 Anaemias 280-285	Women	229
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	266
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	124
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	142
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.221
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	491
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	730
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Both sexes	293
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Men	146
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Women	147
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	928
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	345
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	583
C¾rdoba	Group 0500 Mental disorders  290-319	Both sexes	1.005
C¾rdoba	Group 0500 Mental disorders  290-319	Men	526
C¾rdoba	Group 0500 Mental disorders  290-319	Women	479
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	26
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	13
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	13
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	37
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	32
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	5
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	56
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	43
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	13
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	259
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	151
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	108
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	290
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	139
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	151
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	337
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	148
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	189
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.178
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	578
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	600
C¾rdoba	Group 0601 Alzheimer's disease  3310	Both sexes	16
C¾rdoba	Group 0601 Alzheimer's disease  3310	Men	6
C¾rdoba	Group 0601 Alzheimer's disease  3310	Women	10
C¾rdoba	Group 0602 Multiple sclerosis 340	Both sexes	24
C¾rdoba	Group 0602 Multiple sclerosis 340	Men	8
C¾rdoba	Group 0602 Multiple sclerosis 340	Women	16
C¾rdoba	Group 0603 Epilepsy  345	Both sexes	156
C¾rdoba	Group 0603 Epilepsy  345	Men	83
C¾rdoba	Group 0603 Epilepsy  345	Women	73
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Both sexes	188
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Men	101
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Women	87
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	794
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	380
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	414
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	932
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	535
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	397
C¾rdoba	Grupo 0701 Cataract  366	Both sexes	140
C¾rdoba	Grupo 0701 Cataract  366	Men	80
C¾rdoba	Grupo 0701 Cataract  366	Women	60
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	792
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	455
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	337
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	271
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Men	133
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Women	138
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.434
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.037
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.397
C¾rdoba	Group 0901 Hypertensive disease  401-405	Both sexes	366
C¾rdoba	Group 0901 Hypertensive disease  401-405	Men	165
C¾rdoba	Group 0901 Hypertensive disease  401-405	Women	201
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Both sexes	577
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Men	364
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Women	213
C¾rdoba	Group 0903 Acute myocardial infarction  410	Both sexes	899
C¾rdoba	Group 0903 Acute myocardial infarction  410	Men	656
C¾rdoba	Group 0903 Acute myocardial infarction  410	Women	243
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	672
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	530
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	142
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	310
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Men	139
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Women	171
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.309
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	721
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	588
C¾rdoba	Grupo 0907 Heart failure  428	Both sexes	1.966
C¾rdoba	Grupo 0907 Heart failure  428	Men	924
C¾rdoba	Grupo 0907 Heart failure  428	Women	1.042
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.874
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.074
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	800
C¾rdoba	Grupo 0909 Atherosclerosis  440	Both sexes	279
C¾rdoba	Grupo 0909 Atherosclerosis  440	Men	226
C¾rdoba	Grupo 0909 Atherosclerosis  440	Women	53
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Both sexes	119
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Men	56
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Women	63
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.063
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.182
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	881
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.772
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.427
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.345
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	253
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	144
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	109
C¾rdoba	Group 1002 Pneumonia 480-486	Both sexes	1.903
C¾rdoba	Group 1002 Pneumonia 480-486	Men	1.108
C¾rdoba	Group 1002 Pneumonia 480-486	Women	795
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	390
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Men	211
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Women	179
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	136
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	59
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	77
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	393
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	234
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	159
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.389
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.094
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	295
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	191
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Men	46
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Women	145
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.117
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.531
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.586
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.220
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Men	5.650
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Women	4.570
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	162
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	82
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	80
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	207
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	110
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	97
C¾rdoba	Group 1103 Diseases of the esophagus 530	Both sexes	235
C¾rdoba	Group 1103 Diseases of the esophagus 530	Men	139
C¾rdoba	Group 1103 Diseases of the esophagus 530	Women	96
C¾rdoba	Group 1104 Peptic ulcer 531-534	Both sexes	196
C¾rdoba	Group 1104 Peptic ulcer 531-534	Men	133
C¾rdoba	Group 1104 Peptic ulcer 531-534	Women	63
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	182
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	92
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	90
C¾rdoba	Group 1106 Appendicitis  540-543	Both sexes	778
C¾rdoba	Group 1106 Appendicitis  540-543	Men	421
C¾rdoba	Group 1106 Appendicitis  540-543	Women	357
C¾rdoba	Group 1107 Inguinal hernia  550	Both sexes	800
C¾rdoba	Group 1107 Inguinal hernia  550	Men	716
C¾rdoba	Group 1107 Inguinal hernia  550	Women	84
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Both sexes	1.009
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Men	441
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Women	568
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	207
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	108
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	99
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	547
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	276
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	271
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Both sexes	564
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Men	314
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Women	250
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Both sexes	371
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Men	175
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Women	196
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	598
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	389
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	209
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	317
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	155
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	162
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	245
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Men	219
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Women	26
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	362
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Men	238
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Women	124
C¾rdoba	Group 1117 Cholelithiasis  574	Both sexes	1.990
C¾rdoba	Group 1117 Cholelithiasis  574	Men	850
C¾rdoba	Group 1117 Cholelithiasis  574	Women	1.140
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	315
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	171
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	144
C¾rdoba	Group 1119 Pancreatic diseases 577	Both sexes	701
C¾rdoba	Group 1119 Pancreatic diseases 577	Men	383
C¾rdoba	Group 1119 Pancreatic diseases 577	Women	318
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	434
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	238
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	196
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	690
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	379
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	311
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	386
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	240
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	146
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	18
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	11
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	286
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	132
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	154
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.841
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.024
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.817
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
C¾rdoba	Group 1303 Internal derangement of knee 717	Both sexes	382
C¾rdoba	Group 1303 Internal derangement of knee 717	Men	261
C¾rdoba	Group 1303 Internal derangement of knee 717	Women	121
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.349
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	833
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.516
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	95
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	39
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	56
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	286
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	133
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	153
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	414
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	220
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	194
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	45
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	22
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	23
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	368
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	199
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	169
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	902
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	317
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	585
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.243
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.936
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.307
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	438
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	176
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	262
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	629
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Men	358
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Women	271
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	581
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Men	314
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Women	267
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	747
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	418
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	329
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Both sexes	298
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Men	298
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Women	..
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	324
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Men	324
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Women	..
C¾rdoba	Group 1407 Disorders of breast  610-612	Both sexes	489
C¾rdoba	Group 1407 Disorders of breast  610-612	Men	45
C¾rdoba	Group 1407 Disorders of breast  610-612	Women	444
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	120
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	120
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	31
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	31
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	586
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	583
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.228
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.228
C¾rdoba	Group 1501 Legally induced abortion  635	Both sexes	3
C¾rdoba	Group 1501 Legally induced abortion  635	Men	..
C¾rdoba	Group 1501 Legally induced abortion  635	Women	3
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	305
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	305
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.271
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.271
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.016
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.016
C¾rdoba	Group 1505 Single spontaneous delivery  650	Both sexes	713
C¾rdoba	Group 1505 Single spontaneous delivery  650	Men	..
C¾rdoba	Group 1505 Single spontaneous delivery  650	Women	713
C¾rdoba	Group 1506 Other deliveries  6695-6697	Both sexes	387
C¾rdoba	Group 1506 Other deliveries  6695-6697	Men	..
C¾rdoba	Group 1506 Other deliveries  6695-6697	Women	387
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Both sexes	43
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Men	..
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Women	43
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	490
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	490
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	921
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Men	515
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Women	406
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	283
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	136
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	147
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	638
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	379
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	259
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Both sexes	986
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Men	457
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Women	529
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.736
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.489
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.247
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	480
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Men	298
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Women	182
C¾rdoba	Group 1802 Abdominal pain   7890	Both sexes	485
C¾rdoba	Group 1802 Abdominal pain   7890	Men	184
C¾rdoba	Group 1802 Abdominal pain   7890	Women	301
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	23
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	15
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	8
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.748
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	992
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	756
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Both sexes	5.823
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Men	3.052
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Women	2.771
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	379
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	224
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	155
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	197
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	155
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	42
C¾rdoba	Group 1903 Radius and ulna fracture 813	Both sexes	307
C¾rdoba	Group 1903 Radius and ulna fracture 813	Men	153
C¾rdoba	Group 1903 Radius and ulna fracture 813	Women	154
C¾rdoba	Group 1904 Femur fracture  820-821	Both sexes	1.076
C¾rdoba	Group 1904 Femur fracture  820-821	Men	344
C¾rdoba	Group 1904 Femur fracture  820-821	Women	732
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	401
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Men	227
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Women	174
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.155
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	742
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	413
C¾rdoba	Group 1907 Burns  940-949	Both sexes	68
C¾rdoba	Group 1907 Burns  940-949	Men	35
C¾rdoba	Group 1907 Burns  940-949	Women	33
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	190
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	87
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	103
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.919
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.018
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	901
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	4
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	127
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	65
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	62
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	846
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	499
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	347
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	52
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	28
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	24
C¾rdoba	Group 2102 Contraceptive management  V25	Both sexes	5
C¾rdoba	Group 2102 Contraceptive management  V25	Men	1
C¾rdoba	Group 2102 Contraceptive management  V25	Women	4
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	496
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	317
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	179
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	293
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	153
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	140
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	73.482
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.031
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	40.451
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.951
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.088
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	863
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	167
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	91
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	76
Granada	Group 0102 Imprecise intestinal infections 009	Both sexes	85
Granada	Group 0102 Imprecise intestinal infections 009	Men	47
Granada	Group 0102 Imprecise intestinal infections 009	Women	38
Granada	Group 0103 Tuberculosis 010-018, 137	Both sexes	63
Granada	Group 0103 Tuberculosis 010-018, 137	Men	41
Granada	Group 0103 Tuberculosis 010-018, 137	Women	22
Granada	Group 0104 Septicaemia  038	Both sexes	1.086
Granada	Group 0104 Septicaemia  038	Men	585
Granada	Group 0104 Septicaemia  038	Women	501
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	39
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	31
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	8
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	511
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	293
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	218
Granada	Group 0200 Neoplasms  140-239	Both sexes	7.279
Granada	Group 0200 Neoplasms  140-239	Men	3.733
Granada	Group 0200 Neoplasms  140-239	Women	3.546
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	718
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	416
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	302
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	491
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	405
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	86
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	288
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	173
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	115
Granada	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	639
Granada	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Granada	Group 0204 Malignant neoplasm of breast  174-175	Women	635
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	189
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	189
Granada	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	77
Granada	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Granada	Group 0206 Malignant neoplasm of ovary  1830	Women	77
Granada	Group 0207 Malignant neoplasm of prostate  185	Both sexes	178
Granada	Group 0207 Malignant neoplasm of prostate  185	Men	178
Granada	Group 0207 Malignant neoplasm of prostate  185	Women	..
Granada	Group 0208 Malignant neoplasm of bladder  188	Both sexes	674
Granada	Group 0208 Malignant neoplasm of bladder  188	Men	553
Granada	Group 0208 Malignant neoplasm of bladder  188	Women	121
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.549
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.497
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.052
Granada	Group 0210 Carcinoma in situ  230-234	Both sexes	63
Granada	Group 0210 Carcinoma in situ  230-234	Men	16
Granada	Group 0210 Carcinoma in situ  230-234	Women	47
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	43
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	23
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	20
Granada	Grupo 0212 Leiomyoma of uterus  218	Both sexes	409
Granada	Grupo 0212 Leiomyoma of uterus  218	Men	..
Granada	Grupo 0212 Leiomyoma of uterus  218	Women	409
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	961
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	468
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	493
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	535
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	252
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	283
Granada	Group 0301 Anaemias 280-285	Both sexes	207
Granada	Group 0301 Anaemias 280-285	Men	112
Granada	Group 0301 Anaemias 280-285	Women	95
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	328
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	140
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	188
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.436
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	547
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	889
Granada	Group 0401 Diabetes mellitus  249-250	Both sexes	458
Granada	Group 0401 Diabetes mellitus  249-250	Men	269
Granada	Group 0401 Diabetes mellitus  249-250	Women	189
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	978
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	278
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	700
Granada	Group 0500 Mental disorders  290-319	Both sexes	1.295
Granada	Group 0500 Mental disorders  290-319	Men	716
Granada	Group 0500 Mental disorders  290-319	Women	579
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	17
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	8
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	9
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	70
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	48
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	22
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	86
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	72
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	14
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	501
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	325
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	176
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	312
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	134
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	178
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	309
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	129
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	180
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.559
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	794
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	765
Granada	Group 0601 Alzheimer's disease  3310	Both sexes	15
Granada	Group 0601 Alzheimer's disease  3310	Men	2
Granada	Group 0601 Alzheimer's disease  3310	Women	13
Granada	Group 0602 Multiple sclerosis 340	Both sexes	26
Granada	Group 0602 Multiple sclerosis 340	Men	11
Granada	Group 0602 Multiple sclerosis 340	Women	15
Granada	Group 0603 Epilepsy  345	Both sexes	237
Granada	Group 0603 Epilepsy  345	Men	126
Granada	Group 0603 Epilepsy  345	Women	111
Granada	Group 0604 Transient cerebral ischemia 435	Both sexes	226
Granada	Group 0604 Transient cerebral ischemia 435	Men	124
Granada	Group 0604 Transient cerebral ischemia 435	Women	102
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.055
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	531
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	524
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	562
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	314
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	248
Granada	Grupo 0701 Cataract  366	Both sexes	82
Granada	Grupo 0701 Cataract  366	Men	49
Granada	Grupo 0701 Cataract  366	Women	33
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	480
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	265
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	215
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	352
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Men	171
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Women	181
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.007
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.584
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.423
Granada	Group 0901 Hypertensive disease  401-405	Both sexes	665
Granada	Group 0901 Hypertensive disease  401-405	Men	265
Granada	Group 0901 Hypertensive disease  401-405	Women	400
Granada	Group 0902 Angina pectoris  4111, 413	Both sexes	581
Granada	Group 0902 Angina pectoris  4111, 413	Men	349
Granada	Group 0902 Angina pectoris  4111, 413	Women	232
Granada	Group 0903 Acute myocardial infarction  410	Both sexes	1.107
Granada	Group 0903 Acute myocardial infarction  410	Men	755
Granada	Group 0903 Acute myocardial infarction  410	Women	352
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	543
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	403
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	140
Granada	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	449
Granada	Group 0905 Diseases of the lungs circulation 415-417	Men	217
Granada	Group 0905 Diseases of the lungs circulation 415-417	Women	232
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.189
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	643
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	546
Granada	Grupo 0907 Heart failure  428	Both sexes	1.614
Granada	Grupo 0907 Heart failure  428	Men	746
Granada	Grupo 0907 Heart failure  428	Women	868
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.031
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.096
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	935
Granada	Grupo 0909 Atherosclerosis  440	Both sexes	337
Granada	Grupo 0909 Atherosclerosis  440	Men	251
Granada	Grupo 0909 Atherosclerosis  440	Women	86
Granada	Group 0910 Varicose veins of lower extremities 454	Both sexes	73
Granada	Group 0910 Varicose veins of lower extremities 454	Men	29
Granada	Group 0910 Varicose veins of lower extremities 454	Women	44
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.418
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	830
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	588
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.238
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.215
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.023
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	404
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	224
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	180
Granada	Group 1002 Pneumonia 480-486	Both sexes	1.737
Granada	Group 1002 Pneumonia 480-486	Men	1.085
Granada	Group 1002 Pneumonia 480-486	Women	652
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	704
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Men	363
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Women	341
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	220
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	112
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	108
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	609
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	373
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	236
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	705
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	597
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	108
Granada	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	362
Granada	Group 1007 Asthma 4930-4931,4938-4939	Men	116
Granada	Group 1007 Asthma 4930-4931,4938-4939	Women	246
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.497
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.345
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.152
Granada	Group 1100 Diseases of the digestive system  520-579	Both sexes	9.199
Granada	Group 1100 Diseases of the digestive system  520-579	Men	4.934
Granada	Group 1100 Diseases of the digestive system  520-579	Women	4.265
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	204
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	96
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	108
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	164
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	80
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	84
Granada	Group 1103 Diseases of the esophagus 530	Both sexes	148
Granada	Group 1103 Diseases of the esophagus 530	Men	93
Granada	Group 1103 Diseases of the esophagus 530	Women	55
Granada	Group 1104 Peptic ulcer 531-534	Both sexes	208
Granada	Group 1104 Peptic ulcer 531-534	Men	143
Granada	Group 1104 Peptic ulcer 531-534	Women	65
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	183
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	87
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	96
Granada	Group 1106 Appendicitis  540-543	Both sexes	1.014
Granada	Group 1106 Appendicitis  540-543	Men	566
Granada	Group 1106 Appendicitis  540-543	Women	448
Granada	Group 1107 Inguinal hernia  550	Both sexes	499
Granada	Group 1107 Inguinal hernia  550	Men	435
Granada	Group 1107 Inguinal hernia  550	Women	64
Granada	Group 1108 Other abdominal hernia  551-553	Both sexes	727
Granada	Group 1108 Other abdominal hernia  551-553	Men	304
Granada	Group 1108 Other abdominal hernia  551-553	Women	423
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	184
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	99
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	85
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	309
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	153
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	156
Granada	Group 1111 Intestinal obstruction without hernia 560	Both sexes	421
Granada	Group 1111 Intestinal obstruction without hernia 560	Men	209
Granada	Group 1111 Intestinal obstruction without hernia 560	Women	212
Granada	Group 1112 Intestinal diverticulosis 562	Both sexes	295
Granada	Group 1112 Intestinal diverticulosis 562	Men	142
Granada	Group 1112 Intestinal diverticulosis 562	Women	153
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	747
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	491
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	256
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	216
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	108
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	108
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	123
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Men	101
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Women	22
Granada	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	363
Granada	Group 1116 Other diseases of the liver 570,5714-573	Men	238
Granada	Group 1116 Other diseases of the liver 570,5714-573	Women	125
Granada	Group 1117 Cholelithiasis  574	Both sexes	1.822
Granada	Group 1117 Cholelithiasis  574	Men	768
Granada	Group 1117 Cholelithiasis  574	Women	1.054
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	465
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	251
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	214
Granada	Group 1119 Pancreatic diseases 577	Both sexes	740
Granada	Group 1119 Pancreatic diseases 577	Men	386
Granada	Group 1119 Pancreatic diseases 577	Women	354
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	367
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	184
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	183
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	624
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	362
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	262
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	361
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	236
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	125
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	25
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	13
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	12
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	238
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	113
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	125
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.182
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.944
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.238
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Granada	Group 1303 Internal derangement of knee 717	Both sexes	198
Granada	Group 1303 Internal derangement of knee 717	Men	139
Granada	Group 1303 Internal derangement of knee 717	Women	59
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.017
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	840
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.177
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	168
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	35
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	133
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	376
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	190
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	186
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	343
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	173
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	170
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	43
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	23
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	20
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	468
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	248
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	220
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	569
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	296
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	273
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.351
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.915
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.436
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	510
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	191
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	319
Granada	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	591
Granada	Group 1402 Renal failure  5836-5837, 584-586	Men	375
Granada	Group 1402 Renal failure  5836-5837, 584-586	Women	216
Granada	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	457
Granada	Group 1403 Urolithiasis  592, 594, 7880	Men	265
Granada	Group 1403 Urolithiasis  592, 594, 7880	Women	192
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	808
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	487
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	321
Granada	Group 1405 Prostatic hyperplasia  600	Both sexes	321
Granada	Group 1405 Prostatic hyperplasia  600	Men	321
Granada	Group 1405 Prostatic hyperplasia  600	Women	..
Granada	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	245
Granada	Group 1406 Other diseases of the male genital organs    601-608	Men	245
Granada	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Granada	Group 1407 Disorders of breast  610-612	Both sexes	375
Granada	Group 1407 Disorders of breast  610-612	Men	22
Granada	Group 1407 Disorders of breast  610-612	Women	353
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	142
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	142
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	92
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	92
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	810
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	9
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	801
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	10.554
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	10.554
Granada	Group 1501 Legally induced abortion  635	Both sexes	5
Granada	Group 1501 Legally induced abortion  635	Men	..
Granada	Group 1501 Legally induced abortion  635	Women	5
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	880
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	880
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.134
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.134
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.401
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.401
Granada	Group 1505 Single spontaneous delivery  650	Both sexes	665
Granada	Group 1505 Single spontaneous delivery  650	Men	..
Granada	Group 1505 Single spontaneous delivery  650	Women	665
Granada	Group 1506 Other deliveries  6695-6697	Both sexes	557
Granada	Group 1506 Other deliveries  6695-6697	Men	..
Granada	Group 1506 Other deliveries  6695-6697	Women	557
Granada	Group 1507 Complications related to the puerperium  670-676	Both sexes	78
Granada	Group 1507 Complications related to the puerperium  670-676	Men	..
Granada	Group 1507 Complications related to the puerperium  670-676	Women	78
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	834
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	834
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	927
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Men	532
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Women	395
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	328
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	192
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	136
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	599
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	340
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	259
Granada	Grupo 1700 Congenital abnormalities  740-759	Both sexes	558
Granada	Grupo 1700 Congenital abnormalities  740-759	Men	293
Granada	Grupo 1700 Congenital abnormalities  740-759	Women	265
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.941
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.055
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	886
Granada	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	238
Granada	Group 1801 Pain in throat and chest 7841, 7865	Men	127
Granada	Group 1801 Pain in throat and chest 7841, 7865	Women	111
Granada	Group 1802 Abdominal pain   7890	Both sexes	190
Granada	Group 1802 Abdominal pain   7890	Men	66
Granada	Group 1802 Abdominal pain   7890	Women	124
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	73
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	36
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	37
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.440
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	826
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	614
Granada	Group 1900 Injuries and poisoning  800-999	Both sexes	7.779
Granada	Group 1900 Injuries and poisoning  800-999	Men	4.039
Granada	Group 1900 Injuries and poisoning  800-999	Women	3.740
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	248
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	156
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	92
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	239
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	159
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	80
Granada	Group 1903 Radius and ulna fracture 813	Both sexes	732
Granada	Group 1903 Radius and ulna fracture 813	Men	307
Granada	Group 1903 Radius and ulna fracture 813	Women	425
Granada	Group 1904 Femur fracture  820-821	Both sexes	1.355
Granada	Group 1904 Femur fracture  820-821	Men	395
Granada	Group 1904 Femur fracture  820-821	Women	960
Granada	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	695
Granada	Group 1905 Leg fracture, including the ankle 823-824	Men	408
Granada	Group 1905 Leg fracture, including the ankle 823-824	Women	287
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.106
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.354
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	752
Granada	Group 1907 Burns  940-949	Both sexes	53
Granada	Group 1907 Burns  940-949	Men	27
Granada	Group 1907 Burns  940-949	Women	26
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	233
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	106
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	127
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.906
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.017
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	889
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	49
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	19
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	30
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	163
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	91
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	72
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.153
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	543
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	610
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	36
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	27
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	9
Granada	Group 2102 Contraceptive management  V25	Both sexes	11
Granada	Group 2102 Contraceptive management  V25	Men	2
Granada	Group 2102 Contraceptive management  V25	Women	9
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	471
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	244
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	227
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	635
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	270
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	365
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	40.400
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.356
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	22.044
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	815
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	450
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	365
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	133
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	74
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	59
Huelva	Group 0102 Imprecise intestinal infections 009	Both sexes	50
Huelva	Group 0102 Imprecise intestinal infections 009	Men	21
Huelva	Group 0102 Imprecise intestinal infections 009	Women	29
Huelva	Group 0103 Tuberculosis 010-018, 137	Both sexes	74
Huelva	Group 0103 Tuberculosis 010-018, 137	Men	49
Huelva	Group 0103 Tuberculosis 010-018, 137	Women	25
Huelva	Group 0104 Septicaemia  038	Both sexes	225
Huelva	Group 0104 Septicaemia  038	Men	126
Huelva	Group 0104 Septicaemia  038	Women	99
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	19
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	12
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	314
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	168
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	146
Huelva	Group 0200 Neoplasms  140-239	Both sexes	3.366
Huelva	Group 0200 Neoplasms  140-239	Men	1.808
Huelva	Group 0200 Neoplasms  140-239	Women	1.558
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	454
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	266
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	188
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	279
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	228
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	51
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	17
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	8
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	9
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	290
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Women	286
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	81
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	81
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	47
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Women	47
Huelva	Group 0207 Malignant neoplasm of prostate  185	Both sexes	98
Huelva	Group 0207 Malignant neoplasm of prostate  185	Men	98
Huelva	Group 0207 Malignant neoplasm of prostate  185	Women	..
Huelva	Group 0208 Malignant neoplasm of bladder  188	Both sexes	349
Huelva	Group 0208 Malignant neoplasm of bladder  188	Men	300
Huelva	Group 0208 Malignant neoplasm of bladder  188	Women	49
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.097
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	693
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	404
Huelva	Group 0210 Carcinoma in situ  230-234	Both sexes	27
Huelva	Group 0210 Carcinoma in situ  230-234	Men	9
Huelva	Group 0210 Carcinoma in situ  230-234	Women	18
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	23
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	16
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	7
Huelva	Grupo 0212 Leiomyoma of uterus  218	Both sexes	189
Huelva	Grupo 0212 Leiomyoma of uterus  218	Men	..
Huelva	Grupo 0212 Leiomyoma of uterus  218	Women	189
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	415
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	186
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	229
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	589
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	272
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	317
Huelva	Group 0301 Anaemias 280-285	Both sexes	405
Huelva	Group 0301 Anaemias 280-285	Men	188
Huelva	Group 0301 Anaemias 280-285	Women	217
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	184
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	84
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	100
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	707
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	279
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	428
Huelva	Group 0401 Diabetes mellitus  249-250	Both sexes	268
Huelva	Group 0401 Diabetes mellitus  249-250	Men	155
Huelva	Group 0401 Diabetes mellitus  249-250	Women	113
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	439
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	124
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	315
Huelva	Group 0500 Mental disorders  290-319	Both sexes	936
Huelva	Group 0500 Mental disorders  290-319	Men	496
Huelva	Group 0500 Mental disorders  290-319	Women	440
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	21
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	8
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	13
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	37
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	33
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	4
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	47
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	37
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	10
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	296
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	205
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	91
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	171
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	63
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	108
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	364
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	150
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	214
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	961
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	507
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	454
Huelva	Group 0601 Alzheimer's disease  3310	Both sexes	20
Huelva	Group 0601 Alzheimer's disease  3310	Men	7
Huelva	Group 0601 Alzheimer's disease  3310	Women	13
Huelva	Group 0602 Multiple sclerosis 340	Both sexes	22
Huelva	Group 0602 Multiple sclerosis 340	Men	5
Huelva	Group 0602 Multiple sclerosis 340	Women	17
Huelva	Group 0603 Epilepsy  345	Both sexes	194
Huelva	Group 0603 Epilepsy  345	Men	99
Huelva	Group 0603 Epilepsy  345	Women	95
Huelva	Group 0604 Transient cerebral ischemia 435	Both sexes	202
Huelva	Group 0604 Transient cerebral ischemia 435	Men	114
Huelva	Group 0604 Transient cerebral ischemia 435	Women	88
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	523
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	282
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	241
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	179
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	105
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	74
Huelva	Grupo 0701 Cataract  366	Both sexes	6
Huelva	Grupo 0701 Cataract  366	Men	5
Huelva	Grupo 0701 Cataract  366	Women	1
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	173
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	100
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	73
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	277
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Men	131
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Women	146
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.230
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.463
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.767
Huelva	Group 0901 Hypertensive disease  401-405	Both sexes	647
Huelva	Group 0901 Hypertensive disease  401-405	Men	280
Huelva	Group 0901 Hypertensive disease  401-405	Women	367
Huelva	Group 0902 Angina pectoris  4111, 413	Both sexes	391
Huelva	Group 0902 Angina pectoris  4111, 413	Men	219
Huelva	Group 0902 Angina pectoris  4111, 413	Women	172
Huelva	Group 0903 Acute myocardial infarction  410	Both sexes	499
Huelva	Group 0903 Acute myocardial infarction  410	Men	332
Huelva	Group 0903 Acute myocardial infarction  410	Women	167
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	465
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	346
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	119
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	140
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Men	49
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Women	91
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	925
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	465
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	460
Huelva	Grupo 0907 Heart failure  428	Both sexes	1.043
Huelva	Grupo 0907 Heart failure  428	Men	496
Huelva	Grupo 0907 Heart failure  428	Women	547
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.086
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	640
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	446
Huelva	Grupo 0909 Atherosclerosis  440	Both sexes	176
Huelva	Grupo 0909 Atherosclerosis  440	Men	146
Huelva	Grupo 0909 Atherosclerosis  440	Women	30
Huelva	Group 0910 Varicose veins of lower extremities 454	Both sexes	48
Huelva	Group 0910 Varicose veins of lower extremities 454	Men	18
Huelva	Group 0910 Varicose veins of lower extremities 454	Women	30
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	810
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	472
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	338
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	3.811
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.198
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.613
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	193
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	92
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	101
Huelva	Group 1002 Pneumonia 480-486	Both sexes	909
Huelva	Group 1002 Pneumonia 480-486	Men	507
Huelva	Group 1002 Pneumonia 480-486	Women	402
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	458
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Men	209
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Women	249
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	206
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	110
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	96
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	385
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	264
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	121
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	492
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	408
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	84
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	130
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Men	31
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Women	99
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.038
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	577
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	461
Huelva	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.880
Huelva	Group 1100 Diseases of the digestive system  520-579	Men	2.621
Huelva	Group 1100 Diseases of the digestive system  520-579	Women	2.259
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	14
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	4
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	10
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	46
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	25
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	21
Huelva	Group 1103 Diseases of the esophagus 530	Both sexes	113
Huelva	Group 1103 Diseases of the esophagus 530	Men	60
Huelva	Group 1103 Diseases of the esophagus 530	Women	53
Huelva	Group 1104 Peptic ulcer 531-534	Both sexes	131
Huelva	Group 1104 Peptic ulcer 531-534	Men	95
Huelva	Group 1104 Peptic ulcer 531-534	Women	36
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	172
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	91
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	81
Huelva	Group 1106 Appendicitis  540-543	Both sexes	371
Huelva	Group 1106 Appendicitis  540-543	Men	221
Huelva	Group 1106 Appendicitis  540-543	Women	150
Huelva	Group 1107 Inguinal hernia  550	Both sexes	318
Huelva	Group 1107 Inguinal hernia  550	Men	275
Huelva	Group 1107 Inguinal hernia  550	Women	43
Huelva	Group 1108 Other abdominal hernia  551-553	Both sexes	344
Huelva	Group 1108 Other abdominal hernia  551-553	Men	151
Huelva	Group 1108 Other abdominal hernia  551-553	Women	193
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	129
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	75
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	54
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	323
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	156
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	167
Huelva	Group 1111 Intestinal obstruction without hernia 560	Both sexes	179
Huelva	Group 1111 Intestinal obstruction without hernia 560	Men	91
Huelva	Group 1111 Intestinal obstruction without hernia 560	Women	88
Huelva	Group 1112 Intestinal diverticulosis 562	Both sexes	142
Huelva	Group 1112 Intestinal diverticulosis 562	Men	81
Huelva	Group 1112 Intestinal diverticulosis 562	Women	61
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	404
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	244
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	160
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	153
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	57
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	96
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	120
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Men	109
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Women	11
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	189
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Men	105
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Women	84
Huelva	Group 1117 Cholelithiasis  574	Both sexes	882
Huelva	Group 1117 Cholelithiasis  574	Men	319
Huelva	Group 1117 Cholelithiasis  574	Women	563
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	233
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	123
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	110
Huelva	Group 1119 Pancreatic diseases 577	Both sexes	355
Huelva	Group 1119 Pancreatic diseases 577	Men	182
Huelva	Group 1119 Pancreatic diseases 577	Women	173
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	262
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	157
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	105
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	377
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	202
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	175
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	218
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	133
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	85
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	16
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	10
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	143
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	59
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	84
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.595
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.213
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.382
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Huelva	Group 1303 Internal derangement of knee 717	Both sexes	148
Huelva	Group 1303 Internal derangement of knee 717	Men	99
Huelva	Group 1303 Internal derangement of knee 717	Women	49
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.124
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	452
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	672
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	50
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	25
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	25
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	136
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	64
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	72
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	300
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	151
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	149
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	113
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	34
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	79
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	339
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	217
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	122
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	385
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	171
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	214
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.175
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	949
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.226
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	248
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	82
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	166
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	232
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Men	142
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Women	90
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	413
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Men	225
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Women	188
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	522
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	215
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	307
Huelva	Group 1405 Prostatic hyperplasia  600	Both sexes	109
Huelva	Group 1405 Prostatic hyperplasia  600	Men	109
Huelva	Group 1405 Prostatic hyperplasia  600	Women	..
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	147
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Men	147
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Huelva	Group 1407 Disorders of breast  610-612	Both sexes	79
Huelva	Group 1407 Disorders of breast  610-612	Men	28
Huelva	Group 1407 Disorders of breast  610-612	Women	51
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	65
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	65
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	34
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	34
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	326
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	325
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.464
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.464
Huelva	Group 1501 Legally induced abortion  635	Both sexes	9
Huelva	Group 1501 Legally induced abortion  635	Men	..
Huelva	Group 1501 Legally induced abortion  635	Women	9
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	307
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	307
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.813
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.813
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	408
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	408
Huelva	Group 1505 Single spontaneous delivery  650	Both sexes	354
Huelva	Group 1505 Single spontaneous delivery  650	Men	..
Huelva	Group 1505 Single spontaneous delivery  650	Women	354
Huelva	Group 1506 Other deliveries  6695-6697	Both sexes	135
Huelva	Group 1506 Other deliveries  6695-6697	Men	..
Huelva	Group 1506 Other deliveries  6695-6697	Women	135
Huelva	Group 1507 Complications related to the puerperium  670-676	Both sexes	49
Huelva	Group 1507 Complications related to the puerperium  670-676	Men	..
Huelva	Group 1507 Complications related to the puerperium  670-676	Women	49
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	389
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	389
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	400
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Men	231
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Women	169
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	163
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	97
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	66
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	237
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	134
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	103
Huelva	Grupo 1700 Congenital abnormalities  740-759	Both sexes	160
Huelva	Grupo 1700 Congenital abnormalities  740-759	Men	88
Huelva	Grupo 1700 Congenital abnormalities  740-759	Women	72
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.705
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.454
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.251
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	577
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Men	341
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Women	236
Huelva	Group 1802 Abdominal pain   7890	Both sexes	367
Huelva	Group 1802 Abdominal pain   7890	Men	149
Huelva	Group 1802 Abdominal pain   7890	Women	218
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	31
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	17
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	14
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.730
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	947
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	783
Huelva	Group 1900 Injuries and poisoning  800-999	Both sexes	3.241
Huelva	Group 1900 Injuries and poisoning  800-999	Men	1.620
Huelva	Group 1900 Injuries and poisoning  800-999	Women	1.621
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	122
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	73
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	49
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	59
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	47
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	12
Huelva	Group 1903 Radius and ulna fracture 813	Both sexes	306
Huelva	Group 1903 Radius and ulna fracture 813	Men	161
Huelva	Group 1903 Radius and ulna fracture 813	Women	145
Huelva	Group 1904 Femur fracture  820-821	Both sexes	508
Huelva	Group 1904 Femur fracture  820-821	Men	119
Huelva	Group 1904 Femur fracture  820-821	Women	389
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	280
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Men	149
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Women	131
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	979
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	554
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	425
Huelva	Group 1907 Burns  940-949	Both sexes	8
Huelva	Group 1907 Burns  940-949	Men	2
Huelva	Group 1907 Burns  940-949	Women	6
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	122
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	65
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	57
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	779
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	404
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	375
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	8
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	4
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	70
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	42
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	28
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	532
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	269
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	263
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	21
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	11
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	10
Huelva	Group 2102 Contraceptive management  V25	Both sexes	1
Huelva	Group 2102 Contraceptive management  V25	Men	..
Huelva	Group 2102 Contraceptive management  V25	Women	1
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	185
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	117
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	68
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	325
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	141
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	184
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	47.363
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	21.777
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	25.586
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	861
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	499
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	362
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	102
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	64
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	38
JaÚn	Group 0102 Imprecise intestinal infections 009	Both sexes	14
JaÚn	Group 0102 Imprecise intestinal infections 009	Men	7
JaÚn	Group 0102 Imprecise intestinal infections 009	Women	7
JaÚn	Group 0103 Tuberculosis 010-018, 137	Both sexes	21
JaÚn	Group 0103 Tuberculosis 010-018, 137	Men	15
JaÚn	Group 0103 Tuberculosis 010-018, 137	Women	6
JaÚn	Group 0104 Septicaemia  038	Both sexes	329
JaÚn	Group 0104 Septicaemia  038	Men	176
JaÚn	Group 0104 Septicaemia  038	Women	153
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	32
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	20
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	12
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	363
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	217
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	146
JaÚn	Group 0200 Neoplasms  140-239	Both sexes	3.931
JaÚn	Group 0200 Neoplasms  140-239	Men	2.100
JaÚn	Group 0200 Neoplasms  140-239	Women	1.831
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	612
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	355
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	257
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	340
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	285
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	55
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	40
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	16
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	24
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	316
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Men	2
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Women	314
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	80
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	80
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	49
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Men	..
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Women	49
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Both sexes	59
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Men	59
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Women	..
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Both sexes	395
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Men	316
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Women	79
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.261
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	780
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	481
JaÚn	Group 0210 Carcinoma in situ  230-234	Both sexes	41
JaÚn	Group 0210 Carcinoma in situ  230-234	Men	19
JaÚn	Group 0210 Carcinoma in situ  230-234	Women	22
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	55
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	44
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	11
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Both sexes	217
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Men	..
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Women	217
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	466
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	224
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	242
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	468
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	236
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	232
JaÚn	Group 0301 Anaemias 280-285	Both sexes	259
JaÚn	Group 0301 Anaemias 280-285	Men	120
JaÚn	Group 0301 Anaemias 280-285	Women	139
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	209
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	116
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	93
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	985
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	506
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	479
JaÚn	Group 0401 Diabetes mellitus  249-250	Both sexes	335
JaÚn	Group 0401 Diabetes mellitus  249-250	Men	235
JaÚn	Group 0401 Diabetes mellitus  249-250	Women	100
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	650
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	271
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	379
JaÚn	Group 0500 Mental disorders  290-319	Both sexes	1.065
JaÚn	Group 0500 Mental disorders  290-319	Men	546
JaÚn	Group 0500 Mental disorders  290-319	Women	519
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	30
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	12
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	18
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	31
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	28
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	3
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	46
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	39
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	7
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	269
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	168
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	101
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	291
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	115
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	176
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	398
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	184
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	214
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.000
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	510
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	490
JaÚn	Group 0601 Alzheimer's disease  3310	Both sexes	24
JaÚn	Group 0601 Alzheimer's disease  3310	Men	12
JaÚn	Group 0601 Alzheimer's disease  3310	Women	12
JaÚn	Group 0602 Multiple sclerosis 340	Both sexes	40
JaÚn	Group 0602 Multiple sclerosis 340	Men	13
JaÚn	Group 0602 Multiple sclerosis 340	Women	27
JaÚn	Group 0603 Epilepsy  345	Both sexes	214
JaÚn	Group 0603 Epilepsy  345	Men	119
JaÚn	Group 0603 Epilepsy  345	Women	95
JaÚn	Group 0604 Transient cerebral ischemia 435	Both sexes	242
JaÚn	Group 0604 Transient cerebral ischemia 435	Men	121
JaÚn	Group 0604 Transient cerebral ischemia 435	Women	121
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	480
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	245
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	235
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	582
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	325
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	257
JaÚn	Grupo 0701 Cataract  366	Both sexes	65
JaÚn	Grupo 0701 Cataract  366	Men	42
JaÚn	Grupo 0701 Cataract  366	Women	23
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	517
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	283
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	234
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	166
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Men	85
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Women	81
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.123
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.471
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.652
JaÚn	Group 0901 Hypertensive disease  401-405	Both sexes	329
JaÚn	Group 0901 Hypertensive disease  401-405	Men	123
JaÚn	Group 0901 Hypertensive disease  401-405	Women	206
JaÚn	Group 0902 Angina pectoris  4111, 413	Both sexes	388
JaÚn	Group 0902 Angina pectoris  4111, 413	Men	272
JaÚn	Group 0902 Angina pectoris  4111, 413	Women	116
JaÚn	Group 0903 Acute myocardial infarction  410	Both sexes	861
JaÚn	Group 0903 Acute myocardial infarction  410	Men	597
JaÚn	Group 0903 Acute myocardial infarction  410	Women	264
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	210
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	169
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	41
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	229
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Men	105
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Women	124
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	741
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	366
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	375
JaÚn	Grupo 0907 Heart failure  428	Both sexes	1.112
JaÚn	Grupo 0907 Heart failure  428	Men	508
JaÚn	Grupo 0907 Heart failure  428	Women	604
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.278
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	705
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	573
JaÚn	Grupo 0909 Atherosclerosis  440	Both sexes	162
JaÚn	Grupo 0909 Atherosclerosis  440	Men	146
JaÚn	Grupo 0909 Atherosclerosis  440	Women	16
JaÚn	Group 0910 Varicose veins of lower extremities 454	Both sexes	45
JaÚn	Group 0910 Varicose veins of lower extremities 454	Men	12
JaÚn	Group 0910 Varicose veins of lower extremities 454	Women	33
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	768
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	468
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	300
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.818
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.428
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.390
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	231
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	113
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	118
JaÚn	Group 1002 Pneumonia 480-486	Both sexes	1.457
JaÚn	Group 1002 Pneumonia 480-486	Men	831
JaÚn	Group 1002 Pneumonia 480-486	Women	626
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	413
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Men	233
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Women	180
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	83
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	41
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	42
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	334
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	218
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	116
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	634
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	533
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	101
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	122
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Men	54
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Women	68
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.544
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.405
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.139
JaÚn	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.854
JaÚn	Group 1100 Diseases of the digestive system  520-579	Men	3.240
JaÚn	Group 1100 Diseases of the digestive system  520-579	Women	2.614
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	82
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	44
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	38
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	88
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	47
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	41
JaÚn	Group 1103 Diseases of the esophagus 530	Both sexes	103
JaÚn	Group 1103 Diseases of the esophagus 530	Men	64
JaÚn	Group 1103 Diseases of the esophagus 530	Women	39
JaÚn	Group 1104 Peptic ulcer 531-534	Both sexes	158
JaÚn	Group 1104 Peptic ulcer 531-534	Men	120
JaÚn	Group 1104 Peptic ulcer 531-534	Women	38
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	141
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	65
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	76
JaÚn	Group 1106 Appendicitis  540-543	Both sexes	484
JaÚn	Group 1106 Appendicitis  540-543	Men	259
JaÚn	Group 1106 Appendicitis  540-543	Women	225
JaÚn	Group 1107 Inguinal hernia  550	Both sexes	329
JaÚn	Group 1107 Inguinal hernia  550	Men	286
JaÚn	Group 1107 Inguinal hernia  550	Women	43
JaÚn	Group 1108 Other abdominal hernia  551-553	Both sexes	426
JaÚn	Group 1108 Other abdominal hernia  551-553	Men	161
JaÚn	Group 1108 Other abdominal hernia  551-553	Women	265
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	152
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	83
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	69
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	262
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	138
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	124
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Both sexes	259
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Men	141
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Women	118
JaÚn	Group 1112 Intestinal diverticulosis 562	Both sexes	216
JaÚn	Group 1112 Intestinal diverticulosis 562	Men	102
JaÚn	Group 1112 Intestinal diverticulosis 562	Women	114
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	414
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	280
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	134
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	173
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	91
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	82
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	130
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Men	116
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Women	14
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	243
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Men	179
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Women	64
JaÚn	Group 1117 Cholelithiasis  574	Both sexes	1.082
JaÚn	Group 1117 Cholelithiasis  574	Men	447
JaÚn	Group 1117 Cholelithiasis  574	Women	635
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	287
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	169
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	118
JaÚn	Group 1119 Pancreatic diseases 577	Both sexes	496
JaÚn	Group 1119 Pancreatic diseases 577	Men	269
JaÚn	Group 1119 Pancreatic diseases 577	Women	227
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	329
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	179
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	150
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	321
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	158
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	163
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	226
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	111
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	115
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	13
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	4
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	9
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	82
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	43
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	39
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.444
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.158
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.286
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
JaÚn	Group 1303 Internal derangement of knee 717	Both sexes	184
JaÚn	Group 1303 Internal derangement of knee 717	Men	143
JaÚn	Group 1303 Internal derangement of knee 717	Women	41
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.345
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	521
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	824
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	49
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	23
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	26
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	139
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	77
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	62
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	162
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	106
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	56
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	45
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	18
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	27
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	277
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	156
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	121
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	243
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	114
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	129
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.681
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.134
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.547
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	276
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	100
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	176
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	500
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Men	284
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Women	216
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	386
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Men	219
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Women	167
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	463
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	228
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	235
JaÚn	Group 1405 Prostatic hyperplasia  600	Both sexes	121
JaÚn	Group 1405 Prostatic hyperplasia  600	Men	121
JaÚn	Group 1405 Prostatic hyperplasia  600	Women	..
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	161
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Men	161
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Women	..
JaÚn	Group 1407 Disorders of breast  610-612	Both sexes	78
JaÚn	Group 1407 Disorders of breast  610-612	Men	17
JaÚn	Group 1407 Disorders of breast  610-612	Women	61
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	72
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	72
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	45
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	45
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	579
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	4
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	575
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	6.502
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	6.502
JaÚn	Group 1501 Legally induced abortion  635	Both sexes	3
JaÚn	Group 1501 Legally induced abortion  635	Men	..
JaÚn	Group 1501 Legally induced abortion  635	Women	3
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	351
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	351
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.134
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.134
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.263
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.263
JaÚn	Group 1505 Single spontaneous delivery  650	Both sexes	399
JaÚn	Group 1505 Single spontaneous delivery  650	Men	..
JaÚn	Group 1505 Single spontaneous delivery  650	Women	399
JaÚn	Group 1506 Other deliveries  6695-6697	Both sexes	94
JaÚn	Group 1506 Other deliveries  6695-6697	Men	..
JaÚn	Group 1506 Other deliveries  6695-6697	Women	94
JaÚn	Group 1507 Complications related to the puerperium  670-676	Both sexes	34
JaÚn	Group 1507 Complications related to the puerperium  670-676	Men	..
JaÚn	Group 1507 Complications related to the puerperium  670-676	Women	34
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	224
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	224
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	681
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Men	373
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Women	308
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	253
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	141
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	112
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	428
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	232
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	196
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Both sexes	125
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Men	66
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Women	59
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.745
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.425
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.320
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	332
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Men	189
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Women	143
JaÚn	Group 1802 Abdominal pain   7890	Both sexes	240
JaÚn	Group 1802 Abdominal pain   7890	Men	106
JaÚn	Group 1802 Abdominal pain   7890	Women	134
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	722
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	338
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	384
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.451
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	792
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	659
JaÚn	Group 1900 Injuries and poisoning  800-999	Both sexes	4.243
JaÚn	Group 1900 Injuries and poisoning  800-999	Men	2.112
JaÚn	Group 1900 Injuries and poisoning  800-999	Women	2.131
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	239
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	136
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	103
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	111
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	78
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	33
JaÚn	Group 1903 Radius and ulna fracture 813	Both sexes	312
JaÚn	Group 1903 Radius and ulna fracture 813	Men	154
JaÚn	Group 1903 Radius and ulna fracture 813	Women	158
JaÚn	Group 1904 Femur fracture  820-821	Both sexes	903
JaÚn	Group 1904 Femur fracture  820-821	Men	237
JaÚn	Group 1904 Femur fracture  820-821	Women	666
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	359
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Men	189
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Women	170
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.119
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	669
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	450
JaÚn	Group 1907 Burns  940-949	Both sexes	17
JaÚn	Group 1907 Burns  940-949	Men	11
JaÚn	Group 1907 Burns  940-949	Women	6
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	158
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	70
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	88
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	932
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	519
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	413
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	84
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	46
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	38
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	768
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	405
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	363
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	21
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	11
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	10
JaÚn	Group 2102 Contraceptive management  V25	Both sexes	10
JaÚn	Group 2102 Contraceptive management  V25	Men	1
JaÚn	Group 2102 Contraceptive management  V25	Women	9
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	363
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	232
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	131
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	374
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	161
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	213
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	140.302
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	62.728
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	77.574
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.194
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.734
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.460
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	402
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	217
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	185
Mßlaga	Group 0102 Imprecise intestinal infections 009	Both sexes	489
Mßlaga	Group 0102 Imprecise intestinal infections 009	Men	227
Mßlaga	Group 0102 Imprecise intestinal infections 009	Women	262
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Both sexes	81
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Men	48
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Women	32
Mßlaga	Group 0104 Septicaemia  038	Both sexes	1.072
Mßlaga	Group 0104 Septicaemia  038	Men	571
Mßlaga	Group 0104 Septicaemia  038	Women	501
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	131
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	100
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	31
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.019
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	570
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	449
Mßlaga	Group 0200 Neoplasms  140-239	Both sexes	13.718
Mßlaga	Group 0200 Neoplasms  140-239	Men	7.000
Mßlaga	Group 0200 Neoplasms  140-239	Women	6.718
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.211
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	733
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	478
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	940
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	738
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	203
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	344
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	209
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	135
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.158
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Men	12
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Women	1.146
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	268
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	268
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	167
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Women	167
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Both sexes	456
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Men	456
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Women	..
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.182
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Men	1.004
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Women	178
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.851
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.918
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.933
Mßlaga	Group 0210 Carcinoma in situ  230-234	Both sexes	208
Mßlaga	Group 0210 Carcinoma in situ  230-234	Men	60
Mßlaga	Group 0210 Carcinoma in situ  230-234	Women	148
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	92
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	50
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	41
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Both sexes	907
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Men	..
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Women	907
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.934
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	821
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.113
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.063
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	542
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	521
Mßlaga	Group 0301 Anaemias 280-285	Both sexes	474
Mßlaga	Group 0301 Anaemias 280-285	Men	252
Mßlaga	Group 0301 Anaemias 280-285	Women	222
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	588
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	290
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	299
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.209
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	844
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.366
Mßlaga	Group 0401 Diabetes mellitus  249-250	Both sexes	623
Mßlaga	Group 0401 Diabetes mellitus  249-250	Men	394
Mßlaga	Group 0401 Diabetes mellitus  249-250	Women	229
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.587
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	450
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.136
Mßlaga	Group 0500 Mental disorders  290-319	Both sexes	2.540
Mßlaga	Group 0500 Mental disorders  290-319	Men	1.441
Mßlaga	Group 0500 Mental disorders  290-319	Women	1.099
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	39
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	15
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	24
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	100
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	84
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	16
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	173
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	139
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	34
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	807
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	550
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	257
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	650
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	270
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	380
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	771
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	384
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	388
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.495
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.194
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.301
Mßlaga	Group 0601 Alzheimer's disease  3310	Both sexes	34
Mßlaga	Group 0601 Alzheimer's disease  3310	Men	16
Mßlaga	Group 0601 Alzheimer's disease  3310	Women	18
Mßlaga	Group 0602 Multiple sclerosis 340	Both sexes	91
Mßlaga	Group 0602 Multiple sclerosis 340	Men	26
Mßlaga	Group 0602 Multiple sclerosis 340	Women	65
Mßlaga	Group 0603 Epilepsy  345	Both sexes	367
Mßlaga	Group 0603 Epilepsy  345	Men	185
Mßlaga	Group 0603 Epilepsy  345	Women	183
Mßlaga	Group 0604 Transient cerebral ischemia 435	Both sexes	339
Mßlaga	Group 0604 Transient cerebral ischemia 435	Men	183
Mßlaga	Group 0604 Transient cerebral ischemia 435	Women	156
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.663
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	784
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	879
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	986
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	526
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	460
Mßlaga	Grupo 0701 Cataract  366	Both sexes	222
Mßlaga	Grupo 0701 Cataract  366	Men	126
Mßlaga	Grupo 0701 Cataract  366	Women	96
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	764
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	400
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	364
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	767
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Men	389
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Women	378
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.717
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.411
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.306
Mßlaga	Group 0901 Hypertensive disease  401-405	Both sexes	1.175
Mßlaga	Group 0901 Hypertensive disease  401-405	Men	517
Mßlaga	Group 0901 Hypertensive disease  401-405	Women	658
Mßlaga	Group 0902 Angina pectoris  4111, 413	Both sexes	1.038
Mßlaga	Group 0902 Angina pectoris  4111, 413	Men	674
Mßlaga	Group 0902 Angina pectoris  4111, 413	Women	363
Mßlaga	Group 0903 Acute myocardial infarction  410	Both sexes	2.009
Mßlaga	Group 0903 Acute myocardial infarction  410	Men	1.436
Mßlaga	Group 0903 Acute myocardial infarction  410	Women	572
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.842
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.396
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	446
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	408
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Men	201
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Women	207
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.684
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	970
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	714
Mßlaga	Grupo 0907 Heart failure  428	Both sexes	2.404
Mßlaga	Grupo 0907 Heart failure  428	Men	1.261
Mßlaga	Grupo 0907 Heart failure  428	Women	1.144
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.851
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.575
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.277
Mßlaga	Grupo 0909 Atherosclerosis  440	Both sexes	572
Mßlaga	Grupo 0909 Atherosclerosis  440	Men	412
Mßlaga	Grupo 0909 Atherosclerosis  440	Women	160
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Both sexes	772
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Men	277
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Women	496
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.962
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.693
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.269
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	12.913
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.230
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.683
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	654
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	326
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	328
Mßlaga	Group 1002 Pneumonia 480-486	Both sexes	2.838
Mßlaga	Group 1002 Pneumonia 480-486	Men	1.611
Mßlaga	Group 1002 Pneumonia 480-486	Women	1.227
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.018
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Men	543
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Women	475
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	983
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	476
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	507
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.578
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	902
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	675
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.384
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	939
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	445
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	387
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Men	80
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Women	307
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.071
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.353
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.718
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Both sexes	17.682
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Men	9.404
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Women	8.278
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	292
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	143
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	148
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	221
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	119
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	102
Mßlaga	Group 1103 Diseases of the esophagus 530	Both sexes	309
Mßlaga	Group 1103 Diseases of the esophagus 530	Men	165
Mßlaga	Group 1103 Diseases of the esophagus 530	Women	144
Mßlaga	Group 1104 Peptic ulcer 531-534	Both sexes	330
Mßlaga	Group 1104 Peptic ulcer 531-534	Men	228
Mßlaga	Group 1104 Peptic ulcer 531-534	Women	102
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	493
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	228
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	264
Mßlaga	Group 1106 Appendicitis  540-543	Both sexes	1.735
Mßlaga	Group 1106 Appendicitis  540-543	Men	981
Mßlaga	Group 1106 Appendicitis  540-543	Women	754
Mßlaga	Group 1107 Inguinal hernia  550	Both sexes	1.634
Mßlaga	Group 1107 Inguinal hernia  550	Men	1.446
Mßlaga	Group 1107 Inguinal hernia  550	Women	188
Mßlaga	Group 1108 Other abdominal hernia  551-553	Both sexes	1.420
Mßlaga	Group 1108 Other abdominal hernia  551-553	Men	620
Mßlaga	Group 1108 Other abdominal hernia  551-553	Women	800
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	453
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	219
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	234
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.049
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	443
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	606
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Both sexes	619
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Men	286
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Women	333
Mßlaga	Group 1112 Intestinal diverticulosis 562	Both sexes	939
Mßlaga	Group 1112 Intestinal diverticulosis 562	Men	485
Mßlaga	Group 1112 Intestinal diverticulosis 562	Women	454
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	989
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	664
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	325
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	424
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	191
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	233
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	208
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Men	176
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Women	32
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	527
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Men	307
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Women	220
Mßlaga	Group 1117 Cholelithiasis  574	Both sexes	3.545
Mßlaga	Group 1117 Cholelithiasis  574	Men	1.380
Mßlaga	Group 1117 Cholelithiasis  574	Women	2.165
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	788
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	430
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	358
Mßlaga	Group 1119 Pancreatic diseases 577	Both sexes	1.082
Mßlaga	Group 1119 Pancreatic diseases 577	Men	555
Mßlaga	Group 1119 Pancreatic diseases 577	Women	527
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	626
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	339
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	287
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.353
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	759
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	594
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	910
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	558
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	352
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	48
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	23
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	25
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	395
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	178
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	217
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.069
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.346
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.723
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Mßlaga	Group 1303 Internal derangement of knee 717	Both sexes	1.167
Mßlaga	Group 1303 Internal derangement of knee 717	Men	791
Mßlaga	Group 1303 Internal derangement of knee 717	Women	375
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.174
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.385
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.789
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	178
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	72
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	106
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	351
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	158
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	193
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	962
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	478
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	483
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	314
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	123
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	191
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.543
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	817
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	727
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.381
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	522
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	859
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.327
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.262
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	6.065
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.139
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	407
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	732
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	809
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Men	489
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Women	320
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.437
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Men	844
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Women	594
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.895
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	966
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	929
Mßlaga	Group 1405 Prostatic hyperplasia  600	Both sexes	848
Mßlaga	Group 1405 Prostatic hyperplasia  600	Men	848
Mßlaga	Group 1405 Prostatic hyperplasia  600	Women	..
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	604
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Men	604
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Mßlaga	Group 1407 Disorders of breast  610-612	Both sexes	1.490
Mßlaga	Group 1407 Disorders of breast  610-612	Men	71
Mßlaga	Group 1407 Disorders of breast  610-612	Women	1.419
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	344
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	344
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	143
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	143
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.619
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	34
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.585
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.123
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.123
Mßlaga	Group 1501 Legally induced abortion  635	Both sexes	53
Mßlaga	Group 1501 Legally induced abortion  635	Men	..
Mßlaga	Group 1501 Legally induced abortion  635	Women	53
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	981
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	981
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.831
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.831
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.913
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.913
Mßlaga	Group 1505 Single spontaneous delivery  650	Both sexes	569
Mßlaga	Group 1505 Single spontaneous delivery  650	Men	..
Mßlaga	Group 1505 Single spontaneous delivery  650	Women	569
Mßlaga	Group 1506 Other deliveries  6695-6697	Both sexes	378
Mßlaga	Group 1506 Other deliveries  6695-6697	Men	..
Mßlaga	Group 1506 Other deliveries  6695-6697	Women	378
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Both sexes	186
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Men	..
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Women	186
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.211
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.211
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.085
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.144
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Women	942
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	674
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	350
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	324
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.411
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	793
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	618
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.311
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Men	722
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Women	589
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	5.525
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.967
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.557
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	624
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Men	330
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Women	294
Mßlaga	Group 1802 Abdominal pain   7890	Both sexes	598
Mßlaga	Group 1802 Abdominal pain   7890	Men	206
Mßlaga	Group 1802 Abdominal pain   7890	Women	392
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	297
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	164
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	132
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.006
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.267
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.739
Mßlaga	Group 1900 Injuries and poisoning  800-999	Both sexes	13.078
Mßlaga	Group 1900 Injuries and poisoning  800-999	Men	6.693
Mßlaga	Group 1900 Injuries and poisoning  800-999	Women	6.385
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	565
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	362
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	203
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	411
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	292
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	119
Mßlaga	Group 1903 Radius and ulna fracture 813	Both sexes	881
Mßlaga	Group 1903 Radius and ulna fracture 813	Men	419
Mßlaga	Group 1903 Radius and ulna fracture 813	Women	462
Mßlaga	Group 1904 Femur fracture  820-821	Both sexes	2.257
Mßlaga	Group 1904 Femur fracture  820-821	Men	681
Mßlaga	Group 1904 Femur fracture  820-821	Women	1.576
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.138
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Men	578
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Women	559
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.637
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.169
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.469
Mßlaga	Group 1907 Burns  940-949	Both sexes	172
Mßlaga	Group 1907 Burns  940-949	Men	92
Mßlaga	Group 1907 Burns  940-949	Women	80
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	357
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	162
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	196
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.264
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.704
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.560
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	100
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	73
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	27
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	296
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	161
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	134
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.144
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.119
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.025
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	130
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	74
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	57
Mßlaga	Group 2102 Contraceptive management  V25	Both sexes	38
Mßlaga	Group 2102 Contraceptive management  V25	Men	5
Mßlaga	Group 2102 Contraceptive management  V25	Women	33
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	644
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	412
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	232
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.332
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	629
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.703
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	164.783
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	72.311
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	92.472
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.358
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.425
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.933
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	619
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	355
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	264
Sevilla	Group 0102 Imprecise intestinal infections 009	Both sexes	372
Sevilla	Group 0102 Imprecise intestinal infections 009	Men	187
Sevilla	Group 0102 Imprecise intestinal infections 009	Women	185
Sevilla	Group 0103 Tuberculosis 010-018, 137	Both sexes	126
Sevilla	Group 0103 Tuberculosis 010-018, 137	Men	71
Sevilla	Group 0103 Tuberculosis 010-018, 137	Women	55
Sevilla	Group 0104 Septicaemia  038	Both sexes	1.974
Sevilla	Group 0104 Septicaemia  038	Men	1.036
Sevilla	Group 0104 Septicaemia  038	Women	938
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	106
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	88
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	18
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.161
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	688
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	473
Sevilla	Group 0200 Neoplasms  140-239	Both sexes	16.193
Sevilla	Group 0200 Neoplasms  140-239	Men	8.192
Sevilla	Group 0200 Neoplasms  140-239	Women	8.001
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.562
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	966
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	596
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.131
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	928
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	203
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	354
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	202
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	152
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.311
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Men	19
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Women	1.292
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	329
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	329
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	229
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Women	229
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Both sexes	402
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Men	402
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Women	..
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.551
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Men	1.311
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Women	240
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.773
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.322
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.451
Sevilla	Group 0210 Carcinoma in situ  230-234	Both sexes	161
Sevilla	Group 0210 Carcinoma in situ  230-234	Men	44
Sevilla	Group 0210 Carcinoma in situ  230-234	Women	117
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	164
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	92
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	72
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Both sexes	924
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Men	..
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Women	924
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.302
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	906
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.396
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.423
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	694
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	729
Sevilla	Group 0301 Anaemias 280-285	Both sexes	903
Sevilla	Group 0301 Anaemias 280-285	Men	447
Sevilla	Group 0301 Anaemias 280-285	Women	456
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	520
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	247
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	273
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.786
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.088
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.698
Sevilla	Group 0401 Diabetes mellitus  249-250	Both sexes	797
Sevilla	Group 0401 Diabetes mellitus  249-250	Men	480
Sevilla	Group 0401 Diabetes mellitus  249-250	Women	317
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.989
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	608
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.381
Sevilla	Group 0500 Mental disorders  290-319	Both sexes	3.575
Sevilla	Group 0500 Mental disorders  290-319	Men	1.995
Sevilla	Group 0500 Mental disorders  290-319	Women	1.580
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	51
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	19
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	32
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	139
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	110
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	29
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	216
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	166
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	50
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.158
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	783
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	375
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	884
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	354
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	530
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.127
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	563
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	564
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.247
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.642
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.605
Sevilla	Group 0601 Alzheimer's disease  3310	Both sexes	64
Sevilla	Group 0601 Alzheimer's disease  3310	Men	29
Sevilla	Group 0601 Alzheimer's disease  3310	Women	35
Sevilla	Group 0602 Multiple sclerosis 340	Both sexes	70
Sevilla	Group 0602 Multiple sclerosis 340	Men	19
Sevilla	Group 0602 Multiple sclerosis 340	Women	51
Sevilla	Group 0603 Epilepsy  345	Both sexes	630
Sevilla	Group 0603 Epilepsy  345	Men	343
Sevilla	Group 0603 Epilepsy  345	Women	287
Sevilla	Group 0604 Transient cerebral ischemia 435	Both sexes	474
Sevilla	Group 0604 Transient cerebral ischemia 435	Men	251
Sevilla	Group 0604 Transient cerebral ischemia 435	Women	223
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.009
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.000
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.009
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	712
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	396
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	316
Sevilla	Grupo 0701 Cataract  366	Both sexes	62
Sevilla	Grupo 0701 Cataract  366	Men	39
Sevilla	Grupo 0701 Cataract  366	Women	23
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	650
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	357
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	293
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	718
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Men	372
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Women	346
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	22.179
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	12.329
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.850
Sevilla	Group 0901 Hypertensive disease  401-405	Both sexes	2.091
Sevilla	Group 0901 Hypertensive disease  401-405	Men	900
Sevilla	Group 0901 Hypertensive disease  401-405	Women	1.191
Sevilla	Group 0902 Angina pectoris  4111, 413	Both sexes	1.138
Sevilla	Group 0902 Angina pectoris  4111, 413	Men	661
Sevilla	Group 0902 Angina pectoris  4111, 413	Women	477
Sevilla	Group 0903 Acute myocardial infarction  410	Both sexes	2.420
Sevilla	Group 0903 Acute myocardial infarction  410	Men	1.550
Sevilla	Group 0903 Acute myocardial infarction  410	Women	870
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.681
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.278
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	403
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	469
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Men	208
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Women	261
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.987
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.579
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.408
Sevilla	Grupo 0907 Heart failure  428	Both sexes	3.846
Sevilla	Grupo 0907 Heart failure  428	Men	1.868
Sevilla	Grupo 0907 Heart failure  428	Women	1.978
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.379
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.853
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.526
Sevilla	Grupo 0909 Atherosclerosis  440	Both sexes	886
Sevilla	Grupo 0909 Atherosclerosis  440	Men	646
Sevilla	Grupo 0909 Atherosclerosis  440	Women	240
Sevilla	Group 0910 Varicose veins of lower extremities 454	Both sexes	452
Sevilla	Group 0910 Varicose veins of lower extremities 454	Men	166
Sevilla	Group 0910 Varicose veins of lower extremities 454	Women	286
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.830
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.620
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.210
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	13.837
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.912
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.925
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	790
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	400
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	390
Sevilla	Group 1002 Pneumonia 480-486	Both sexes	2.958
Sevilla	Group 1002 Pneumonia 480-486	Men	1.660
Sevilla	Group 1002 Pneumonia 480-486	Women	1.298
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.812
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Men	985
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Women	827
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	660
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	349
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	311
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.382
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	804
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	578
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.310
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.015
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	295
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	347
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Men	99
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Women	248
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.578
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.600
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.978
Sevilla	Group 1100 Diseases of the digestive system  520-579	Both sexes	19.455
Sevilla	Group 1100 Diseases of the digestive system  520-579	Men	10.254
Sevilla	Group 1100 Diseases of the digestive system  520-579	Women	9.201
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	332
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	159
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	173
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	245
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	118
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	127
Sevilla	Group 1103 Diseases of the esophagus 530	Both sexes	720
Sevilla	Group 1103 Diseases of the esophagus 530	Men	417
Sevilla	Group 1103 Diseases of the esophagus 530	Women	303
Sevilla	Group 1104 Peptic ulcer 531-534	Both sexes	357
Sevilla	Group 1104 Peptic ulcer 531-534	Men	230
Sevilla	Group 1104 Peptic ulcer 531-534	Women	127
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	525
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	234
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	291
Sevilla	Group 1106 Appendicitis  540-543	Both sexes	1.590
Sevilla	Group 1106 Appendicitis  540-543	Men	877
Sevilla	Group 1106 Appendicitis  540-543	Women	713
Sevilla	Group 1107 Inguinal hernia  550	Both sexes	1.637
Sevilla	Group 1107 Inguinal hernia  550	Men	1.266
Sevilla	Group 1107 Inguinal hernia  550	Women	371
Sevilla	Group 1108 Other abdominal hernia  551-553	Both sexes	1.668
Sevilla	Group 1108 Other abdominal hernia  551-553	Men	704
Sevilla	Group 1108 Other abdominal hernia  551-553	Women	964
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	464
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	260
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	204
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.059
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	480
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	579
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Both sexes	730
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Men	331
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Women	399
Sevilla	Group 1112 Intestinal diverticulosis 562	Both sexes	638
Sevilla	Group 1112 Intestinal diverticulosis 562	Men	337
Sevilla	Group 1112 Intestinal diverticulosis 562	Women	301
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.039
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	675
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	364
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	611
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	284
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	327
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	373
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Men	322
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Women	51
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	687
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Men	402
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Women	285
Sevilla	Group 1117 Cholelithiasis  574	Both sexes	3.818
Sevilla	Group 1117 Cholelithiasis  574	Men	1.561
Sevilla	Group 1117 Cholelithiasis  574	Women	2.257
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	873
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	452
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	421
Sevilla	Group 1119 Pancreatic diseases 577	Both sexes	1.251
Sevilla	Group 1119 Pancreatic diseases 577	Men	692
Sevilla	Group 1119 Pancreatic diseases 577	Women	559
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	838
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	453
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	385
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.343
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	701
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	642
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	729
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	414
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	315
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	71
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	47
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	24
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	543
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	240
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	303
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	11.852
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.300
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.552
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Sevilla	Group 1303 Internal derangement of knee 717	Both sexes	1.416
Sevilla	Group 1303 Internal derangement of knee 717	Men	875
Sevilla	Group 1303 Internal derangement of knee 717	Women	541
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.382
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.813
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.569
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	191
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	59
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	132
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	695
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	332
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	363
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.494
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	704
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	790
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	338
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	138
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	200
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.692
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	717
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	975
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.644
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	662
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	982
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	9.498
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.024
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.474
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	995
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	390
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	605
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.010
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Men	568
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Women	442
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.387
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Men	725
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Women	662
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.884
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	869
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.015
Sevilla	Group 1405 Prostatic hyperplasia  600	Both sexes	676
Sevilla	Group 1405 Prostatic hyperplasia  600	Men	676
Sevilla	Group 1405 Prostatic hyperplasia  600	Women	..
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	699
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Men	699
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Sevilla	Group 1407 Disorders of breast  610-612	Both sexes	883
Sevilla	Group 1407 Disorders of breast  610-612	Men	69
Sevilla	Group 1407 Disorders of breast  610-612	Women	814
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	294
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	294
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	105
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	105
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.565
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	28
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.537
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	23.026
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	23.026
Sevilla	Group 1501 Legally induced abortion  635	Both sexes	31
Sevilla	Group 1501 Legally induced abortion  635	Men	..
Sevilla	Group 1501 Legally induced abortion  635	Women	31
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.059
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.059
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	14.757
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	14.757
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.645
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.645
Sevilla	Group 1505 Single spontaneous delivery  650	Both sexes	1.473
Sevilla	Group 1505 Single spontaneous delivery  650	Men	..
Sevilla	Group 1505 Single spontaneous delivery  650	Women	1.473
Sevilla	Group 1506 Other deliveries  6695-6697	Both sexes	520
Sevilla	Group 1506 Other deliveries  6695-6697	Men	..
Sevilla	Group 1506 Other deliveries  6695-6697	Women	520
Sevilla	Group 1507 Complications related to the puerperium  670-676	Both sexes	218
Sevilla	Group 1507 Complications related to the puerperium  670-676	Men	..
Sevilla	Group 1507 Complications related to the puerperium  670-676	Women	218
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.323
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.323
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.104
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.116
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Women	988
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	863
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	448
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	415
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.241
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	668
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	573
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.880
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Men	1.081
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Women	799
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	8.302
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.210
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	4.092
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.351
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Men	698
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Women	653
Sevilla	Group 1802 Abdominal pain   7890	Both sexes	1.113
Sevilla	Group 1802 Abdominal pain   7890	Men	398
Sevilla	Group 1802 Abdominal pain   7890	Women	715
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	437
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	253
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	184
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.401
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.861
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.540
Sevilla	Group 1900 Injuries and poisoning  800-999	Both sexes	15.200
Sevilla	Group 1900 Injuries and poisoning  800-999	Men	7.236
Sevilla	Group 1900 Injuries and poisoning  800-999	Women	7.964
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	639
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	384
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	255
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	389
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	274
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	115
Sevilla	Group 1903 Radius and ulna fracture 813	Both sexes	1.119
Sevilla	Group 1903 Radius and ulna fracture 813	Men	486
Sevilla	Group 1903 Radius and ulna fracture 813	Women	633
Sevilla	Group 1904 Femur fracture  820-821	Both sexes	2.300
Sevilla	Group 1904 Femur fracture  820-821	Men	688
Sevilla	Group 1904 Femur fracture  820-821	Women	1.612
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.336
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Men	615
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Women	721
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.388
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.091
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.297
Sevilla	Group 1907 Burns  940-949	Both sexes	148
Sevilla	Group 1907 Burns  940-949	Men	99
Sevilla	Group 1907 Burns  940-949	Women	49
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	421
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	209
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	212
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	4.179
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.237
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.942
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	43
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	26
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	17
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	238
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	127
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	111
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.095
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.344
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.751
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	243
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	148
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	95
Sevilla	Group 2102 Contraceptive management  V25	Both sexes	39
Sevilla	Group 2102 Contraceptive management  V25	Men	4
Sevilla	Group 2102 Contraceptive management  V25	Women	35
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.020
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	628
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	392
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.793
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	564
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.229
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	153.369
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	75.423
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	77.946
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.167
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.779
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.388
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	603
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	328
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	275
ARAGËN	Group 0102 Imprecise intestinal infections 009	Both sexes	232
ARAGËN	Group 0102 Imprecise intestinal infections 009	Men	112
ARAGËN	Group 0102 Imprecise intestinal infections 009	Women	120
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Both sexes	148
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Men	79
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Women	69
ARAGËN	Group 0104 Septicaemia  038	Both sexes	1.332
ARAGËN	Group 0104 Septicaemia  038	Men	739
ARAGËN	Group 0104 Septicaemia  038	Women	593
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	44
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	31
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	13
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	808
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	490
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	318
ARAGËN	Group 0200 Neoplasms  140-239	Both sexes	15.218
ARAGËN	Group 0200 Neoplasms  140-239	Men	7.972
ARAGËN	Group 0200 Neoplasms  140-239	Women	7.246
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.493
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	903
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	590
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.088
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	890
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	198
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	344
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	208
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	136
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.052
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Men	14
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Women	1.038
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	264
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	264
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	149
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Women	149
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Both sexes	498
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Men	498
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Women	..
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.265
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Men	1.060
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Women	205
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.991
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.904
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.087
ARAGËN	Group 0210 Carcinoma in situ  230-234	Both sexes	663
ARAGËN	Group 0210 Carcinoma in situ  230-234	Men	215
ARAGËN	Group 0210 Carcinoma in situ  230-234	Women	448
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	164
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	97
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	67
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Both sexes	681
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Men	..
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Women	681
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.566
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.183
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.383
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.377
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	654
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	723
ARAGËN	Group 0301 Anaemias 280-285	Both sexes	961
ARAGËN	Group 0301 Anaemias 280-285	Men	446
ARAGËN	Group 0301 Anaemias 280-285	Women	515
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	416
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	208
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	208
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.158
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.265
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.893
ARAGËN	Group 0401 Diabetes mellitus  249-250	Both sexes	889
ARAGËN	Group 0401 Diabetes mellitus  249-250	Men	526
ARAGËN	Group 0401 Diabetes mellitus  249-250	Women	363
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.269
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	739
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.530
ARAGËN	Group 0500 Mental disorders  290-319	Both sexes	3.405
ARAGËN	Group 0500 Mental disorders  290-319	Men	1.689
ARAGËN	Group 0500 Mental disorders  290-319	Women	1.716
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	176
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	87
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	89
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	179
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	128
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	51
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	106
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	78
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	28
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	871
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	518
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	353
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	821
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	316
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	505
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.252
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	562
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	689
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	4.078
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.098
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.980
ARAGËN	Group 0601 Alzheimer's disease  3310	Both sexes	93
ARAGËN	Group 0601 Alzheimer's disease  3310	Men	37
ARAGËN	Group 0601 Alzheimer's disease  3310	Women	56
ARAGËN	Group 0602 Multiple sclerosis 340	Both sexes	63
ARAGËN	Group 0602 Multiple sclerosis 340	Men	17
ARAGËN	Group 0602 Multiple sclerosis 340	Women	46
ARAGËN	Group 0603 Epilepsy  345	Both sexes	443
ARAGËN	Group 0603 Epilepsy  345	Men	235
ARAGËN	Group 0603 Epilepsy  345	Women	208
ARAGËN	Group 0604 Transient cerebral ischemia 435	Both sexes	397
ARAGËN	Group 0604 Transient cerebral ischemia 435	Men	219
ARAGËN	Group 0604 Transient cerebral ischemia 435	Women	178
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.082
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.590
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.492
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	930
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	480
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	450
ARAGËN	Grupo 0701 Cataract  366	Both sexes	202
ARAGËN	Grupo 0701 Cataract  366	Men	102
ARAGËN	Grupo 0701 Cataract  366	Women	100
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	728
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	378
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	350
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	691
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Men	329
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Women	362
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	19.445
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.882
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	8.563
ARAGËN	Group 0901 Hypertensive disease  401-405	Both sexes	536
ARAGËN	Group 0901 Hypertensive disease  401-405	Men	272
ARAGËN	Group 0901 Hypertensive disease  401-405	Women	264
ARAGËN	Group 0902 Angina pectoris  4111, 413	Both sexes	789
ARAGËN	Group 0902 Angina pectoris  4111, 413	Men	488
ARAGËN	Group 0902 Angina pectoris  4111, 413	Women	301
ARAGËN	Group 0903 Acute myocardial infarction  410	Both sexes	1.345
ARAGËN	Group 0903 Acute myocardial infarction  410	Men	970
ARAGËN	Group 0903 Acute myocardial infarction  410	Women	375
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.276
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	974
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	302
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	615
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Men	270
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Women	345
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.340
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.262
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.078
ARAGËN	Grupo 0907 Heart failure  428	Both sexes	4.862
ARAGËN	Grupo 0907 Heart failure  428	Men	2.391
ARAGËN	Grupo 0907 Heart failure  428	Women	2.471
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.175
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.746
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.429
ARAGËN	Grupo 0909 Atherosclerosis  440	Both sexes	507
ARAGËN	Grupo 0909 Atherosclerosis  440	Men	376
ARAGËN	Grupo 0909 Atherosclerosis  440	Women	131
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Both sexes	936
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Men	320
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Women	616
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.064
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.813
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.251
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	17.668
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	10.107
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	7.561
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	747
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	380
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	367
ARAGËN	Group 1002 Pneumonia 480-486	Both sexes	4.095
ARAGËN	Group 1002 Pneumonia 480-486	Men	2.401
ARAGËN	Group 1002 Pneumonia 480-486	Women	1.694
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.956
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Men	918
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.038
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	676
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	354
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	322
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.668
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.102
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	566
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.852
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.156
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	696
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	537
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Men	153
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Women	384
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.137
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.643
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.494
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Both sexes	18.873
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Men	11.025
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Women	7.848
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	225
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	109
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	116
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	262
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	146
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	116
ARAGËN	Group 1103 Diseases of the esophagus 530	Both sexes	305
ARAGËN	Group 1103 Diseases of the esophagus 530	Men	194
ARAGËN	Group 1103 Diseases of the esophagus 530	Women	111
ARAGËN	Group 1104 Peptic ulcer 531-534	Both sexes	442
ARAGËN	Group 1104 Peptic ulcer 531-534	Men	302
ARAGËN	Group 1104 Peptic ulcer 531-534	Women	140
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	505
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	236
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	269
ARAGËN	Group 1106 Appendicitis  540-543	Both sexes	1.288
ARAGËN	Group 1106 Appendicitis  540-543	Men	735
ARAGËN	Group 1106 Appendicitis  540-543	Women	553
ARAGËN	Group 1107 Inguinal hernia  550	Both sexes	2.687
ARAGËN	Group 1107 Inguinal hernia  550	Men	2.395
ARAGËN	Group 1107 Inguinal hernia  550	Women	292
ARAGËN	Group 1108 Other abdominal hernia  551-553	Both sexes	1.799
ARAGËN	Group 1108 Other abdominal hernia  551-553	Men	947
ARAGËN	Group 1108 Other abdominal hernia  551-553	Women	852
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	347
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	185
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	162
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	935
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	465
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	470
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Both sexes	930
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Men	447
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Women	483
ARAGËN	Group 1112 Intestinal diverticulosis 562	Both sexes	769
ARAGËN	Group 1112 Intestinal diverticulosis 562	Men	361
ARAGËN	Group 1112 Intestinal diverticulosis 562	Women	408
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.161
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	723
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	438
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	641
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	295
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	346
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	285
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Men	254
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Women	31
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	611
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Men	382
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Women	229
ARAGËN	Group 1117 Cholelithiasis  574	Both sexes	3.199
ARAGËN	Group 1117 Cholelithiasis  574	Men	1.438
ARAGËN	Group 1117 Cholelithiasis  574	Women	1.761
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	829
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	496
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	333
ARAGËN	Group 1119 Pancreatic diseases 577	Both sexes	899
ARAGËN	Group 1119 Pancreatic diseases 577	Men	517
ARAGËN	Group 1119 Pancreatic diseases 577	Women	382
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	754
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	398
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	356
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.433
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	798
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	635
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	965
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	585
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	380
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	69
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	35
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	34
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	399
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	178
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	221
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	11.225
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.647
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.578
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ARAGËN	Group 1303 Internal derangement of knee 717	Both sexes	1.714
ARAGËN	Group 1303 Internal derangement of knee 717	Men	1.120
ARAGËN	Group 1303 Internal derangement of knee 717	Women	594
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.351
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.579
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.772
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	212
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	83
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	129
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	485
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	222
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	263
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.023
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	607
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	416
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	275
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	121
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	154
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	2.153
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.222
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	931
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.012
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	693
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.319
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.308
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.909
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.399
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	746
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	261
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	485
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	872
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Men	490
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Women	382
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.553
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Men	940
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Women	613
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.641
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.329
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.312
ARAGËN	Group 1405 Prostatic hyperplasia  600	Both sexes	1.038
ARAGËN	Group 1405 Prostatic hyperplasia  600	Men	1.038
ARAGËN	Group 1405 Prostatic hyperplasia  600	Women	..
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	797
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Men	797
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ARAGËN	Group 1407 Disorders of breast  610-612	Both sexes	645
ARAGËN	Group 1407 Disorders of breast  610-612	Men	41
ARAGËN	Group 1407 Disorders of breast  610-612	Women	604
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	252
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	252
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	149
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	149
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.615
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	13
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.602
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	12.895
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	12.895
ARAGËN	Group 1501 Legally induced abortion  635	Both sexes	1
ARAGËN	Group 1501 Legally induced abortion  635	Men	..
ARAGËN	Group 1501 Legally induced abortion  635	Women	1
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	750
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	750
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.824
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.824
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.011
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.011
ARAGËN	Group 1505 Single spontaneous delivery  650	Both sexes	993
ARAGËN	Group 1505 Single spontaneous delivery  650	Men	..
ARAGËN	Group 1505 Single spontaneous delivery  650	Women	993
ARAGËN	Group 1506 Other deliveries  6695-6697	Both sexes	305
ARAGËN	Group 1506 Other deliveries  6695-6697	Men	..
ARAGËN	Group 1506 Other deliveries  6695-6697	Women	305
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Both sexes	106
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Men	..
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Women	106
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	905
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	905
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.071
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.146
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Women	925
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	376
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	215
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	161
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.695
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	931
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	764
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.416
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Men	737
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Women	679
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.942
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.266
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.676
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	953
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Men	523
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Women	430
ARAGËN	Group 1802 Abdominal pain   7890	Both sexes	860
ARAGËN	Group 1802 Abdominal pain   7890	Men	343
ARAGËN	Group 1802 Abdominal pain   7890	Women	517
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	733
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	380
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	353
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.396
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	3.020
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.376
ARAGËN	Group 1900 Injuries and poisoning  800-999	Both sexes	14.374
ARAGËN	Group 1900 Injuries and poisoning  800-999	Men	7.674
ARAGËN	Group 1900 Injuries and poisoning  800-999	Women	6.700
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	745
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	445
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	300
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	428
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	310
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	118
ARAGËN	Group 1903 Radius and ulna fracture 813	Both sexes	814
ARAGËN	Group 1903 Radius and ulna fracture 813	Men	355
ARAGËN	Group 1903 Radius and ulna fracture 813	Women	459
ARAGËN	Group 1904 Femur fracture  820-821	Both sexes	2.488
ARAGËN	Group 1904 Femur fracture  820-821	Men	669
ARAGËN	Group 1904 Femur fracture  820-821	Women	1.819
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	843
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Men	427
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Women	416
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	5.167
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.336
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.831
ARAGËN	Group 1907 Burns  940-949	Both sexes	129
ARAGËN	Group 1907 Burns  940-949	Men	88
ARAGËN	Group 1907 Burns  940-949	Women	41
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	227
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	109
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	118
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.132
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.706
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.426
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	388
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	221
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	167
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.695
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.966
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.729
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	192
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	115
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	77
ARAGËN	Group 2102 Contraceptive management  V25	Both sexes	47
ARAGËN	Group 2102 Contraceptive management  V25	Men	2
ARAGËN	Group 2102 Contraceptive management  V25	Women	45
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	916
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	549
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	367
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.540
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.300
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.240
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	21.266
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	10.290
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	10.976
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	700
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	404
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	296
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	108
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	56
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	52
Huesca	Group 0102 Imprecise intestinal infections 009	Both sexes	70
Huesca	Group 0102 Imprecise intestinal infections 009	Men	37
Huesca	Group 0102 Imprecise intestinal infections 009	Women	33
Huesca	Group 0103 Tuberculosis 010-018, 137	Both sexes	24
Huesca	Group 0103 Tuberculosis 010-018, 137	Men	13
Huesca	Group 0103 Tuberculosis 010-018, 137	Women	11
Huesca	Group 0104 Septicaemia  038	Both sexes	351
Huesca	Group 0104 Septicaemia  038	Men	211
Huesca	Group 0104 Septicaemia  038	Women	140
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	6
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	5
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	141
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	82
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	59
Huesca	Group 0200 Neoplasms  140-239	Both sexes	1.747
Huesca	Group 0200 Neoplasms  140-239	Men	923
Huesca	Group 0200 Neoplasms  140-239	Women	824
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	250
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	166
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	84
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	122
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	92
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	30
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	16
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	8
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	8
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	151
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Women	151
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	26
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	26
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	21
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Women	21
Huesca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	36
Huesca	Group 0207 Malignant neoplasm of prostate  185	Men	36
Huesca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Huesca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	164
Huesca	Group 0208 Malignant neoplasm of bladder  188	Men	138
Huesca	Group 0208 Malignant neoplasm of bladder  188	Women	26
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	575
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	332
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	243
Huesca	Group 0210 Carcinoma in situ  230-234	Both sexes	51
Huesca	Group 0210 Carcinoma in situ  230-234	Men	23
Huesca	Group 0210 Carcinoma in situ  230-234	Women	28
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	14
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	8
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	6
Huesca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	72
Huesca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Huesca	Grupo 0212 Leiomyoma of uterus  218	Women	72
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	249
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	120
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	129
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	200
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	114
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	86
Huesca	Group 0301 Anaemias 280-285	Both sexes	161
Huesca	Group 0301 Anaemias 280-285	Men	94
Huesca	Group 0301 Anaemias 280-285	Women	67
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	39
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	20
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	19
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	333
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	154
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	179
Huesca	Group 0401 Diabetes mellitus  249-250	Both sexes	143
Huesca	Group 0401 Diabetes mellitus  249-250	Men	90
Huesca	Group 0401 Diabetes mellitus  249-250	Women	53
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	190
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	64
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	126
Huesca	Group 0500 Mental disorders  290-319	Both sexes	767
Huesca	Group 0500 Mental disorders  290-319	Men	378
Huesca	Group 0500 Mental disorders  290-319	Women	389
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	31
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	18
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	13
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	43
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	29
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	14
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	23
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	15
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	8
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	193
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	107
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	86
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	251
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	92
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	159
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	226
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	117
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	109
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	512
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	237
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	275
Huesca	Group 0601 Alzheimer's disease  3310	Both sexes	14
Huesca	Group 0601 Alzheimer's disease  3310	Men	6
Huesca	Group 0601 Alzheimer's disease  3310	Women	8
Huesca	Group 0602 Multiple sclerosis 340	Both sexes	3
Huesca	Group 0602 Multiple sclerosis 340	Men	2
Huesca	Group 0602 Multiple sclerosis 340	Women	1
Huesca	Group 0603 Epilepsy  345	Both sexes	73
Huesca	Group 0603 Epilepsy  345	Men	39
Huesca	Group 0603 Epilepsy  345	Women	34
Huesca	Group 0604 Transient cerebral ischemia 435	Both sexes	76
Huesca	Group 0604 Transient cerebral ischemia 435	Men	38
Huesca	Group 0604 Transient cerebral ischemia 435	Women	38
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	346
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	152
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	194
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	129
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	76
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	53
Huesca	Grupo 0701 Cataract  366	Both sexes	71
Huesca	Grupo 0701 Cataract  366	Men	45
Huesca	Grupo 0701 Cataract  366	Women	26
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	58
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	31
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	27
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	71
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	41
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	30
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.719
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.387
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.332
Huesca	Group 0901 Hypertensive disease  401-405	Both sexes	131
Huesca	Group 0901 Hypertensive disease  401-405	Men	61
Huesca	Group 0901 Hypertensive disease  401-405	Women	70
Huesca	Group 0902 Angina pectoris  4111, 413	Both sexes	126
Huesca	Group 0902 Angina pectoris  4111, 413	Men	72
Huesca	Group 0902 Angina pectoris  4111, 413	Women	54
Huesca	Group 0903 Acute myocardial infarction  410	Both sexes	152
Huesca	Group 0903 Acute myocardial infarction  410	Men	102
Huesca	Group 0903 Acute myocardial infarction  410	Women	50
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	71
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	50
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	21
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	76
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Men	34
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Women	42
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	381
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	184
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	197
Huesca	Grupo 0907 Heart failure  428	Both sexes	773
Huesca	Grupo 0907 Heart failure  428	Men	369
Huesca	Grupo 0907 Heart failure  428	Women	404
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	443
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	239
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	204
Huesca	Grupo 0909 Atherosclerosis  440	Both sexes	76
Huesca	Grupo 0909 Atherosclerosis  440	Men	53
Huesca	Grupo 0909 Atherosclerosis  440	Women	23
Huesca	Group 0910 Varicose veins of lower extremities 454	Both sexes	162
Huesca	Group 0910 Varicose veins of lower extremities 454	Men	43
Huesca	Group 0910 Varicose veins of lower extremities 454	Women	119
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	328
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	180
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	148
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.608
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.446
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.162
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	120
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	59
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	61
Huesca	Group 1002 Pneumonia 480-486	Both sexes	502
Huesca	Group 1002 Pneumonia 480-486	Men	267
Huesca	Group 1002 Pneumonia 480-486	Women	235
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	384
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	149
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	235
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	35
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	14
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	21
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	257
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	176
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	81
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	386
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	319
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	67
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	57
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Men	14
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Women	43
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	867
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	448
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	419
Huesca	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.779
Huesca	Group 1100 Diseases of the digestive system  520-579	Men	1.636
Huesca	Group 1100 Diseases of the digestive system  520-579	Women	1.143
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	18
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	5
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	13
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	21
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	15
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	6
Huesca	Group 1103 Diseases of the esophagus 530	Both sexes	35
Huesca	Group 1103 Diseases of the esophagus 530	Men	20
Huesca	Group 1103 Diseases of the esophagus 530	Women	15
Huesca	Group 1104 Peptic ulcer 531-534	Both sexes	79
Huesca	Group 1104 Peptic ulcer 531-534	Men	55
Huesca	Group 1104 Peptic ulcer 531-534	Women	24
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	104
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	53
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	51
Huesca	Group 1106 Appendicitis  540-543	Both sexes	200
Huesca	Group 1106 Appendicitis  540-543	Men	104
Huesca	Group 1106 Appendicitis  540-543	Women	96
Huesca	Group 1107 Inguinal hernia  550	Both sexes	338
Huesca	Group 1107 Inguinal hernia  550	Men	312
Huesca	Group 1107 Inguinal hernia  550	Women	26
Huesca	Group 1108 Other abdominal hernia  551-553	Both sexes	259
Huesca	Group 1108 Other abdominal hernia  551-553	Men	138
Huesca	Group 1108 Other abdominal hernia  551-553	Women	121
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	43
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	22
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	21
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	166
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	88
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	78
Huesca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	128
Huesca	Group 1111 Intestinal obstruction without hernia 560	Men	65
Huesca	Group 1111 Intestinal obstruction without hernia 560	Women	63
Huesca	Group 1112 Intestinal diverticulosis 562	Both sexes	101
Huesca	Group 1112 Intestinal diverticulosis 562	Men	46
Huesca	Group 1112 Intestinal diverticulosis 562	Women	55
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	139
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	86
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	53
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	110
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	51
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	59
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	53
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Men	51
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	106
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Men	70
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Women	36
Huesca	Group 1117 Cholelithiasis  574	Both sexes	504
Huesca	Group 1117 Cholelithiasis  574	Men	237
Huesca	Group 1117 Cholelithiasis  574	Women	267
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	131
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	87
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	44
Huesca	Group 1119 Pancreatic diseases 577	Both sexes	143
Huesca	Group 1119 Pancreatic diseases 577	Men	83
Huesca	Group 1119 Pancreatic diseases 577	Women	60
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	101
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	48
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	53
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	279
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	157
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	122
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	174
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	110
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	64
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	5
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	3
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	100
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	44
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	56
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.368
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	678
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	690
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Huesca	Group 1303 Internal derangement of knee 717	Both sexes	262
Huesca	Group 1303 Internal derangement of knee 717	Men	171
Huesca	Group 1303 Internal derangement of knee 717	Women	91
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	469
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	241
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	228
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	39
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	13
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	26
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	16
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	6
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	10
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	66
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	31
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	35
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	52
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	16
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	36
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	250
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	134
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	116
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	214
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	66
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	148
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.383
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	696
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	687
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	109
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	47
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	62
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	177
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Men	106
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Women	71
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	191
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Men	107
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Women	84
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	469
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	254
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	215
Huesca	Group 1405 Prostatic hyperplasia  600	Both sexes	106
Huesca	Group 1405 Prostatic hyperplasia  600	Men	106
Huesca	Group 1405 Prostatic hyperplasia  600	Women	..
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	72
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Men	72
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Huesca	Group 1407 Disorders of breast  610-612	Both sexes	48
Huesca	Group 1407 Disorders of breast  610-612	Men	3
Huesca	Group 1407 Disorders of breast  610-612	Women	45
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	27
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	27
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	16
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	16
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	168
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	167
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.873
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.873
Huesca	Group 1501 Legally induced abortion  635	Both sexes	..
Huesca	Group 1501 Legally induced abortion  635	Men	..
Huesca	Group 1501 Legally induced abortion  635	Women	..
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	108
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	108
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.067
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.067
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	314
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	314
Huesca	Group 1505 Single spontaneous delivery  650	Both sexes	113
Huesca	Group 1505 Single spontaneous delivery  650	Men	..
Huesca	Group 1505 Single spontaneous delivery  650	Women	113
Huesca	Group 1506 Other deliveries  6695-6697	Both sexes	60
Huesca	Group 1506 Other deliveries  6695-6697	Men	..
Huesca	Group 1506 Other deliveries  6695-6697	Women	60
Huesca	Group 1507 Complications related to the puerperium  670-676	Both sexes	18
Huesca	Group 1507 Complications related to the puerperium  670-676	Men	..
Huesca	Group 1507 Complications related to the puerperium  670-676	Women	18
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	193
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	193
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	236
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	138
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	98
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	65
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	44
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	21
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	171
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	94
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	77
Huesca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	50
Huesca	Grupo 1700 Congenital abnormalities  740-759	Men	27
Huesca	Grupo 1700 Congenital abnormalities  740-759	Women	23
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.167
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	629
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	538
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	124
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Men	75
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Women	49
Huesca	Group 1802 Abdominal pain   7890	Both sexes	183
Huesca	Group 1802 Abdominal pain   7890	Men	74
Huesca	Group 1802 Abdominal pain   7890	Women	109
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	859
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	479
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	380
Huesca	Group 1900 Injuries and poisoning  800-999	Both sexes	1.725
Huesca	Group 1900 Injuries and poisoning  800-999	Men	841
Huesca	Group 1900 Injuries and poisoning  800-999	Women	884
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	116
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	73
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	43
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	18
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	11
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	7
Huesca	Group 1903 Radius and ulna fracture 813	Both sexes	94
Huesca	Group 1903 Radius and ulna fracture 813	Men	40
Huesca	Group 1903 Radius and ulna fracture 813	Women	54
Huesca	Group 1904 Femur fracture  820-821	Both sexes	388
Huesca	Group 1904 Femur fracture  820-821	Men	124
Huesca	Group 1904 Femur fracture  820-821	Women	264
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	128
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Men	63
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Women	65
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	495
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	275
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	220
Huesca	Group 1907 Burns  940-949	Both sexes	3
Huesca	Group 1907 Burns  940-949	Men	2
Huesca	Group 1907 Burns  940-949	Women	1
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	36
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	16
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	20
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	381
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	203
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	178
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	65
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	34
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	31
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	620
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	328
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	292
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	8
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	5
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	3
Huesca	Group 2102 Contraceptive management  V25	Both sexes	9
Huesca	Group 2102 Contraceptive management  V25	Men	..
Huesca	Group 2102 Contraceptive management  V25	Women	9
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	86
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	60
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	26
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	517
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	263
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	254
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.034
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	7.043
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	6.991
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	250
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	139
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	111
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	89
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	54
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	35
Teruel	Group 0102 Imprecise intestinal infections 009	Both sexes	11
Teruel	Group 0102 Imprecise intestinal infections 009	Men	7
Teruel	Group 0102 Imprecise intestinal infections 009	Women	4
Teruel	Group 0103 Tuberculosis 010-018, 137	Both sexes	4
Teruel	Group 0103 Tuberculosis 010-018, 137	Men	2
Teruel	Group 0103 Tuberculosis 010-018, 137	Women	2
Teruel	Group 0104 Septicaemia  038	Both sexes	64
Teruel	Group 0104 Septicaemia  038	Men	29
Teruel	Group 0104 Septicaemia  038	Women	35
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	..
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	82
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	47
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	35
Teruel	Group 0200 Neoplasms  140-239	Both sexes	1.143
Teruel	Group 0200 Neoplasms  140-239	Men	633
Teruel	Group 0200 Neoplasms  140-239	Women	510
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	168
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	103
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	65
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	100
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	87
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	13
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	7
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	4
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	3
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	90
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Women	90
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	18
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	18
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	9
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Women	9
Teruel	Group 0207 Malignant neoplasm of prostate  185	Both sexes	44
Teruel	Group 0207 Malignant neoplasm of prostate  185	Men	44
Teruel	Group 0207 Malignant neoplasm of prostate  185	Women	..
Teruel	Group 0208 Malignant neoplasm of bladder  188	Both sexes	110
Teruel	Group 0208 Malignant neoplasm of bladder  188	Men	85
Teruel	Group 0208 Malignant neoplasm of bladder  188	Women	25
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	394
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	245
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	149
Teruel	Group 0210 Carcinoma in situ  230-234	Both sexes	27
Teruel	Group 0210 Carcinoma in situ  230-234	Men	8
Teruel	Group 0210 Carcinoma in situ  230-234	Women	19
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	13
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	7
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	6
Teruel	Grupo 0212 Leiomyoma of uterus  218	Both sexes	37
Teruel	Grupo 0212 Leiomyoma of uterus  218	Men	..
Teruel	Grupo 0212 Leiomyoma of uterus  218	Women	37
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	126
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	50
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	76
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	127
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	62
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	65
Teruel	Group 0301 Anaemias 280-285	Both sexes	85
Teruel	Group 0301 Anaemias 280-285	Men	42
Teruel	Group 0301 Anaemias 280-285	Women	43
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	42
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	20
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	22
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	207
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	107
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	100
Teruel	Group 0401 Diabetes mellitus  249-250	Both sexes	71
Teruel	Group 0401 Diabetes mellitus  249-250	Men	46
Teruel	Group 0401 Diabetes mellitus  249-250	Women	25
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	136
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	61
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	75
Teruel	Group 0500 Mental disorders  290-319	Both sexes	307
Teruel	Group 0500 Mental disorders  290-319	Men	184
Teruel	Group 0500 Mental disorders  290-319	Women	123
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	21
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	11
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	10
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	29
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	22
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	7
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	5
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	4
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	89
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	58
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	31
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	61
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	32
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	29
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	102
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	57
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	45
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	234
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	129
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	105
Teruel	Group 0601 Alzheimer's disease  3310	Both sexes	12
Teruel	Group 0601 Alzheimer's disease  3310	Men	5
Teruel	Group 0601 Alzheimer's disease  3310	Women	7
Teruel	Group 0602 Multiple sclerosis 340	Both sexes	1
Teruel	Group 0602 Multiple sclerosis 340	Men	..
Teruel	Group 0602 Multiple sclerosis 340	Women	1
Teruel	Group 0603 Epilepsy  345	Both sexes	50
Teruel	Group 0603 Epilepsy  345	Men	29
Teruel	Group 0603 Epilepsy  345	Women	21
Teruel	Group 0604 Transient cerebral ischemia 435	Both sexes	55
Teruel	Group 0604 Transient cerebral ischemia 435	Men	31
Teruel	Group 0604 Transient cerebral ischemia 435	Women	24
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	116
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	64
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	52
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	49
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	27
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	22
Teruel	Grupo 0701 Cataract  366	Both sexes	20
Teruel	Grupo 0701 Cataract  366	Men	9
Teruel	Grupo 0701 Cataract  366	Women	11
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	29
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	18
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	11
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	40
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Men	24
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Women	16
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.709
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	924
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	785
Teruel	Group 0901 Hypertensive disease  401-405	Both sexes	47
Teruel	Group 0901 Hypertensive disease  401-405	Men	24
Teruel	Group 0901 Hypertensive disease  401-405	Women	23
Teruel	Group 0902 Angina pectoris  4111, 413	Both sexes	111
Teruel	Group 0902 Angina pectoris  4111, 413	Men	74
Teruel	Group 0902 Angina pectoris  4111, 413	Women	37
Teruel	Group 0903 Acute myocardial infarction  410	Both sexes	77
Teruel	Group 0903 Acute myocardial infarction  410	Men	50
Teruel	Group 0903 Acute myocardial infarction  410	Women	27
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	45
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	38
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	7
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	80
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Men	36
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Women	44
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	192
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	105
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	87
Teruel	Grupo 0907 Heart failure  428	Both sexes	584
Teruel	Grupo 0907 Heart failure  428	Men	303
Teruel	Grupo 0907 Heart failure  428	Women	281
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	291
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	150
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	141
Teruel	Grupo 0909 Atherosclerosis  440	Both sexes	24
Teruel	Grupo 0909 Atherosclerosis  440	Men	15
Teruel	Grupo 0909 Atherosclerosis  440	Women	9
Teruel	Group 0910 Varicose veins of lower extremities 454	Both sexes	39
Teruel	Group 0910 Varicose veins of lower extremities 454	Men	5
Teruel	Group 0910 Varicose veins of lower extremities 454	Women	34
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	219
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	124
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	95
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.209
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.296
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	913
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	138
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	69
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	69
Teruel	Group 1002 Pneumonia 480-486	Both sexes	582
Teruel	Group 1002 Pneumonia 480-486	Men	366
Teruel	Group 1002 Pneumonia 480-486	Women	216
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	293
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Men	124
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Women	169
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	39
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	17
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	22
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	118
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	72
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	46
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	424
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	334
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	90
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	63
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Men	19
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Women	44
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	552
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	295
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	257
Teruel	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.208
Teruel	Group 1100 Diseases of the digestive system  520-579	Men	1.283
Teruel	Group 1100 Diseases of the digestive system  520-579	Women	925
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	16
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	7
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	9
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	14
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	10
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	4
Teruel	Group 1103 Diseases of the esophagus 530	Both sexes	25
Teruel	Group 1103 Diseases of the esophagus 530	Men	13
Teruel	Group 1103 Diseases of the esophagus 530	Women	12
Teruel	Group 1104 Peptic ulcer 531-534	Both sexes	54
Teruel	Group 1104 Peptic ulcer 531-534	Men	36
Teruel	Group 1104 Peptic ulcer 531-534	Women	18
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	52
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	27
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	25
Teruel	Group 1106 Appendicitis  540-543	Both sexes	137
Teruel	Group 1106 Appendicitis  540-543	Men	81
Teruel	Group 1106 Appendicitis  540-543	Women	56
Teruel	Group 1107 Inguinal hernia  550	Both sexes	353
Teruel	Group 1107 Inguinal hernia  550	Men	311
Teruel	Group 1107 Inguinal hernia  550	Women	42
Teruel	Group 1108 Other abdominal hernia  551-553	Both sexes	192
Teruel	Group 1108 Other abdominal hernia  551-553	Men	101
Teruel	Group 1108 Other abdominal hernia  551-553	Women	91
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	30
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	16
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	14
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	136
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	66
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	70
Teruel	Group 1111 Intestinal obstruction without hernia 560	Both sexes	125
Teruel	Group 1111 Intestinal obstruction without hernia 560	Men	63
Teruel	Group 1111 Intestinal obstruction without hernia 560	Women	62
Teruel	Group 1112 Intestinal diverticulosis 562	Both sexes	74
Teruel	Group 1112 Intestinal diverticulosis 562	Men	37
Teruel	Group 1112 Intestinal diverticulosis 562	Women	37
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	101
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	66
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	35
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	81
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	38
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	43
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	27
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Men	19
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	74
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Men	41
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Women	33
Teruel	Group 1117 Cholelithiasis  574	Both sexes	400
Teruel	Group 1117 Cholelithiasis  574	Men	179
Teruel	Group 1117 Cholelithiasis  574	Women	221
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	114
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	68
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	46
Teruel	Group 1119 Pancreatic diseases 577	Both sexes	100
Teruel	Group 1119 Pancreatic diseases 577	Men	53
Teruel	Group 1119 Pancreatic diseases 577	Women	47
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	103
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	51
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	52
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	175
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	94
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	81
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	118
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	61
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	57
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	6
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	6
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	..
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	51
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	27
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	24
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	719
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	311
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	408
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Teruel	Group 1303 Internal derangement of knee 717	Both sexes	108
Teruel	Group 1303 Internal derangement of knee 717	Men	65
Teruel	Group 1303 Internal derangement of knee 717	Women	43
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	336
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	137
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	199
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	30
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	11
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	19
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	4
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	3
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	26
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	14
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	12
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	26
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	12
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	14
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	79
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	42
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	37
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	110
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	29
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	81
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	790
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	428
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	362
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	52
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	25
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	27
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	88
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Men	49
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Women	39
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	106
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Men	67
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Women	39
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	230
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	97
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	133
Teruel	Group 1405 Prostatic hyperplasia  600	Both sexes	118
Teruel	Group 1405 Prostatic hyperplasia  600	Men	118
Teruel	Group 1405 Prostatic hyperplasia  600	Women	..
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	67
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Men	67
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Teruel	Group 1407 Disorders of breast  610-612	Both sexes	16
Teruel	Group 1407 Disorders of breast  610-612	Men	4
Teruel	Group 1407 Disorders of breast  610-612	Women	12
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	22
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	22
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	9
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	9
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	82
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	81
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.134
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.134
Teruel	Group 1501 Legally induced abortion  635	Both sexes	1
Teruel	Group 1501 Legally induced abortion  635	Men	..
Teruel	Group 1501 Legally induced abortion  635	Women	1
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	93
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	93
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	515
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	515
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	264
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	264
Teruel	Group 1505 Single spontaneous delivery  650	Both sexes	150
Teruel	Group 1505 Single spontaneous delivery  650	Men	..
Teruel	Group 1505 Single spontaneous delivery  650	Women	150
Teruel	Group 1506 Other deliveries  6695-6697	Both sexes	14
Teruel	Group 1506 Other deliveries  6695-6697	Men	..
Teruel	Group 1506 Other deliveries  6695-6697	Women	14
Teruel	Group 1507 Complications related to the puerperium  670-676	Both sexes	4
Teruel	Group 1507 Complications related to the puerperium  670-676	Men	..
Teruel	Group 1507 Complications related to the puerperium  670-676	Women	4
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	93
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	93
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	509
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Men	268
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Women	241
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	22
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	15
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	7
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	487
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	253
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	234
Teruel	Grupo 1700 Congenital abnormalities  740-759	Both sexes	40
Teruel	Grupo 1700 Congenital abnormalities  740-759	Men	20
Teruel	Grupo 1700 Congenital abnormalities  740-759	Women	20
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	690
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	373
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	317
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	43
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Men	29
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Women	14
Teruel	Group 1802 Abdominal pain   7890	Both sexes	81
Teruel	Group 1802 Abdominal pain   7890	Men	40
Teruel	Group 1802 Abdominal pain   7890	Women	41
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	56
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	21
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	35
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	510
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	283
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	227
Teruel	Group 1900 Injuries and poisoning  800-999	Both sexes	1.107
Teruel	Group 1900 Injuries and poisoning  800-999	Men	544
Teruel	Group 1900 Injuries and poisoning  800-999	Women	563
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	82
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	45
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	37
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	11
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	10
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	1
Teruel	Group 1903 Radius and ulna fracture 813	Both sexes	49
Teruel	Group 1903 Radius and ulna fracture 813	Men	30
Teruel	Group 1903 Radius and ulna fracture 813	Women	19
Teruel	Group 1904 Femur fracture  820-821	Both sexes	320
Teruel	Group 1904 Femur fracture  820-821	Men	99
Teruel	Group 1904 Femur fracture  820-821	Women	221
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	72
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Men	41
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Women	31
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	267
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	166
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	101
Teruel	Group 1907 Burns  940-949	Both sexes	..
Teruel	Group 1907 Burns  940-949	Men	..
Teruel	Group 1907 Burns  940-949	Women	..
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	15
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	7
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	8
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	223
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	112
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	111
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	66
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	32
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	34
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	387
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	197
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	190
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	31
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	24
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	7
Teruel	Group 2102 Contraceptive management  V25	Both sexes	1
Teruel	Group 2102 Contraceptive management  V25	Men	..
Teruel	Group 2102 Contraceptive management  V25	Women	1
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	48
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	30
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	18
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	307
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	143
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	164
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	118.069
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	58.090
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	59.979
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.217
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.236
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	981
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	406
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	218
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	188
Zaragoza	Group 0102 Imprecise intestinal infections 009	Both sexes	151
Zaragoza	Group 0102 Imprecise intestinal infections 009	Men	68
Zaragoza	Group 0102 Imprecise intestinal infections 009	Women	83
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Both sexes	120
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Men	64
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Women	56
Zaragoza	Group 0104 Septicaemia  038	Both sexes	917
Zaragoza	Group 0104 Septicaemia  038	Men	499
Zaragoza	Group 0104 Septicaemia  038	Women	418
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	38
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	26
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	12
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	585
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	361
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	224
Zaragoza	Group 0200 Neoplasms  140-239	Both sexes	12.328
Zaragoza	Group 0200 Neoplasms  140-239	Men	6.416
Zaragoza	Group 0200 Neoplasms  140-239	Women	5.912
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.075
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	634
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	441
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	866
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	711
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	155
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	321
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	196
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	125
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	811
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Men	14
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Women	797
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	220
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	220
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	119
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Women	119
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Both sexes	418
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Men	418
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Women	..
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Both sexes	991
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Men	837
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Women	154
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.022
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.327
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.695
Zaragoza	Group 0210 Carcinoma in situ  230-234	Both sexes	585
Zaragoza	Group 0210 Carcinoma in situ  230-234	Men	184
Zaragoza	Group 0210 Carcinoma in situ  230-234	Women	401
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	137
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	82
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	55
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Both sexes	572
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Men	..
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Women	572
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.191
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.013
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.178
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.050
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	478
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	572
Zaragoza	Group 0301 Anaemias 280-285	Both sexes	715
Zaragoza	Group 0301 Anaemias 280-285	Men	310
Zaragoza	Group 0301 Anaemias 280-285	Women	405
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	335
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	168
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	167
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.618
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.004
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.614
Zaragoza	Group 0401 Diabetes mellitus  249-250	Both sexes	675
Zaragoza	Group 0401 Diabetes mellitus  249-250	Men	390
Zaragoza	Group 0401 Diabetes mellitus  249-250	Women	285
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.943
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	614
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.329
Zaragoza	Group 0500 Mental disorders  290-319	Both sexes	2.331
Zaragoza	Group 0500 Mental disorders  290-319	Men	1.127
Zaragoza	Group 0500 Mental disorders  290-319	Women	1.204
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	124
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	58
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	66
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	107
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	77
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	30
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	78
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	59
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	19
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	589
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	353
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	236
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	509
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	192
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	317
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	924
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	388
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	535
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.332
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.732
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.600
Zaragoza	Group 0601 Alzheimer's disease  3310	Both sexes	67
Zaragoza	Group 0601 Alzheimer's disease  3310	Men	26
Zaragoza	Group 0601 Alzheimer's disease  3310	Women	41
Zaragoza	Group 0602 Multiple sclerosis 340	Both sexes	59
Zaragoza	Group 0602 Multiple sclerosis 340	Men	15
Zaragoza	Group 0602 Multiple sclerosis 340	Women	44
Zaragoza	Group 0603 Epilepsy  345	Both sexes	320
Zaragoza	Group 0603 Epilepsy  345	Men	167
Zaragoza	Group 0603 Epilepsy  345	Women	153
Zaragoza	Group 0604 Transient cerebral ischemia 435	Both sexes	266
Zaragoza	Group 0604 Transient cerebral ischemia 435	Men	150
Zaragoza	Group 0604 Transient cerebral ischemia 435	Women	116
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.620
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.374
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.246
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	752
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	377
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	375
Zaragoza	Grupo 0701 Cataract  366	Both sexes	111
Zaragoza	Grupo 0701 Cataract  366	Men	48
Zaragoza	Grupo 0701 Cataract  366	Women	63
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	641
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	329
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	312
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	580
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Men	264
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Women	316
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	15.017
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.571
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.446
Zaragoza	Group 0901 Hypertensive disease  401-405	Both sexes	358
Zaragoza	Group 0901 Hypertensive disease  401-405	Men	187
Zaragoza	Group 0901 Hypertensive disease  401-405	Women	171
Zaragoza	Group 0902 Angina pectoris  4111, 413	Both sexes	552
Zaragoza	Group 0902 Angina pectoris  4111, 413	Men	342
Zaragoza	Group 0902 Angina pectoris  4111, 413	Women	210
Zaragoza	Group 0903 Acute myocardial infarction  410	Both sexes	1.116
Zaragoza	Group 0903 Acute myocardial infarction  410	Men	818
Zaragoza	Group 0903 Acute myocardial infarction  410	Women	298
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.160
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	886
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	274
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	459
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Men	200
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Women	259
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.767
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	973
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	794
Zaragoza	Grupo 0907 Heart failure  428	Both sexes	3.505
Zaragoza	Grupo 0907 Heart failure  428	Men	1.719
Zaragoza	Grupo 0907 Heart failure  428	Women	1.786
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.441
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.357
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.084
Zaragoza	Grupo 0909 Atherosclerosis  440	Both sexes	407
Zaragoza	Grupo 0909 Atherosclerosis  440	Men	308
Zaragoza	Grupo 0909 Atherosclerosis  440	Women	99
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Both sexes	735
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Men	272
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Women	463
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.517
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.509
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.008
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	12.851
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.365
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.486
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	489
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	252
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	237
Zaragoza	Group 1002 Pneumonia 480-486	Both sexes	3.011
Zaragoza	Group 1002 Pneumonia 480-486	Men	1.768
Zaragoza	Group 1002 Pneumonia 480-486	Women	1.243
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.279
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Men	645
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Women	634
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	602
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	323
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	279
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.293
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	854
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	439
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.042
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.503
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	539
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	417
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Men	120
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Women	297
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.718
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.900
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.818
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.886
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Men	8.106
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Women	5.780
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	191
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	97
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	94
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	227
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	121
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	106
Zaragoza	Group 1103 Diseases of the esophagus 530	Both sexes	245
Zaragoza	Group 1103 Diseases of the esophagus 530	Men	161
Zaragoza	Group 1103 Diseases of the esophagus 530	Women	84
Zaragoza	Group 1104 Peptic ulcer 531-534	Both sexes	309
Zaragoza	Group 1104 Peptic ulcer 531-534	Men	211
Zaragoza	Group 1104 Peptic ulcer 531-534	Women	98
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	349
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	156
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	193
Zaragoza	Group 1106 Appendicitis  540-543	Both sexes	951
Zaragoza	Group 1106 Appendicitis  540-543	Men	550
Zaragoza	Group 1106 Appendicitis  540-543	Women	401
Zaragoza	Group 1107 Inguinal hernia  550	Both sexes	1.996
Zaragoza	Group 1107 Inguinal hernia  550	Men	1.772
Zaragoza	Group 1107 Inguinal hernia  550	Women	224
Zaragoza	Group 1108 Other abdominal hernia  551-553	Both sexes	1.348
Zaragoza	Group 1108 Other abdominal hernia  551-553	Men	708
Zaragoza	Group 1108 Other abdominal hernia  551-553	Women	640
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	274
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	147
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	127
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	633
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	311
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	322
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Both sexes	677
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Men	319
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Women	358
Zaragoza	Group 1112 Intestinal diverticulosis 562	Both sexes	594
Zaragoza	Group 1112 Intestinal diverticulosis 562	Men	278
Zaragoza	Group 1112 Intestinal diverticulosis 562	Women	316
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	921
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	571
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	350
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	450
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	206
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	244
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	205
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Men	184
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Women	21
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	431
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Men	271
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Women	160
Zaragoza	Group 1117 Cholelithiasis  574	Both sexes	2.295
Zaragoza	Group 1117 Cholelithiasis  574	Men	1.022
Zaragoza	Group 1117 Cholelithiasis  574	Women	1.273
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	584
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	341
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	243
Zaragoza	Group 1119 Pancreatic diseases 577	Both sexes	656
Zaragoza	Group 1119 Pancreatic diseases 577	Men	381
Zaragoza	Group 1119 Pancreatic diseases 577	Women	275
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	550
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	299
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	251
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	979
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	547
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	432
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	673
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	414
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	259
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	58
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	26
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	32
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	248
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	107
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	141
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.138
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.658
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.480
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Zaragoza	Group 1303 Internal derangement of knee 717	Both sexes	1.344
Zaragoza	Group 1303 Internal derangement of knee 717	Men	884
Zaragoza	Group 1303 Internal derangement of knee 717	Women	460
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.546
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.201
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.345
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	143
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	59
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	84
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	465
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	215
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	250
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	931
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	562
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	369
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	197
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	93
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	104
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.824
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.046
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	778
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.688
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	598
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.090
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	8.135
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.785
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.350
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	585
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	189
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	396
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	607
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Men	335
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Women	272
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.256
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Men	766
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Women	490
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.942
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	978
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	964
Zaragoza	Group 1405 Prostatic hyperplasia  600	Both sexes	814
Zaragoza	Group 1405 Prostatic hyperplasia  600	Men	814
Zaragoza	Group 1405 Prostatic hyperplasia  600	Women	..
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	658
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Men	658
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Zaragoza	Group 1407 Disorders of breast  610-612	Both sexes	581
Zaragoza	Group 1407 Disorders of breast  610-612	Men	34
Zaragoza	Group 1407 Disorders of breast  610-612	Women	547
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	203
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	203
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	124
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	124
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.365
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.354
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.888
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.888
Zaragoza	Group 1501 Legally induced abortion  635	Both sexes	..
Zaragoza	Group 1501 Legally induced abortion  635	Men	..
Zaragoza	Group 1501 Legally induced abortion  635	Women	..
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	549
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	549
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.242
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.242
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.433
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.433
Zaragoza	Group 1505 Single spontaneous delivery  650	Both sexes	730
Zaragoza	Group 1505 Single spontaneous delivery  650	Men	..
Zaragoza	Group 1505 Single spontaneous delivery  650	Women	730
Zaragoza	Group 1506 Other deliveries  6695-6697	Both sexes	231
Zaragoza	Group 1506 Other deliveries  6695-6697	Men	..
Zaragoza	Group 1506 Other deliveries  6695-6697	Women	231
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Both sexes	84
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Men	..
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Women	84
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	619
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	619
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.326
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Men	740
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Women	586
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	289
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	156
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	133
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.037
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	584
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	453
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.326
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Men	690
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Women	636
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.085
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.264
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.821
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	786
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Men	419
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Women	367
Zaragoza	Group 1802 Abdominal pain   7890	Both sexes	596
Zaragoza	Group 1802 Abdominal pain   7890	Men	229
Zaragoza	Group 1802 Abdominal pain   7890	Women	367
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	676
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	358
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	318
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.027
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.258
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.769
Zaragoza	Group 1900 Injuries and poisoning  800-999	Both sexes	11.542
Zaragoza	Group 1900 Injuries and poisoning  800-999	Men	6.289
Zaragoza	Group 1900 Injuries and poisoning  800-999	Women	5.253
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	547
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	327
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	220
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	399
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	289
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	110
Zaragoza	Group 1903 Radius and ulna fracture 813	Both sexes	671
Zaragoza	Group 1903 Radius and ulna fracture 813	Men	285
Zaragoza	Group 1903 Radius and ulna fracture 813	Women	386
Zaragoza	Group 1904 Femur fracture  820-821	Both sexes	1.780
Zaragoza	Group 1904 Femur fracture  820-821	Men	446
Zaragoza	Group 1904 Femur fracture  820-821	Women	1.334
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	643
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Men	323
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Women	320
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.405
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.895
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.510
Zaragoza	Group 1907 Burns  940-949	Both sexes	126
Zaragoza	Group 1907 Burns  940-949	Men	86
Zaragoza	Group 1907 Burns  940-949	Women	40
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	176
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	86
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	90
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.528
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.391
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.137
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	10
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	6
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	257
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	155
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	102
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.688
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.441
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.247
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	153
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	86
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	67
Zaragoza	Group 2102 Contraceptive management  V25	Both sexes	37
Zaragoza	Group 2102 Contraceptive management  V25	Men	2
Zaragoza	Group 2102 Contraceptive management  V25	Women	35
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	782
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	459
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	323
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.716
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	894
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	822
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	117.057
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	57.488
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	59.569
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.108
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.124
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	984
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	332
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	167
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	165
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Both sexes	137
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Men	68
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Women	69
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	97
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Men	57
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Women	40
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Both sexes	835
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Men	428
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Women	407
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	50
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	34
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	16
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	657
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	370
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	287
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Both sexes	11.405
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Men	6.302
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Women	5.103
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.325
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	851
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	474
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.140
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	857
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	283
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	158
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	76
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	82
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	699
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Men	6
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Women	693
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	199
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	199
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	125
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Women	125
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	504
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Men	504
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	915
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Men	759
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Women	156
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.032
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.394
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.638
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Both sexes	349
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Men	242
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Women	107
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	114
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	68
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	46
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	511
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Women	511
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.334
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	545
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	789
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.078
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	483
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	595
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Both sexes	809
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Men	332
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Women	477
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	269
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	151
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	118
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.736
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	730
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.006
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Both sexes	753
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Men	407
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Women	346
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	983
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	323
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	660
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Both sexes	2.978
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Men	1.501
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Women	1.477
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	90
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	42
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	48
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	206
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	162
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	44
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	177
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	138
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	39
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	748
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	432
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	316
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	666
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	222
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	444
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.091
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	505
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	586
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.344
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.236
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.108
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Both sexes	28
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Men	8
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Women	20
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Both sexes	92
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Men	34
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Women	58
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Both sexes	447
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Men	272
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Women	175
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Both sexes	452
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Men	237
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Women	215
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.325
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	685
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	640
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	511
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	223
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	288
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Both sexes	204
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Men	76
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Women	128
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	307
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	147
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	160
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	427
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	190
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	237
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	19.743
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.649
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.094
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Both sexes	1.420
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Men	585
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Women	835
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Both sexes	1.010
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Men	627
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Women	383
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Both sexes	1.647
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Men	1.119
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Women	528
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	910
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	690
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	220
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	768
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Men	338
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Women	430
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.895
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.034
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	861
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Both sexes	3.694
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Men	1.830
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Women	1.864
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.373
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.728
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.645
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Both sexes	727
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Men	525
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Women	202
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.461
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Men	498
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Women	963
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.838
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.675
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.163
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	16.934
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	9.446
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	7.488
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	651
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	355
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	296
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Both sexes	3.872
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Men	2.225
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Women	1.647
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	701
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	337
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	364
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	198
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	84
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	114
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	751
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	443
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	308
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.192
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.534
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	658
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.681
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Men	615
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Women	1.066
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.888
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.853
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.035
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.498
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Men	7.728
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Women	5.770
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	107
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	48
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	59
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	144
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	77
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	67
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Both sexes	223
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Men	135
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Women	88
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Both sexes	183
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Men	121
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Women	62
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	291
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	154
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	137
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Both sexes	1.070
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Men	597
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Women	473
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Both sexes	1.373
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Men	1.273
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Women	100
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Both sexes	1.019
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Men	545
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Women	474
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	324
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	137
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	187
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	775
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	350
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	425
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	913
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Men	500
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Women	413
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Both sexes	751
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Men	355
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Women	396
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	686
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	391
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	295
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	489
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	245
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	244
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	338
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	296
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	42
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	463
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Men	293
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Women	170
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Both sexes	2.146
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Men	954
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Women	1.192
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	858
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	491
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	367
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Both sexes	775
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Men	447
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Women	328
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	570
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	319
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	251
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.130
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	592
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	538
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	706
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	397
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	309
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	40
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	22
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	18
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	384
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	173
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	211
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	8.372
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.063
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.309
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Both sexes	788
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Men	498
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Women	290
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.182
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.983
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.199
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	99
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	52
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	47
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	344
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	147
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	197
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	829
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	425
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	404
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	227
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	103
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	124
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	934
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	515
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	419
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	969
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	340
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	629
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.084
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.314
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.770
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	494
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	177
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	317
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	548
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Men	321
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Women	227
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	995
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Men	592
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Women	403
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.673
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.159
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.514
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Both sexes	569
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Men	569
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Women	..
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	442
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Men	442
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Both sexes	301
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Men	32
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Women	269
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	150
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	150
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	57
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	57
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	855
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	22
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	833
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.688
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.688
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Both sexes	60
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Men	..
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Women	60
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	287
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	287
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.896
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.896
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.024
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.024
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Both sexes	719
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Men	..
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Women	719
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Both sexes	373
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Men	..
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Women	373
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	90
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Men	..
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Women	90
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	239
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	239
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.046
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	590
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	456
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	228
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	121
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	107
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	818
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	469
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	349
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	555
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Men	295
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Women	260
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.457
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.235
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.222
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	612
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Men	345
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Women	267
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Both sexes	676
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Men	281
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Women	395
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	405
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	216
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	189
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.764
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.393
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.371
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Both sexes	10.436
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Men	4.968
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Women	5.468
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	429
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	223
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	206
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	241
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	166
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	75
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Both sexes	413
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Men	178
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Women	235
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Both sexes	2.165
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Men	537
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Women	1.628
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	748
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Men	329
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Women	419
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.076
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.791
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.285
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Both sexes	66
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Men	35
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Women	31
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	365
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	150
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	215
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.654
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.421
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.233
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	11
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	268
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	130
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	138
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.527
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	819
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	708
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	44
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	31
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	13
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Both sexes	17
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Men	1
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Women	16
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	810
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	473
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	337
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	656
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	314
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	342
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	129.603
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	62.445
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	67.158
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.432
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.834
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.598
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	594
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	310
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	284
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Both sexes	738
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Men	334
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Women	404
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Both sexes	81
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Men	61
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Women	19
BALEARS, ILLES	Group 0104 Septicaemia  038	Both sexes	966
BALEARS, ILLES	Group 0104 Septicaemia  038	Men	524
BALEARS, ILLES	Group 0104 Septicaemia  038	Women	442
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	70
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	50
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	19
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	983
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	554
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	429
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Both sexes	8.925
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Men	4.713
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Women	4.212
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	875
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	540
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	335
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	734
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	547
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	187
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	168
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	89
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	80
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	867
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Men	10
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Women	857
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	184
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	184
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	82
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Men	..
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Women	82
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Both sexes	303
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Men	303
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Women	..
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Both sexes	736
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Men	616
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Women	120
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.962
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.754
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.208
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Both sexes	248
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Men	168
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Women	80
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	106
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	58
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	47
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Both sexes	353
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Men	..
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Women	353
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.309
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	629
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	680
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	986
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	457
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	528
BALEARS, ILLES	Group 0301 Anaemias 280-285	Both sexes	665
BALEARS, ILLES	Group 0301 Anaemias 280-285	Men	300
BALEARS, ILLES	Group 0301 Anaemias 280-285	Women	365
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	320
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	157
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	163
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.053
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	935
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.118
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Both sexes	797
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Men	478
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Women	320
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.256
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	458
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	798
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Both sexes	3.352
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Men	1.683
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Women	1.669
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	130
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	54
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	77
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	361
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	256
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	105
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	118
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	78
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	40
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	808
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	477
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	330
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	826
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	344
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	483
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.109
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	475
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	634
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.781
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.947
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.834
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Both sexes	92
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Men	32
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Women	60
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Both sexes	46
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Men	14
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Women	32
BALEARS, ILLES	Group 0603 Epilepsy  345	Both sexes	634
BALEARS, ILLES	Group 0603 Epilepsy  345	Men	368
BALEARS, ILLES	Group 0603 Epilepsy  345	Women	266
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Both sexes	413
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Men	230
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Women	183
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.595
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.303
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.292
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	711
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	392
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	319
BALEARS, ILLES	Grupo 0701 Cataract  366	Both sexes	55
BALEARS, ILLES	Grupo 0701 Cataract  366	Men	37
BALEARS, ILLES	Grupo 0701 Cataract  366	Women	18
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	656
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	355
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	301
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	905
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Men	454
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Women	450
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	14.402
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.363
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.038
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Both sexes	757
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Men	340
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Women	417
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Both sexes	992
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Men	605
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Women	387
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Both sexes	1.253
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Men	924
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Women	329
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	790
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	610
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	180
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	314
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Men	145
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Women	169
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.083
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.189
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	894
BALEARS, ILLES	Grupo 0907 Heart failure  428	Both sexes	2.769
BALEARS, ILLES	Grupo 0907 Heart failure  428	Men	1.370
BALEARS, ILLES	Grupo 0907 Heart failure  428	Women	1.399
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.190
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.259
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	930
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Both sexes	518
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Men	410
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Women	108
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Both sexes	478
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Men	163
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Women	314
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.257
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.348
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	909
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	16.483
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.902
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	7.581
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	932
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	516
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	416
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Both sexes	3.893
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Men	2.187
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Women	1.706
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	3.041
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.342
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.698
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	537
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	253
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	284
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.139
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	663
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	476
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.841
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.999
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	843
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	616
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Men	184
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Women	431
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.485
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.758
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.728
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Both sexes	15.176
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Men	8.282
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Women	6.894
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	234
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	111
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	123
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	184
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	97
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	88
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Both sexes	225
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Men	135
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Women	90
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Both sexes	213
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Men	144
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Women	69
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	672
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	313
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	359
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Both sexes	1.370
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Men	788
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Women	582
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Both sexes	1.251
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Men	1.110
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Women	141
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Both sexes	1.096
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Men	539
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Women	557
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	237
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	108
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	129
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.962
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	879
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.083
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Both sexes	657
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Men	315
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Women	343
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Both sexes	756
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Men	368
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Women	388
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	735
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	454
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	280
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	456
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	206
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	250
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	172
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Men	130
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Women	42
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	378
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Men	233
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Women	145
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Both sexes	2.367
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Men	1.127
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Women	1.240
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	828
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	410
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	418
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Both sexes	708
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Men	440
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Women	268
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	675
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	376
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	299
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.592
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	856
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	737
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.133
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	663
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	470
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	60
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	23
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	37
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	399
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	169
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	230
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.955
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.897
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.058
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Both sexes	1.039
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Men	703
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Women	336
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.417
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.615
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.802
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	101
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	45
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	55
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	505
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	250
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	255
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	865
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	466
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	399
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	723
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	320
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	403
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.744
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	893
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	851
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.560
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	603
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	957
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	8.964
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.450
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.514
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	895
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	304
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	590
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	576
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Men	338
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Women	238
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.987
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Men	1.244
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Women	743
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.605
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.246
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.359
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Both sexes	585
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Men	585
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Women	..
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	678
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Men	678
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Women	..
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Both sexes	379
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Men	36
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Women	343
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	212
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	212
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	107
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	107
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	941
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	18
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	923
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.109
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.109
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Both sexes	167
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Men	..
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Women	167
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	501
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	501
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.082
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.082
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.496
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.496
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Both sexes	2.059
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Men	..
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Women	2.059
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Both sexes	273
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Men	..
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Women	273
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Both sexes	90
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Men	..
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Women	90
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	441
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	441
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.430
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Men	763
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Women	667
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	310
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	155
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	155
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.119
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	608
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	512
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Both sexes	823
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Men	485
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Women	339
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	10.051
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	5.108
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	4.943
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	941
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Men	550
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Women	391
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Both sexes	1.467
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Men	488
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Women	979
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.206
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	581
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	625
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	6.437
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	3.488
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.948
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Both sexes	13.103
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Men	6.916
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Women	6.187
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.013
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	586
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	426
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	451
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	330
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	121
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Both sexes	787
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Men	340
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Women	446
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Both sexes	1.763
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Men	588
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Women	1.175
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	967
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Men	436
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Women	531
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	5.019
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.990
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.029
BALEARS, ILLES	Group 1907 Burns  940-949	Both sexes	112
BALEARS, ILLES	Group 1907 Burns  940-949	Men	63
BALEARS, ILLES	Group 1907 Burns  940-949	Women	48
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	341
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	150
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	190
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.124
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.134
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	989
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	11
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	9
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	516
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	287
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	229
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.370
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.009
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.362
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	48
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	24
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	24
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Both sexes	41
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Men	6
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Women	35
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	546
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	337
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	209
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.735
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	642
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.094
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	177.579
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	82.949
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	94.630
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.735
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.962
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.772
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	404
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	199
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	205
CANARIAS	Group 0102 Imprecise intestinal infections 009	Both sexes	185
CANARIAS	Group 0102 Imprecise intestinal infections 009	Men	88
CANARIAS	Group 0102 Imprecise intestinal infections 009	Women	97
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Both sexes	95
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Men	63
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Women	32
CANARIAS	Group 0104 Septicaemia  038	Both sexes	1.868
CANARIAS	Group 0104 Septicaemia  038	Men	978
CANARIAS	Group 0104 Septicaemia  038	Women	889
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	57
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	48
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	9
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.126
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	586
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	540
CANARIAS	Group 0200 Neoplasms  140-239	Both sexes	16.048
CANARIAS	Group 0200 Neoplasms  140-239	Men	7.977
CANARIAS	Group 0200 Neoplasms  140-239	Women	8.071
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.401
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	870
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	531
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.221
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	886
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	335
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	346
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	208
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	138
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.114
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Men	12
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Women	1.102
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	449
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	449
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	176
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Women	176
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Both sexes	748
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Men	748
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Women	..
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.058
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Men	897
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Women	161
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.653
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.137
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.516
CANARIAS	Group 0210 Carcinoma in situ  230-234	Both sexes	390
CANARIAS	Group 0210 Carcinoma in situ  230-234	Men	127
CANARIAS	Group 0210 Carcinoma in situ  230-234	Women	263
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	193
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	107
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	86
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Both sexes	930
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Men	..
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Women	930
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.369
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	985
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.384
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.248
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	607
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	641
CANARIAS	Group 0301 Anaemias 280-285	Both sexes	678
CANARIAS	Group 0301 Anaemias 280-285	Men	319
CANARIAS	Group 0301 Anaemias 280-285	Women	359
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	570
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	288
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	282
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.966
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.678
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.288
CANARIAS	Group 0401 Diabetes mellitus  249-250	Both sexes	1.190
CANARIAS	Group 0401 Diabetes mellitus  249-250	Men	724
CANARIAS	Group 0401 Diabetes mellitus  249-250	Women	466
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.776
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	954
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.822
CANARIAS	Group 0500 Mental disorders  290-319	Both sexes	3.856
CANARIAS	Group 0500 Mental disorders  290-319	Men	2.161
CANARIAS	Group 0500 Mental disorders  290-319	Women	1.695
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	87
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	50
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	37
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	455
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	369
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	86
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	498
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	377
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	121
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.203
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	710
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	493
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	896
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	344
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	552
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	717
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	311
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	406
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.910
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.019
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.890
CANARIAS	Group 0601 Alzheimer's disease  3310	Both sexes	70
CANARIAS	Group 0601 Alzheimer's disease  3310	Men	20
CANARIAS	Group 0601 Alzheimer's disease  3310	Women	50
CANARIAS	Group 0602 Multiple sclerosis 340	Both sexes	215
CANARIAS	Group 0602 Multiple sclerosis 340	Men	57
CANARIAS	Group 0602 Multiple sclerosis 340	Women	158
CANARIAS	Group 0603 Epilepsy  345	Both sexes	396
CANARIAS	Group 0603 Epilepsy  345	Men	203
CANARIAS	Group 0603 Epilepsy  345	Women	193
CANARIAS	Group 0604 Transient cerebral ischemia 435	Both sexes	383
CANARIAS	Group 0604 Transient cerebral ischemia 435	Men	214
CANARIAS	Group 0604 Transient cerebral ischemia 435	Women	169
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.845
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.525
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.320
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.078
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	570
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	508
CANARIAS	Grupo 0701 Cataract  366	Both sexes	100
CANARIAS	Grupo 0701 Cataract  366	Men	46
CANARIAS	Grupo 0701 Cataract  366	Women	54
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	978
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	524
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	454
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	946
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Men	431
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Women	515
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	23.176
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	13.412
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.764
CANARIAS	Group 0901 Hypertensive disease  401-405	Both sexes	1.380
CANARIAS	Group 0901 Hypertensive disease  401-405	Men	662
CANARIAS	Group 0901 Hypertensive disease  401-405	Women	718
CANARIAS	Group 0902 Angina pectoris  4111, 413	Both sexes	781
CANARIAS	Group 0902 Angina pectoris  4111, 413	Men	461
CANARIAS	Group 0902 Angina pectoris  4111, 413	Women	320
CANARIAS	Group 0903 Acute myocardial infarction  410	Both sexes	2.684
CANARIAS	Group 0903 Acute myocardial infarction  410	Men	1.962
CANARIAS	Group 0903 Acute myocardial infarction  410	Women	722
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.875
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.390
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	485
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	535
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Men	234
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Women	301
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.783
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.616
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.166
CANARIAS	Grupo 0907 Heart failure  428	Both sexes	3.714
CANARIAS	Grupo 0907 Heart failure  428	Men	1.778
CANARIAS	Grupo 0907 Heart failure  428	Women	1.935
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.830
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.153
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.677
CANARIAS	Grupo 0909 Atherosclerosis  440	Both sexes	749
CANARIAS	Grupo 0909 Atherosclerosis  440	Men	539
CANARIAS	Grupo 0909 Atherosclerosis  440	Women	210
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Both sexes	962
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Men	354
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Women	608
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.883
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	2.262
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.621
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	20.046
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	10.638
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	9.408
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	887
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	483
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	404
CANARIAS	Group 1002 Pneumonia 480-486	Both sexes	5.186
CANARIAS	Group 1002 Pneumonia 480-486	Men	2.735
CANARIAS	Group 1002 Pneumonia 480-486	Women	2.450
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.278
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.135
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.143
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.482
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	752
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	730
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.876
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.140
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	736
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.339
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.557
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	782
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	971
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Men	330
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Women	641
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.027
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.505
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.522
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Both sexes	22.310
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Men	12.413
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Women	9.896
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	501
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	220
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	281
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	344
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	183
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	161
CANARIAS	Group 1103 Diseases of the esophagus 530	Both sexes	370
CANARIAS	Group 1103 Diseases of the esophagus 530	Men	236
CANARIAS	Group 1103 Diseases of the esophagus 530	Women	134
CANARIAS	Group 1104 Peptic ulcer 531-534	Both sexes	386
CANARIAS	Group 1104 Peptic ulcer 531-534	Men	262
CANARIAS	Group 1104 Peptic ulcer 531-534	Women	124
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	510
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	238
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	272
CANARIAS	Group 1106 Appendicitis  540-543	Both sexes	1.821
CANARIAS	Group 1106 Appendicitis  540-543	Men	1.086
CANARIAS	Group 1106 Appendicitis  540-543	Women	735
CANARIAS	Group 1107 Inguinal hernia  550	Both sexes	2.722
CANARIAS	Group 1107 Inguinal hernia  550	Men	2.462
CANARIAS	Group 1107 Inguinal hernia  550	Women	260
CANARIAS	Group 1108 Other abdominal hernia  551-553	Both sexes	2.353
CANARIAS	Group 1108 Other abdominal hernia  551-553	Men	1.234
CANARIAS	Group 1108 Other abdominal hernia  551-553	Women	1.119
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	466
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	234
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	232
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.602
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	723
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	879
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Both sexes	778
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Men	397
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Women	381
CANARIAS	Group 1112 Intestinal diverticulosis 562	Both sexes	980
CANARIAS	Group 1112 Intestinal diverticulosis 562	Men	512
CANARIAS	Group 1112 Intestinal diverticulosis 562	Women	468
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	979
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	647
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	332
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	710
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	317
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	393
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	579
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Men	497
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Women	82
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	687
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Men	402
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Women	285
CANARIAS	Group 1117 Cholelithiasis  574	Both sexes	3.984
CANARIAS	Group 1117 Cholelithiasis  574	Men	1.432
CANARIAS	Group 1117 Cholelithiasis  574	Women	2.552
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	898
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	453
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	445
CANARIAS	Group 1119 Pancreatic diseases 577	Both sexes	1.043
CANARIAS	Group 1119 Pancreatic diseases 577	Men	569
CANARIAS	Group 1119 Pancreatic diseases 577	Women	474
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	596
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	309
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	287
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.523
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.383
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.140
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.691
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	996
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	695
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	100
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	52
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	48
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	732
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	335
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	397
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	12.743
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	6.248
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.495
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CANARIAS	Group 1303 Internal derangement of knee 717	Both sexes	2.019
CANARIAS	Group 1303 Internal derangement of knee 717	Men	1.373
CANARIAS	Group 1303 Internal derangement of knee 717	Women	646
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.679
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.961
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.718
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	243
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	63
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	180
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	608
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	330
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	278
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.593
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	749
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	844
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	350
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	143
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	207
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.680
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	941
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	739
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.571
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	688
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	883
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.956
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.455
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	6.501
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.084
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	404
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	680
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	706
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Men	408
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Women	298
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.203
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Men	709
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Women	494
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.048
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.273
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.775
CANARIAS	Group 1405 Prostatic hyperplasia  600	Both sexes	792
CANARIAS	Group 1405 Prostatic hyperplasia  600	Men	792
CANARIAS	Group 1405 Prostatic hyperplasia  600	Women	..
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	728
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Men	728
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CANARIAS	Group 1407 Disorders of breast  610-612	Both sexes	1.077
CANARIAS	Group 1407 Disorders of breast  610-612	Men	128
CANARIAS	Group 1407 Disorders of breast  610-612	Women	949
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	391
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	391
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	142
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	142
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.785
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	13
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.772
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	18.051
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	18.051
CANARIAS	Group 1501 Legally induced abortion  635	Both sexes	166
CANARIAS	Group 1501 Legally induced abortion  635	Men	..
CANARIAS	Group 1501 Legally induced abortion  635	Women	166
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	915
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	915
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.533
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.533
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.023
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.023
CANARIAS	Group 1505 Single spontaneous delivery  650	Both sexes	294
CANARIAS	Group 1505 Single spontaneous delivery  650	Men	..
CANARIAS	Group 1505 Single spontaneous delivery  650	Women	294
CANARIAS	Group 1506 Other deliveries  6695-6697	Both sexes	42
CANARIAS	Group 1506 Other deliveries  6695-6697	Men	..
CANARIAS	Group 1506 Other deliveries  6695-6697	Women	42
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Both sexes	95
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Men	..
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Women	95
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	983
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	983
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.477
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.382
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.095
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	587
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	324
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	263
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.890
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.058
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	832
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.480
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Men	836
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Women	644
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.392
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.839
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.552
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	805
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Men	436
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Women	369
CANARIAS	Group 1802 Abdominal pain   7890	Both sexes	832
CANARIAS	Group 1802 Abdominal pain   7890	Men	310
CANARIAS	Group 1802 Abdominal pain   7890	Women	522
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	825
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	404
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	421
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.930
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.689
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.240
CANARIAS	Group 1900 Injuries and poisoning  800-999	Both sexes	17.399
CANARIAS	Group 1900 Injuries and poisoning  800-999	Men	9.137
CANARIAS	Group 1900 Injuries and poisoning  800-999	Women	8.262
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.093
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	642
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	451
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	653
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	442
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	211
CANARIAS	Group 1903 Radius and ulna fracture 813	Both sexes	1.345
CANARIAS	Group 1903 Radius and ulna fracture 813	Men	571
CANARIAS	Group 1903 Radius and ulna fracture 813	Women	774
CANARIAS	Group 1904 Femur fracture  820-821	Both sexes	2.121
CANARIAS	Group 1904 Femur fracture  820-821	Men	670
CANARIAS	Group 1904 Femur fracture  820-821	Women	1.451
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.632
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Men	743
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Women	889
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.819
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.903
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.916
CANARIAS	Group 1907 Burns  940-949	Both sexes	117
CANARIAS	Group 1907 Burns  940-949	Men	76
CANARIAS	Group 1907 Burns  940-949	Women	41
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	288
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	147
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	141
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	4.797
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.670
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.127
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	26
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	18
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	8
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	508
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	255
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	253
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	4.238
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.799
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.439
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	299
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	153
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	146
CANARIAS	Group 2102 Contraceptive management  V25	Both sexes	177
CANARIAS	Group 2102 Contraceptive management  V25	Men	10
CANARIAS	Group 2102 Contraceptive management  V25	Women	167
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.395
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	808
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	587
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.367
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	828
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.539
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	83.517
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	39.471
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	44.046
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.527
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	833
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	694
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	231
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	111
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	120
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Both sexes	86
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Men	42
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Women	44
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Both sexes	51
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Men	31
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Women	20
Palmas, Las	Group 0104 Septicaemia  038	Both sexes	665
Palmas, Las	Group 0104 Septicaemia  038	Men	371
Palmas, Las	Group 0104 Septicaemia  038	Women	294
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	5
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	3
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	489
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	275
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	214
Palmas, Las	Group 0200 Neoplasms  140-239	Both sexes	7.830
Palmas, Las	Group 0200 Neoplasms  140-239	Men	3.920
Palmas, Las	Group 0200 Neoplasms  140-239	Women	3.910
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	633
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	403
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	230
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	669
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	495
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	174
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	121
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	70
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	51
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	500
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Women	497
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	258
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	258
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	88
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Women	88
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Both sexes	299
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Men	299
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Women	..
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Both sexes	448
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Men	386
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Women	62
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.800
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.581
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.219
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Both sexes	198
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Men	91
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Women	107
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	85
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	50
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	35
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Both sexes	458
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Men	..
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Women	458
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.273
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	542
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	731
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	524
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	246
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	278
Palmas, Las	Group 0301 Anaemias 280-285	Both sexes	272
Palmas, Las	Group 0301 Anaemias 280-285	Men	132
Palmas, Las	Group 0301 Anaemias 280-285	Women	140
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	252
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	114
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	138
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.037
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	898
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.139
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Both sexes	675
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Men	422
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Women	253
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.362
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	476
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	886
Palmas, Las	Group 0500 Mental disorders  290-319	Both sexes	2.095
Palmas, Las	Group 0500 Mental disorders  290-319	Men	1.201
Palmas, Las	Group 0500 Mental disorders  290-319	Women	894
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	58
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	30
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	28
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	186
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	150
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	36
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	261
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	198
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	63
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	692
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	423
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	269
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	477
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	205
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	272
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	421
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	195
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	226
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.486
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	795
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	691
Palmas, Las	Group 0601 Alzheimer's disease  3310	Both sexes	26
Palmas, Las	Group 0601 Alzheimer's disease  3310	Men	9
Palmas, Las	Group 0601 Alzheimer's disease  3310	Women	17
Palmas, Las	Group 0602 Multiple sclerosis 340	Both sexes	33
Palmas, Las	Group 0602 Multiple sclerosis 340	Men	6
Palmas, Las	Group 0602 Multiple sclerosis 340	Women	27
Palmas, Las	Group 0603 Epilepsy  345	Both sexes	175
Palmas, Las	Group 0603 Epilepsy  345	Men	91
Palmas, Las	Group 0603 Epilepsy  345	Women	84
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Both sexes	159
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Men	96
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Women	63
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.093
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	593
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	500
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	293
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	150
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	143
Palmas, Las	Grupo 0701 Cataract  366	Both sexes	13
Palmas, Las	Grupo 0701 Cataract  366	Men	6
Palmas, Las	Grupo 0701 Cataract  366	Women	7
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	280
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	144
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	136
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	497
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Men	228
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Women	269
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	11.430
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.804
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.626
Palmas, Las	Group 0901 Hypertensive disease  401-405	Both sexes	740
Palmas, Las	Group 0901 Hypertensive disease  401-405	Men	355
Palmas, Las	Group 0901 Hypertensive disease  401-405	Women	385
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Both sexes	502
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Men	300
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Women	202
Palmas, Las	Group 0903 Acute myocardial infarction  410	Both sexes	1.537
Palmas, Las	Group 0903 Acute myocardial infarction  410	Men	1.135
Palmas, Las	Group 0903 Acute myocardial infarction  410	Women	402
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	913
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	669
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	244
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	251
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Men	115
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Women	136
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.302
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	772
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	530
Palmas, Las	Grupo 0907 Heart failure  428	Both sexes	1.863
Palmas, Las	Grupo 0907 Heart failure  428	Men	893
Palmas, Las	Grupo 0907 Heart failure  428	Women	970
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.856
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.104
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	752
Palmas, Las	Grupo 0909 Atherosclerosis  440	Both sexes	385
Palmas, Las	Grupo 0909 Atherosclerosis  440	Men	293
Palmas, Las	Grupo 0909 Atherosclerosis  440	Women	92
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Both sexes	439
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Men	167
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Women	272
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.642
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.001
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	641
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	8.835
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.802
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.033
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	346
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	195
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	151
Palmas, Las	Group 1002 Pneumonia 480-486	Both sexes	2.353
Palmas, Las	Group 1002 Pneumonia 480-486	Men	1.310
Palmas, Las	Group 1002 Pneumonia 480-486	Women	1.043
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	894
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Men	467
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Women	427
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	649
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	328
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	321
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	891
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	530
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	361
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	987
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	654
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	333
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	527
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Men	195
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Women	332
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.188
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.123
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.065
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.078
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Men	5.627
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Women	4.451
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	199
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	102
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	97
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	114
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	64
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	50
Palmas, Las	Group 1103 Diseases of the esophagus 530	Both sexes	169
Palmas, Las	Group 1103 Diseases of the esophagus 530	Men	103
Palmas, Las	Group 1103 Diseases of the esophagus 530	Women	66
Palmas, Las	Group 1104 Peptic ulcer 531-534	Both sexes	204
Palmas, Las	Group 1104 Peptic ulcer 531-534	Men	139
Palmas, Las	Group 1104 Peptic ulcer 531-534	Women	65
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	191
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	98
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	93
Palmas, Las	Group 1106 Appendicitis  540-543	Both sexes	922
Palmas, Las	Group 1106 Appendicitis  540-543	Men	564
Palmas, Las	Group 1106 Appendicitis  540-543	Women	358
Palmas, Las	Group 1107 Inguinal hernia  550	Both sexes	1.230
Palmas, Las	Group 1107 Inguinal hernia  550	Men	1.118
Palmas, Las	Group 1107 Inguinal hernia  550	Women	112
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Both sexes	1.194
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Men	598
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Women	596
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	255
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	132
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	123
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	612
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	290
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	322
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Both sexes	392
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Men	188
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Women	204
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Both sexes	440
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Men	225
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Women	215
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	345
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	231
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	114
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	298
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	146
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	152
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	193
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Men	158
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Women	35
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	313
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Men	186
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Women	127
Palmas, Las	Group 1117 Cholelithiasis  574	Both sexes	1.864
Palmas, Las	Group 1117 Cholelithiasis  574	Men	673
Palmas, Las	Group 1117 Cholelithiasis  574	Women	1.191
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	381
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	198
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	183
Palmas, Las	Group 1119 Pancreatic diseases 577	Both sexes	542
Palmas, Las	Group 1119 Pancreatic diseases 577	Men	301
Palmas, Las	Group 1119 Pancreatic diseases 577	Women	241
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	220
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	113
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	107
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.023
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	556
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	467
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	591
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	354
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	237
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	26
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	14
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	406
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	190
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	216
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.033
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.996
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.037
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Palmas, Las	Group 1303 Internal derangement of knee 717	Both sexes	896
Palmas, Las	Group 1303 Internal derangement of knee 717	Men	653
Palmas, Las	Group 1303 Internal derangement of knee 717	Women	243
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.033
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	852
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.181
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	139
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	42
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	97
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	347
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	181
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	166
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.001
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	464
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	537
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	203
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	82
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	121
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	693
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	399
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	294
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	721
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	323
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	398
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.207
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.126
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.081
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	552
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	196
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	356
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	388
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Men	223
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Women	165
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	519
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Men	324
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Women	195
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.194
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	523
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	671
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Both sexes	427
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Men	427
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Women	..
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	346
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Men	346
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Palmas, Las	Group 1407 Disorders of breast  610-612	Both sexes	681
Palmas, Las	Group 1407 Disorders of breast  610-612	Men	80
Palmas, Las	Group 1407 Disorders of breast  610-612	Women	601
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	158
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	158
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	73
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	73
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	869
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	862
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.965
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.965
Palmas, Las	Group 1501 Legally induced abortion  635	Both sexes	85
Palmas, Las	Group 1501 Legally induced abortion  635	Men	..
Palmas, Las	Group 1501 Legally induced abortion  635	Women	85
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	442
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	442
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.189
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.189
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.658
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.658
Palmas, Las	Group 1505 Single spontaneous delivery  650	Both sexes	116
Palmas, Las	Group 1505 Single spontaneous delivery  650	Men	..
Palmas, Las	Group 1505 Single spontaneous delivery  650	Women	116
Palmas, Las	Group 1506 Other deliveries  6695-6697	Both sexes	22
Palmas, Las	Group 1506 Other deliveries  6695-6697	Men	..
Palmas, Las	Group 1506 Other deliveries  6695-6697	Women	22
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Both sexes	50
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Men	..
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Women	50
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	403
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	403
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.413
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Men	789
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Women	624
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	316
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	168
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	148
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.097
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	621
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	476
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Both sexes	909
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Men	526
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Women	383
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.744
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.009
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.735
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	327
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Men	169
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Women	158
Palmas, Las	Group 1802 Abdominal pain   7890	Both sexes	282
Palmas, Las	Group 1802 Abdominal pain   7890	Men	106
Palmas, Las	Group 1802 Abdominal pain   7890	Women	176
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	589
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	289
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	300
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.546
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.445
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.101
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Both sexes	7.657
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Men	4.143
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Women	3.514
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	567
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	352
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	215
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	206
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	144
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	62
Palmas, Las	Group 1903 Radius and ulna fracture 813	Both sexes	479
Palmas, Las	Group 1903 Radius and ulna fracture 813	Men	226
Palmas, Las	Group 1903 Radius and ulna fracture 813	Women	253
Palmas, Las	Group 1904 Femur fracture  820-821	Both sexes	992
Palmas, Las	Group 1904 Femur fracture  820-821	Men	341
Palmas, Las	Group 1904 Femur fracture  820-821	Women	651
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	730
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Men	352
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Women	378
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.088
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.272
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	816
Palmas, Las	Group 1907 Burns  940-949	Both sexes	58
Palmas, Las	Group 1907 Burns  940-949	Men	38
Palmas, Las	Group 1907 Burns  940-949	Women	20
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	160
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	81
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	79
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.200
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.236
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	964
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	164
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	93
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	71
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.934
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	822
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.112
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	186
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	98
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	88
Palmas, Las	Group 2102 Contraceptive management  V25	Both sexes	73
Palmas, Las	Group 2102 Contraceptive management  V25	Men	2
Palmas, Las	Group 2102 Contraceptive management  V25	Women	71
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	476
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	255
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	221
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.199
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	467
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	732
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	94.062
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	43.478
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	50.584
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.208
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.129
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.078
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	173
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	88
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	85
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Both sexes	99
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Men	46
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Women	53
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Both sexes	44
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Men	32
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Women	12
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Both sexes	1.203
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Men	607
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Women	595
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	52
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	45
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	637
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	311
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	326
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Both sexes	8.218
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Men	4.057
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Women	4.161
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	768
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	467
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	301
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	552
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	391
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	161
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	225
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	138
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	87
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	614
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Men	9
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Women	605
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	191
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	191
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	88
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Women	88
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Both sexes	449
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Men	449
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Women	..
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Both sexes	610
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Men	511
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Women	99
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.853
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.556
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.297
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Both sexes	192
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Men	36
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Women	156
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	108
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	57
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	51
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Both sexes	472
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Men	..
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Women	472
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.096
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	443
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	653
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	724
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	361
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	363
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Both sexes	406
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Men	187
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Women	219
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	318
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	174
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	144
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.929
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	780
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.149
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Both sexes	515
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Men	302
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Women	213
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.414
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	478
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	936
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Both sexes	1.761
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Men	960
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Women	801
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	29
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	20
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	9
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	269
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	219
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	50
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	237
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	179
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	58
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	511
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	287
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	224
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	419
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	139
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	280
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	296
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	116
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	180
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.424
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.224
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.199
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Both sexes	44
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Men	11
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Women	33
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Both sexes	182
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Men	51
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Women	131
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Both sexes	221
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Men	112
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Women	109
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Both sexes	224
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Men	118
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Women	106
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.752
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	932
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	820
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	785
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	420
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	365
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Both sexes	87
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Men	40
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Women	47
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	698
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	380
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	318
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	449
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Men	203
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Women	246
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	11.746
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.608
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	5.138
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Both sexes	640
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Men	307
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Women	333
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Both sexes	279
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Men	161
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Women	118
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Both sexes	1.147
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Men	827
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Women	320
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	962
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	721
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	241
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	284
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Men	119
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Women	165
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.481
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	844
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	636
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Both sexes	1.851
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Men	885
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Women	965
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.974
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.049
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	925
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Both sexes	364
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Men	246
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Women	118
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Both sexes	523
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Men	187
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Women	336
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.241
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.261
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	980
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	11.211
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.836
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.375
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	541
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	288
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	253
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Both sexes	2.833
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Men	1.425
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Women	1.407
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.384
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Men	668
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Women	716
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	833
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	424
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	409
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	985
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	610
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	375
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.352
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	903
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	449
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	444
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Men	135
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Women	309
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.839
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.382
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.457
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Both sexes	12.232
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Men	6.786
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Women	5.445
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	302
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	118
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	184
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	230
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	119
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	111
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Both sexes	201
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Men	133
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Women	68
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Both sexes	182
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Men	123
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Women	59
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	319
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	140
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	179
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Both sexes	899
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Men	522
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Women	377
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Both sexes	1.492
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Men	1.344
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Women	148
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Both sexes	1.159
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Men	636
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Women	523
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	211
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	102
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	109
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	990
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	433
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	557
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Both sexes	386
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Men	209
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Women	177
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Both sexes	540
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Men	287
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Women	253
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	634
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	416
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	218
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	412
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	171
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	241
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	386
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Men	339
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Women	47
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	374
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Men	216
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Women	158
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Both sexes	2.120
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Men	759
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Women	1.361
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	517
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	255
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	262
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Both sexes	501
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Men	268
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Women	233
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	376
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	196
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	180
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.500
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	827
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	673
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.100
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	642
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	458
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	74
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	40
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	34
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	326
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	145
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	181
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.710
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.252
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.458
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Both sexes	1.123
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Men	720
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Women	403
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.646
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.109
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.537
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	104
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	21
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	83
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	261
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	149
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	112
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	592
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	285
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	307
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	147
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	61
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	86
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	987
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	542
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	445
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	850
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	365
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	485
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.749
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.329
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.420
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	532
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	208
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	324
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	318
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Men	185
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Women	133
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	684
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Men	385
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Women	299
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.854
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	750
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.104
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Both sexes	365
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Men	365
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Women	..
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	382
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Men	382
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Both sexes	396
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Men	48
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Women	348
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	233
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	233
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	69
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	69
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	916
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	6
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	910
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.086
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.086
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Both sexes	81
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Men	..
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Women	81
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	473
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	473
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.344
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.344
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.365
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.365
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Both sexes	178
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Men	..
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Women	178
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Both sexes	20
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Men	..
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Women	20
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Both sexes	45
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Men	..
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Women	45
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	580
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	580
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.064
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Men	593
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Women	471
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	271
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	156
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	115
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	793
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	437
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	356
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Both sexes	571
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Men	310
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Women	261
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.648
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.830
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.817
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	478
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Men	267
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Women	211
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Both sexes	550
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Men	204
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Women	346
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	236
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	115
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	121
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.384
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.244
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.139
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Both sexes	9.742
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Men	4.994
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Women	4.748
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	526
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	290
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	236
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	447
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	298
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	149
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Both sexes	866
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Men	345
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Women	521
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Both sexes	1.129
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Men	329
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Women	800
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	902
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Men	391
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Women	511
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.731
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.631
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.100
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Both sexes	59
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Men	38
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Women	21
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	128
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	66
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	62
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.597
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.434
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.163
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	10
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	344
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	162
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	182
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.304
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	977
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.327
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	113
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	55
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	58
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Both sexes	104
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Men	8
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Women	96
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	919
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	553
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	366
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.168
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	361
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	807
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	60.659
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	29.542
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	31.117
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.593
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	888
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	705
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	241
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	132
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	109
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Both sexes	26
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Men	12
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Women	14
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Both sexes	51
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Men	28
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Women	23
CANTABRIA	Group 0104 Septicaemia  038	Both sexes	839
CANTABRIA	Group 0104 Septicaemia  038	Men	443
CANTABRIA	Group 0104 Septicaemia  038	Women	396
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	20
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	17
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	416
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	256
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	160
CANTABRIA	Group 0200 Neoplasms  140-239	Both sexes	5.604
CANTABRIA	Group 0200 Neoplasms  140-239	Men	2.939
CANTABRIA	Group 0200 Neoplasms  140-239	Women	2.665
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	533
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	311
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	222
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	430
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	328
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	102
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	103
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	54
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	49
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	380
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Men	1
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Women	379
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	106
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	106
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	50
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Women	50
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	179
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Men	179
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	476
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Men	382
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Women	94
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.047
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.191
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	856
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Both sexes	132
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Men	63
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Women	69
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	78
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	49
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	29
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	217
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Women	217
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	873
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	381
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	492
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	670
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	344
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	326
CANTABRIA	Group 0301 Anaemias 280-285	Both sexes	445
CANTABRIA	Group 0301 Anaemias 280-285	Men	212
CANTABRIA	Group 0301 Anaemias 280-285	Women	233
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	225
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	132
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	93
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.139
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	443
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	696
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Both sexes	386
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Men	206
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Women	180
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	753
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	237
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	516
CANTABRIA	Group 0500 Mental disorders  290-319	Both sexes	1.088
CANTABRIA	Group 0500 Mental disorders  290-319	Men	531
CANTABRIA	Group 0500 Mental disorders  290-319	Women	557
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	88
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	40
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	48
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	120
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	93
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	27
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	55
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	34
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	21
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	267
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	122
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	145
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	212
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	82
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	130
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	346
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	160
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	186
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.225
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	592
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	633
CANTABRIA	Group 0601 Alzheimer's disease  3310	Both sexes	63
CANTABRIA	Group 0601 Alzheimer's disease  3310	Men	27
CANTABRIA	Group 0601 Alzheimer's disease  3310	Women	36
CANTABRIA	Group 0602 Multiple sclerosis 340	Both sexes	15
CANTABRIA	Group 0602 Multiple sclerosis 340	Men	4
CANTABRIA	Group 0602 Multiple sclerosis 340	Women	11
CANTABRIA	Group 0603 Epilepsy  345	Both sexes	183
CANTABRIA	Group 0603 Epilepsy  345	Men	107
CANTABRIA	Group 0603 Epilepsy  345	Women	76
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Both sexes	180
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Men	78
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Women	102
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	784
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	376
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	408
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	183
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	102
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	81
CANTABRIA	Grupo 0701 Cataract  366	Both sexes	29
CANTABRIA	Grupo 0701 Cataract  366	Men	15
CANTABRIA	Grupo 0701 Cataract  366	Women	14
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	154
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	87
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	67
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	234
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	114
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	120
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.378
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.927
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.451
CANTABRIA	Group 0901 Hypertensive disease  401-405	Both sexes	494
CANTABRIA	Group 0901 Hypertensive disease  401-405	Men	234
CANTABRIA	Group 0901 Hypertensive disease  401-405	Women	260
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Both sexes	379
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Men	232
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Women	147
CANTABRIA	Group 0903 Acute myocardial infarction  410	Both sexes	573
CANTABRIA	Group 0903 Acute myocardial infarction  410	Men	404
CANTABRIA	Group 0903 Acute myocardial infarction  410	Women	169
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	650
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	512
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	138
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	272
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Men	110
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Women	162
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.180
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	677
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	503
CANTABRIA	Grupo 0907 Heart failure  428	Both sexes	1.463
CANTABRIA	Grupo 0907 Heart failure  428	Men	757
CANTABRIA	Grupo 0907 Heart failure  428	Women	706
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.366
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	696
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	670
CANTABRIA	Grupo 0909 Atherosclerosis  440	Both sexes	424
CANTABRIA	Grupo 0909 Atherosclerosis  440	Men	332
CANTABRIA	Grupo 0909 Atherosclerosis  440	Women	92
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Both sexes	44
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Men	20
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Women	24
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.533
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	953
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	580
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.509
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.158
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.351
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	295
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	139
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	156
CANTABRIA	Group 1002 Pneumonia 480-486	Both sexes	1.474
CANTABRIA	Group 1002 Pneumonia 480-486	Men	864
CANTABRIA	Group 1002 Pneumonia 480-486	Women	610
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	321
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	144
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	177
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	492
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	256
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	236
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	327
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	209
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	118
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.527
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.107
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	420
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	530
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Men	193
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Women	337
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.543
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.246
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.297
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.421
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Men	3.513
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Women	2.908
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	60
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	26
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	34
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	86
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	49
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	37
CANTABRIA	Group 1103 Diseases of the esophagus 530	Both sexes	117
CANTABRIA	Group 1103 Diseases of the esophagus 530	Men	64
CANTABRIA	Group 1103 Diseases of the esophagus 530	Women	53
CANTABRIA	Group 1104 Peptic ulcer 531-534	Both sexes	154
CANTABRIA	Group 1104 Peptic ulcer 531-534	Men	95
CANTABRIA	Group 1104 Peptic ulcer 531-534	Women	59
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	140
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	70
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	70
CANTABRIA	Group 1106 Appendicitis  540-543	Both sexes	610
CANTABRIA	Group 1106 Appendicitis  540-543	Men	358
CANTABRIA	Group 1106 Appendicitis  540-543	Women	252
CANTABRIA	Group 1107 Inguinal hernia  550	Both sexes	424
CANTABRIA	Group 1107 Inguinal hernia  550	Men	353
CANTABRIA	Group 1107 Inguinal hernia  550	Women	71
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Both sexes	478
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Men	225
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Women	253
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	170
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	81
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	89
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	379
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	183
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	196
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	330
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Men	171
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Women	159
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Both sexes	319
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Men	138
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Women	181
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	261
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	163
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	98
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	238
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	95
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	143
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	117
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Men	89
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Women	28
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	193
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Men	124
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Women	69
CANTABRIA	Group 1117 Cholelithiasis  574	Both sexes	1.348
CANTABRIA	Group 1117 Cholelithiasis  574	Men	641
CANTABRIA	Group 1117 Cholelithiasis  574	Women	707
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	329
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	188
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	141
CANTABRIA	Group 1119 Pancreatic diseases 577	Both sexes	374
CANTABRIA	Group 1119 Pancreatic diseases 577	Men	223
CANTABRIA	Group 1119 Pancreatic diseases 577	Women	151
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	294
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	177
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	117
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	638
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	310
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	328
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	328
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	176
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	152
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	42
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	21
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	21
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	268
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	113
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	155
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.649
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.215
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.434
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CANTABRIA	Group 1303 Internal derangement of knee 717	Both sexes	419
CANTABRIA	Group 1303 Internal derangement of knee 717	Men	305
CANTABRIA	Group 1303 Internal derangement of knee 717	Women	114
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.198
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.047
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.151
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	105
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	39
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	66
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	98
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	41
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	57
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	204
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	101
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	103
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	23
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	12
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	11
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	588
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	309
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	279
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.014
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	361
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	653
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.386
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.625
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.761
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	251
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	101
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	150
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	360
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Men	218
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Women	142
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	390
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Men	245
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Women	145
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	975
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	420
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	555
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Both sexes	268
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Men	268
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Women	..
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	364
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Men	364
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CANTABRIA	Group 1407 Disorders of breast  610-612	Both sexes	97
CANTABRIA	Group 1407 Disorders of breast  610-612	Men	9
CANTABRIA	Group 1407 Disorders of breast  610-612	Women	88
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	124
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	124
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	74
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	74
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	483
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	483
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.054
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.054
CANTABRIA	Group 1501 Legally induced abortion  635	Both sexes	2
CANTABRIA	Group 1501 Legally induced abortion  635	Men	..
CANTABRIA	Group 1501 Legally induced abortion  635	Women	2
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	495
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	495
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.444
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.444
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	545
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	545
CANTABRIA	Group 1505 Single spontaneous delivery  650	Both sexes	84
CANTABRIA	Group 1505 Single spontaneous delivery  650	Men	..
CANTABRIA	Group 1505 Single spontaneous delivery  650	Women	84
CANTABRIA	Group 1506 Other deliveries  6695-6697	Both sexes	47
CANTABRIA	Group 1506 Other deliveries  6695-6697	Men	..
CANTABRIA	Group 1506 Other deliveries  6695-6697	Women	47
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Both sexes	86
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Men	..
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Women	86
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	351
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	351
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	773
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	402
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	371
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	138
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	67
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	71
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	635
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	335
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	300
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	459
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Men	299
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Women	160
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.607
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.831
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.776
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	270
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Men	150
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Women	120
CANTABRIA	Group 1802 Abdominal pain   7890	Both sexes	179
CANTABRIA	Group 1802 Abdominal pain   7890	Men	73
CANTABRIA	Group 1802 Abdominal pain   7890	Women	106
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.451
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	673
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	778
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.707
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	935
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	772
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Both sexes	6.931
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Men	3.641
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Women	3.290
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	360
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	205
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	155
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	130
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	93
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	37
CANTABRIA	Group 1903 Radius and ulna fracture 813	Both sexes	458
CANTABRIA	Group 1903 Radius and ulna fracture 813	Men	164
CANTABRIA	Group 1903 Radius and ulna fracture 813	Women	294
CANTABRIA	Group 1904 Femur fracture  820-821	Both sexes	867
CANTABRIA	Group 1904 Femur fracture  820-821	Men	239
CANTABRIA	Group 1904 Femur fracture  820-821	Women	628
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	503
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Men	259
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Women	244
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.860
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.211
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	649
CANTABRIA	Group 1907 Burns  940-949	Both sexes	29
CANTABRIA	Group 1907 Burns  940-949	Men	13
CANTABRIA	Group 1907 Burns  940-949	Women	16
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	133
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	73
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	60
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.093
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.177
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	916
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	24
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	19
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	474
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	188
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	286
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.118
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	668
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	450
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	55
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	32
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	23
CANTABRIA	Group 2102 Contraceptive management  V25	Both sexes	12
CANTABRIA	Group 2102 Contraceptive management  V25	Men	..
CANTABRIA	Group 2102 Contraceptive management  V25	Women	12
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	515
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	355
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	160
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	536
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	281
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	255
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	268.958
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	135.531
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	133.427
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	6.617
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	3.682
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.935
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.321
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	699
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	622
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Both sexes	411
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Men	199
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Women	212
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Both sexes	206
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Men	126
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Women	80
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Both sexes	3.085
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Men	1.753
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Women	1.332
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	86
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	62
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	24
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.508
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	843
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	665
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Both sexes	27.750
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Men	15.289
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Women	12.461
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	3.460
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	2.203
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.257
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.994
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.586
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	408
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	626
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	338
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	288
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.746
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Men	14
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Women	1.732
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	471
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	471
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	298
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Women	298
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.068
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Men	1.068
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Women	..
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.446
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Men	2.096
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Women	350
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	9.853
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	5.783
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	4.070
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Both sexes	443
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Men	162
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Women	281
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	288
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	180
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	108
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.048
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Men	..
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Women	1.048
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	4.009
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.859
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.150
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.468
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.255
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.213
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Both sexes	1.603
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Men	782
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Women	821
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	865
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	473
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	392
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	5.013
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	2.108
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.905
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Both sexes	1.741
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Men	970
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Women	771
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.272
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.138
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.134
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Both sexes	6.269
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Men	3.177
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Women	3.092
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	208
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	102
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	106
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	499
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	386
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	113
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	439
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	350
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	89
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.611
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	926
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	685
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.582
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	525
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.057
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.930
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	888
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.042
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.062
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.401
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.661
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Both sexes	141
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Men	48
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Women	93
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Both sexes	155
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Men	64
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Women	91
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Both sexes	802
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Men	455
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Women	347
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Both sexes	923
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Men	422
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Women	501
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.041
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.412
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.629
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.939
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	976
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	963
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Both sexes	380
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Men	178
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Women	202
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.559
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	798
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	761
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.719
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Men	859
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Women	860
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	37.147
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	20.818
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	16.329
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Both sexes	2.036
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Men	812
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Women	1.224
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Both sexes	1.232
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Men	838
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Women	394
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Both sexes	3.447
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Men	2.472
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Women	975
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.704
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.307
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	397
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.657
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Men	781
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Women	876
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.826
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.665
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.161
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Both sexes	8.294
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Men	4.002
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Women	4.292
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	5.883
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.147
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.736
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Both sexes	1.129
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Men	852
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Women	277
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Both sexes	982
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Men	380
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Women	602
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	5.957
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.562
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.395
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	36.005
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	20.967
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	15.038
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.585
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	825
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	760
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Both sexes	7.916
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Men	4.841
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Women	3.075
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.733
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.213
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.520
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.935
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.028
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	907
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	3.380
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	2.224
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.156
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	5.671
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	4.554
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.117
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.372
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Men	415
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Women	957
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	11.413
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	5.867
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	5.546
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Both sexes	35.833
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Men	21.320
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Women	14.513
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	412
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	206
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	206
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	455
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	266
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	189
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Both sexes	603
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Men	381
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Women	222
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Both sexes	730
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Men	468
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Women	262
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	863
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	456
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	407
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Both sexes	2.588
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Men	1.483
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Women	1.105
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Both sexes	5.530
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Men	4.971
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Women	559
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Both sexes	2.780
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Men	1.508
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Women	1.272
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	526
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	275
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	251
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	2.210
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.042
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.168
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Both sexes	2.019
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Men	1.069
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Women	950
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Both sexes	1.491
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Men	712
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Women	779
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.882
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.238
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	644
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.403
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	661
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	742
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	590
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Men	511
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Women	79
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.062
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Men	651
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Women	411
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Both sexes	6.003
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Men	2.818
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Women	3.185
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.575
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	907
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	668
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Both sexes	1.499
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Men	838
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Women	661
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.612
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	859
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	753
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.951
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.644
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.307
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.682
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.014
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	668
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	121
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	57
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	64
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	1.148
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	573
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	575
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	16.357
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	7.924
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	8.433
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Both sexes	1.899
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Men	1.280
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Women	619
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	6.512
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	3.035
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.477
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	426
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	139
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	287
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	770
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	403
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	367
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.306
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	673
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	633
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	567
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	268
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	299
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	2.270
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.276
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	994
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.607
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	850
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.757
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	17.260
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.596
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	8.664
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.224
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	494
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	730
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.590
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Men	963
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Women	627
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.380
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Men	1.386
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Women	994
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.612
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.822
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.790
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Both sexes	1.489
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Men	1.489
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Women	..
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.350
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Men	1.350
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Both sexes	631
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Men	65
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Women	566
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	410
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	410
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	266
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	266
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.308
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	27
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.281
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.867
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.867
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Both sexes	11
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Men	..
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Women	11
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.342
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.342
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.713
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.713
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.390
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.390
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Both sexes	1.312
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Men	..
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Women	1.312
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Both sexes	766
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Men	..
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Women	766
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Both sexes	156
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Men	..
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Women	156
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.177
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.177
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.837
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.537
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.300
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	595
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	301
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	294
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.242
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.236
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	1.006
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.485
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Men	874
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Women	611
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	12.951
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	7.148
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.803
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.204
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Men	748
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Women	456
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Both sexes	1.414
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Men	599
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Women	815
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2.172
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1.205
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	967
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.161
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.596
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.565
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Both sexes	24.129
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Men	12.146
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Women	11.983
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.440
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	814
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	626
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	728
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	499
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	229
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Both sexes	1.132
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Men	512
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Women	620
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Both sexes	4.591
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Men	1.180
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Women	3.411
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.455
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Men	713
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Women	742
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	6.656
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.993
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.663
CASTILLA Y LEËN	Group 1907 Burns  940-949	Both sexes	184
CASTILLA Y LEËN	Group 1907 Burns  940-949	Men	113
CASTILLA Y LEËN	Group 1907 Burns  940-949	Women	71
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	708
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	341
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	367
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	6.462
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	3.590
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.872
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	33
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	22
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	11
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	740
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	369
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	371
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	5.299
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	2.810
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.489
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	160
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	98
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	62
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Both sexes	123
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Men	5
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Women	118
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	2.346
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.406
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	940
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.670
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.301
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.369
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.708
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	7.482
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	7.226
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	411
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	218
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	193
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	126
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	56
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	70
┴vila	Group 0102 Imprecise intestinal infections 009	Both sexes	13
┴vila	Group 0102 Imprecise intestinal infections 009	Men	3
┴vila	Group 0102 Imprecise intestinal infections 009	Women	10
┴vila	Group 0103 Tuberculosis 010-018, 137	Both sexes	7
┴vila	Group 0103 Tuberculosis 010-018, 137	Men	3
┴vila	Group 0103 Tuberculosis 010-018, 137	Women	4
┴vila	Group 0104 Septicaemia  038	Both sexes	165
┴vila	Group 0104 Septicaemia  038	Men	96
┴vila	Group 0104 Septicaemia  038	Women	69
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	8
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	5
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	92
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	55
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	37
┴vila	Group 0200 Neoplasms  140-239	Both sexes	1.338
┴vila	Group 0200 Neoplasms  140-239	Men	738
┴vila	Group 0200 Neoplasms  140-239	Women	600
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	188
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	112
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	76
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	94
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	85
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	9
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	45
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	26
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	19
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	113
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Men	..
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Women	113
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	38
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	38
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	16
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Men	..
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Women	16
┴vila	Group 0207 Malignant neoplasm of prostate  185	Both sexes	68
┴vila	Group 0207 Malignant neoplasm of prostate  185	Men	68
┴vila	Group 0207 Malignant neoplasm of prostate  185	Women	..
┴vila	Group 0208 Malignant neoplasm of bladder  188	Both sexes	126
┴vila	Group 0208 Malignant neoplasm of bladder  188	Men	104
┴vila	Group 0208 Malignant neoplasm of bladder  188	Women	22
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	432
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	286
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	146
┴vila	Group 0210 Carcinoma in situ  230-234	Both sexes	16
┴vila	Group 0210 Carcinoma in situ  230-234	Men	9
┴vila	Group 0210 Carcinoma in situ  230-234	Women	7
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	16
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	10
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	6
┴vila	Grupo 0212 Leiomyoma of uterus  218	Both sexes	54
┴vila	Grupo 0212 Leiomyoma of uterus  218	Men	..
┴vila	Grupo 0212 Leiomyoma of uterus  218	Women	54
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	132
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	38
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	94
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	115
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	62
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	53
┴vila	Group 0301 Anaemias 280-285	Both sexes	69
┴vila	Group 0301 Anaemias 280-285	Men	32
┴vila	Group 0301 Anaemias 280-285	Women	37
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	46
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	30
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	16
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	315
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	121
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	194
┴vila	Group 0401 Diabetes mellitus  249-250	Both sexes	97
┴vila	Group 0401 Diabetes mellitus  249-250	Men	56
┴vila	Group 0401 Diabetes mellitus  249-250	Women	41
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	218
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	65
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	153
┴vila	Group 0500 Mental disorders  290-319	Both sexes	345
┴vila	Group 0500 Mental disorders  290-319	Men	155
┴vila	Group 0500 Mental disorders  290-319	Women	190
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	7
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	4
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	18
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	11
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	7
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	12
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	7
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	79
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	47
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	32
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	90
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	33
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	57
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	139
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	53
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	86
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	264
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	119
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	145
┴vila	Group 0601 Alzheimer's disease  3310	Both sexes	4
┴vila	Group 0601 Alzheimer's disease  3310	Men	..
┴vila	Group 0601 Alzheimer's disease  3310	Women	4
┴vila	Group 0602 Multiple sclerosis 340	Both sexes	2
┴vila	Group 0602 Multiple sclerosis 340	Men	..
┴vila	Group 0602 Multiple sclerosis 340	Women	2
┴vila	Group 0603 Epilepsy  345	Both sexes	53
┴vila	Group 0603 Epilepsy  345	Men	28
┴vila	Group 0603 Epilepsy  345	Women	25
┴vila	Group 0604 Transient cerebral ischemia 435	Both sexes	54
┴vila	Group 0604 Transient cerebral ischemia 435	Men	18
┴vila	Group 0604 Transient cerebral ischemia 435	Women	36
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	151
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	73
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	78
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	77
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	51
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	26
┴vila	Grupo 0701 Cataract  366	Both sexes	15
┴vila	Grupo 0701 Cataract  366	Men	9
┴vila	Grupo 0701 Cataract  366	Women	6
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	62
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	42
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	20
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	68
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Men	29
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Women	39
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.941
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.018
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	923
┴vila	Group 0901 Hypertensive disease  401-405	Both sexes	123
┴vila	Group 0901 Hypertensive disease  401-405	Men	53
┴vila	Group 0901 Hypertensive disease  401-405	Women	70
┴vila	Group 0902 Angina pectoris  4111, 413	Both sexes	105
┴vila	Group 0902 Angina pectoris  4111, 413	Men	69
┴vila	Group 0902 Angina pectoris  4111, 413	Women	36
┴vila	Group 0903 Acute myocardial infarction  410	Both sexes	128
┴vila	Group 0903 Acute myocardial infarction  410	Men	90
┴vila	Group 0903 Acute myocardial infarction  410	Women	38
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	12
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	9
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	3
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	109
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Men	57
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Women	52
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	314
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	167
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	147
┴vila	Grupo 0907 Heart failure  428	Both sexes	584
┴vila	Grupo 0907 Heart failure  428	Men	265
┴vila	Grupo 0907 Heart failure  428	Women	319
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	328
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	179
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	149
┴vila	Grupo 0909 Atherosclerosis  440	Both sexes	1
┴vila	Grupo 0909 Atherosclerosis  440	Men	..
┴vila	Grupo 0909 Atherosclerosis  440	Women	1
┴vila	Group 0910 Varicose veins of lower extremities 454	Both sexes	42
┴vila	Group 0910 Varicose veins of lower extremities 454	Men	19
┴vila	Group 0910 Varicose veins of lower extremities 454	Women	23
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	195
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	110
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	85
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.253
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.350
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	903
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	59
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	35
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	24
┴vila	Group 1002 Pneumonia 480-486	Both sexes	444
┴vila	Group 1002 Pneumonia 480-486	Men	267
┴vila	Group 1002 Pneumonia 480-486	Women	177
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	83
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Men	40
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Women	43
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	91
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	52
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	39
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	221
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	156
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	65
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	326
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	284
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	42
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	62
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Men	11
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Women	51
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	967
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	505
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	462
┴vila	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.212
┴vila	Group 1100 Diseases of the digestive system  520-579	Men	1.351
┴vila	Group 1100 Diseases of the digestive system  520-579	Women	861
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	27
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	15
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	12
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	23
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	13
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	10
┴vila	Group 1103 Diseases of the esophagus 530	Both sexes	42
┴vila	Group 1103 Diseases of the esophagus 530	Men	28
┴vila	Group 1103 Diseases of the esophagus 530	Women	14
┴vila	Group 1104 Peptic ulcer 531-534	Both sexes	39
┴vila	Group 1104 Peptic ulcer 531-534	Men	30
┴vila	Group 1104 Peptic ulcer 531-534	Women	9
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	39
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	25
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	14
┴vila	Group 1106 Appendicitis  540-543	Both sexes	163
┴vila	Group 1106 Appendicitis  540-543	Men	95
┴vila	Group 1106 Appendicitis  540-543	Women	68
┴vila	Group 1107 Inguinal hernia  550	Both sexes	423
┴vila	Group 1107 Inguinal hernia  550	Men	379
┴vila	Group 1107 Inguinal hernia  550	Women	44
┴vila	Group 1108 Other abdominal hernia  551-553	Both sexes	142
┴vila	Group 1108 Other abdominal hernia  551-553	Men	81
┴vila	Group 1108 Other abdominal hernia  551-553	Women	61
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	21
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	10
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	11
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	139
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	65
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	74
┴vila	Group 1111 Intestinal obstruction without hernia 560	Both sexes	109
┴vila	Group 1111 Intestinal obstruction without hernia 560	Men	68
┴vila	Group 1111 Intestinal obstruction without hernia 560	Women	41
┴vila	Group 1112 Intestinal diverticulosis 562	Both sexes	67
┴vila	Group 1112 Intestinal diverticulosis 562	Men	27
┴vila	Group 1112 Intestinal diverticulosis 562	Women	40
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	132
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	80
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	52
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	75
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	34
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	41
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	28
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Men	22
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Women	6
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	53
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Men	26
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Women	27
┴vila	Group 1117 Cholelithiasis  574	Both sexes	355
┴vila	Group 1117 Cholelithiasis  574	Men	163
┴vila	Group 1117 Cholelithiasis  574	Women	192
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	109
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	58
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	51
┴vila	Group 1119 Pancreatic diseases 577	Both sexes	94
┴vila	Group 1119 Pancreatic diseases 577	Men	60
┴vila	Group 1119 Pancreatic diseases 577	Women	34
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	132
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	72
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	60
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	193
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	107
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	86
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	125
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	73
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	52
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	5
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	4
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	1
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	63
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	30
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	33
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	490
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	223
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	267
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
┴vila	Group 1303 Internal derangement of knee 717	Both sexes	68
┴vila	Group 1303 Internal derangement of knee 717	Men	43
┴vila	Group 1303 Internal derangement of knee 717	Women	25
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	212
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	94
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	118
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	12
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	3
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	9
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	5
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	3
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	2
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	31
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	20
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	11
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	5
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	1
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	4
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	75
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	45
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	30
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	82
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	14
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	68
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.010
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	576
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	434
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	52
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	27
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	25
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	85
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Men	53
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Women	32
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	131
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Men	76
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Women	55
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	395
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	206
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	189
┴vila	Group 1405 Prostatic hyperplasia  600	Both sexes	107
┴vila	Group 1405 Prostatic hyperplasia  600	Men	107
┴vila	Group 1405 Prostatic hyperplasia  600	Women	..
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	105
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Men	105
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Women	..
┴vila	Group 1407 Disorders of breast  610-612	Both sexes	16
┴vila	Group 1407 Disorders of breast  610-612	Men	2
┴vila	Group 1407 Disorders of breast  610-612	Women	14
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	27
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	27
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	5
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	5
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	87
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	87
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.113
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.113
┴vila	Group 1501 Legally induced abortion  635	Both sexes	..
┴vila	Group 1501 Legally induced abortion  635	Men	..
┴vila	Group 1501 Legally induced abortion  635	Women	..
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	79
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	79
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	589
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	589
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	292
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	292
┴vila	Group 1505 Single spontaneous delivery  650	Both sexes	38
┴vila	Group 1505 Single spontaneous delivery  650	Men	..
┴vila	Group 1505 Single spontaneous delivery  650	Women	38
┴vila	Group 1506 Other deliveries  6695-6697	Both sexes	43
┴vila	Group 1506 Other deliveries  6695-6697	Men	..
┴vila	Group 1506 Other deliveries  6695-6697	Women	43
┴vila	Group 1507 Complications related to the puerperium  670-676	Both sexes	14
┴vila	Group 1507 Complications related to the puerperium  670-676	Men	..
┴vila	Group 1507 Complications related to the puerperium  670-676	Women	14
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	58
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	58
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	245
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Men	138
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Women	107
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	30
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	14
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	16
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	215
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	124
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	91
┴vila	Grupo 1700 Congenital abnormalities  740-759	Both sexes	52
┴vila	Grupo 1700 Congenital abnormalities  740-759	Men	37
┴vila	Grupo 1700 Congenital abnormalities  740-759	Women	15
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.035
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	598
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	437
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	135
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Men	92
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Women	43
┴vila	Group 1802 Abdominal pain   7890	Both sexes	140
┴vila	Group 1802 Abdominal pain   7890	Men	64
┴vila	Group 1802 Abdominal pain   7890	Women	76
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	..
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	760
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	442
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	318
┴vila	Group 1900 Injuries and poisoning  800-999	Both sexes	1.145
┴vila	Group 1900 Injuries and poisoning  800-999	Men	550
┴vila	Group 1900 Injuries and poisoning  800-999	Women	595
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	92
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	50
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	42
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	25
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	19
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	6
┴vila	Group 1903 Radius and ulna fracture 813	Both sexes	40
┴vila	Group 1903 Radius and ulna fracture 813	Men	17
┴vila	Group 1903 Radius and ulna fracture 813	Women	23
┴vila	Group 1904 Femur fracture  820-821	Both sexes	292
┴vila	Group 1904 Femur fracture  820-821	Men	80
┴vila	Group 1904 Femur fracture  820-821	Women	212
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	82
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Men	39
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Women	43
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	237
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	143
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	94
┴vila	Group 1907 Burns  940-949	Both sexes	5
┴vila	Group 1907 Burns  940-949	Men	3
┴vila	Group 1907 Burns  940-949	Women	2
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	26
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	15
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	11
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	292
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	157
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	135
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	54
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	27
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	27
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	86
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	41
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	45
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	3
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	1
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
┴vila	Group 2102 Contraceptive management  V25	Both sexes	6
┴vila	Group 2102 Contraceptive management  V25	Men	..
┴vila	Group 2102 Contraceptive management  V25	Women	6
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	47
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	25
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	22
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	30
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	15
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	15
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	42.881
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	21.983
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	20.898
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.104
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	663
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	441
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	190
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	103
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	87
Burgos	Group 0102 Imprecise intestinal infections 009	Both sexes	49
Burgos	Group 0102 Imprecise intestinal infections 009	Men	25
Burgos	Group 0102 Imprecise intestinal infections 009	Women	24
Burgos	Group 0103 Tuberculosis 010-018, 137	Both sexes	54
Burgos	Group 0103 Tuberculosis 010-018, 137	Men	34
Burgos	Group 0103 Tuberculosis 010-018, 137	Women	20
Burgos	Group 0104 Septicaemia  038	Both sexes	536
Burgos	Group 0104 Septicaemia  038	Men	325
Burgos	Group 0104 Septicaemia  038	Women	211
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	37
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	28
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	9
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	238
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	148
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	90
Burgos	Group 0200 Neoplasms  140-239	Both sexes	4.436
Burgos	Group 0200 Neoplasms  140-239	Men	2.435
Burgos	Group 0200 Neoplasms  140-239	Women	2.001
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	551
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	374
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	177
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	340
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	244
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	96
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	104
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	59
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	45
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	291
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Women	290
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	58
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	58
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	52
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Women	52
Burgos	Group 0207 Malignant neoplasm of prostate  185	Both sexes	137
Burgos	Group 0207 Malignant neoplasm of prostate  185	Men	137
Burgos	Group 0207 Malignant neoplasm of prostate  185	Women	..
Burgos	Group 0208 Malignant neoplasm of bladder  188	Both sexes	382
Burgos	Group 0208 Malignant neoplasm of bladder  188	Men	344
Burgos	Group 0208 Malignant neoplasm of bladder  188	Women	38
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.622
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	958
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	664
Burgos	Group 0210 Carcinoma in situ  230-234	Both sexes	88
Burgos	Group 0210 Carcinoma in situ  230-234	Men	27
Burgos	Group 0210 Carcinoma in situ  230-234	Women	61
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	88
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	54
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	34
Burgos	Grupo 0212 Leiomyoma of uterus  218	Both sexes	109
Burgos	Grupo 0212 Leiomyoma of uterus  218	Men	..
Burgos	Grupo 0212 Leiomyoma of uterus  218	Women	109
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	614
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	237
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	377
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	446
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	211
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	235
Burgos	Group 0301 Anaemias 280-285	Both sexes	318
Burgos	Group 0301 Anaemias 280-285	Men	152
Burgos	Group 0301 Anaemias 280-285	Women	166
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	128
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	59
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	69
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	760
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	329
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	431
Burgos	Group 0401 Diabetes mellitus  249-250	Both sexes	220
Burgos	Group 0401 Diabetes mellitus  249-250	Men	103
Burgos	Group 0401 Diabetes mellitus  249-250	Women	117
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	540
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	226
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	314
Burgos	Group 0500 Mental disorders  290-319	Both sexes	1.112
Burgos	Group 0500 Mental disorders  290-319	Men	462
Burgos	Group 0500 Mental disorders  290-319	Women	650
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	13
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	5
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	8
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	85
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	68
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	17
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	29
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	24
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	260
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	136
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	124
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	485
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	123
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	362
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	240
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	106
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	134
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	728
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	385
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	343
Burgos	Group 0601 Alzheimer's disease  3310	Both sexes	13
Burgos	Group 0601 Alzheimer's disease  3310	Men	4
Burgos	Group 0601 Alzheimer's disease  3310	Women	9
Burgos	Group 0602 Multiple sclerosis 340	Both sexes	12
Burgos	Group 0602 Multiple sclerosis 340	Men	7
Burgos	Group 0602 Multiple sclerosis 340	Women	5
Burgos	Group 0603 Epilepsy  345	Both sexes	140
Burgos	Group 0603 Epilepsy  345	Men	77
Burgos	Group 0603 Epilepsy  345	Women	63
Burgos	Group 0604 Transient cerebral ischemia 435	Both sexes	111
Burgos	Group 0604 Transient cerebral ischemia 435	Men	63
Burgos	Group 0604 Transient cerebral ischemia 435	Women	48
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	452
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	234
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	218
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	441
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	220
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	221
Burgos	Grupo 0701 Cataract  366	Both sexes	121
Burgos	Grupo 0701 Cataract  366	Men	62
Burgos	Grupo 0701 Cataract  366	Women	59
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	320
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	158
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	162
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	242
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Men	126
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Women	116
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.957
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.830
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.127
Burgos	Group 0901 Hypertensive disease  401-405	Both sexes	196
Burgos	Group 0901 Hypertensive disease  401-405	Men	86
Burgos	Group 0901 Hypertensive disease  401-405	Women	110
Burgos	Group 0902 Angina pectoris  4111, 413	Both sexes	179
Burgos	Group 0902 Angina pectoris  4111, 413	Men	134
Burgos	Group 0902 Angina pectoris  4111, 413	Women	45
Burgos	Group 0903 Acute myocardial infarction  410	Both sexes	328
Burgos	Group 0903 Acute myocardial infarction  410	Men	252
Burgos	Group 0903 Acute myocardial infarction  410	Women	76
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	205
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	160
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	45
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	175
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Men	80
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Women	95
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	697
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	385
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	312
Burgos	Grupo 0907 Heart failure  428	Both sexes	1.354
Burgos	Grupo 0907 Heart failure  428	Men	662
Burgos	Grupo 0907 Heart failure  428	Women	692
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	919
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	503
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	416
Burgos	Grupo 0909 Atherosclerosis  440	Both sexes	193
Burgos	Grupo 0909 Atherosclerosis  440	Men	142
Burgos	Grupo 0909 Atherosclerosis  440	Women	51
Burgos	Group 0910 Varicose veins of lower extremities 454	Both sexes	35
Burgos	Group 0910 Varicose veins of lower extremities 454	Men	13
Burgos	Group 0910 Varicose veins of lower extremities 454	Women	22
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	676
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	413
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	263
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.023
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.543
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.480
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	404
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	207
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	197
Burgos	Group 1002 Pneumonia 480-486	Both sexes	1.523
Burgos	Group 1002 Pneumonia 480-486	Men	944
Burgos	Group 1002 Pneumonia 480-486	Women	579
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	332
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Men	158
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Women	174
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	342
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	185
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	157
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	501
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	342
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	159
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.042
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	793
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	249
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	314
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Men	120
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Women	194
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.565
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	794
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	771
Burgos	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.893
Burgos	Group 1100 Diseases of the digestive system  520-579	Men	3.593
Burgos	Group 1100 Diseases of the digestive system  520-579	Women	2.300
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	58
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	30
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	28
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	77
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	48
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	29
Burgos	Group 1103 Diseases of the esophagus 530	Both sexes	90
Burgos	Group 1103 Diseases of the esophagus 530	Men	60
Burgos	Group 1103 Diseases of the esophagus 530	Women	30
Burgos	Group 1104 Peptic ulcer 531-534	Both sexes	109
Burgos	Group 1104 Peptic ulcer 531-534	Men	74
Burgos	Group 1104 Peptic ulcer 531-534	Women	35
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	110
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	59
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	51
Burgos	Group 1106 Appendicitis  540-543	Both sexes	453
Burgos	Group 1106 Appendicitis  540-543	Men	256
Burgos	Group 1106 Appendicitis  540-543	Women	197
Burgos	Group 1107 Inguinal hernia  550	Both sexes	1.101
Burgos	Group 1107 Inguinal hernia  550	Men	958
Burgos	Group 1107 Inguinal hernia  550	Women	143
Burgos	Group 1108 Other abdominal hernia  551-553	Both sexes	533
Burgos	Group 1108 Other abdominal hernia  551-553	Men	291
Burgos	Group 1108 Other abdominal hernia  551-553	Women	242
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	69
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	35
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	34
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	376
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	181
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	195
Burgos	Group 1111 Intestinal obstruction without hernia 560	Both sexes	364
Burgos	Group 1111 Intestinal obstruction without hernia 560	Men	203
Burgos	Group 1111 Intestinal obstruction without hernia 560	Women	161
Burgos	Group 1112 Intestinal diverticulosis 562	Both sexes	163
Burgos	Group 1112 Intestinal diverticulosis 562	Men	73
Burgos	Group 1112 Intestinal diverticulosis 562	Women	90
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	267
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	171
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	96
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	197
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	88
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	109
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	97
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Men	80
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Women	17
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	196
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Men	110
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Women	86
Burgos	Group 1117 Cholelithiasis  574	Both sexes	812
Burgos	Group 1117 Cholelithiasis  574	Men	381
Burgos	Group 1117 Cholelithiasis  574	Women	431
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	304
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	171
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	133
Burgos	Group 1119 Pancreatic diseases 577	Both sexes	275
Burgos	Group 1119 Pancreatic diseases 577	Men	169
Burgos	Group 1119 Pancreatic diseases 577	Women	106
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	242
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	155
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	87
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	675
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	388
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	287
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	335
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	211
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	124
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	30
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	16
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	14
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	310
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	161
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	149
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.810
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.492
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.318
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Burgos	Group 1303 Internal derangement of knee 717	Both sexes	552
Burgos	Group 1303 Internal derangement of knee 717	Men	360
Burgos	Group 1303 Internal derangement of knee 717	Women	192
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	976
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	522
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	454
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	47
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	15
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	32
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	110
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	62
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	48
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	161
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	98
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	63
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	98
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	46
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	52
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	418
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	251
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	167
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	448
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	138
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	310
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.781
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.367
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.414
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	244
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	96
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	148
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	201
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Men	117
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Women	84
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	457
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Men	262
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Women	195
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.000
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	518
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	482
Burgos	Group 1405 Prostatic hyperplasia  600	Both sexes	209
Burgos	Group 1405 Prostatic hyperplasia  600	Men	209
Burgos	Group 1405 Prostatic hyperplasia  600	Women	..
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	147
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Men	147
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Burgos	Group 1407 Disorders of breast  610-612	Both sexes	147
Burgos	Group 1407 Disorders of breast  610-612	Men	9
Burgos	Group 1407 Disorders of breast  610-612	Women	138
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	69
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	69
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	18
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	18
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	289
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	9
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	280
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.104
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.104
Burgos	Group 1501 Legally induced abortion  635	Both sexes	4
Burgos	Group 1501 Legally induced abortion  635	Men	..
Burgos	Group 1501 Legally induced abortion  635	Women	4
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	183
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	183
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.887
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.887
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	622
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	622
Burgos	Group 1505 Single spontaneous delivery  650	Both sexes	145
Burgos	Group 1505 Single spontaneous delivery  650	Men	..
Burgos	Group 1505 Single spontaneous delivery  650	Women	145
Burgos	Group 1506 Other deliveries  6695-6697	Both sexes	51
Burgos	Group 1506 Other deliveries  6695-6697	Men	..
Burgos	Group 1506 Other deliveries  6695-6697	Women	51
Burgos	Group 1507 Complications related to the puerperium  670-676	Both sexes	20
Burgos	Group 1507 Complications related to the puerperium  670-676	Men	..
Burgos	Group 1507 Complications related to the puerperium  670-676	Women	20
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	192
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	192
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	553
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Men	299
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Women	254
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	114
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	60
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	54
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	439
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	239
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	200
Burgos	Grupo 1700 Congenital abnormalities  740-759	Both sexes	325
Burgos	Grupo 1700 Congenital abnormalities  740-759	Men	179
Burgos	Grupo 1700 Congenital abnormalities  740-759	Women	146
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.643
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	882
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	761
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	126
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Men	76
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Women	50
Burgos	Group 1802 Abdominal pain   7890	Both sexes	241
Burgos	Group 1802 Abdominal pain   7890	Men	109
Burgos	Group 1802 Abdominal pain   7890	Women	132
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.274
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	697
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	577
Burgos	Group 1900 Injuries and poisoning  800-999	Both sexes	4.122
Burgos	Group 1900 Injuries and poisoning  800-999	Men	2.207
Burgos	Group 1900 Injuries and poisoning  800-999	Women	1.915
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	268
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	159
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	109
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	178
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	126
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	52
Burgos	Group 1903 Radius and ulna fracture 813	Both sexes	241
Burgos	Group 1903 Radius and ulna fracture 813	Men	103
Burgos	Group 1903 Radius and ulna fracture 813	Women	138
Burgos	Group 1904 Femur fracture  820-821	Both sexes	611
Burgos	Group 1904 Femur fracture  820-821	Men	171
Burgos	Group 1904 Femur fracture  820-821	Women	440
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	222
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Men	116
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Women	106
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.381
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	853
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	528
Burgos	Group 1907 Burns  940-949	Both sexes	56
Burgos	Group 1907 Burns  940-949	Men	33
Burgos	Group 1907 Burns  940-949	Women	23
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	92
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	47
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	45
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	939
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	531
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	408
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	8
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	6
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	126
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	62
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	64
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	726
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	372
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	354
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	33
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	23
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	10
Burgos	Group 2102 Contraceptive management  V25	Both sexes	13
Burgos	Group 2102 Contraceptive management  V25	Men	..
Burgos	Group 2102 Contraceptive management  V25	Women	13
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	127
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	66
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	61
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	553
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	283
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	270
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	59.446
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	29.232
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	30.214
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.100
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	603
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	497
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	187
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	105
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	82
Le¾n	Group 0102 Imprecise intestinal infections 009	Both sexes	187
Le¾n	Group 0102 Imprecise intestinal infections 009	Men	96
Le¾n	Group 0102 Imprecise intestinal infections 009	Women	91
Le¾n	Group 0103 Tuberculosis 010-018, 137	Both sexes	59
Le¾n	Group 0103 Tuberculosis 010-018, 137	Men	39
Le¾n	Group 0103 Tuberculosis 010-018, 137	Women	20
Le¾n	Group 0104 Septicaemia  038	Both sexes	396
Le¾n	Group 0104 Septicaemia  038	Men	213
Le¾n	Group 0104 Septicaemia  038	Women	183
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	..
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	271
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	150
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	121
Le¾n	Group 0200 Neoplasms  140-239	Both sexes	6.055
Le¾n	Group 0200 Neoplasms  140-239	Men	3.238
Le¾n	Group 0200 Neoplasms  140-239	Women	2.817
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	856
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	510
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	346
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	404
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	331
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	73
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	259
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	134
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	125
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	377
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Men	7
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Women	370
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	110
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	110
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	68
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Women	68
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Both sexes	213
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Men	213
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Women	..
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Both sexes	593
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Men	489
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Women	104
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.079
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.167
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	912
Le¾n	Group 0210 Carcinoma in situ  230-234	Both sexes	124
Le¾n	Group 0210 Carcinoma in situ  230-234	Men	38
Le¾n	Group 0210 Carcinoma in situ  230-234	Women	86
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	62
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	43
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	19
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Both sexes	206
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Men	..
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Women	206
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	704
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	306
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	398
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	460
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	226
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	234
Le¾n	Group 0301 Anaemias 280-285	Both sexes	293
Le¾n	Group 0301 Anaemias 280-285	Men	127
Le¾n	Group 0301 Anaemias 280-285	Women	166
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	167
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	99
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	68
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	970
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	414
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	556
Le¾n	Group 0401 Diabetes mellitus  249-250	Both sexes	336
Le¾n	Group 0401 Diabetes mellitus  249-250	Men	183
Le¾n	Group 0401 Diabetes mellitus  249-250	Women	153
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	634
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	231
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	403
Le¾n	Group 0500 Mental disorders  290-319	Both sexes	1.084
Le¾n	Group 0500 Mental disorders  290-319	Men	559
Le¾n	Group 0500 Mental disorders  290-319	Women	525
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	60
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	29
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	31
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	47
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	38
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	9
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	20
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	14
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	6
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	350
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	203
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	147
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	202
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	77
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	125
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	405
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	198
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	207
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.161
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	549
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	612
Le¾n	Group 0601 Alzheimer's disease  3310	Both sexes	32
Le¾n	Group 0601 Alzheimer's disease  3310	Men	11
Le¾n	Group 0601 Alzheimer's disease  3310	Women	21
Le¾n	Group 0602 Multiple sclerosis 340	Both sexes	48
Le¾n	Group 0602 Multiple sclerosis 340	Men	17
Le¾n	Group 0602 Multiple sclerosis 340	Women	31
Le¾n	Group 0603 Epilepsy  345	Both sexes	138
Le¾n	Group 0603 Epilepsy  345	Men	76
Le¾n	Group 0603 Epilepsy  345	Women	62
Le¾n	Group 0604 Transient cerebral ischemia 435	Both sexes	299
Le¾n	Group 0604 Transient cerebral ischemia 435	Men	136
Le¾n	Group 0604 Transient cerebral ischemia 435	Women	163
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	644
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	309
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	335
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	660
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	336
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	324
Le¾n	Grupo 0701 Cataract  366	Both sexes	143
Le¾n	Grupo 0701 Cataract  366	Men	61
Le¾n	Grupo 0701 Cataract  366	Women	82
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	517
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	275
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	242
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	220
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Men	104
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Women	116
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.265
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.051
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.214
Le¾n	Group 0901 Hypertensive disease  401-405	Both sexes	640
Le¾n	Group 0901 Hypertensive disease  401-405	Men	249
Le¾n	Group 0901 Hypertensive disease  401-405	Women	391
Le¾n	Group 0902 Angina pectoris  4111, 413	Both sexes	167
Le¾n	Group 0902 Angina pectoris  4111, 413	Men	113
Le¾n	Group 0902 Angina pectoris  4111, 413	Women	54
Le¾n	Group 0903 Acute myocardial infarction  410	Both sexes	809
Le¾n	Group 0903 Acute myocardial infarction  410	Men	584
Le¾n	Group 0903 Acute myocardial infarction  410	Women	225
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	457
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	354
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	103
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	377
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Men	196
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Women	181
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.156
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	565
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	591
Le¾n	Grupo 0907 Heart failure  428	Both sexes	2.013
Le¾n	Grupo 0907 Heart failure  428	Men	990
Le¾n	Grupo 0907 Heart failure  428	Women	1.023
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.345
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	698
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	647
Le¾n	Grupo 0909 Atherosclerosis  440	Both sexes	249
Le¾n	Grupo 0909 Atherosclerosis  440	Men	184
Le¾n	Grupo 0909 Atherosclerosis  440	Women	65
Le¾n	Group 0910 Varicose veins of lower extremities 454	Both sexes	387
Le¾n	Group 0910 Varicose veins of lower extremities 454	Men	142
Le¾n	Group 0910 Varicose veins of lower extremities 454	Women	245
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.665
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	976
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	689
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.728
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.354
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.374
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	225
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	117
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	108
Le¾n	Group 1002 Pneumonia 480-486	Both sexes	1.667
Le¾n	Group 1002 Pneumonia 480-486	Men	993
Le¾n	Group 1002 Pneumonia 480-486	Women	674
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	534
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Men	251
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Women	283
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	285
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	151
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	134
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	588
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	366
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	222
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.245
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	935
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	310
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	277
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Men	78
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Women	199
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.907
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.463
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.444
Le¾n	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.500
Le¾n	Group 1100 Diseases of the digestive system  520-579	Men	4.458
Le¾n	Group 1100 Diseases of the digestive system  520-579	Women	3.042
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	97
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	40
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	57
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	95
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	56
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	39
Le¾n	Group 1103 Diseases of the esophagus 530	Both sexes	90
Le¾n	Group 1103 Diseases of the esophagus 530	Men	63
Le¾n	Group 1103 Diseases of the esophagus 530	Women	27
Le¾n	Group 1104 Peptic ulcer 531-534	Both sexes	116
Le¾n	Group 1104 Peptic ulcer 531-534	Men	72
Le¾n	Group 1104 Peptic ulcer 531-534	Women	44
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	227
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	112
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	115
Le¾n	Group 1106 Appendicitis  540-543	Both sexes	508
Le¾n	Group 1106 Appendicitis  540-543	Men	295
Le¾n	Group 1106 Appendicitis  540-543	Women	213
Le¾n	Group 1107 Inguinal hernia  550	Both sexes	1.215
Le¾n	Group 1107 Inguinal hernia  550	Men	1.095
Le¾n	Group 1107 Inguinal hernia  550	Women	120
Le¾n	Group 1108 Other abdominal hernia  551-553	Both sexes	571
Le¾n	Group 1108 Other abdominal hernia  551-553	Men	340
Le¾n	Group 1108 Other abdominal hernia  551-553	Women	231
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	97
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	54
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	43
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	524
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	236
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	288
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Both sexes	378
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Men	195
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Women	183
Le¾n	Group 1112 Intestinal diverticulosis 562	Both sexes	367
Le¾n	Group 1112 Intestinal diverticulosis 562	Men	178
Le¾n	Group 1112 Intestinal diverticulosis 562	Women	189
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	424
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	286
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	138
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	369
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	163
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	206
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	112
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Men	91
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Women	21
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	196
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Men	108
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Women	88
Le¾n	Group 1117 Cholelithiasis  574	Both sexes	1.251
Le¾n	Group 1117 Cholelithiasis  574	Men	590
Le¾n	Group 1117 Cholelithiasis  574	Women	661
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	301
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	174
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	127
Le¾n	Group 1119 Pancreatic diseases 577	Both sexes	312
Le¾n	Group 1119 Pancreatic diseases 577	Men	163
Le¾n	Group 1119 Pancreatic diseases 577	Women	149
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	250
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	147
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	103
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	728
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	399
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	329
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	376
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	232
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	144
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	35
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	13
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	22
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	317
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	154
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	163
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.624
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.139
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.485
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Le¾n	Group 1303 Internal derangement of knee 717	Both sexes	464
Le¾n	Group 1303 Internal derangement of knee 717	Men	295
Le¾n	Group 1303 Internal derangement of knee 717	Women	169
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.761
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	779
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	982
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	88
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	37
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	51
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	298
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	154
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	144
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	375
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	184
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	191
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	287
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	131
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	156
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	682
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	336
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	346
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	669
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	223
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	446
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.556
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.423
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.133
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	189
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	79
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	110
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	309
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Men	187
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Women	122
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	381
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Men	205
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Women	176
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.223
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	495
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	728
Le¾n	Group 1405 Prostatic hyperplasia  600	Both sexes	202
Le¾n	Group 1405 Prostatic hyperplasia  600	Men	202
Le¾n	Group 1405 Prostatic hyperplasia  600	Women	..
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	239
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Men	239
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Le¾n	Group 1407 Disorders of breast  610-612	Both sexes	131
Le¾n	Group 1407 Disorders of breast  610-612	Men	15
Le¾n	Group 1407 Disorders of breast  610-612	Women	116
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	73
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	73
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	147
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	147
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	662
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	661
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.671
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.671
Le¾n	Group 1501 Legally induced abortion  635	Both sexes	4
Le¾n	Group 1501 Legally induced abortion  635	Men	..
Le¾n	Group 1501 Legally induced abortion  635	Women	4
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	245
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	245
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.046
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.046
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	575
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	575
Le¾n	Group 1505 Single spontaneous delivery  650	Both sexes	413
Le¾n	Group 1505 Single spontaneous delivery  650	Men	..
Le¾n	Group 1505 Single spontaneous delivery  650	Women	413
Le¾n	Group 1506 Other deliveries  6695-6697	Both sexes	154
Le¾n	Group 1506 Other deliveries  6695-6697	Men	..
Le¾n	Group 1506 Other deliveries  6695-6697	Women	154
Le¾n	Group 1507 Complications related to the puerperium  670-676	Both sexes	36
Le¾n	Group 1507 Complications related to the puerperium  670-676	Men	..
Le¾n	Group 1507 Complications related to the puerperium  670-676	Women	36
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	198
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	198
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	530
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Men	286
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Women	244
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	147
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	75
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	72
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	383
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	211
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	172
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Both sexes	274
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Men	158
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Women	116
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.666
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.394
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.272
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	232
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Men	137
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Women	95
Le¾n	Group 1802 Abdominal pain   7890	Both sexes	278
Le¾n	Group 1802 Abdominal pain   7890	Men	101
Le¾n	Group 1802 Abdominal pain   7890	Women	177
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	390
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	182
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	208
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.766
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	974
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	792
Le¾n	Group 1900 Injuries and poisoning  800-999	Both sexes	5.381
Le¾n	Group 1900 Injuries and poisoning  800-999	Men	2.604
Le¾n	Group 1900 Injuries and poisoning  800-999	Women	2.777
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	363
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	200
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	163
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	168
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	111
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	57
Le¾n	Group 1903 Radius and ulna fracture 813	Both sexes	211
Le¾n	Group 1903 Radius and ulna fracture 813	Men	97
Le¾n	Group 1903 Radius and ulna fracture 813	Women	114
Le¾n	Group 1904 Femur fracture  820-821	Both sexes	1.104
Le¾n	Group 1904 Femur fracture  820-821	Men	296
Le¾n	Group 1904 Femur fracture  820-821	Women	808
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	321
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Men	141
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Women	180
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.608
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	918
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	690
Le¾n	Group 1907 Burns  940-949	Both sexes	34
Le¾n	Group 1907 Burns  940-949	Men	23
Le¾n	Group 1907 Burns  940-949	Women	11
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	114
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	49
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	65
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.281
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	689
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	592
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	12
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	9
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	165
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	71
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	94
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.813
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	937
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	876
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	38
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	25
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	13
Le¾n	Group 2102 Contraceptive management  V25	Both sexes	18
Le¾n	Group 2102 Contraceptive management  V25	Men	..
Le¾n	Group 2102 Contraceptive management  V25	Women	18
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	436
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	275
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	161
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.321
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	637
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	684
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.188
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	9.367
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	8.821
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	435
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	245
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	190
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	147
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	83
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	64
Palencia	Group 0102 Imprecise intestinal infections 009	Both sexes	20
Palencia	Group 0102 Imprecise intestinal infections 009	Men	10
Palencia	Group 0102 Imprecise intestinal infections 009	Women	10
Palencia	Group 0103 Tuberculosis 010-018, 137	Both sexes	19
Palencia	Group 0103 Tuberculosis 010-018, 137	Men	10
Palencia	Group 0103 Tuberculosis 010-018, 137	Women	9
Palencia	Group 0104 Septicaemia  038	Both sexes	108
Palencia	Group 0104 Septicaemia  038	Men	60
Palencia	Group 0104 Septicaemia  038	Women	48
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	9
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	6
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	132
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	76
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	56
Palencia	Group 0200 Neoplasms  140-239	Both sexes	1.665
Palencia	Group 0200 Neoplasms  140-239	Men	957
Palencia	Group 0200 Neoplasms  140-239	Women	708
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	208
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	146
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	62
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	109
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	91
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	18
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	8
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	1
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	7
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	108
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Women	107
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	35
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	35
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	12
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Women	12
Palencia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	60
Palencia	Group 0207 Malignant neoplasm of prostate  185	Men	60
Palencia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Palencia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	173
Palencia	Group 0208 Malignant neoplasm of bladder  188	Men	145
Palencia	Group 0208 Malignant neoplasm of bladder  188	Women	28
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	612
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	389
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	223
Palencia	Group 0210 Carcinoma in situ  230-234	Both sexes	28
Palencia	Group 0210 Carcinoma in situ  230-234	Men	10
Palencia	Group 0210 Carcinoma in situ  230-234	Women	18
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	14
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	10
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	4
Palencia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	73
Palencia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Palencia	Grupo 0212 Leiomyoma of uterus  218	Women	73
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	225
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	104
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	121
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	160
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	96
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	64
Palencia	Group 0301 Anaemias 280-285	Both sexes	115
Palencia	Group 0301 Anaemias 280-285	Men	73
Palencia	Group 0301 Anaemias 280-285	Women	42
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	45
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	23
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	22
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	285
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	126
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	159
Palencia	Group 0401 Diabetes mellitus  249-250	Both sexes	109
Palencia	Group 0401 Diabetes mellitus  249-250	Men	51
Palencia	Group 0401 Diabetes mellitus  249-250	Women	58
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	176
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	75
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	101
Palencia	Group 0500 Mental disorders  290-319	Both sexes	715
Palencia	Group 0500 Mental disorders  290-319	Men	405
Palencia	Group 0500 Mental disorders  290-319	Women	310
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	38
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	18
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	20
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	57
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	43
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	14
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	117
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	102
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	15
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	164
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	101
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	63
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	155
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	41
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	114
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	184
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	100
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	84
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	343
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	167
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	176
Palencia	Group 0601 Alzheimer's disease  3310	Both sexes	30
Palencia	Group 0601 Alzheimer's disease  3310	Men	9
Palencia	Group 0601 Alzheimer's disease  3310	Women	21
Palencia	Group 0602 Multiple sclerosis 340	Both sexes	31
Palencia	Group 0602 Multiple sclerosis 340	Men	15
Palencia	Group 0602 Multiple sclerosis 340	Women	16
Palencia	Group 0603 Epilepsy  345	Both sexes	64
Palencia	Group 0603 Epilepsy  345	Men	39
Palencia	Group 0603 Epilepsy  345	Women	25
Palencia	Group 0604 Transient cerebral ischemia 435	Both sexes	58
Palencia	Group 0604 Transient cerebral ischemia 435	Men	25
Palencia	Group 0604 Transient cerebral ischemia 435	Women	33
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	160
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	79
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	81
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	94
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	44
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	50
Palencia	Grupo 0701 Cataract  366	Both sexes	38
Palencia	Grupo 0701 Cataract  366	Men	17
Palencia	Grupo 0701 Cataract  366	Women	21
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	56
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	27
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	29
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	97
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	53
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	44
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.329
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.204
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.125
Palencia	Group 0901 Hypertensive disease  401-405	Both sexes	204
Palencia	Group 0901 Hypertensive disease  401-405	Men	77
Palencia	Group 0901 Hypertensive disease  401-405	Women	127
Palencia	Group 0902 Angina pectoris  4111, 413	Both sexes	92
Palencia	Group 0902 Angina pectoris  4111, 413	Men	60
Palencia	Group 0902 Angina pectoris  4111, 413	Women	32
Palencia	Group 0903 Acute myocardial infarction  410	Both sexes	221
Palencia	Group 0903 Acute myocardial infarction  410	Men	145
Palencia	Group 0903 Acute myocardial infarction  410	Women	76
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	97
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	71
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	26
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	98
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Men	48
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Women	50
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	468
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	245
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	223
Palencia	Grupo 0907 Heart failure  428	Both sexes	499
Palencia	Grupo 0907 Heart failure  428	Men	223
Palencia	Grupo 0907 Heart failure  428	Women	276
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	347
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	166
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	181
Palencia	Grupo 0909 Atherosclerosis  440	Both sexes	23
Palencia	Grupo 0909 Atherosclerosis  440	Men	10
Palencia	Grupo 0909 Atherosclerosis  440	Women	13
Palencia	Group 0910 Varicose veins of lower extremities 454	Both sexes	4
Palencia	Group 0910 Varicose veins of lower extremities 454	Men	1
Palencia	Group 0910 Varicose veins of lower extremities 454	Women	3
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	276
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	158
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	118
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.910
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.658
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.252
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	176
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	91
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	85
Palencia	Group 1002 Pneumonia 480-486	Both sexes	492
Palencia	Group 1002 Pneumonia 480-486	Men	314
Palencia	Group 1002 Pneumonia 480-486	Women	178
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	197
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	88
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	109
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	197
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	108
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	89
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	314
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	206
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	108
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	580
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	459
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	121
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	102
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Men	24
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Women	78
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	852
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	368
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	484
Palencia	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.530
Palencia	Group 1100 Diseases of the digestive system  520-579	Men	1.523
Palencia	Group 1100 Diseases of the digestive system  520-579	Women	1.007
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	12
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	6
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	6
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	17
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	11
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	6
Palencia	Group 1103 Diseases of the esophagus 530	Both sexes	49
Palencia	Group 1103 Diseases of the esophagus 530	Men	32
Palencia	Group 1103 Diseases of the esophagus 530	Women	17
Palencia	Group 1104 Peptic ulcer 531-534	Both sexes	59
Palencia	Group 1104 Peptic ulcer 531-534	Men	41
Palencia	Group 1104 Peptic ulcer 531-534	Women	18
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	58
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	26
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	32
Palencia	Group 1106 Appendicitis  540-543	Both sexes	148
Palencia	Group 1106 Appendicitis  540-543	Men	82
Palencia	Group 1106 Appendicitis  540-543	Women	66
Palencia	Group 1107 Inguinal hernia  550	Both sexes	426
Palencia	Group 1107 Inguinal hernia  550	Men	393
Palencia	Group 1107 Inguinal hernia  550	Women	33
Palencia	Group 1108 Other abdominal hernia  551-553	Both sexes	172
Palencia	Group 1108 Other abdominal hernia  551-553	Men	89
Palencia	Group 1108 Other abdominal hernia  551-553	Women	83
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	38
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	14
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	24
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	213
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	101
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	112
Palencia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	108
Palencia	Group 1111 Intestinal obstruction without hernia 560	Men	49
Palencia	Group 1111 Intestinal obstruction without hernia 560	Women	59
Palencia	Group 1112 Intestinal diverticulosis 562	Both sexes	88
Palencia	Group 1112 Intestinal diverticulosis 562	Men	38
Palencia	Group 1112 Intestinal diverticulosis 562	Women	50
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	162
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	105
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	57
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	103
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	60
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	43
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	60
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Men	57
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Women	3
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	79
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Men	53
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Women	26
Palencia	Group 1117 Cholelithiasis  574	Both sexes	448
Palencia	Group 1117 Cholelithiasis  574	Men	210
Palencia	Group 1117 Cholelithiasis  574	Women	238
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	128
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	70
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	58
Palencia	Group 1119 Pancreatic diseases 577	Both sexes	77
Palencia	Group 1119 Pancreatic diseases 577	Men	44
Palencia	Group 1119 Pancreatic diseases 577	Women	33
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	85
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	42
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	43
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	195
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	119
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	76
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	137
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	90
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	47
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	8
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	6
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	50
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	23
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	27
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	931
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	499
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	432
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Palencia	Group 1303 Internal derangement of knee 717	Both sexes	118
Palencia	Group 1303 Internal derangement of knee 717	Men	95
Palencia	Group 1303 Internal derangement of knee 717	Women	23
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	397
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	195
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	202
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	19
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	5
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	14
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	11
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	2
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	9
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	32
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	14
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	18
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	46
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	27
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	19
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	164
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	109
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	55
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	144
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	52
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	92
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.416
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	786
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	630
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	75
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	20
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	55
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	123
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Men	75
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Women	48
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	205
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Men	120
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Women	85
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	512
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	281
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	231
Palencia	Group 1405 Prostatic hyperplasia  600	Both sexes	168
Palencia	Group 1405 Prostatic hyperplasia  600	Men	168
Palencia	Group 1405 Prostatic hyperplasia  600	Women	..
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	117
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Men	117
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Palencia	Group 1407 Disorders of breast  610-612	Both sexes	17
Palencia	Group 1407 Disorders of breast  610-612	Men	4
Palencia	Group 1407 Disorders of breast  610-612	Women	13
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	21
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	21
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	16
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	16
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	162
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	161
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.268
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.268
Palencia	Group 1501 Legally induced abortion  635	Both sexes	1
Palencia	Group 1501 Legally induced abortion  635	Men	..
Palencia	Group 1501 Legally induced abortion  635	Women	1
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	149
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	149
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	710
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	710
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	233
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	233
Palencia	Group 1505 Single spontaneous delivery  650	Both sexes	35
Palencia	Group 1505 Single spontaneous delivery  650	Men	..
Palencia	Group 1505 Single spontaneous delivery  650	Women	35
Palencia	Group 1506 Other deliveries  6695-6697	Both sexes	73
Palencia	Group 1506 Other deliveries  6695-6697	Men	..
Palencia	Group 1506 Other deliveries  6695-6697	Women	73
Palencia	Group 1507 Complications related to the puerperium  670-676	Both sexes	14
Palencia	Group 1507 Complications related to the puerperium  670-676	Men	..
Palencia	Group 1507 Complications related to the puerperium  670-676	Women	14
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	53
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	53
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	192
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	111
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	81
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	42
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	26
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	16
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	150
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	85
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	65
Palencia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	62
Palencia	Grupo 1700 Congenital abnormalities  740-759	Men	35
Palencia	Grupo 1700 Congenital abnormalities  740-759	Women	27
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	820
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	455
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	365
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	142
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Men	97
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Women	45
Palencia	Group 1802 Abdominal pain   7890	Both sexes	91
Palencia	Group 1802 Abdominal pain   7890	Men	40
Palencia	Group 1802 Abdominal pain   7890	Women	51
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	9
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	8
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	578
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	310
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	268
Palencia	Group 1900 Injuries and poisoning  800-999	Both sexes	1.501
Palencia	Group 1900 Injuries and poisoning  800-999	Men	723
Palencia	Group 1900 Injuries and poisoning  800-999	Women	778
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	113
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	53
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	60
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	21
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	10
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	11
Palencia	Group 1903 Radius and ulna fracture 813	Both sexes	82
Palencia	Group 1903 Radius and ulna fracture 813	Men	45
Palencia	Group 1903 Radius and ulna fracture 813	Women	37
Palencia	Group 1904 Femur fracture  820-821	Both sexes	326
Palencia	Group 1904 Femur fracture  820-821	Men	77
Palencia	Group 1904 Femur fracture  820-821	Women	249
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	90
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Men	44
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Women	46
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	362
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	222
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	140
Palencia	Group 1907 Burns  940-949	Both sexes	2
Palencia	Group 1907 Burns  940-949	Men	..
Palencia	Group 1907 Burns  940-949	Women	2
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	61
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	27
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	34
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	389
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	218
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	171
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	55
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	27
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	28
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	240
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	161
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	79
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	..
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	..
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	..
Palencia	Group 2102 Contraceptive management  V25	Both sexes	1
Palencia	Group 2102 Contraceptive management  V25	Men	..
Palencia	Group 2102 Contraceptive management  V25	Women	1
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	172
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	130
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	42
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	67
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	31
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	36
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	34.241
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	17.256
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	16.985
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.074
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	605
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	469
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	114
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	59
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	55
Salamanca	Group 0102 Imprecise intestinal infections 009	Both sexes	33
Salamanca	Group 0102 Imprecise intestinal infections 009	Men	16
Salamanca	Group 0102 Imprecise intestinal infections 009	Women	17
Salamanca	Group 0103 Tuberculosis 010-018, 137	Both sexes	21
Salamanca	Group 0103 Tuberculosis 010-018, 137	Men	12
Salamanca	Group 0103 Tuberculosis 010-018, 137	Women	9
Salamanca	Group 0104 Septicaemia  038	Both sexes	744
Salamanca	Group 0104 Septicaemia  038	Men	428
Salamanca	Group 0104 Septicaemia  038	Women	316
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	15
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	12
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	147
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	78
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	69
Salamanca	Group 0200 Neoplasms  140-239	Both sexes	3.802
Salamanca	Group 0200 Neoplasms  140-239	Men	2.072
Salamanca	Group 0200 Neoplasms  140-239	Women	1.730
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	452
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	282
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	170
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	307
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	227
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	80
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	98
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	52
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	46
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	180
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Women	180
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	58
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	58
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	31
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Women	31
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	122
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Men	122
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	287
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Men	241
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Women	46
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.414
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	761
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	653
Salamanca	Group 0210 Carcinoma in situ  230-234	Both sexes	24
Salamanca	Group 0210 Carcinoma in situ  230-234	Men	4
Salamanca	Group 0210 Carcinoma in situ  230-234	Women	20
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	17
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	12
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	5
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	147
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Women	147
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	665
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	371
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	294
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	333
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	171
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	162
Salamanca	Group 0301 Anaemias 280-285	Both sexes	225
Salamanca	Group 0301 Anaemias 280-285	Men	113
Salamanca	Group 0301 Anaemias 280-285	Women	112
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	108
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	58
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	50
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	805
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	377
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	428
Salamanca	Group 0401 Diabetes mellitus  249-250	Both sexes	357
Salamanca	Group 0401 Diabetes mellitus  249-250	Men	218
Salamanca	Group 0401 Diabetes mellitus  249-250	Women	139
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	448
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	159
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	289
Salamanca	Group 0500 Mental disorders  290-319	Both sexes	699
Salamanca	Group 0500 Mental disorders  290-319	Men	401
Salamanca	Group 0500 Mental disorders  290-319	Women	298
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	10
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	7
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	68
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	51
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	17
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	158
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	124
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	34
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	147
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	87
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	60
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	148
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	53
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	95
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	168
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	79
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	89
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	862
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	375
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	487
Salamanca	Group 0601 Alzheimer's disease  3310	Both sexes	6
Salamanca	Group 0601 Alzheimer's disease  3310	Men	3
Salamanca	Group 0601 Alzheimer's disease  3310	Women	3
Salamanca	Group 0602 Multiple sclerosis 340	Both sexes	5
Salamanca	Group 0602 Multiple sclerosis 340	Men	2
Salamanca	Group 0602 Multiple sclerosis 340	Women	3
Salamanca	Group 0603 Epilepsy  345	Both sexes	64
Salamanca	Group 0603 Epilepsy  345	Men	40
Salamanca	Group 0603 Epilepsy  345	Women	24
Salamanca	Group 0604 Transient cerebral ischemia 435	Both sexes	66
Salamanca	Group 0604 Transient cerebral ischemia 435	Men	37
Salamanca	Group 0604 Transient cerebral ischemia 435	Women	29
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	721
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	293
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	428
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	131
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	72
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	59
Salamanca	Grupo 0701 Cataract  366	Both sexes	6
Salamanca	Grupo 0701 Cataract  366	Men	3
Salamanca	Grupo 0701 Cataract  366	Women	3
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	125
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	69
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	56
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	264
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	136
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	128
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.595
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.636
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.959
Salamanca	Group 0901 Hypertensive disease  401-405	Both sexes	244
Salamanca	Group 0901 Hypertensive disease  401-405	Men	91
Salamanca	Group 0901 Hypertensive disease  401-405	Women	153
Salamanca	Group 0902 Angina pectoris  4111, 413	Both sexes	117
Salamanca	Group 0902 Angina pectoris  4111, 413	Men	87
Salamanca	Group 0902 Angina pectoris  4111, 413	Women	30
Salamanca	Group 0903 Acute myocardial infarction  410	Both sexes	594
Salamanca	Group 0903 Acute myocardial infarction  410	Men	433
Salamanca	Group 0903 Acute myocardial infarction  410	Women	161
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	139
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	111
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	28
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	241
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Men	114
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Women	127
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	381
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	225
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	156
Salamanca	Grupo 0907 Heart failure  428	Both sexes	916
Salamanca	Grupo 0907 Heart failure  428	Men	475
Salamanca	Grupo 0907 Heart failure  428	Women	441
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	799
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	436
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	363
Salamanca	Grupo 0909 Atherosclerosis  440	Both sexes	176
Salamanca	Grupo 0909 Atherosclerosis  440	Men	137
Salamanca	Grupo 0909 Atherosclerosis  440	Women	39
Salamanca	Group 0910 Varicose veins of lower extremities 454	Both sexes	168
Salamanca	Group 0910 Varicose veins of lower extremities 454	Men	48
Salamanca	Group 0910 Varicose veins of lower extremities 454	Women	120
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	820
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	479
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	341
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.196
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.515
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.681
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	117
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	60
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	57
Salamanca	Group 1002 Pneumonia 480-486	Both sexes	892
Salamanca	Group 1002 Pneumonia 480-486	Men	552
Salamanca	Group 1002 Pneumonia 480-486	Women	340
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	536
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	245
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	291
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	122
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	56
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	66
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	470
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	304
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	166
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	554
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	476
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	78
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	177
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Men	59
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Women	118
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.328
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	763
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	565
Salamanca	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.192
Salamanca	Group 1100 Diseases of the digestive system  520-579	Men	2.417
Salamanca	Group 1100 Diseases of the digestive system  520-579	Women	1.775
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	52
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	29
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	23
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	80
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	47
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	33
Salamanca	Group 1103 Diseases of the esophagus 530	Both sexes	90
Salamanca	Group 1103 Diseases of the esophagus 530	Men	52
Salamanca	Group 1103 Diseases of the esophagus 530	Women	38
Salamanca	Group 1104 Peptic ulcer 531-534	Both sexes	110
Salamanca	Group 1104 Peptic ulcer 531-534	Men	63
Salamanca	Group 1104 Peptic ulcer 531-534	Women	47
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	106
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	55
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	51
Salamanca	Group 1106 Appendicitis  540-543	Both sexes	289
Salamanca	Group 1106 Appendicitis  540-543	Men	166
Salamanca	Group 1106 Appendicitis  540-543	Women	123
Salamanca	Group 1107 Inguinal hernia  550	Both sexes	435
Salamanca	Group 1107 Inguinal hernia  550	Men	389
Salamanca	Group 1107 Inguinal hernia  550	Women	46
Salamanca	Group 1108 Other abdominal hernia  551-553	Both sexes	300
Salamanca	Group 1108 Other abdominal hernia  551-553	Men	149
Salamanca	Group 1108 Other abdominal hernia  551-553	Women	151
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	69
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	40
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	29
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	177
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	96
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	81
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	316
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Men	166
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Women	150
Salamanca	Group 1112 Intestinal diverticulosis 562	Both sexes	188
Salamanca	Group 1112 Intestinal diverticulosis 562	Men	97
Salamanca	Group 1112 Intestinal diverticulosis 562	Women	91
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	233
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	151
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	82
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	159
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	80
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	79
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	53
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Men	45
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	124
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Men	83
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Women	41
Salamanca	Group 1117 Cholelithiasis  574	Both sexes	764
Salamanca	Group 1117 Cholelithiasis  574	Men	357
Salamanca	Group 1117 Cholelithiasis  574	Women	407
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	214
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	131
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	83
Salamanca	Group 1119 Pancreatic diseases 577	Both sexes	186
Salamanca	Group 1119 Pancreatic diseases 577	Men	105
Salamanca	Group 1119 Pancreatic diseases 577	Women	81
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	247
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	116
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	131
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	238
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	122
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	116
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	121
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	68
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	53
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	10
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	4
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	107
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	50
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	57
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.571
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	729
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	842
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Salamanca	Group 1303 Internal derangement of knee 717	Both sexes	62
Salamanca	Group 1303 Internal derangement of knee 717	Men	45
Salamanca	Group 1303 Internal derangement of knee 717	Women	17
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	645
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	274
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	371
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	47
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	15
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	32
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	116
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	62
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	54
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	281
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	146
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	135
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	23
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	9
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	14
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	155
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	79
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	76
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	242
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	99
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	143
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.959
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	924
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.035
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	173
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	81
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	92
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	204
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Men	114
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Women	90
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	270
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Men	153
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Women	117
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	534
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	274
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	260
Salamanca	Group 1405 Prostatic hyperplasia  600	Both sexes	140
Salamanca	Group 1405 Prostatic hyperplasia  600	Men	140
Salamanca	Group 1405 Prostatic hyperplasia  600	Women	..
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	147
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Men	147
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Salamanca	Group 1407 Disorders of breast  610-612	Both sexes	99
Salamanca	Group 1407 Disorders of breast  610-612	Men	4
Salamanca	Group 1407 Disorders of breast  610-612	Women	95
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	61
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	61
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	32
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	32
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	299
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	288
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.797
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.797
Salamanca	Group 1501 Legally induced abortion  635	Both sexes	..
Salamanca	Group 1501 Legally induced abortion  635	Men	..
Salamanca	Group 1501 Legally induced abortion  635	Women	..
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	187
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	187
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.533
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.533
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	684
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	684
Salamanca	Group 1505 Single spontaneous delivery  650	Both sexes	133
Salamanca	Group 1505 Single spontaneous delivery  650	Men	..
Salamanca	Group 1505 Single spontaneous delivery  650	Women	133
Salamanca	Group 1506 Other deliveries  6695-6697	Both sexes	81
Salamanca	Group 1506 Other deliveries  6695-6697	Men	..
Salamanca	Group 1506 Other deliveries  6695-6697	Women	81
Salamanca	Group 1507 Complications related to the puerperium  670-676	Both sexes	13
Salamanca	Group 1507 Complications related to the puerperium  670-676	Men	..
Salamanca	Group 1507 Complications related to the puerperium  670-676	Women	13
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	166
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	166
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	391
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	212
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	179
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	127
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	64
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	63
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	264
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	148
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	116
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	240
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Men	170
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Women	70
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.840
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.049
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	791
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	90
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Men	61
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Women	29
Salamanca	Group 1802 Abdominal pain   7890	Both sexes	173
Salamanca	Group 1802 Abdominal pain   7890	Men	77
Salamanca	Group 1802 Abdominal pain   7890	Women	96
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	698
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	379
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	319
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	879
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	532
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	347
Salamanca	Group 1900 Injuries and poisoning  800-999	Both sexes	3.326
Salamanca	Group 1900 Injuries and poisoning  800-999	Men	1.712
Salamanca	Group 1900 Injuries and poisoning  800-999	Women	1.614
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	195
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	120
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	75
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	76
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	56
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	20
Salamanca	Group 1903 Radius and ulna fracture 813	Both sexes	181
Salamanca	Group 1903 Radius and ulna fracture 813	Men	83
Salamanca	Group 1903 Radius and ulna fracture 813	Women	98
Salamanca	Group 1904 Femur fracture  820-821	Both sexes	611
Salamanca	Group 1904 Femur fracture  820-821	Men	143
Salamanca	Group 1904 Femur fracture  820-821	Women	468
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	195
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Men	100
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Women	95
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	906
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	587
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	319
Salamanca	Group 1907 Burns  940-949	Both sexes	28
Salamanca	Group 1907 Burns  940-949	Men	17
Salamanca	Group 1907 Burns  940-949	Women	11
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	98
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	53
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	45
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	942
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	510
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	432
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	94
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	43
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	51
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	926
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	561
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	365
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	17
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	7
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	10
Salamanca	Group 2102 Contraceptive management  V25	Both sexes	22
Salamanca	Group 2102 Contraceptive management  V25	Men	1
Salamanca	Group 2102 Contraceptive management  V25	Women	21
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	745
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	490
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	255
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	142
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	63
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	79
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	12.612
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	6.389
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	6.223
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	278
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	159
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	119
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	73
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	40
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	33
Segovia	Group 0102 Imprecise intestinal infections 009	Both sexes	11
Segovia	Group 0102 Imprecise intestinal infections 009	Men	4
Segovia	Group 0102 Imprecise intestinal infections 009	Women	7
Segovia	Group 0103 Tuberculosis 010-018, 137	Both sexes	..
Segovia	Group 0103 Tuberculosis 010-018, 137	Men	..
Segovia	Group 0103 Tuberculosis 010-018, 137	Women	..
Segovia	Group 0104 Septicaemia  038	Both sexes	116
Segovia	Group 0104 Septicaemia  038	Men	71
Segovia	Group 0104 Septicaemia  038	Women	45
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	1
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	1
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	77
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	43
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	34
Segovia	Group 0200 Neoplasms  140-239	Both sexes	1.082
Segovia	Group 0200 Neoplasms  140-239	Men	612
Segovia	Group 0200 Neoplasms  140-239	Women	470
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	175
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	116
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	59
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	69
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	60
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	9
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	6
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	4
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	2
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	80
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Women	80
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	27
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	27
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	7
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Women	7
Segovia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	56
Segovia	Group 0207 Malignant neoplasm of prostate  185	Men	56
Segovia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Segovia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	83
Segovia	Group 0208 Malignant neoplasm of bladder  188	Men	70
Segovia	Group 0208 Malignant neoplasm of bladder  188	Women	13
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	423
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	240
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	183
Segovia	Group 0210 Carcinoma in situ  230-234	Both sexes	35
Segovia	Group 0210 Carcinoma in situ  230-234	Men	19
Segovia	Group 0210 Carcinoma in situ  230-234	Women	16
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	5
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	3
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	2
Segovia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	29
Segovia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Segovia	Grupo 0212 Leiomyoma of uterus  218	Women	29
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	87
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	44
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	43
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	110
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	52
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	58
Segovia	Group 0301 Anaemias 280-285	Both sexes	67
Segovia	Group 0301 Anaemias 280-285	Men	31
Segovia	Group 0301 Anaemias 280-285	Women	36
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	43
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	21
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	22
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	182
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	79
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	103
Segovia	Group 0401 Diabetes mellitus  249-250	Both sexes	51
Segovia	Group 0401 Diabetes mellitus  249-250	Men	23
Segovia	Group 0401 Diabetes mellitus  249-250	Women	28
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	131
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	56
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	75
Segovia	Group 0500 Mental disorders  290-319	Both sexes	395
Segovia	Group 0500 Mental disorders  290-319	Men	213
Segovia	Group 0500 Mental disorders  290-319	Women	182
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	16
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	4
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	12
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	55
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	43
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	16
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	13
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	93
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	49
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	44
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	93
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	42
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	51
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	122
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	62
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	60
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	246
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	112
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	134
Segovia	Group 0601 Alzheimer's disease  3310	Both sexes	8
Segovia	Group 0601 Alzheimer's disease  3310	Men	5
Segovia	Group 0601 Alzheimer's disease  3310	Women	3
Segovia	Group 0602 Multiple sclerosis 340	Both sexes	8
Segovia	Group 0602 Multiple sclerosis 340	Men	3
Segovia	Group 0602 Multiple sclerosis 340	Women	5
Segovia	Group 0603 Epilepsy  345	Both sexes	46
Segovia	Group 0603 Epilepsy  345	Men	20
Segovia	Group 0603 Epilepsy  345	Women	26
Segovia	Group 0604 Transient cerebral ischemia 435	Both sexes	55
Segovia	Group 0604 Transient cerebral ischemia 435	Men	27
Segovia	Group 0604 Transient cerebral ischemia 435	Women	28
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	129
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	57
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	72
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	163
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	84
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	79
Segovia	Grupo 0701 Cataract  366	Both sexes	17
Segovia	Grupo 0701 Cataract  366	Men	7
Segovia	Grupo 0701 Cataract  366	Women	10
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	146
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	77
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	69
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	103
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	47
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	56
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.593
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	868
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	725
Segovia	Group 0901 Hypertensive disease  401-405	Both sexes	68
Segovia	Group 0901 Hypertensive disease  401-405	Men	31
Segovia	Group 0901 Hypertensive disease  401-405	Women	37
Segovia	Group 0902 Angina pectoris  4111, 413	Both sexes	58
Segovia	Group 0902 Angina pectoris  4111, 413	Men	29
Segovia	Group 0902 Angina pectoris  4111, 413	Women	29
Segovia	Group 0903 Acute myocardial infarction  410	Both sexes	151
Segovia	Group 0903 Acute myocardial infarction  410	Men	106
Segovia	Group 0903 Acute myocardial infarction  410	Women	45
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	63
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	52
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	11
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	78
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Men	34
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Women	44
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	218
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	131
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	87
Segovia	Grupo 0907 Heart failure  428	Both sexes	455
Segovia	Grupo 0907 Heart failure  428	Men	197
Segovia	Grupo 0907 Heart failure  428	Women	258
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	268
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	144
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	124
Segovia	Grupo 0909 Atherosclerosis  440	Both sexes	25
Segovia	Grupo 0909 Atherosclerosis  440	Men	14
Segovia	Grupo 0909 Atherosclerosis  440	Women	11
Segovia	Group 0910 Varicose veins of lower extremities 454	Both sexes	13
Segovia	Group 0910 Varicose veins of lower extremities 454	Men	8
Segovia	Group 0910 Varicose veins of lower extremities 454	Women	5
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	196
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	122
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	74
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.634
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	982
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	652
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	109
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	58
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	51
Segovia	Group 1002 Pneumonia 480-486	Both sexes	397
Segovia	Group 1002 Pneumonia 480-486	Men	241
Segovia	Group 1002 Pneumonia 480-486	Women	156
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	97
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	54
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	43
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	107
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	57
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	50
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	172
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	124
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	48
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	254
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	215
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	39
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	52
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Men	21
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Women	31
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	446
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	212
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	234
Segovia	Group 1100 Diseases of the digestive system  520-579	Both sexes	1.640
Segovia	Group 1100 Diseases of the digestive system  520-579	Men	987
Segovia	Group 1100 Diseases of the digestive system  520-579	Women	653
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	5
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	3
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	2
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	15
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	9
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	6
Segovia	Group 1103 Diseases of the esophagus 530	Both sexes	27
Segovia	Group 1103 Diseases of the esophagus 530	Men	18
Segovia	Group 1103 Diseases of the esophagus 530	Women	9
Segovia	Group 1104 Peptic ulcer 531-534	Both sexes	37
Segovia	Group 1104 Peptic ulcer 531-534	Men	27
Segovia	Group 1104 Peptic ulcer 531-534	Women	10
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	29
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	15
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	14
Segovia	Group 1106 Appendicitis  540-543	Both sexes	152
Segovia	Group 1106 Appendicitis  540-543	Men	87
Segovia	Group 1106 Appendicitis  540-543	Women	65
Segovia	Group 1107 Inguinal hernia  550	Both sexes	209
Segovia	Group 1107 Inguinal hernia  550	Men	195
Segovia	Group 1107 Inguinal hernia  550	Women	14
Segovia	Group 1108 Other abdominal hernia  551-553	Both sexes	104
Segovia	Group 1108 Other abdominal hernia  551-553	Men	47
Segovia	Group 1108 Other abdominal hernia  551-553	Women	57
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	15
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	7
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	8
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	98
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	50
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	48
Segovia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	116
Segovia	Group 1111 Intestinal obstruction without hernia 560	Men	58
Segovia	Group 1111 Intestinal obstruction without hernia 560	Women	58
Segovia	Group 1112 Intestinal diverticulosis 562	Both sexes	81
Segovia	Group 1112 Intestinal diverticulosis 562	Men	36
Segovia	Group 1112 Intestinal diverticulosis 562	Women	45
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	95
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	65
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	30
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	50
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	31
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	19
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	16
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Men	14
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	56
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Men	42
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Women	14
Segovia	Group 1117 Cholelithiasis  574	Both sexes	297
Segovia	Group 1117 Cholelithiasis  574	Men	144
Segovia	Group 1117 Cholelithiasis  574	Women	153
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	91
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	60
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	31
Segovia	Group 1119 Pancreatic diseases 577	Both sexes	80
Segovia	Group 1119 Pancreatic diseases 577	Men	42
Segovia	Group 1119 Pancreatic diseases 577	Women	38
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	67
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	37
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	30
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	172
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	94
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	78
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	101
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	60
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	41
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	3
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	..
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	3
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	68
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	34
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	34
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	847
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	432
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	415
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Segovia	Group 1303 Internal derangement of knee 717	Both sexes	104
Segovia	Group 1303 Internal derangement of knee 717	Men	70
Segovia	Group 1303 Internal derangement of knee 717	Women	34
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	462
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	227
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	235
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	13
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	2
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	11
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	6
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	5
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	11
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	4
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	7
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	16
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	11
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	5
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	125
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	78
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	47
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	110
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	39
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	71
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	884
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	525
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	359
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	62
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	22
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	40
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	65
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Men	45
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Women	20
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	152
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Men	91
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Women	61
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	247
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	148
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	99
Segovia	Group 1405 Prostatic hyperplasia  600	Both sexes	124
Segovia	Group 1405 Prostatic hyperplasia  600	Men	124
Segovia	Group 1405 Prostatic hyperplasia  600	Women	..
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	92
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Men	92
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Segovia	Group 1407 Disorders of breast  610-612	Both sexes	9
Segovia	Group 1407 Disorders of breast  610-612	Men	1
Segovia	Group 1407 Disorders of breast  610-612	Women	8
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	20
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	20
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	6
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	6
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	107
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	105
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.081
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.081
Segovia	Group 1501 Legally induced abortion  635	Both sexes	..
Segovia	Group 1501 Legally induced abortion  635	Men	..
Segovia	Group 1501 Legally induced abortion  635	Women	..
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	45
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	45
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	626
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	626
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	240
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	240
Segovia	Group 1505 Single spontaneous delivery  650	Both sexes	53
Segovia	Group 1505 Single spontaneous delivery  650	Men	..
Segovia	Group 1505 Single spontaneous delivery  650	Women	53
Segovia	Group 1506 Other deliveries  6695-6697	Both sexes	6
Segovia	Group 1506 Other deliveries  6695-6697	Men	..
Segovia	Group 1506 Other deliveries  6695-6697	Women	6
Segovia	Group 1507 Complications related to the puerperium  670-676	Both sexes	10
Segovia	Group 1507 Complications related to the puerperium  670-676	Men	..
Segovia	Group 1507 Complications related to the puerperium  670-676	Women	10
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	101
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	101
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	136
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	64
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	72
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	46
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	19
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	27
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	90
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	45
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	45
Segovia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	60
Segovia	Grupo 1700 Congenital abnormalities  740-759	Men	35
Segovia	Grupo 1700 Congenital abnormalities  740-759	Women	25
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	544
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	279
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	265
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	37
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Men	22
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Women	15
Segovia	Group 1802 Abdominal pain   7890	Both sexes	113
Segovia	Group 1802 Abdominal pain   7890	Men	49
Segovia	Group 1802 Abdominal pain   7890	Women	64
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	393
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	207
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	186
Segovia	Group 1900 Injuries and poisoning  800-999	Both sexes	1.250
Segovia	Group 1900 Injuries and poisoning  800-999	Men	639
Segovia	Group 1900 Injuries and poisoning  800-999	Women	611
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	57
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	35
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	22
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	14
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	11
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3
Segovia	Group 1903 Radius and ulna fracture 813	Both sexes	81
Segovia	Group 1903 Radius and ulna fracture 813	Men	33
Segovia	Group 1903 Radius and ulna fracture 813	Women	48
Segovia	Group 1904 Femur fracture  820-821	Both sexes	248
Segovia	Group 1904 Femur fracture  820-821	Men	73
Segovia	Group 1904 Femur fracture  820-821	Women	175
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	80
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Men	47
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Women	33
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	344
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	204
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	140
Segovia	Group 1907 Burns  940-949	Both sexes	4
Segovia	Group 1907 Burns  940-949	Men	2
Segovia	Group 1907 Burns  940-949	Women	2
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	44
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	22
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	22
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	325
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	189
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	136
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	53
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	23
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	30
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	212
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	126
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	86
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	6
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	1
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Segovia	Group 2102 Contraceptive management  V25	Both sexes	10
Segovia	Group 2102 Contraceptive management  V25	Men	1
Segovia	Group 2102 Contraceptive management  V25	Women	9
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	118
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	73
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	45
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	78
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	51
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	27
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	8.218
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	4.318
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	3.900
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	245
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	146
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	99
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	46
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	24
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	22
Soria	Group 0102 Imprecise intestinal infections 009	Both sexes	1
Soria	Group 0102 Imprecise intestinal infections 009	Men	..
Soria	Group 0102 Imprecise intestinal infections 009	Women	1
Soria	Group 0103 Tuberculosis 010-018, 137	Both sexes	2
Soria	Group 0103 Tuberculosis 010-018, 137	Men	2
Soria	Group 0103 Tuberculosis 010-018, 137	Women	..
Soria	Group 0104 Septicaemia  038	Both sexes	153
Soria	Group 0104 Septicaemia  038	Men	99
Soria	Group 0104 Septicaemia  038	Women	54
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	1
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	42
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	21
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	21
Soria	Group 0200 Neoplasms  140-239	Both sexes	797
Soria	Group 0200 Neoplasms  140-239	Men	455
Soria	Group 0200 Neoplasms  140-239	Women	342
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	107
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	61
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	46
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	38
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	31
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	3
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	2
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	1
Soria	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	75
Soria	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Soria	Group 0204 Malignant neoplasm of breast  174-175	Women	74
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	15
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	15
Soria	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	6
Soria	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Soria	Group 0206 Malignant neoplasm of ovary  1830	Women	6
Soria	Group 0207 Malignant neoplasm of prostate  185	Both sexes	77
Soria	Group 0207 Malignant neoplasm of prostate  185	Men	77
Soria	Group 0207 Malignant neoplasm of prostate  185	Women	..
Soria	Group 0208 Malignant neoplasm of bladder  188	Both sexes	89
Soria	Group 0208 Malignant neoplasm of bladder  188	Men	74
Soria	Group 0208 Malignant neoplasm of bladder  188	Women	15
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	260
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	166
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	94
Soria	Group 0210 Carcinoma in situ  230-234	Both sexes	10
Soria	Group 0210 Carcinoma in situ  230-234	Men	3
Soria	Group 0210 Carcinoma in situ  230-234	Women	7
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	4
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	3
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	1
Soria	Grupo 0212 Leiomyoma of uterus  218	Both sexes	34
Soria	Grupo 0212 Leiomyoma of uterus  218	Men	..
Soria	Grupo 0212 Leiomyoma of uterus  218	Women	34
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	79
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	37
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	42
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	82
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	48
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	34
Soria	Group 0301 Anaemias 280-285	Both sexes	59
Soria	Group 0301 Anaemias 280-285	Men	33
Soria	Group 0301 Anaemias 280-285	Women	26
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	23
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	15
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	8
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	111
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	47
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	64
Soria	Group 0401 Diabetes mellitus  249-250	Both sexes	45
Soria	Group 0401 Diabetes mellitus  249-250	Men	28
Soria	Group 0401 Diabetes mellitus  249-250	Women	17
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	66
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	19
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	47
Soria	Group 0500 Mental disorders  290-319	Both sexes	260
Soria	Group 0500 Mental disorders  290-319	Men	145
Soria	Group 0500 Mental disorders  290-319	Women	115
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	4
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	3
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	22
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	19
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	3
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	15
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	10
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	72
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	41
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	31
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	45
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	21
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	24
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	102
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	51
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	51
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	179
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	97
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	82
Soria	Group 0601 Alzheimer's disease  3310	Both sexes	13
Soria	Group 0601 Alzheimer's disease  3310	Men	3
Soria	Group 0601 Alzheimer's disease  3310	Women	10
Soria	Group 0602 Multiple sclerosis 340	Both sexes	4
Soria	Group 0602 Multiple sclerosis 340	Men	2
Soria	Group 0602 Multiple sclerosis 340	Women	2
Soria	Group 0603 Epilepsy  345	Both sexes	49
Soria	Group 0603 Epilepsy  345	Men	30
Soria	Group 0603 Epilepsy  345	Women	19
Soria	Group 0604 Transient cerebral ischemia 435	Both sexes	51
Soria	Group 0604 Transient cerebral ischemia 435	Men	25
Soria	Group 0604 Transient cerebral ischemia 435	Women	26
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	62
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	37
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	25
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	14
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	10
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	4
Soria	Grupo 0701 Cataract  366	Both sexes	1
Soria	Grupo 0701 Cataract  366	Men	1
Soria	Grupo 0701 Cataract  366	Women	..
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	13
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	9
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	4
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	21
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Men	11
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Women	10
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.256
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	707
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	549
Soria	Group 0901 Hypertensive disease  401-405	Both sexes	48
Soria	Group 0901 Hypertensive disease  401-405	Men	19
Soria	Group 0901 Hypertensive disease  401-405	Women	29
Soria	Group 0902 Angina pectoris  4111, 413	Both sexes	66
Soria	Group 0902 Angina pectoris  4111, 413	Men	46
Soria	Group 0902 Angina pectoris  4111, 413	Women	20
Soria	Group 0903 Acute myocardial infarction  410	Both sexes	126
Soria	Group 0903 Acute myocardial infarction  410	Men	90
Soria	Group 0903 Acute myocardial infarction  410	Women	36
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	37
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	26
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	11
Soria	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	63
Soria	Group 0905 Diseases of the lungs circulation 415-417	Men	36
Soria	Group 0905 Diseases of the lungs circulation 415-417	Women	27
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	168
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	91
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	77
Soria	Grupo 0907 Heart failure  428	Both sexes	356
Soria	Grupo 0907 Heart failure  428	Men	188
Soria	Grupo 0907 Heart failure  428	Women	168
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	212
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	117
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	95
Soria	Grupo 0909 Atherosclerosis  440	Both sexes	18
Soria	Grupo 0909 Atherosclerosis  440	Men	11
Soria	Grupo 0909 Atherosclerosis  440	Women	7
Soria	Group 0910 Varicose veins of lower extremities 454	Both sexes	70
Soria	Group 0910 Varicose veins of lower extremities 454	Men	29
Soria	Group 0910 Varicose veins of lower extremities 454	Women	41
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	92
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	54
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	38
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.203
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	716
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	487
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	18
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	9
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	9
Soria	Group 1002 Pneumonia 480-486	Both sexes	321
Soria	Group 1002 Pneumonia 480-486	Men	190
Soria	Group 1002 Pneumonia 480-486	Women	131
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	24
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Men	15
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Women	9
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	80
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	52
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	28
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	111
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	76
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	35
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	127
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	93
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	34
Soria	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	23
Soria	Group 1007 Asthma 4930-4931,4938-4939	Men	10
Soria	Group 1007 Asthma 4930-4931,4938-4939	Women	13
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	499
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	271
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	228
Soria	Group 1100 Diseases of the digestive system  520-579	Both sexes	1.195
Soria	Group 1100 Diseases of the digestive system  520-579	Men	731
Soria	Group 1100 Diseases of the digestive system  520-579	Women	464
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	3
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	2
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	1
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	12
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	7
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	5
Soria	Group 1103 Diseases of the esophagus 530	Both sexes	21
Soria	Group 1103 Diseases of the esophagus 530	Men	13
Soria	Group 1103 Diseases of the esophagus 530	Women	8
Soria	Group 1104 Peptic ulcer 531-534	Both sexes	31
Soria	Group 1104 Peptic ulcer 531-534	Men	14
Soria	Group 1104 Peptic ulcer 531-534	Women	17
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	24
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	14
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	10
Soria	Group 1106 Appendicitis  540-543	Both sexes	96
Soria	Group 1106 Appendicitis  540-543	Men	57
Soria	Group 1106 Appendicitis  540-543	Women	39
Soria	Group 1107 Inguinal hernia  550	Both sexes	159
Soria	Group 1107 Inguinal hernia  550	Men	138
Soria	Group 1107 Inguinal hernia  550	Women	21
Soria	Group 1108 Other abdominal hernia  551-553	Both sexes	101
Soria	Group 1108 Other abdominal hernia  551-553	Men	54
Soria	Group 1108 Other abdominal hernia  551-553	Women	47
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	11
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	8
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	3
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	59
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	32
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	27
Soria	Group 1111 Intestinal obstruction without hernia 560	Both sexes	71
Soria	Group 1111 Intestinal obstruction without hernia 560	Men	40
Soria	Group 1111 Intestinal obstruction without hernia 560	Women	31
Soria	Group 1112 Intestinal diverticulosis 562	Both sexes	47
Soria	Group 1112 Intestinal diverticulosis 562	Men	30
Soria	Group 1112 Intestinal diverticulosis 562	Women	17
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	46
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	35
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	11
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	31
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	12
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	19
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	12
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Men	12
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Women	..
Soria	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	35
Soria	Group 1116 Other diseases of the liver 570,5714-573	Men	27
Soria	Group 1116 Other diseases of the liver 570,5714-573	Women	8
Soria	Group 1117 Cholelithiasis  574	Both sexes	201
Soria	Group 1117 Cholelithiasis  574	Men	90
Soria	Group 1117 Cholelithiasis  574	Women	111
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	66
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	42
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	24
Soria	Group 1119 Pancreatic diseases 577	Both sexes	62
Soria	Group 1119 Pancreatic diseases 577	Men	40
Soria	Group 1119 Pancreatic diseases 577	Women	22
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	107
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	64
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	43
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	76
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	42
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	34
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	57
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	32
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	25
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	3
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	2
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	1
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	16
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	8
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	8
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	480
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	259
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	221
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Soria	Group 1303 Internal derangement of knee 717	Both sexes	109
Soria	Group 1303 Internal derangement of knee 717	Men	78
Soria	Group 1303 Internal derangement of knee 717	Women	31
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	194
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	101
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	93
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	9
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	4
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	5
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	8
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	5
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	3
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	13
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	6
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	7
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	15
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	4
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	11
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	74
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	44
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	30
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	58
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	17
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	41
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	416
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	224
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	192
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	46
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	14
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	32
Soria	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	46
Soria	Group 1402 Renal failure  5836-5837, 584-586	Men	22
Soria	Group 1402 Renal failure  5836-5837, 584-586	Women	24
Soria	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	48
Soria	Group 1403 Urolithiasis  592, 594, 7880	Men	30
Soria	Group 1403 Urolithiasis  592, 594, 7880	Women	18
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	163
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	81
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	82
Soria	Group 1405 Prostatic hyperplasia  600	Both sexes	38
Soria	Group 1405 Prostatic hyperplasia  600	Men	38
Soria	Group 1405 Prostatic hyperplasia  600	Women	..
Soria	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	38
Soria	Group 1406 Other diseases of the male genital organs    601-608	Men	38
Soria	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Soria	Group 1407 Disorders of breast  610-612	Both sexes	20
Soria	Group 1407 Disorders of breast  610-612	Men	1
Soria	Group 1407 Disorders of breast  610-612	Women	19
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	3
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	3
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	13
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	13
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	638
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	638
Soria	Group 1501 Legally induced abortion  635	Both sexes	..
Soria	Group 1501 Legally induced abortion  635	Men	..
Soria	Group 1501 Legally induced abortion  635	Women	..
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	22
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	22
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	463
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	463
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	111
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	111
Soria	Group 1505 Single spontaneous delivery  650	Both sexes	8
Soria	Group 1505 Single spontaneous delivery  650	Men	..
Soria	Group 1505 Single spontaneous delivery  650	Women	8
Soria	Group 1506 Other deliveries  6695-6697	Both sexes	14
Soria	Group 1506 Other deliveries  6695-6697	Men	..
Soria	Group 1506 Other deliveries  6695-6697	Women	14
Soria	Group 1507 Complications related to the puerperium  670-676	Both sexes	3
Soria	Group 1507 Complications related to the puerperium  670-676	Men	..
Soria	Group 1507 Complications related to the puerperium  670-676	Women	3
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	17
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	17
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	87
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Men	40
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Women	47
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	17
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	6
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	11
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	70
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	34
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	36
Soria	Grupo 1700 Congenital abnormalities  740-759	Both sexes	28
Soria	Grupo 1700 Congenital abnormalities  740-759	Men	23
Soria	Grupo 1700 Congenital abnormalities  740-759	Women	5
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	329
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	207
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	122
Soria	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	54
Soria	Group 1801 Pain in throat and chest 7841, 7865	Men	31
Soria	Group 1801 Pain in throat and chest 7841, 7865	Women	23
Soria	Group 1802 Abdominal pain   7890	Both sexes	56
Soria	Group 1802 Abdominal pain   7890	Men	27
Soria	Group 1802 Abdominal pain   7890	Women	29
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	218
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	148
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	70
Soria	Group 1900 Injuries and poisoning  800-999	Both sexes	715
Soria	Group 1900 Injuries and poisoning  800-999	Men	361
Soria	Group 1900 Injuries and poisoning  800-999	Women	354
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	45
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	24
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	21
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	8
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	6
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	2
Soria	Group 1903 Radius and ulna fracture 813	Both sexes	33
Soria	Group 1903 Radius and ulna fracture 813	Men	19
Soria	Group 1903 Radius and ulna fracture 813	Women	14
Soria	Group 1904 Femur fracture  820-821	Both sexes	190
Soria	Group 1904 Femur fracture  820-821	Men	61
Soria	Group 1904 Femur fracture  820-821	Women	129
Soria	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	50
Soria	Group 1905 Leg fracture, including the ankle 823-824	Men	23
Soria	Group 1905 Leg fracture, including the ankle 823-824	Women	27
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	183
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	105
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	78
Soria	Group 1907 Burns  940-949	Both sexes	1
Soria	Group 1907 Burns  940-949	Men	1
Soria	Group 1907 Burns  940-949	Women	..
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	24
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	14
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	10
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	162
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	93
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	69
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	19
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	15
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	4
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	86
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	49
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	37
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	3
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	2
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1
Soria	Group 2102 Contraceptive management  V25	Both sexes	2
Soria	Group 2102 Contraceptive management  V25	Men	2
Soria	Group 2102 Contraceptive management  V25	Women	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	56
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	29
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	27
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	25
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	16
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	9
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	60.053
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	30.180
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	29.873
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.232
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	670
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	562
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	274
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	146
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	128
Valladolid	Group 0102 Imprecise intestinal infections 009	Both sexes	43
Valladolid	Group 0102 Imprecise intestinal infections 009	Men	27
Valladolid	Group 0102 Imprecise intestinal infections 009	Women	16
Valladolid	Group 0103 Tuberculosis 010-018, 137	Both sexes	29
Valladolid	Group 0103 Tuberculosis 010-018, 137	Men	18
Valladolid	Group 0103 Tuberculosis 010-018, 137	Women	11
Valladolid	Group 0104 Septicaemia  038	Both sexes	591
Valladolid	Group 0104 Septicaemia  038	Men	312
Valladolid	Group 0104 Septicaemia  038	Women	279
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	..
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	295
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	167
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	128
Valladolid	Group 0200 Neoplasms  140-239	Both sexes	6.528
Valladolid	Group 0200 Neoplasms  140-239	Men	3.616
Valladolid	Group 0200 Neoplasms  140-239	Women	2.912
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	621
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	399
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	222
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	511
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	417
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	94
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	87
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	52
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	35
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	396
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Women	393
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	88
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	88
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	69
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Women	69
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Both sexes	257
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Men	257
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Women	..
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Both sexes	490
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Men	437
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Women	53
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.226
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.332
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	894
Valladolid	Group 0210 Carcinoma in situ  230-234	Both sexes	97
Valladolid	Group 0210 Carcinoma in situ  230-234	Men	42
Valladolid	Group 0210 Carcinoma in situ  230-234	Women	55
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	62
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	33
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	29
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Both sexes	331
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Men	..
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Women	331
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.293
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	644
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	649
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	574
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	284
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	290
Valladolid	Group 0301 Anaemias 280-285	Both sexes	354
Valladolid	Group 0301 Anaemias 280-285	Men	168
Valladolid	Group 0301 Anaemias 280-285	Women	186
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	220
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	116
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	104
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.208
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	455
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	753
Valladolid	Group 0401 Diabetes mellitus  249-250	Both sexes	372
Valladolid	Group 0401 Diabetes mellitus  249-250	Men	227
Valladolid	Group 0401 Diabetes mellitus  249-250	Women	145
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	836
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	228
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	608
Valladolid	Group 0500 Mental disorders  290-319	Both sexes	1.273
Valladolid	Group 0500 Mental disorders  290-319	Men	635
Valladolid	Group 0500 Mental disorders  290-319	Women	638
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	55
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	29
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	26
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	127
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	97
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	30
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	59
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	43
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	16
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	289
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	166
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	123
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	279
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	102
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	177
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	464
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	198
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	266
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.039
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	485
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	554
Valladolid	Group 0601 Alzheimer's disease  3310	Both sexes	29
Valladolid	Group 0601 Alzheimer's disease  3310	Men	9
Valladolid	Group 0601 Alzheimer's disease  3310	Women	20
Valladolid	Group 0602 Multiple sclerosis 340	Both sexes	39
Valladolid	Group 0602 Multiple sclerosis 340	Men	13
Valladolid	Group 0602 Multiple sclerosis 340	Women	26
Valladolid	Group 0603 Epilepsy  345	Both sexes	199
Valladolid	Group 0603 Epilepsy  345	Men	119
Valladolid	Group 0603 Epilepsy  345	Women	80
Valladolid	Group 0604 Transient cerebral ischemia 435	Both sexes	163
Valladolid	Group 0604 Transient cerebral ischemia 435	Men	64
Valladolid	Group 0604 Transient cerebral ischemia 435	Women	99
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	609
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	280
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	329
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	313
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	137
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	176
Valladolid	Grupo 0701 Cataract  366	Both sexes	36
Valladolid	Grupo 0701 Cataract  366	Men	16
Valladolid	Grupo 0701 Cataract  366	Women	20
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	277
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	121
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	156
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	548
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Men	279
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Women	269
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.802
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.239
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.563
Valladolid	Group 0901 Hypertensive disease  401-405	Both sexes	409
Valladolid	Group 0901 Hypertensive disease  401-405	Men	169
Valladolid	Group 0901 Hypertensive disease  401-405	Women	240
Valladolid	Group 0902 Angina pectoris  4111, 413	Both sexes	396
Valladolid	Group 0902 Angina pectoris  4111, 413	Men	259
Valladolid	Group 0902 Angina pectoris  4111, 413	Women	137
Valladolid	Group 0903 Acute myocardial infarction  410	Both sexes	866
Valladolid	Group 0903 Acute myocardial infarction  410	Men	617
Valladolid	Group 0903 Acute myocardial infarction  410	Women	249
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	641
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	483
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	158
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	390
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Men	159
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Women	231
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.109
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	664
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	445
Valladolid	Grupo 0907 Heart failure  428	Both sexes	1.461
Valladolid	Grupo 0907 Heart failure  428	Men	703
Valladolid	Grupo 0907 Heart failure  428	Women	758
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.222
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	691
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	531
Valladolid	Grupo 0909 Atherosclerosis  440	Both sexes	418
Valladolid	Grupo 0909 Atherosclerosis  440	Men	336
Valladolid	Grupo 0909 Atherosclerosis  440	Women	82
Valladolid	Group 0910 Varicose veins of lower extremities 454	Both sexes	188
Valladolid	Group 0910 Varicose veins of lower extremities 454	Men	87
Valladolid	Group 0910 Varicose veins of lower extremities 454	Women	101
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.702
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.071
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	631
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.129
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.145
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.984
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	288
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	153
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	135
Valladolid	Group 1002 Pneumonia 480-486	Both sexes	1.546
Valladolid	Group 1002 Pneumonia 480-486	Men	935
Valladolid	Group 1002 Pneumonia 480-486	Women	611
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	624
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Men	247
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Women	377
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	539
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	280
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	259
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	752
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	508
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	244
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.043
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	850
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	193
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	218
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Men	56
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Women	162
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.119
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.116
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.003
Valladolid	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.908
Valladolid	Group 1100 Diseases of the digestive system  520-579	Men	4.664
Valladolid	Group 1100 Diseases of the digestive system  520-579	Women	3.244
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	146
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	76
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	70
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	97
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	53
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	44
Valladolid	Group 1103 Diseases of the esophagus 530	Both sexes	135
Valladolid	Group 1103 Diseases of the esophagus 530	Men	84
Valladolid	Group 1103 Diseases of the esophagus 530	Women	51
Valladolid	Group 1104 Peptic ulcer 531-534	Both sexes	154
Valladolid	Group 1104 Peptic ulcer 531-534	Men	95
Valladolid	Group 1104 Peptic ulcer 531-534	Women	59
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	175
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	93
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	82
Valladolid	Group 1106 Appendicitis  540-543	Both sexes	588
Valladolid	Group 1106 Appendicitis  540-543	Men	334
Valladolid	Group 1106 Appendicitis  540-543	Women	254
Valladolid	Group 1107 Inguinal hernia  550	Both sexes	1.183
Valladolid	Group 1107 Inguinal hernia  550	Men	1.076
Valladolid	Group 1107 Inguinal hernia  550	Women	107
Valladolid	Group 1108 Other abdominal hernia  551-553	Both sexes	706
Valladolid	Group 1108 Other abdominal hernia  551-553	Men	374
Valladolid	Group 1108 Other abdominal hernia  551-553	Women	332
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	143
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	82
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	61
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	440
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	194
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	246
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Both sexes	378
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Men	190
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Women	188
Valladolid	Group 1112 Intestinal diverticulosis 562	Both sexes	358
Valladolid	Group 1112 Intestinal diverticulosis 562	Men	178
Valladolid	Group 1112 Intestinal diverticulosis 562	Women	180
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	426
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	279
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	147
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	288
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	129
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	159
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	179
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Men	161
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Women	18
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	232
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Men	151
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Women	81
Valladolid	Group 1117 Cholelithiasis  574	Both sexes	1.359
Valladolid	Group 1117 Cholelithiasis  574	Men	645
Valladolid	Group 1117 Cholelithiasis  574	Women	714
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	294
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	163
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	131
Valladolid	Group 1119 Pancreatic diseases 577	Both sexes	277
Valladolid	Group 1119 Pancreatic diseases 577	Men	151
Valladolid	Group 1119 Pancreatic diseases 577	Women	126
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	350
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	156
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	194
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	533
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	293
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	240
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	333
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	191
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	142
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	20
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	10
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	10
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	180
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	92
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	88
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.748
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.778
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.970
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Valladolid	Group 1303 Internal derangement of knee 717	Both sexes	346
Valladolid	Group 1303 Internal derangement of knee 717	Men	244
Valladolid	Group 1303 Internal derangement of knee 717	Women	102
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.408
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	649
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	759
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	178
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	51
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	127
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	206
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	106
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	100
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	359
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	180
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	179
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	68
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	38
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	30
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	473
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	279
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	194
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	710
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	231
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	479
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.970
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.081
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.889
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	273
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	119
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	154
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	428
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Men	277
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Women	151
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	632
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Men	382
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Women	250
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.098
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	573
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	525
Valladolid	Group 1405 Prostatic hyperplasia  600	Both sexes	315
Valladolid	Group 1405 Prostatic hyperplasia  600	Men	315
Valladolid	Group 1405 Prostatic hyperplasia  600	Women	..
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	388
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Men	388
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Valladolid	Group 1407 Disorders of breast  610-612	Both sexes	172
Valladolid	Group 1407 Disorders of breast  610-612	Men	25
Valladolid	Group 1407 Disorders of breast  610-612	Women	147
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	104
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	104
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	25
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	25
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	535
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	533
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	4.993
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	4.993
Valladolid	Group 1501 Legally induced abortion  635	Both sexes	2
Valladolid	Group 1501 Legally induced abortion  635	Men	..
Valladolid	Group 1501 Legally induced abortion  635	Women	2
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	328
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	328
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.028
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.028
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	499
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	499
Valladolid	Group 1505 Single spontaneous delivery  650	Both sexes	452
Valladolid	Group 1505 Single spontaneous delivery  650	Men	..
Valladolid	Group 1505 Single spontaneous delivery  650	Women	452
Valladolid	Group 1506 Other deliveries  6695-6697	Both sexes	337
Valladolid	Group 1506 Other deliveries  6695-6697	Men	..
Valladolid	Group 1506 Other deliveries  6695-6697	Women	337
Valladolid	Group 1507 Complications related to the puerperium  670-676	Both sexes	32
Valladolid	Group 1507 Complications related to the puerperium  670-676	Men	..
Valladolid	Group 1507 Complications related to the puerperium  670-676	Women	32
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	315
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	315
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	596
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Men	321
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Women	275
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	47
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	21
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	26
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	549
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	300
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	249
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Both sexes	399
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Men	217
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Women	182
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.357
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.894
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.463
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	308
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Men	184
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Women	124
Valladolid	Group 1802 Abdominal pain   7890	Both sexes	234
Valladolid	Group 1802 Abdominal pain   7890	Men	97
Valladolid	Group 1802 Abdominal pain   7890	Women	137
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.028
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	605
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	423
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.787
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.008
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	779
Valladolid	Group 1900 Injuries and poisoning  800-999	Both sexes	5.103
Valladolid	Group 1900 Injuries and poisoning  800-999	Men	2.591
Valladolid	Group 1900 Injuries and poisoning  800-999	Women	2.512
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	202
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	119
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	83
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	187
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	124
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	63
Valladolid	Group 1903 Radius and ulna fracture 813	Both sexes	188
Valladolid	Group 1903 Radius and ulna fracture 813	Men	87
Valladolid	Group 1903 Radius and ulna fracture 813	Women	101
Valladolid	Group 1904 Femur fracture  820-821	Both sexes	857
Valladolid	Group 1904 Femur fracture  820-821	Men	198
Valladolid	Group 1904 Femur fracture  820-821	Women	659
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	305
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Men	142
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Women	163
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.340
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	786
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	554
Valladolid	Group 1907 Burns  940-949	Both sexes	53
Valladolid	Group 1907 Burns  940-949	Men	33
Valladolid	Group 1907 Burns  940-949	Women	20
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	198
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	91
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	107
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.661
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	945
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	716
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	7
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	99
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	59
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	40
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	800
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	396
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	404
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	49
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	32
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	17
Valladolid	Group 2102 Contraceptive management  V25	Both sexes	38
Valladolid	Group 2102 Contraceptive management  V25	Men	1
Valladolid	Group 2102 Contraceptive management  V25	Women	37
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	390
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	237
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	153
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	323
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	126
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	197
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.611
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	9.324
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	9.287
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	738
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	373
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	365
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	164
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	83
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	81
Zamora	Group 0102 Imprecise intestinal infections 009	Both sexes	54
Zamora	Group 0102 Imprecise intestinal infections 009	Men	18
Zamora	Group 0102 Imprecise intestinal infections 009	Women	36
Zamora	Group 0103 Tuberculosis 010-018, 137	Both sexes	15
Zamora	Group 0103 Tuberculosis 010-018, 137	Men	8
Zamora	Group 0103 Tuberculosis 010-018, 137	Women	7
Zamora	Group 0104 Septicaemia  038	Both sexes	276
Zamora	Group 0104 Septicaemia  038	Men	149
Zamora	Group 0104 Septicaemia  038	Women	127
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	15
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	10
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	214
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	105
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	109
Zamora	Group 0200 Neoplasms  140-239	Both sexes	2.047
Zamora	Group 0200 Neoplasms  140-239	Men	1.166
Zamora	Group 0200 Neoplasms  140-239	Women	881
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	302
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	203
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	99
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	122
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	100
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	22
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	16
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	8
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	8
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	126
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Women	125
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	42
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	42
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	37
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Women	37
Zamora	Group 0207 Malignant neoplasm of prostate  185	Both sexes	78
Zamora	Group 0207 Malignant neoplasm of prostate  185	Men	78
Zamora	Group 0207 Malignant neoplasm of prostate  185	Women	..
Zamora	Group 0208 Malignant neoplasm of bladder  188	Both sexes	223
Zamora	Group 0208 Malignant neoplasm of bladder  188	Men	192
Zamora	Group 0208 Malignant neoplasm of bladder  188	Women	31
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	785
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	484
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	301
Zamora	Group 0210 Carcinoma in situ  230-234	Both sexes	21
Zamora	Group 0210 Carcinoma in situ  230-234	Men	10
Zamora	Group 0210 Carcinoma in situ  230-234	Women	11
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	20
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	12
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	8
Zamora	Grupo 0212 Leiomyoma of uterus  218	Both sexes	65
Zamora	Grupo 0212 Leiomyoma of uterus  218	Men	..
Zamora	Grupo 0212 Leiomyoma of uterus  218	Women	65
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	210
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	78
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	132
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	188
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	105
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	83
Zamora	Group 0301 Anaemias 280-285	Both sexes	103
Zamora	Group 0301 Anaemias 280-285	Men	53
Zamora	Group 0301 Anaemias 280-285	Women	50
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	85
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	52
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	33
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	377
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	160
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	217
Zamora	Group 0401 Diabetes mellitus  249-250	Both sexes	154
Zamora	Group 0401 Diabetes mellitus  249-250	Men	81
Zamora	Group 0401 Diabetes mellitus  249-250	Women	73
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	223
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	79
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	144
Zamora	Group 0500 Mental disorders  290-319	Both sexes	386
Zamora	Group 0500 Mental disorders  290-319	Men	202
Zamora	Group 0500 Mental disorders  290-319	Women	184
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	5
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	3
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	2
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	20
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	16
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	4
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	13
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	13
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	..
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	157
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	96
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	61
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	85
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	33
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	52
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	106
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	41
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	65
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	240
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	112
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	128
Zamora	Group 0601 Alzheimer's disease  3310	Both sexes	6
Zamora	Group 0601 Alzheimer's disease  3310	Men	4
Zamora	Group 0601 Alzheimer's disease  3310	Women	2
Zamora	Group 0602 Multiple sclerosis 340	Both sexes	6
Zamora	Group 0602 Multiple sclerosis 340	Men	5
Zamora	Group 0602 Multiple sclerosis 340	Women	1
Zamora	Group 0603 Epilepsy  345	Both sexes	49
Zamora	Group 0603 Epilepsy  345	Men	26
Zamora	Group 0603 Epilepsy  345	Women	23
Zamora	Group 0604 Transient cerebral ischemia 435	Both sexes	66
Zamora	Group 0604 Transient cerebral ischemia 435	Men	27
Zamora	Group 0604 Transient cerebral ischemia 435	Women	39
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	113
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	50
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	63
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	46
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	22
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	24
Zamora	Grupo 0701 Cataract  366	Both sexes	3
Zamora	Grupo 0701 Cataract  366	Men	2
Zamora	Grupo 0701 Cataract  366	Women	1
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	43
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	20
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	23
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	156
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Men	74
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Women	82
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.409
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.265
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.144
Zamora	Group 0901 Hypertensive disease  401-405	Both sexes	104
Zamora	Group 0901 Hypertensive disease  401-405	Men	37
Zamora	Group 0901 Hypertensive disease  401-405	Women	67
Zamora	Group 0902 Angina pectoris  4111, 413	Both sexes	52
Zamora	Group 0902 Angina pectoris  4111, 413	Men	41
Zamora	Group 0902 Angina pectoris  4111, 413	Women	11
Zamora	Group 0903 Acute myocardial infarction  410	Both sexes	224
Zamora	Group 0903 Acute myocardial infarction  410	Men	155
Zamora	Group 0903 Acute myocardial infarction  410	Women	69
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	53
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	41
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	12
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	126
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Men	57
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Women	69
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	315
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	192
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	123
Zamora	Grupo 0907 Heart failure  428	Both sexes	656
Zamora	Grupo 0907 Heart failure  428	Men	299
Zamora	Grupo 0907 Heart failure  428	Women	357
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	443
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	213
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	230
Zamora	Grupo 0909 Atherosclerosis  440	Both sexes	26
Zamora	Grupo 0909 Atherosclerosis  440	Men	18
Zamora	Grupo 0909 Atherosclerosis  440	Women	8
Zamora	Group 0910 Varicose veins of lower extremities 454	Both sexes	75
Zamora	Group 0910 Varicose veins of lower extremities 454	Men	33
Zamora	Group 0910 Varicose veins of lower extremities 454	Women	42
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	335
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	179
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	156
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.929
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.704
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.225
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	189
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	95
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	94
Zamora	Group 1002 Pneumonia 480-486	Both sexes	634
Zamora	Group 1002 Pneumonia 480-486	Men	405
Zamora	Group 1002 Pneumonia 480-486	Women	229
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	306
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Men	115
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Women	191
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	172
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	87
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	85
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	251
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	142
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	109
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	500
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	449
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	51
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	147
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Men	36
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Women	111
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	730
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	375
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	355
Zamora	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.763
Zamora	Group 1100 Diseases of the digestive system  520-579	Men	1.596
Zamora	Group 1100 Diseases of the digestive system  520-579	Women	1.167
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	12
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	5
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	7
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	39
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	22
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	17
Zamora	Group 1103 Diseases of the esophagus 530	Both sexes	59
Zamora	Group 1103 Diseases of the esophagus 530	Men	31
Zamora	Group 1103 Diseases of the esophagus 530	Women	28
Zamora	Group 1104 Peptic ulcer 531-534	Both sexes	75
Zamora	Group 1104 Peptic ulcer 531-534	Men	52
Zamora	Group 1104 Peptic ulcer 531-534	Women	23
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	95
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	57
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	38
Zamora	Group 1106 Appendicitis  540-543	Both sexes	191
Zamora	Group 1106 Appendicitis  540-543	Men	111
Zamora	Group 1106 Appendicitis  540-543	Women	80
Zamora	Group 1107 Inguinal hernia  550	Both sexes	379
Zamora	Group 1107 Inguinal hernia  550	Men	348
Zamora	Group 1107 Inguinal hernia  550	Women	31
Zamora	Group 1108 Other abdominal hernia  551-553	Both sexes	151
Zamora	Group 1108 Other abdominal hernia  551-553	Men	83
Zamora	Group 1108 Other abdominal hernia  551-553	Women	68
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	63
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	25
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	38
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	184
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	87
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	97
Zamora	Group 1111 Intestinal obstruction without hernia 560	Both sexes	179
Zamora	Group 1111 Intestinal obstruction without hernia 560	Men	100
Zamora	Group 1111 Intestinal obstruction without hernia 560	Women	79
Zamora	Group 1112 Intestinal diverticulosis 562	Both sexes	132
Zamora	Group 1112 Intestinal diverticulosis 562	Men	55
Zamora	Group 1112 Intestinal diverticulosis 562	Women	77
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	97
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	66
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	31
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	131
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	64
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	67
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	33
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Men	29
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Women	4
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	91
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Men	51
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Women	40
Zamora	Group 1117 Cholelithiasis  574	Both sexes	516
Zamora	Group 1117 Cholelithiasis  574	Men	238
Zamora	Group 1117 Cholelithiasis  574	Women	278
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	68
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	38
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	30
Zamora	Group 1119 Pancreatic diseases 577	Both sexes	136
Zamora	Group 1119 Pancreatic diseases 577	Men	64
Zamora	Group 1119 Pancreatic diseases 577	Women	72
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	132
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	70
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	62
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	141
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	80
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	61
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	97
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	57
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	40
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	7
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	2
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	5
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	37
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	21
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	16
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	856
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	373
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	483
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Zamora	Group 1303 Internal derangement of knee 717	Both sexes	76
Zamora	Group 1303 Internal derangement of knee 717	Men	50
Zamora	Group 1303 Internal derangement of knee 717	Women	26
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	457
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	194
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	263
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	13
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	7
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	6
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	10
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	8
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	2
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	43
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	21
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	22
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	9
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	1
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	8
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	104
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	55
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	49
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	144
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	37
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	107
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.268
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	690
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	578
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	110
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	36
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	74
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	129
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Men	73
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Women	56
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	104
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Men	67
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Women	37
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	440
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	246
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	194
Zamora	Group 1405 Prostatic hyperplasia  600	Both sexes	186
Zamora	Group 1405 Prostatic hyperplasia  600	Men	186
Zamora	Group 1405 Prostatic hyperplasia  600	Women	..
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	77
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Men	77
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Zamora	Group 1407 Disorders of breast  610-612	Both sexes	20
Zamora	Group 1407 Disorders of breast  610-612	Men	4
Zamora	Group 1407 Disorders of breast  610-612	Women	16
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	34
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	34
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	14
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	14
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	154
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	153
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.202
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.202
Zamora	Group 1501 Legally induced abortion  635	Both sexes	..
Zamora	Group 1501 Legally induced abortion  635	Men	..
Zamora	Group 1501 Legally induced abortion  635	Women	..
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	104
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	104
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	831
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	831
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	134
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	134
Zamora	Group 1505 Single spontaneous delivery  650	Both sexes	35
Zamora	Group 1505 Single spontaneous delivery  650	Men	..
Zamora	Group 1505 Single spontaneous delivery  650	Women	35
Zamora	Group 1506 Other deliveries  6695-6697	Both sexes	7
Zamora	Group 1506 Other deliveries  6695-6697	Men	..
Zamora	Group 1506 Other deliveries  6695-6697	Women	7
Zamora	Group 1507 Complications related to the puerperium  670-676	Both sexes	14
Zamora	Group 1507 Complications related to the puerperium  670-676	Men	..
Zamora	Group 1507 Complications related to the puerperium  670-676	Women	14
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	77
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	77
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	107
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Men	66
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Women	41
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	25
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	16
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	9
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	82
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	50
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	32
Zamora	Grupo 1700 Congenital abnormalities  740-759	Both sexes	45
Zamora	Grupo 1700 Congenital abnormalities  740-759	Men	20
Zamora	Grupo 1700 Congenital abnormalities  740-759	Women	25
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	717
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	390
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	327
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	80
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Men	48
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Women	32
Zamora	Group 1802 Abdominal pain   7890	Both sexes	88
Zamora	Group 1802 Abdominal pain   7890	Men	35
Zamora	Group 1802 Abdominal pain   7890	Women	53
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	43
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	29
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	14
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	506
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	278
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	228
Zamora	Group 1900 Injuries and poisoning  800-999	Both sexes	1.586
Zamora	Group 1900 Injuries and poisoning  800-999	Men	759
Zamora	Group 1900 Injuries and poisoning  800-999	Women	827
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	105
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	54
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	51
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	51
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	36
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	15
Zamora	Group 1903 Radius and ulna fracture 813	Both sexes	75
Zamora	Group 1903 Radius and ulna fracture 813	Men	28
Zamora	Group 1903 Radius and ulna fracture 813	Women	47
Zamora	Group 1904 Femur fracture  820-821	Both sexes	352
Zamora	Group 1904 Femur fracture  820-821	Men	81
Zamora	Group 1904 Femur fracture  820-821	Women	271
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	110
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Men	61
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Women	49
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	295
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	175
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	120
Zamora	Group 1907 Burns  940-949	Both sexes	1
Zamora	Group 1907 Burns  940-949	Men	1
Zamora	Group 1907 Burns  940-949	Women	..
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	51
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	23
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	28
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	471
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	258
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	213
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	75
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	42
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	33
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	410
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	167
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	243
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	11
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	7
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	4
Zamora	Group 2102 Contraceptive management  V25	Both sexes	13
Zamora	Group 2102 Contraceptive management  V25	Men	..
Zamora	Group 2102 Contraceptive management  V25	Women	13
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	255
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	81
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	174
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	131
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	79
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	52
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	176.141
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	84.275
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	91.866
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.641
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.610
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.031
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	782
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	439
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	343
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Both sexes	212
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Men	108
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Women	104
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Both sexes	97
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Men	66
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Women	31
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Both sexes	2.310
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Men	1.251
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Women	1.059
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	72
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	51
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	21
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.168
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	695
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	473
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Both sexes	15.702
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Men	8.790
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Women	6.912
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.809
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.123
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	686
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.272
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.070
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	202
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	366
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	218
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	148
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.083
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Men	9
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Women	1.074
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	300
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	300
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	166
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Women	166
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	513
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Men	513
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.177
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Men	1.015
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Women	162
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.425
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.311
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.114
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Both sexes	226
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Men	101
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Women	125
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	196
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	121
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	75
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	609
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Women	609
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.560
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.309
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.251
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.632
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	824
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	808
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Both sexes	953
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Men	452
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Women	501
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	679
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	372
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	307
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.899
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.197
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.702
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Both sexes	990
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Men	571
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Women	419
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.909
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	626
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.283
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Both sexes	4.122
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Men	2.049
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Women	2.073
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	108
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	52
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	56
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	249
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	181
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	68
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	159
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	109
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	50
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.250
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	808
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	442
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	927
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	318
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	609
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.429
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	581
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	848
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	4.482
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.293
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.189
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Both sexes	63
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Men	23
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Women	40
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Both sexes	119
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Men	23
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Women	96
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Both sexes	539
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Men	286
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Women	253
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Both sexes	660
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Men	312
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Women	348
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.101
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.649
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.452
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	969
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	529
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	440
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Both sexes	138
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Men	75
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Women	63
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	831
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	454
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	377
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	753
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	331
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	422
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	23.471
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	13.063
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	10.408
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Both sexes	1.262
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Men	545
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Women	717
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Both sexes	1.000
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Men	634
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Women	366
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Both sexes	2.209
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Men	1.615
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Women	594
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.227
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	916
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	311
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	886
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Men	414
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Women	472
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	3.264
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.758
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.506
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Both sexes	5.415
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Men	2.373
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Women	3.042
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	4.059
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.238
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.821
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Both sexes	781
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Men	611
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Women	170
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Both sexes	206
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Men	80
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Women	126
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.162
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.879
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.283
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	24.281
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	14.113
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	10.168
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.115
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	628
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	487
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Both sexes	6.308
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Men	3.872
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Women	2.436
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.001
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	907
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.094
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	814
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	441
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	373
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.315
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	869
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	446
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.590
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.973
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	617
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	733
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Men	239
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Women	494
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	8.405
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	4.184
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	4.221
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Both sexes	22.423
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Men	12.393
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Women	10.030
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	313
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	148
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	165
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	283
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	154
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	129
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Both sexes	427
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Men	267
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Women	160
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Both sexes	527
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Men	362
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Women	165
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	527
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	262
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	265
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Both sexes	1.925
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Men	1.143
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Women	782
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Both sexes	1.623
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Men	1.444
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Women	179
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Both sexes	1.775
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Men	762
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Women	1.013
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	420
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	225
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	195
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.395
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	686
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	709
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.279
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Men	620
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Women	659
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Both sexes	786
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Men	412
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Women	374
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.260
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	859
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	401
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	889
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	404
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	485
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	289
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Men	247
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Women	42
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	627
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Men	406
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Women	221
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Both sexes	4.184
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Men	1.830
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Women	2.354
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.365
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	748
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	617
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Both sexes	1.540
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Men	868
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Women	672
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	989
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	546
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	443
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.468
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	782
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	686
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	901
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	511
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	390
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	66
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	38
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	28
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	501
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	233
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	268
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.738
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.694
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.044
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Both sexes	897
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Men	634
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Women	263
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.873
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.612
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.261
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	178
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	80
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	98
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	705
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	376
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	329
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	917
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	463
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	454
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	202
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	117
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	85
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.428
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	801
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	627
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.538
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	611
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	927
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	11.752
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	5.354
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	6.398
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.061
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	416
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	645
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.268
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Men	691
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Women	577
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.609
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Men	932
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Women	677
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.556
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.763
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.793
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Both sexes	649
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Men	649
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Women	..
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	844
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Men	844
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Both sexes	555
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Men	47
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Women	508
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	324
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	324
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	164
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	164
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.722
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	12
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.710
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	18.710
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	18.710
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Both sexes	20
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Men	..
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Women	20
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.531
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.531
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.709
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.709
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.328
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.328
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Both sexes	1.048
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Men	..
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Women	1.048
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Both sexes	769
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Men	..
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Women	769
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Both sexes	153
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Men	..
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Women	153
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.152
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.152
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.934
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.585
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.349
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	767
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	410
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	357
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.167
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.175
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	992
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.029
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Men	637
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Women	392
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.657
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.127
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.530
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	790
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Men	446
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Women	344
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Both sexes	945
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Men	416
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Women	529
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	643
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	318
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	325
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.279
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.947
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.332
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Both sexes	14.868
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Men	7.458
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Women	7.410
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	782
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	447
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	335
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	332
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	249
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	83
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Both sexes	857
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Men	401
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Women	456
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Both sexes	3.101
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Men	921
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Women	2.180
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.052
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Men	526
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Women	526
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.935
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.431
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.504
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Both sexes	40
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Men	29
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Women	11
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	481
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	223
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	258
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.699
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.957
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.742
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	47
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	24
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	23
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	542
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	250
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	292
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.610
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.446
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.164
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	185
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	114
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	71
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Both sexes	44
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Men	5
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Women	39
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.284
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	762
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	522
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.097
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	565
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	532
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	41.350
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	19.477
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	21.873
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.097
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	629
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	468
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	182
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	100
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	82
Albacete	Group 0102 Imprecise intestinal infections 009	Both sexes	66
Albacete	Group 0102 Imprecise intestinal infections 009	Men	34
Albacete	Group 0102 Imprecise intestinal infections 009	Women	32
Albacete	Group 0103 Tuberculosis 010-018, 137	Both sexes	23
Albacete	Group 0103 Tuberculosis 010-018, 137	Men	17
Albacete	Group 0103 Tuberculosis 010-018, 137	Women	6
Albacete	Group 0104 Septicaemia  038	Both sexes	516
Albacete	Group 0104 Septicaemia  038	Men	297
Albacete	Group 0104 Septicaemia  038	Women	219
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	18
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	11
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	292
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	170
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	122
Albacete	Group 0200 Neoplasms  140-239	Both sexes	3.617
Albacete	Group 0200 Neoplasms  140-239	Men	1.992
Albacete	Group 0200 Neoplasms  140-239	Women	1.625
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	384
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	245
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	139
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	304
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	257
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	47
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	108
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	63
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	45
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	256
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Men	2
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Women	254
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	59
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	59
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	41
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Women	41
Albacete	Group 0207 Malignant neoplasm of prostate  185	Both sexes	94
Albacete	Group 0207 Malignant neoplasm of prostate  185	Men	94
Albacete	Group 0207 Malignant neoplasm of prostate  185	Women	..
Albacete	Group 0208 Malignant neoplasm of bladder  188	Both sexes	297
Albacete	Group 0208 Malignant neoplasm of bladder  188	Men	259
Albacete	Group 0208 Malignant neoplasm of bladder  188	Women	38
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.305
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	827
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	478
Albacete	Group 0210 Carcinoma in situ  230-234	Both sexes	64
Albacete	Group 0210 Carcinoma in situ  230-234	Men	16
Albacete	Group 0210 Carcinoma in situ  230-234	Women	48
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	29
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	13
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	16
Albacete	Grupo 0212 Leiomyoma of uterus  218	Both sexes	146
Albacete	Grupo 0212 Leiomyoma of uterus  218	Men	..
Albacete	Grupo 0212 Leiomyoma of uterus  218	Women	146
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	530
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	216
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	314
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	345
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	177
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	168
Albacete	Group 0301 Anaemias 280-285	Both sexes	192
Albacete	Group 0301 Anaemias 280-285	Men	89
Albacete	Group 0301 Anaemias 280-285	Women	103
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	153
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	88
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	65
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	686
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	266
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	420
Albacete	Group 0401 Diabetes mellitus  249-250	Both sexes	226
Albacete	Group 0401 Diabetes mellitus  249-250	Men	134
Albacete	Group 0401 Diabetes mellitus  249-250	Women	92
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	460
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	132
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	328
Albacete	Group 0500 Mental disorders  290-319	Both sexes	923
Albacete	Group 0500 Mental disorders  290-319	Men	370
Albacete	Group 0500 Mental disorders  290-319	Women	553
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	9
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	5
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	4
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	39
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	25
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	14
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	36
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	18
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	18
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	246
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	158
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	88
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	239
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	84
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	155
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	354
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	80
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	274
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	621
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	306
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	315
Albacete	Group 0601 Alzheimer's disease  3310	Both sexes	6
Albacete	Group 0601 Alzheimer's disease  3310	Men	2
Albacete	Group 0601 Alzheimer's disease  3310	Women	4
Albacete	Group 0602 Multiple sclerosis 340	Both sexes	10
Albacete	Group 0602 Multiple sclerosis 340	Men	..
Albacete	Group 0602 Multiple sclerosis 340	Women	10
Albacete	Group 0603 Epilepsy  345	Both sexes	123
Albacete	Group 0603 Epilepsy  345	Men	57
Albacete	Group 0603 Epilepsy  345	Women	66
Albacete	Group 0604 Transient cerebral ischemia 435	Both sexes	125
Albacete	Group 0604 Transient cerebral ischemia 435	Men	57
Albacete	Group 0604 Transient cerebral ischemia 435	Women	68
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	357
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	190
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	167
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	182
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	91
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	91
Albacete	Grupo 0701 Cataract  366	Both sexes	71
Albacete	Grupo 0701 Cataract  366	Men	38
Albacete	Grupo 0701 Cataract  366	Women	33
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	111
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	53
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	58
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	138
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Men	65
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Women	73
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.208
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.979
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.229
Albacete	Group 0901 Hypertensive disease  401-405	Both sexes	309
Albacete	Group 0901 Hypertensive disease  401-405	Men	162
Albacete	Group 0901 Hypertensive disease  401-405	Women	147
Albacete	Group 0902 Angina pectoris  4111, 413	Both sexes	233
Albacete	Group 0902 Angina pectoris  4111, 413	Men	146
Albacete	Group 0902 Angina pectoris  4111, 413	Women	87
Albacete	Group 0903 Acute myocardial infarction  410	Both sexes	522
Albacete	Group 0903 Acute myocardial infarction  410	Men	399
Albacete	Group 0903 Acute myocardial infarction  410	Women	123
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	291
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	216
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	75
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	210
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Men	93
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Women	117
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	564
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	299
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	265
Albacete	Grupo 0907 Heart failure  428	Both sexes	1.184
Albacete	Grupo 0907 Heart failure  428	Men	559
Albacete	Grupo 0907 Heart failure  428	Women	625
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	959
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	519
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	440
Albacete	Grupo 0909 Atherosclerosis  440	Both sexes	157
Albacete	Grupo 0909 Atherosclerosis  440	Men	123
Albacete	Grupo 0909 Atherosclerosis  440	Women	34
Albacete	Group 0910 Varicose veins of lower extremities 454	Both sexes	36
Albacete	Group 0910 Varicose veins of lower extremities 454	Men	18
Albacete	Group 0910 Varicose veins of lower extremities 454	Women	18
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	743
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	445
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	298
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.041
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.821
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.220
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	245
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	133
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	112
Albacete	Group 1002 Pneumonia 480-486	Both sexes	1.202
Albacete	Group 1002 Pneumonia 480-486	Men	695
Albacete	Group 1002 Pneumonia 480-486	Women	507
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	593
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Men	272
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Women	321
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	203
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	107
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	96
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	217
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	118
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	99
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	551
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	460
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	91
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	137
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Men	35
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Women	102
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.893
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.001
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	892
Albacete	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.937
Albacete	Group 1100 Diseases of the digestive system  520-579	Men	2.826
Albacete	Group 1100 Diseases of the digestive system  520-579	Women	2.111
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	64
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	37
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	27
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	58
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	36
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	22
Albacete	Group 1103 Diseases of the esophagus 530	Both sexes	104
Albacete	Group 1103 Diseases of the esophagus 530	Men	58
Albacete	Group 1103 Diseases of the esophagus 530	Women	46
Albacete	Group 1104 Peptic ulcer 531-534	Both sexes	165
Albacete	Group 1104 Peptic ulcer 531-534	Men	114
Albacete	Group 1104 Peptic ulcer 531-534	Women	51
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	140
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	80
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	60
Albacete	Group 1106 Appendicitis  540-543	Both sexes	442
Albacete	Group 1106 Appendicitis  540-543	Men	280
Albacete	Group 1106 Appendicitis  540-543	Women	162
Albacete	Group 1107 Inguinal hernia  550	Both sexes	324
Albacete	Group 1107 Inguinal hernia  550	Men	281
Albacete	Group 1107 Inguinal hernia  550	Women	43
Albacete	Group 1108 Other abdominal hernia  551-553	Both sexes	367
Albacete	Group 1108 Other abdominal hernia  551-553	Men	145
Albacete	Group 1108 Other abdominal hernia  551-553	Women	222
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	91
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	55
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	36
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	264
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	135
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	129
Albacete	Group 1111 Intestinal obstruction without hernia 560	Both sexes	271
Albacete	Group 1111 Intestinal obstruction without hernia 560	Men	136
Albacete	Group 1111 Intestinal obstruction without hernia 560	Women	135
Albacete	Group 1112 Intestinal diverticulosis 562	Both sexes	179
Albacete	Group 1112 Intestinal diverticulosis 562	Men	109
Albacete	Group 1112 Intestinal diverticulosis 562	Women	70
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	368
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	279
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	89
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	164
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	74
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	90
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	66
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Men	51
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Women	15
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	145
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Men	84
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Women	61
Albacete	Group 1117 Cholelithiasis  574	Both sexes	812
Albacete	Group 1117 Cholelithiasis  574	Men	360
Albacete	Group 1117 Cholelithiasis  574	Women	452
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	349
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	186
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	163
Albacete	Group 1119 Pancreatic diseases 577	Both sexes	321
Albacete	Group 1119 Pancreatic diseases 577	Men	195
Albacete	Group 1119 Pancreatic diseases 577	Women	126
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	243
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	131
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	112
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	350
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	169
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	181
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	204
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	103
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	101
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	15
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	8
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	131
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	59
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	72
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.214
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.126
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.088
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Albacete	Group 1303 Internal derangement of knee 717	Both sexes	98
Albacete	Group 1303 Internal derangement of knee 717	Men	70
Albacete	Group 1303 Internal derangement of knee 717	Women	28
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	958
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	436
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	522
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	31
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	12
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	19
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	188
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	107
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	81
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	328
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	172
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	156
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	33
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	19
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	14
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	317
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	191
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	126
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	261
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	119
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	142
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.153
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.355
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.798
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	180
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	88
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	92
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	275
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Men	147
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Women	128
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	618
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Men	351
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Women	267
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	816
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	413
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	403
Albacete	Group 1405 Prostatic hyperplasia  600	Both sexes	120
Albacete	Group 1405 Prostatic hyperplasia  600	Men	120
Albacete	Group 1405 Prostatic hyperplasia  600	Women	..
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	220
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Men	220
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Albacete	Group 1407 Disorders of breast  610-612	Both sexes	275
Albacete	Group 1407 Disorders of breast  610-612	Men	9
Albacete	Group 1407 Disorders of breast  610-612	Women	266
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	78
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	78
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	31
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	31
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	540
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	533
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	4.892
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	4.892
Albacete	Group 1501 Legally induced abortion  635	Both sexes	15
Albacete	Group 1501 Legally induced abortion  635	Men	..
Albacete	Group 1501 Legally induced abortion  635	Women	15
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	350
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	350
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.821
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.821
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	718
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	718
Albacete	Group 1505 Single spontaneous delivery  650	Both sexes	496
Albacete	Group 1505 Single spontaneous delivery  650	Men	..
Albacete	Group 1505 Single spontaneous delivery  650	Women	496
Albacete	Group 1506 Other deliveries  6695-6697	Both sexes	228
Albacete	Group 1506 Other deliveries  6695-6697	Men	..
Albacete	Group 1506 Other deliveries  6695-6697	Women	228
Albacete	Group 1507 Complications related to the puerperium  670-676	Both sexes	47
Albacete	Group 1507 Complications related to the puerperium  670-676	Men	..
Albacete	Group 1507 Complications related to the puerperium  670-676	Women	47
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	217
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	217
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	677
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Men	378
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Women	299
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	180
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	104
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	76
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	497
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	274
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	223
Albacete	Grupo 1700 Congenital abnormalities  740-759	Both sexes	322
Albacete	Grupo 1700 Congenital abnormalities  740-759	Men	203
Albacete	Grupo 1700 Congenital abnormalities  740-759	Women	119
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.357
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.319
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.038
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	184
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Men	109
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Women	75
Albacete	Group 1802 Abdominal pain   7890	Both sexes	297
Albacete	Group 1802 Abdominal pain   7890	Men	171
Albacete	Group 1802 Abdominal pain   7890	Women	126
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	621
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	308
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	313
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.255
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	731
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	524
Albacete	Group 1900 Injuries and poisoning  800-999	Both sexes	3.748
Albacete	Group 1900 Injuries and poisoning  800-999	Men	1.961
Albacete	Group 1900 Injuries and poisoning  800-999	Women	1.787
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	193
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	107
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	86
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	81
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	60
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	21
Albacete	Group 1903 Radius and ulna fracture 813	Both sexes	247
Albacete	Group 1903 Radius and ulna fracture 813	Men	114
Albacete	Group 1903 Radius and ulna fracture 813	Women	133
Albacete	Group 1904 Femur fracture  820-821	Both sexes	699
Albacete	Group 1904 Femur fracture  820-821	Men	204
Albacete	Group 1904 Femur fracture  820-821	Women	495
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	240
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Men	114
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Women	126
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.054
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	704
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	350
Albacete	Group 1907 Burns  940-949	Both sexes	22
Albacete	Group 1907 Burns  940-949	Men	15
Albacete	Group 1907 Burns  940-949	Women	7
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	88
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	38
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	50
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	987
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	533
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	454
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	19
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	11
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	8
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	118
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	61
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	57
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	842
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	444
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	398
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	95
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	57
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	38
Albacete	Group 2102 Contraceptive management  V25	Both sexes	8
Albacete	Group 2102 Contraceptive management  V25	Men	2
Albacete	Group 2102 Contraceptive management  V25	Women	6
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	448
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	273
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	175
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	291
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	112
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	179
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	54.062
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	25.237
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	28.825
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.101
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	608
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	493
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	210
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	115
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	95
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Both sexes	26
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Men	13
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Women	13
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Both sexes	29
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Men	20
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Women	9
Ciudad Real	Group 0104 Septicaemia  038	Both sexes	478
Ciudad Real	Group 0104 Septicaemia  038	Men	253
Ciudad Real	Group 0104 Septicaemia  038	Women	225
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	25
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	18
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	333
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	189
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	144
Ciudad Real	Group 0200 Neoplasms  140-239	Both sexes	5.103
Ciudad Real	Group 0200 Neoplasms  140-239	Men	2.809
Ciudad Real	Group 0200 Neoplasms  140-239	Women	2.294
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	607
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	381
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	226
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	437
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	362
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	75
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	61
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	37
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	24
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	359
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Women	355
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	111
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	111
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	69
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Women	69
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Both sexes	154
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Men	154
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Both sexes	438
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Men	367
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Women	71
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.926
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.138
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	788
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Both sexes	43
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Men	23
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Women	20
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	77
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	49
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	28
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Both sexes	195
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Women	195
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	626
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	294
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	332
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	483
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	241
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	242
Ciudad Real	Group 0301 Anaemias 280-285	Both sexes	295
Ciudad Real	Group 0301 Anaemias 280-285	Men	148
Ciudad Real	Group 0301 Anaemias 280-285	Women	147
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	188
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	93
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	95
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	832
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	334
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	498
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Both sexes	286
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Men	165
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Women	121
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	546
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	169
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	377
Ciudad Real	Group 0500 Mental disorders  290-319	Both sexes	1.099
Ciudad Real	Group 0500 Mental disorders  290-319	Men	523
Ciudad Real	Group 0500 Mental disorders  290-319	Women	576
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	47
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	21
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	26
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	47
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	35
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	29
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	22
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	7
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	259
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	148
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	111
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	226
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	86
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	140
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	491
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	211
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	280
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.328
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	617
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	711
Ciudad Real	Group 0601 Alzheimer's disease  3310	Both sexes	34
Ciudad Real	Group 0601 Alzheimer's disease  3310	Men	9
Ciudad Real	Group 0601 Alzheimer's disease  3310	Women	25
Ciudad Real	Group 0602 Multiple sclerosis 340	Both sexes	39
Ciudad Real	Group 0602 Multiple sclerosis 340	Men	8
Ciudad Real	Group 0602 Multiple sclerosis 340	Women	31
Ciudad Real	Group 0603 Epilepsy  345	Both sexes	149
Ciudad Real	Group 0603 Epilepsy  345	Men	89
Ciudad Real	Group 0603 Epilepsy  345	Women	60
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Both sexes	162
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Men	80
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Women	82
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	944
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	431
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	513
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	369
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	212
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	157
Ciudad Real	Grupo 0701 Cataract  366	Both sexes	17
Ciudad Real	Grupo 0701 Cataract  366	Men	9
Ciudad Real	Grupo 0701 Cataract  366	Women	8
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	352
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	203
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	149
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	290
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Men	126
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Women	164
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	7.194
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.829
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.365
Ciudad Real	Group 0901 Hypertensive disease  401-405	Both sexes	344
Ciudad Real	Group 0901 Hypertensive disease  401-405	Men	117
Ciudad Real	Group 0901 Hypertensive disease  401-405	Women	227
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Both sexes	365
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Men	213
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Women	152
Ciudad Real	Group 0903 Acute myocardial infarction  410	Both sexes	681
Ciudad Real	Group 0903 Acute myocardial infarction  410	Men	478
Ciudad Real	Group 0903 Acute myocardial infarction  410	Women	203
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	317
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	243
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	74
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	278
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Men	136
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Women	142
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	993
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	509
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	484
Ciudad Real	Grupo 0907 Heart failure  428	Both sexes	1.726
Ciudad Real	Grupo 0907 Heart failure  428	Men	684
Ciudad Real	Grupo 0907 Heart failure  428	Women	1.042
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.214
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	652
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	562
Ciudad Real	Grupo 0909 Atherosclerosis  440	Both sexes	303
Ciudad Real	Grupo 0909 Atherosclerosis  440	Men	230
Ciudad Real	Grupo 0909 Atherosclerosis  440	Women	73
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Both sexes	74
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Men	38
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Women	36
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	899
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	529
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	370
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	8.665
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.071
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.594
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	337
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	195
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	142
Ciudad Real	Group 1002 Pneumonia 480-486	Both sexes	2.118
Ciudad Real	Group 1002 Pneumonia 480-486	Men	1.319
Ciudad Real	Group 1002 Pneumonia 480-486	Women	799
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	837
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Men	356
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Women	481
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	363
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	200
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	163
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	543
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	361
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	182
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.522
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.275
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	247
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	234
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Men	74
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Women	160
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.711
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.291
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.420
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.248
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Men	3.857
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Women	3.391
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	96
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	43
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	53
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	97
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	50
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	47
Ciudad Real	Group 1103 Diseases of the esophagus 530	Both sexes	147
Ciudad Real	Group 1103 Diseases of the esophagus 530	Men	94
Ciudad Real	Group 1103 Diseases of the esophagus 530	Women	53
Ciudad Real	Group 1104 Peptic ulcer 531-534	Both sexes	140
Ciudad Real	Group 1104 Peptic ulcer 531-534	Men	92
Ciudad Real	Group 1104 Peptic ulcer 531-534	Women	48
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	165
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	79
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	86
Ciudad Real	Group 1106 Appendicitis  540-543	Both sexes	550
Ciudad Real	Group 1106 Appendicitis  540-543	Men	321
Ciudad Real	Group 1106 Appendicitis  540-543	Women	229
Ciudad Real	Group 1107 Inguinal hernia  550	Both sexes	475
Ciudad Real	Group 1107 Inguinal hernia  550	Men	419
Ciudad Real	Group 1107 Inguinal hernia  550	Women	56
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Both sexes	597
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Men	247
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Women	350
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	127
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	58
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	69
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	390
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	190
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	200
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Both sexes	438
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Men	208
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Women	230
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Both sexes	221
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Men	107
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Women	114
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	299
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	197
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	102
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	296
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	131
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	165
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	101
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Men	90
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Women	11
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	181
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Men	116
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Women	65
Ciudad Real	Group 1117 Cholelithiasis  574	Both sexes	1.667
Ciudad Real	Group 1117 Cholelithiasis  574	Men	720
Ciudad Real	Group 1117 Cholelithiasis  574	Women	947
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	394
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	201
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	193
Ciudad Real	Group 1119 Pancreatic diseases 577	Both sexes	571
Ciudad Real	Group 1119 Pancreatic diseases 577	Men	332
Ciudad Real	Group 1119 Pancreatic diseases 577	Women	239
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	296
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	162
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	134
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	364
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	195
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	169
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	220
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	128
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	92
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	11
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	6
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	5
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	133
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	61
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	72
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.038
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.388
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.650
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ciudad Real	Group 1303 Internal derangement of knee 717	Both sexes	294
Ciudad Real	Group 1303 Internal derangement of knee 717	Men	193
Ciudad Real	Group 1303 Internal derangement of knee 717	Women	101
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.228
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	490
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	738
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	67
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	33
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	34
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	233
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	119
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	114
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	189
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	94
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	95
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	48
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	24
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	24
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	446
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	230
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	216
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	533
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	205
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	328
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.552
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.569
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.983
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	289
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	108
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	181
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	402
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Men	200
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Women	202
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	302
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Men	194
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Women	108
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.312
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	620
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	692
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Both sexes	211
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Men	211
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Women	..
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	220
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Men	220
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ciudad Real	Group 1407 Disorders of breast  610-612	Both sexes	121
Ciudad Real	Group 1407 Disorders of breast  610-612	Men	15
Ciudad Real	Group 1407 Disorders of breast  610-612	Women	106
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	106
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	106
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	78
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	78
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	511
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	510
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.740
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.740
Ciudad Real	Group 1501 Legally induced abortion  635	Both sexes	1
Ciudad Real	Group 1501 Legally induced abortion  635	Men	..
Ciudad Real	Group 1501 Legally induced abortion  635	Women	1
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	512
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	512
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.960
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.960
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	674
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	674
Ciudad Real	Group 1505 Single spontaneous delivery  650	Both sexes	219
Ciudad Real	Group 1505 Single spontaneous delivery  650	Men	..
Ciudad Real	Group 1505 Single spontaneous delivery  650	Women	219
Ciudad Real	Group 1506 Other deliveries  6695-6697	Both sexes	20
Ciudad Real	Group 1506 Other deliveries  6695-6697	Men	..
Ciudad Real	Group 1506 Other deliveries  6695-6697	Women	20
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Both sexes	33
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Men	..
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Women	33
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	321
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	321
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.168
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Men	615
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Women	553
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	246
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	121
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	125
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	922
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	494
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	428
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Both sexes	232
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Men	151
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Women	81
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.901
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.009
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	892
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	212
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Men	115
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Women	97
Ciudad Real	Group 1802 Abdominal pain   7890	Both sexes	142
Ciudad Real	Group 1802 Abdominal pain   7890	Men	48
Ciudad Real	Group 1802 Abdominal pain   7890	Women	94
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.546
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	846
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	700
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Both sexes	3.775
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Men	1.800
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Women	1.975
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	168
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	103
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	65
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	113
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	81
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	32
Ciudad Real	Group 1903 Radius and ulna fracture 813	Both sexes	241
Ciudad Real	Group 1903 Radius and ulna fracture 813	Men	103
Ciudad Real	Group 1903 Radius and ulna fracture 813	Women	138
Ciudad Real	Group 1904 Femur fracture  820-821	Both sexes	934
Ciudad Real	Group 1904 Femur fracture  820-821	Men	296
Ciudad Real	Group 1904 Femur fracture  820-821	Women	638
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	286
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Men	137
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Women	149
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	751
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	412
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	339
Ciudad Real	Group 1907 Burns  940-949	Both sexes	11
Ciudad Real	Group 1907 Burns  940-949	Men	9
Ciudad Real	Group 1907 Burns  940-949	Women	2
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	127
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	66
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	61
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.003
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	528
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	475
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	15
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	126
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	57
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	69
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	580
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	283
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	297
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	49
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	31
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	18
Ciudad Real	Group 2102 Contraceptive management  V25	Both sexes	27
Ciudad Real	Group 2102 Contraceptive management  V25	Men	..
Ciudad Real	Group 2102 Contraceptive management  V25	Women	27
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	284
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	130
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	154
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	220
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	122
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	98
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.160
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	6.973
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	7.187
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	422
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	229
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	193
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	60
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	33
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	27
Cuenca	Group 0102 Imprecise intestinal infections 009	Both sexes	24
Cuenca	Group 0102 Imprecise intestinal infections 009	Men	16
Cuenca	Group 0102 Imprecise intestinal infections 009	Women	8
Cuenca	Group 0103 Tuberculosis 010-018, 137	Both sexes	3
Cuenca	Group 0103 Tuberculosis 010-018, 137	Men	1
Cuenca	Group 0103 Tuberculosis 010-018, 137	Women	2
Cuenca	Group 0104 Septicaemia  038	Both sexes	258
Cuenca	Group 0104 Septicaemia  038	Men	132
Cuenca	Group 0104 Septicaemia  038	Women	126
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	1
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	76
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	47
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	29
Cuenca	Group 0200 Neoplasms  140-239	Both sexes	989
Cuenca	Group 0200 Neoplasms  140-239	Men	561
Cuenca	Group 0200 Neoplasms  140-239	Women	428
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	161
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	104
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	57
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	64
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	53
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	11
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	13
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	10
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	3
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	63
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Women	62
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	12
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	12
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	2
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Women	2
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	29
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Men	29
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	38
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Men	31
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Women	7
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	269
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	166
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	103
Cuenca	Group 0210 Carcinoma in situ  230-234	Both sexes	15
Cuenca	Group 0210 Carcinoma in situ  230-234	Men	8
Cuenca	Group 0210 Carcinoma in situ  230-234	Women	7
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	32
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	21
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	11
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	51
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Women	51
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	240
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	138
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	102
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	155
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	64
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	91
Cuenca	Group 0301 Anaemias 280-285	Both sexes	131
Cuenca	Group 0301 Anaemias 280-285	Men	49
Cuenca	Group 0301 Anaemias 280-285	Women	82
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	24
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	15
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	9
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	230
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	94
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	136
Cuenca	Group 0401 Diabetes mellitus  249-250	Both sexes	92
Cuenca	Group 0401 Diabetes mellitus  249-250	Men	48
Cuenca	Group 0401 Diabetes mellitus  249-250	Women	44
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	138
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	46
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	92
Cuenca	Group 0500 Mental disorders  290-319	Both sexes	436
Cuenca	Group 0500 Mental disorders  290-319	Men	226
Cuenca	Group 0500 Mental disorders  290-319	Women	210
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	12
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	5
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	7
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	26
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	22
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	4
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	15
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	14
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	167
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	107
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	60
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	96
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	24
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	72
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	120
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	54
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	66
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	429
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	205
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	224
Cuenca	Group 0601 Alzheimer's disease  3310	Both sexes	7
Cuenca	Group 0601 Alzheimer's disease  3310	Men	5
Cuenca	Group 0601 Alzheimer's disease  3310	Women	2
Cuenca	Group 0602 Multiple sclerosis 340	Both sexes	33
Cuenca	Group 0602 Multiple sclerosis 340	Men	7
Cuenca	Group 0602 Multiple sclerosis 340	Women	26
Cuenca	Group 0603 Epilepsy  345	Both sexes	75
Cuenca	Group 0603 Epilepsy  345	Men	45
Cuenca	Group 0603 Epilepsy  345	Women	30
Cuenca	Group 0604 Transient cerebral ischemia 435	Both sexes	120
Cuenca	Group 0604 Transient cerebral ischemia 435	Men	51
Cuenca	Group 0604 Transient cerebral ischemia 435	Women	69
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	194
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	97
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	97
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	143
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	76
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	67
Cuenca	Grupo 0701 Cataract  366	Both sexes	6
Cuenca	Grupo 0701 Cataract  366	Men	3
Cuenca	Grupo 0701 Cataract  366	Women	3
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	137
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	73
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	64
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	58
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	22
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	36
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.909
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.047
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	862
Cuenca	Group 0901 Hypertensive disease  401-405	Both sexes	97
Cuenca	Group 0901 Hypertensive disease  401-405	Men	46
Cuenca	Group 0901 Hypertensive disease  401-405	Women	51
Cuenca	Group 0902 Angina pectoris  4111, 413	Both sexes	129
Cuenca	Group 0902 Angina pectoris  4111, 413	Men	90
Cuenca	Group 0902 Angina pectoris  4111, 413	Women	39
Cuenca	Group 0903 Acute myocardial infarction  410	Both sexes	81
Cuenca	Group 0903 Acute myocardial infarction  410	Men	53
Cuenca	Group 0903 Acute myocardial infarction  410	Women	28
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	27
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	23
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	4
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	62
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Men	28
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Women	34
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	321
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	179
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	142
Cuenca	Grupo 0907 Heart failure  428	Both sexes	469
Cuenca	Grupo 0907 Heart failure  428	Men	215
Cuenca	Grupo 0907 Heart failure  428	Women	254
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	388
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	222
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	166
Cuenca	Grupo 0909 Atherosclerosis  440	Both sexes	68
Cuenca	Grupo 0909 Atherosclerosis  440	Men	57
Cuenca	Grupo 0909 Atherosclerosis  440	Women	11
Cuenca	Group 0910 Varicose veins of lower extremities 454	Both sexes	36
Cuenca	Group 0910 Varicose veins of lower extremities 454	Men	10
Cuenca	Group 0910 Varicose veins of lower extremities 454	Women	26
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	231
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	124
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	107
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.227
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.300
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	927
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	117
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	62
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	55
Cuenca	Group 1002 Pneumonia 480-486	Both sexes	439
Cuenca	Group 1002 Pneumonia 480-486	Men	273
Cuenca	Group 1002 Pneumonia 480-486	Women	166
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	88
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	38
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	50
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	41
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	18
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	23
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	65
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	48
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	17
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	309
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	252
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	57
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	54
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Men	19
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Women	35
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.114
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	590
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	524
Cuenca	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.072
Cuenca	Group 1100 Diseases of the digestive system  520-579	Men	1.165
Cuenca	Group 1100 Diseases of the digestive system  520-579	Women	907
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	56
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	20
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	36
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	35
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	24
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	11
Cuenca	Group 1103 Diseases of the esophagus 530	Both sexes	26
Cuenca	Group 1103 Diseases of the esophagus 530	Men	18
Cuenca	Group 1103 Diseases of the esophagus 530	Women	8
Cuenca	Group 1104 Peptic ulcer 531-534	Both sexes	47
Cuenca	Group 1104 Peptic ulcer 531-534	Men	31
Cuenca	Group 1104 Peptic ulcer 531-534	Women	16
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	69
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	29
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	40
Cuenca	Group 1106 Appendicitis  540-543	Both sexes	156
Cuenca	Group 1106 Appendicitis  540-543	Men	94
Cuenca	Group 1106 Appendicitis  540-543	Women	62
Cuenca	Group 1107 Inguinal hernia  550	Both sexes	168
Cuenca	Group 1107 Inguinal hernia  550	Men	159
Cuenca	Group 1107 Inguinal hernia  550	Women	9
Cuenca	Group 1108 Other abdominal hernia  551-553	Both sexes	133
Cuenca	Group 1108 Other abdominal hernia  551-553	Men	56
Cuenca	Group 1108 Other abdominal hernia  551-553	Women	77
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	42
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	19
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	23
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	197
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	88
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	109
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	112
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Men	61
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Women	51
Cuenca	Group 1112 Intestinal diverticulosis 562	Both sexes	72
Cuenca	Group 1112 Intestinal diverticulosis 562	Men	35
Cuenca	Group 1112 Intestinal diverticulosis 562	Women	37
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	139
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	91
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	48
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	96
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	39
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	57
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	30
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Men	26
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Women	4
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	53
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Men	41
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Women	12
Cuenca	Group 1117 Cholelithiasis  574	Both sexes	311
Cuenca	Group 1117 Cholelithiasis  574	Men	152
Cuenca	Group 1117 Cholelithiasis  574	Women	159
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	110
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	63
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	47
Cuenca	Group 1119 Pancreatic diseases 577	Both sexes	105
Cuenca	Group 1119 Pancreatic diseases 577	Men	52
Cuenca	Group 1119 Pancreatic diseases 577	Women	53
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	115
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	67
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	48
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	141
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	85
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	56
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	97
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	61
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	36
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	8
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	4
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	4
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	36
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	20
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	16
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	618
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	294
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	324
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cuenca	Group 1303 Internal derangement of knee 717	Both sexes	109
Cuenca	Group 1303 Internal derangement of knee 717	Men	79
Cuenca	Group 1303 Internal derangement of knee 717	Women	30
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	229
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	90
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	139
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	13
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	6
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	7
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	16
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	11
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	5
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	30
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	12
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	18
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	34
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	25
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	9
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	80
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	41
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	39
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	107
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	30
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	77
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	865
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	411
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	454
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	96
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	29
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	67
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	127
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Men	80
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Women	47
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	127
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Men	68
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Women	59
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	263
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	130
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	133
Cuenca	Group 1405 Prostatic hyperplasia  600	Both sexes	50
Cuenca	Group 1405 Prostatic hyperplasia  600	Men	50
Cuenca	Group 1405 Prostatic hyperplasia  600	Women	..
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	50
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Men	50
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cuenca	Group 1407 Disorders of breast  610-612	Both sexes	11
Cuenca	Group 1407 Disorders of breast  610-612	Men	2
Cuenca	Group 1407 Disorders of breast  610-612	Women	9
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	17
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	17
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	15
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	15
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	109
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	107
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.070
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.070
Cuenca	Group 1501 Legally induced abortion  635	Both sexes	..
Cuenca	Group 1501 Legally induced abortion  635	Men	..
Cuenca	Group 1501 Legally induced abortion  635	Women	..
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	129
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	129
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	531
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	531
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	188
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	188
Cuenca	Group 1505 Single spontaneous delivery  650	Both sexes	37
Cuenca	Group 1505 Single spontaneous delivery  650	Men	..
Cuenca	Group 1505 Single spontaneous delivery  650	Women	37
Cuenca	Group 1506 Other deliveries  6695-6697	Both sexes	123
Cuenca	Group 1506 Other deliveries  6695-6697	Men	..
Cuenca	Group 1506 Other deliveries  6695-6697	Women	123
Cuenca	Group 1507 Complications related to the puerperium  670-676	Both sexes	2
Cuenca	Group 1507 Complications related to the puerperium  670-676	Men	..
Cuenca	Group 1507 Complications related to the puerperium  670-676	Women	2
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	60
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	60
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	105
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	58
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	47
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	33
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	16
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	17
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	72
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	42
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	30
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	50
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Men	23
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Women	27
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	821
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	420
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	401
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	108
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Men	65
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Women	43
Cuenca	Group 1802 Abdominal pain   7890	Both sexes	100
Cuenca	Group 1802 Abdominal pain   7890	Men	34
Cuenca	Group 1802 Abdominal pain   7890	Women	66
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	10
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	6
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	4
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	603
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	315
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	288
Cuenca	Group 1900 Injuries and poisoning  800-999	Both sexes	1.212
Cuenca	Group 1900 Injuries and poisoning  800-999	Men	584
Cuenca	Group 1900 Injuries and poisoning  800-999	Women	628
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	100
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	53
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	47
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	27
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	20
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	7
Cuenca	Group 1903 Radius and ulna fracture 813	Both sexes	49
Cuenca	Group 1903 Radius and ulna fracture 813	Men	29
Cuenca	Group 1903 Radius and ulna fracture 813	Women	20
Cuenca	Group 1904 Femur fracture  820-821	Both sexes	295
Cuenca	Group 1904 Femur fracture  820-821	Men	94
Cuenca	Group 1904 Femur fracture  820-821	Women	201
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	91
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Men	42
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Women	49
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	396
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	221
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	175
Cuenca	Group 1907 Burns  940-949	Both sexes	..
Cuenca	Group 1907 Burns  940-949	Men	..
Cuenca	Group 1907 Burns  940-949	Women	..
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	48
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	20
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	28
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	183
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	96
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	87
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	21
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	8
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	13
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	208
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	109
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	99
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	3
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	1
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
Cuenca	Group 2102 Contraceptive management  V25	Both sexes	1
Cuenca	Group 2102 Contraceptive management  V25	Men	..
Cuenca	Group 2102 Contraceptive management  V25	Women	1
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	105
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	60
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	45
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	99
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	48
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	51
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.673
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	9.268
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	9.405
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	623
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	361
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	262
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	146
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	91
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	55
Guadalajara	Group 0102 Imprecise intestinal infections 009	Both sexes	15
Guadalajara	Group 0102 Imprecise intestinal infections 009	Men	10
Guadalajara	Group 0102 Imprecise intestinal infections 009	Women	5
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Both sexes	15
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Men	7
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Women	8
Guadalajara	Group 0104 Septicaemia  038	Both sexes	290
Guadalajara	Group 0104 Septicaemia  038	Men	151
Guadalajara	Group 0104 Septicaemia  038	Women	139
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	7
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	6
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	150
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	96
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	54
Guadalajara	Group 0200 Neoplasms  140-239	Both sexes	1.438
Guadalajara	Group 0200 Neoplasms  140-239	Men	848
Guadalajara	Group 0200 Neoplasms  140-239	Women	590
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	204
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	132
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	72
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	80
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	66
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	14
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	59
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	36
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	23
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	88
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Women	88
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	25
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	25
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	23
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Women	23
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Both sexes	72
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Men	72
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Women	..
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Both sexes	156
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Men	138
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Women	18
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	503
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	300
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	203
Guadalajara	Group 0210 Carcinoma in situ  230-234	Both sexes	31
Guadalajara	Group 0210 Carcinoma in situ  230-234	Men	21
Guadalajara	Group 0210 Carcinoma in situ  230-234	Women	10
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	15
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	11
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	4
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Both sexes	47
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Men	..
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Women	47
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	135
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	72
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	63
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	231
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	119
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	112
Guadalajara	Group 0301 Anaemias 280-285	Both sexes	135
Guadalajara	Group 0301 Anaemias 280-285	Men	65
Guadalajara	Group 0301 Anaemias 280-285	Women	70
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	96
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	54
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	42
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	305
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	139
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	166
Guadalajara	Group 0401 Diabetes mellitus  249-250	Both sexes	132
Guadalajara	Group 0401 Diabetes mellitus  249-250	Men	74
Guadalajara	Group 0401 Diabetes mellitus  249-250	Women	58
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	173
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	65
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	108
Guadalajara	Group 0500 Mental disorders  290-319	Both sexes	387
Guadalajara	Group 0500 Mental disorders  290-319	Men	208
Guadalajara	Group 0500 Mental disorders  290-319	Women	179
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	19
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	10
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	9
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	43
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	31
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	24
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	11
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	13
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	144
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	91
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	53
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	79
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	33
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	46
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	78
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	32
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	46
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	326
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	143
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	183
Guadalajara	Group 0601 Alzheimer's disease  3310	Both sexes	1
Guadalajara	Group 0601 Alzheimer's disease  3310	Men	..
Guadalajara	Group 0601 Alzheimer's disease  3310	Women	1
Guadalajara	Group 0602 Multiple sclerosis 340	Both sexes	10
Guadalajara	Group 0602 Multiple sclerosis 340	Men	2
Guadalajara	Group 0602 Multiple sclerosis 340	Women	8
Guadalajara	Group 0603 Epilepsy  345	Both sexes	63
Guadalajara	Group 0603 Epilepsy  345	Men	28
Guadalajara	Group 0603 Epilepsy  345	Women	35
Guadalajara	Group 0604 Transient cerebral ischemia 435	Both sexes	64
Guadalajara	Group 0604 Transient cerebral ischemia 435	Men	34
Guadalajara	Group 0604 Transient cerebral ischemia 435	Women	30
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	188
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	79
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	109
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	58
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	32
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	26
Guadalajara	Grupo 0701 Cataract  366	Both sexes	30
Guadalajara	Grupo 0701 Cataract  366	Men	18
Guadalajara	Grupo 0701 Cataract  366	Women	12
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	28
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	14
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	14
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	77
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Men	34
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Women	43
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.852
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.566
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.286
Guadalajara	Group 0901 Hypertensive disease  401-405	Both sexes	286
Guadalajara	Group 0901 Hypertensive disease  401-405	Men	125
Guadalajara	Group 0901 Hypertensive disease  401-405	Women	161
Guadalajara	Group 0902 Angina pectoris  4111, 413	Both sexes	55
Guadalajara	Group 0902 Angina pectoris  4111, 413	Men	33
Guadalajara	Group 0902 Angina pectoris  4111, 413	Women	22
Guadalajara	Group 0903 Acute myocardial infarction  410	Both sexes	215
Guadalajara	Group 0903 Acute myocardial infarction  410	Men	163
Guadalajara	Group 0903 Acute myocardial infarction  410	Women	52
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	188
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	141
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	47
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	90
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Men	34
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Women	56
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	501
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	294
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	207
Guadalajara	Grupo 0907 Heart failure  428	Both sexes	703
Guadalajara	Grupo 0907 Heart failure  428	Men	310
Guadalajara	Grupo 0907 Heart failure  428	Women	393
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	371
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	191
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	180
Guadalajara	Grupo 0909 Atherosclerosis  440	Both sexes	91
Guadalajara	Grupo 0909 Atherosclerosis  440	Men	72
Guadalajara	Grupo 0909 Atherosclerosis  440	Women	19
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Both sexes	18
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Men	6
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Women	12
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	334
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	197
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	137
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.526
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.524
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.002
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	108
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	57
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	51
Guadalajara	Group 1002 Pneumonia 480-486	Both sexes	931
Guadalajara	Group 1002 Pneumonia 480-486	Men	603
Guadalajara	Group 1002 Pneumonia 480-486	Women	328
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	193
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Men	97
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Women	96
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	90
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	49
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	41
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	123
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	89
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	34
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	312
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	242
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	70
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	84
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Men	28
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Women	56
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	685
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	359
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	326
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.532
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Men	1.426
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Women	1.106
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	25
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	10
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	15
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	23
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	11
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	12
Guadalajara	Group 1103 Diseases of the esophagus 530	Both sexes	57
Guadalajara	Group 1103 Diseases of the esophagus 530	Men	43
Guadalajara	Group 1103 Diseases of the esophagus 530	Women	14
Guadalajara	Group 1104 Peptic ulcer 531-534	Both sexes	55
Guadalajara	Group 1104 Peptic ulcer 531-534	Men	43
Guadalajara	Group 1104 Peptic ulcer 531-534	Women	12
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	48
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	23
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	25
Guadalajara	Group 1106 Appendicitis  540-543	Both sexes	210
Guadalajara	Group 1106 Appendicitis  540-543	Men	120
Guadalajara	Group 1106 Appendicitis  540-543	Women	90
Guadalajara	Group 1107 Inguinal hernia  550	Both sexes	237
Guadalajara	Group 1107 Inguinal hernia  550	Men	222
Guadalajara	Group 1107 Inguinal hernia  550	Women	15
Guadalajara	Group 1108 Other abdominal hernia  551-553	Both sexes	188
Guadalajara	Group 1108 Other abdominal hernia  551-553	Men	84
Guadalajara	Group 1108 Other abdominal hernia  551-553	Women	104
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	43
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	24
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	19
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	199
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	93
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	106
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Both sexes	123
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Men	55
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Women	68
Guadalajara	Group 1112 Intestinal diverticulosis 562	Both sexes	96
Guadalajara	Group 1112 Intestinal diverticulosis 562	Men	45
Guadalajara	Group 1112 Intestinal diverticulosis 562	Women	51
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	106
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	73
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	33
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	88
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	42
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	46
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	35
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Men	32
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Women	3
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	64
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Men	45
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Women	19
Guadalajara	Group 1117 Cholelithiasis  574	Both sexes	463
Guadalajara	Group 1117 Cholelithiasis  574	Men	194
Guadalajara	Group 1117 Cholelithiasis  574	Women	269
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	196
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	111
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	85
Guadalajara	Group 1119 Pancreatic diseases 577	Both sexes	135
Guadalajara	Group 1119 Pancreatic diseases 577	Men	76
Guadalajara	Group 1119 Pancreatic diseases 577	Women	59
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	141
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	80
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	61
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	177
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	90
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	87
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	102
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	58
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	44
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	17
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	5
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	58
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	20
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	38
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.059
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	502
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	557
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Guadalajara	Group 1303 Internal derangement of knee 717	Both sexes	87
Guadalajara	Group 1303 Internal derangement of knee 717	Men	61
Guadalajara	Group 1303 Internal derangement of knee 717	Women	26
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	378
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	143
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	235
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	22
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	11
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	11
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	54
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	36
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	18
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	86
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	41
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	45
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	27
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	13
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	14
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	153
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	85
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	68
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	252
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	112
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	140
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.211
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	629
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	582
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	180
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	56
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	124
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	128
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Men	73
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Women	55
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	122
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Men	68
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Women	54
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	419
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	229
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	190
Guadalajara	Group 1405 Prostatic hyperplasia  600	Both sexes	88
Guadalajara	Group 1405 Prostatic hyperplasia  600	Men	88
Guadalajara	Group 1405 Prostatic hyperplasia  600	Women	..
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	109
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Men	109
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Guadalajara	Group 1407 Disorders of breast  610-612	Both sexes	32
Guadalajara	Group 1407 Disorders of breast  610-612	Men	4
Guadalajara	Group 1407 Disorders of breast  610-612	Women	28
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	4
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	4
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	101
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	99
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.818
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.818
Guadalajara	Group 1501 Legally induced abortion  635	Both sexes	1
Guadalajara	Group 1501 Legally induced abortion  635	Men	..
Guadalajara	Group 1501 Legally induced abortion  635	Women	1
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	95
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	95
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.218
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.218
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	254
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	254
Guadalajara	Group 1505 Single spontaneous delivery  650	Both sexes	15
Guadalajara	Group 1505 Single spontaneous delivery  650	Men	..
Guadalajara	Group 1505 Single spontaneous delivery  650	Women	15
Guadalajara	Group 1506 Other deliveries  6695-6697	Both sexes	44
Guadalajara	Group 1506 Other deliveries  6695-6697	Men	..
Guadalajara	Group 1506 Other deliveries  6695-6697	Women	44
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Both sexes	24
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Men	..
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Women	24
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	167
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	167
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	177
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Men	102
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Women	75
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	59
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	37
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	22
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	118
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	65
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	53
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Both sexes	89
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Men	58
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Women	31
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	929
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	500
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	429
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	142
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Men	76
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Women	66
Guadalajara	Group 1802 Abdominal pain   7890	Both sexes	135
Guadalajara	Group 1802 Abdominal pain   7890	Men	47
Guadalajara	Group 1802 Abdominal pain   7890	Women	88
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	..
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	652
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	377
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	275
Guadalajara	Group 1900 Injuries and poisoning  800-999	Both sexes	1.521
Guadalajara	Group 1900 Injuries and poisoning  800-999	Men	769
Guadalajara	Group 1900 Injuries and poisoning  800-999	Women	752
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	78
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	44
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	34
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	27
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	20
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	7
Guadalajara	Group 1903 Radius and ulna fracture 813	Both sexes	58
Guadalajara	Group 1903 Radius and ulna fracture 813	Men	31
Guadalajara	Group 1903 Radius and ulna fracture 813	Women	27
Guadalajara	Group 1904 Femur fracture  820-821	Both sexes	310
Guadalajara	Group 1904 Femur fracture  820-821	Men	80
Guadalajara	Group 1904 Femur fracture  820-821	Women	230
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	81
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Men	44
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Women	37
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	286
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	196
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	90
Guadalajara	Group 1907 Burns  940-949	Both sexes	1
Guadalajara	Group 1907 Burns  940-949	Men	1
Guadalajara	Group 1907 Burns  940-949	Women	..
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	48
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	24
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	24
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	498
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	271
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	227
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	134
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	58
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	76
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	337
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	218
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	119
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	18
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	13
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Guadalajara	Group 2102 Contraceptive management  V25	Both sexes	3
Guadalajara	Group 2102 Contraceptive management  V25	Men	1
Guadalajara	Group 2102 Contraceptive management  V25	Women	2
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	140
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	93
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	47
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	176
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	111
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	65
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	47.896
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	23.320
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	24.576
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.398
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	783
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	615
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	184
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	100
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	84
Toledo	Group 0102 Imprecise intestinal infections 009	Both sexes	81
Toledo	Group 0102 Imprecise intestinal infections 009	Men	35
Toledo	Group 0102 Imprecise intestinal infections 009	Women	46
Toledo	Group 0103 Tuberculosis 010-018, 137	Both sexes	27
Toledo	Group 0103 Tuberculosis 010-018, 137	Men	21
Toledo	Group 0103 Tuberculosis 010-018, 137	Women	6
Toledo	Group 0104 Septicaemia  038	Both sexes	768
Toledo	Group 0104 Septicaemia  038	Men	418
Toledo	Group 0104 Septicaemia  038	Women	350
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	21
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	16
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	317
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	193
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	124
Toledo	Group 0200 Neoplasms  140-239	Both sexes	4.555
Toledo	Group 0200 Neoplasms  140-239	Men	2.580
Toledo	Group 0200 Neoplasms  140-239	Women	1.975
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	453
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	261
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	192
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	387
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	332
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	55
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	125
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	72
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	53
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	317
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Men	2
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Women	315
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	93
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	93
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	31
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Women	31
Toledo	Group 0207 Malignant neoplasm of prostate  185	Both sexes	164
Toledo	Group 0207 Malignant neoplasm of prostate  185	Men	164
Toledo	Group 0207 Malignant neoplasm of prostate  185	Women	..
Toledo	Group 0208 Malignant neoplasm of bladder  188	Both sexes	248
Toledo	Group 0208 Malignant neoplasm of bladder  188	Men	220
Toledo	Group 0208 Malignant neoplasm of bladder  188	Women	28
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.422
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	880
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	542
Toledo	Group 0210 Carcinoma in situ  230-234	Both sexes	73
Toledo	Group 0210 Carcinoma in situ  230-234	Men	33
Toledo	Group 0210 Carcinoma in situ  230-234	Women	40
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	43
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	27
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	16
Toledo	Grupo 0212 Leiomyoma of uterus  218	Both sexes	170
Toledo	Grupo 0212 Leiomyoma of uterus  218	Men	..
Toledo	Grupo 0212 Leiomyoma of uterus  218	Women	170
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.029
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	589
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	440
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	418
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	223
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	195
Toledo	Group 0301 Anaemias 280-285	Both sexes	200
Toledo	Group 0301 Anaemias 280-285	Men	101
Toledo	Group 0301 Anaemias 280-285	Women	99
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	218
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	122
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	96
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	846
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	364
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	482
Toledo	Group 0401 Diabetes mellitus  249-250	Both sexes	254
Toledo	Group 0401 Diabetes mellitus  249-250	Men	150
Toledo	Group 0401 Diabetes mellitus  249-250	Women	104
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	592
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	214
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	378
Toledo	Group 0500 Mental disorders  290-319	Both sexes	1.277
Toledo	Group 0500 Mental disorders  290-319	Men	722
Toledo	Group 0500 Mental disorders  290-319	Women	555
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	21
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	11
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	10
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	94
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	68
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	26
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	55
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	44
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	11
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	434
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	304
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	130
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	287
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	91
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	196
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	386
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	204
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	182
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.778
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.022
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	756
Toledo	Group 0601 Alzheimer's disease  3310	Both sexes	15
Toledo	Group 0601 Alzheimer's disease  3310	Men	7
Toledo	Group 0601 Alzheimer's disease  3310	Women	8
Toledo	Group 0602 Multiple sclerosis 340	Both sexes	27
Toledo	Group 0602 Multiple sclerosis 340	Men	6
Toledo	Group 0602 Multiple sclerosis 340	Women	21
Toledo	Group 0603 Epilepsy  345	Both sexes	129
Toledo	Group 0603 Epilepsy  345	Men	67
Toledo	Group 0603 Epilepsy  345	Women	62
Toledo	Group 0604 Transient cerebral ischemia 435	Both sexes	189
Toledo	Group 0604 Transient cerebral ischemia 435	Men	90
Toledo	Group 0604 Transient cerebral ischemia 435	Women	99
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.418
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	852
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	566
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	217
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	118
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	99
Toledo	Grupo 0701 Cataract  366	Both sexes	14
Toledo	Grupo 0701 Cataract  366	Men	7
Toledo	Grupo 0701 Cataract  366	Women	7
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	203
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	111
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	92
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	190
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Men	84
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Women	106
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.308
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.642
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.666
Toledo	Group 0901 Hypertensive disease  401-405	Both sexes	226
Toledo	Group 0901 Hypertensive disease  401-405	Men	95
Toledo	Group 0901 Hypertensive disease  401-405	Women	131
Toledo	Group 0902 Angina pectoris  4111, 413	Both sexes	218
Toledo	Group 0902 Angina pectoris  4111, 413	Men	152
Toledo	Group 0902 Angina pectoris  4111, 413	Women	66
Toledo	Group 0903 Acute myocardial infarction  410	Both sexes	710
Toledo	Group 0903 Acute myocardial infarction  410	Men	522
Toledo	Group 0903 Acute myocardial infarction  410	Women	188
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	404
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	293
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	111
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	246
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Men	123
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Women	123
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	885
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	477
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	408
Toledo	Grupo 0907 Heart failure  428	Both sexes	1.333
Toledo	Grupo 0907 Heart failure  428	Men	605
Toledo	Grupo 0907 Heart failure  428	Women	728
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.127
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	654
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	473
Toledo	Grupo 0909 Atherosclerosis  440	Both sexes	162
Toledo	Grupo 0909 Atherosclerosis  440	Men	129
Toledo	Grupo 0909 Atherosclerosis  440	Women	33
Toledo	Group 0910 Varicose veins of lower extremities 454	Both sexes	42
Toledo	Group 0910 Varicose veins of lower extremities 454	Men	8
Toledo	Group 0910 Varicose veins of lower extremities 454	Women	34
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	955
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	584
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	371
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.822
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.397
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.425
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	308
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	181
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	127
Toledo	Group 1002 Pneumonia 480-486	Both sexes	1.618
Toledo	Group 1002 Pneumonia 480-486	Men	982
Toledo	Group 1002 Pneumonia 480-486	Women	636
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	290
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Men	144
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Women	146
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	117
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	67
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	50
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	367
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	253
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	114
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	896
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	744
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	152
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	224
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Men	83
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Women	141
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.002
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	943
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.059
Toledo	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.634
Toledo	Group 1100 Diseases of the digestive system  520-579	Men	3.119
Toledo	Group 1100 Diseases of the digestive system  520-579	Women	2.515
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	72
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	38
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	34
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	70
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	33
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	37
Toledo	Group 1103 Diseases of the esophagus 530	Both sexes	93
Toledo	Group 1103 Diseases of the esophagus 530	Men	54
Toledo	Group 1103 Diseases of the esophagus 530	Women	39
Toledo	Group 1104 Peptic ulcer 531-534	Both sexes	120
Toledo	Group 1104 Peptic ulcer 531-534	Men	82
Toledo	Group 1104 Peptic ulcer 531-534	Women	38
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	105
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	51
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	54
Toledo	Group 1106 Appendicitis  540-543	Both sexes	567
Toledo	Group 1106 Appendicitis  540-543	Men	328
Toledo	Group 1106 Appendicitis  540-543	Women	239
Toledo	Group 1107 Inguinal hernia  550	Both sexes	419
Toledo	Group 1107 Inguinal hernia  550	Men	363
Toledo	Group 1107 Inguinal hernia  550	Women	56
Toledo	Group 1108 Other abdominal hernia  551-553	Both sexes	490
Toledo	Group 1108 Other abdominal hernia  551-553	Men	230
Toledo	Group 1108 Other abdominal hernia  551-553	Women	260
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	117
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	69
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	48
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	345
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	180
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	165
Toledo	Group 1111 Intestinal obstruction without hernia 560	Both sexes	335
Toledo	Group 1111 Intestinal obstruction without hernia 560	Men	160
Toledo	Group 1111 Intestinal obstruction without hernia 560	Women	175
Toledo	Group 1112 Intestinal diverticulosis 562	Both sexes	218
Toledo	Group 1112 Intestinal diverticulosis 562	Men	116
Toledo	Group 1112 Intestinal diverticulosis 562	Women	102
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	348
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	219
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	129
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	245
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	118
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	127
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	57
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Men	48
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Women	9
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	184
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Men	120
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Women	64
Toledo	Group 1117 Cholelithiasis  574	Both sexes	931
Toledo	Group 1117 Cholelithiasis  574	Men	404
Toledo	Group 1117 Cholelithiasis  574	Women	527
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	316
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	187
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	129
Toledo	Group 1119 Pancreatic diseases 577	Both sexes	408
Toledo	Group 1119 Pancreatic diseases 577	Men	213
Toledo	Group 1119 Pancreatic diseases 577	Women	195
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	194
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	106
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	88
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	436
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	243
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	193
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	278
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	161
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	117
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	15
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	143
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	73
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	70
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.809
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.384
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.425
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Toledo	Group 1303 Internal derangement of knee 717	Both sexes	309
Toledo	Group 1303 Internal derangement of knee 717	Men	231
Toledo	Group 1303 Internal derangement of knee 717	Women	78
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.080
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	453
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	627
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	45
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	18
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	27
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	214
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	103
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	111
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	284
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	144
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	140
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	60
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	36
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	24
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	432
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	254
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	178
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	385
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	145
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	240
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.971
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.390
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.581
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	316
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	135
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	181
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	336
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Men	191
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Women	145
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	440
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Men	251
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Women	189
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	746
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	371
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	375
Toledo	Group 1405 Prostatic hyperplasia  600	Both sexes	180
Toledo	Group 1405 Prostatic hyperplasia  600	Men	180
Toledo	Group 1405 Prostatic hyperplasia  600	Women	..
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	245
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Men	245
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Toledo	Group 1407 Disorders of breast  610-612	Both sexes	116
Toledo	Group 1407 Disorders of breast  610-612	Men	17
Toledo	Group 1407 Disorders of breast  610-612	Women	99
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	95
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	95
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	36
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	36
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	461
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	461
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.190
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.190
Toledo	Group 1501 Legally induced abortion  635	Both sexes	3
Toledo	Group 1501 Legally induced abortion  635	Men	..
Toledo	Group 1501 Legally induced abortion  635	Women	3
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	445
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	445
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.179
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.179
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	494
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	494
Toledo	Group 1505 Single spontaneous delivery  650	Both sexes	281
Toledo	Group 1505 Single spontaneous delivery  650	Men	..
Toledo	Group 1505 Single spontaneous delivery  650	Women	281
Toledo	Group 1506 Other deliveries  6695-6697	Both sexes	354
Toledo	Group 1506 Other deliveries  6695-6697	Men	..
Toledo	Group 1506 Other deliveries  6695-6697	Women	354
Toledo	Group 1507 Complications related to the puerperium  670-676	Both sexes	47
Toledo	Group 1507 Complications related to the puerperium  670-676	Men	..
Toledo	Group 1507 Complications related to the puerperium  670-676	Women	47
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	387
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	387
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	807
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Men	432
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Women	375
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	249
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	132
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	117
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	558
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	300
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	258
Toledo	Grupo 1700 Congenital abnormalities  740-759	Both sexes	336
Toledo	Grupo 1700 Congenital abnormalities  740-759	Men	202
Toledo	Grupo 1700 Congenital abnormalities  740-759	Women	134
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.649
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	879
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	770
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	144
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Men	81
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Women	63
Toledo	Group 1802 Abdominal pain   7890	Both sexes	271
Toledo	Group 1802 Abdominal pain   7890	Men	116
Toledo	Group 1802 Abdominal pain   7890	Women	155
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	11
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	4
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	7
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.223
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	678
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	545
Toledo	Group 1900 Injuries and poisoning  800-999	Both sexes	4.612
Toledo	Group 1900 Injuries and poisoning  800-999	Men	2.344
Toledo	Group 1900 Injuries and poisoning  800-999	Women	2.268
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	243
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	140
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	103
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	84
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	68
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	16
Toledo	Group 1903 Radius and ulna fracture 813	Both sexes	262
Toledo	Group 1903 Radius and ulna fracture 813	Men	124
Toledo	Group 1903 Radius and ulna fracture 813	Women	138
Toledo	Group 1904 Femur fracture  820-821	Both sexes	863
Toledo	Group 1904 Femur fracture  820-821	Men	247
Toledo	Group 1904 Femur fracture  820-821	Women	616
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	354
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Men	189
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Women	165
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.448
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	898
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	550
Toledo	Group 1907 Burns  940-949	Both sexes	6
Toledo	Group 1907 Burns  940-949	Men	4
Toledo	Group 1907 Burns  940-949	Women	2
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	170
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	75
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	95
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.028
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	529
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	499
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	11
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	4
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	143
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	66
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	77
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	643
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	392
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	251
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	20
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	12
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	8
Toledo	Group 2102 Contraceptive management  V25	Both sexes	5
Toledo	Group 2102 Contraceptive management  V25	Men	2
Toledo	Group 2102 Contraceptive management  V25	Women	3
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	307
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	206
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	101
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	311
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	172
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	139
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	832.753
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	393.515
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	439.238
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	15.859
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	8.844
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	7.015
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	2.369
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.191
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	1.178
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Both sexes	1.953
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Men	978
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Women	975
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Both sexes	605
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Men	403
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Women	202
CATALUÐA	Group 0104 Septicaemia  038	Both sexes	5.098
CATALUÐA	Group 0104 Septicaemia  038	Men	2.822
CATALUÐA	Group 0104 Septicaemia  038	Women	2.277
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	619
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	471
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	148
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	5.215
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.979
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	2.236
CATALUÐA	Group 0200 Neoplasms  140-239	Both sexes	78.941
CATALUÐA	Group 0200 Neoplasms  140-239	Men	42.979
CATALUÐA	Group 0200 Neoplasms  140-239	Women	35.962
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	8.689
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	5.266
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	3.423
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	6.765
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	5.262
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.503
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.088
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	636
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	452
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.600
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Men	48
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Women	5.552
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.735
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.735
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	912
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Women	912
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	2.877
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Men	2.877
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	8.657
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Men	7.249
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Women	1.408
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	28.996
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	17.198
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	11.798
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Both sexes	809
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Men	323
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Women	486
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	892
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	572
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	320
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.379
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Women	3.379
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	8.543
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.548
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	4.995
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.933
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	3.405
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.528
CATALUÐA	Group 0301 Anaemias 280-285	Both sexes	3.939
CATALUÐA	Group 0301 Anaemias 280-285	Men	1.832
CATALUÐA	Group 0301 Anaemias 280-285	Women	2.107
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.994
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.573
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.420
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	14.318
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	5.661
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	8.657
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Both sexes	4.466
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Men	2.583
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Women	1.884
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	9.851
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	3.079
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	6.773
CATALUÐA	Group 0500 Mental disorders  290-319	Both sexes	28.108
CATALUÐA	Group 0500 Mental disorders  290-319	Men	14.646
CATALUÐA	Group 0500 Mental disorders  290-319	Women	13.461
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	1.978
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	848
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1.130
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.844
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.340
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	504
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.657
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	1.219
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	438
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	8.470
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	5.245
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	3.226
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	6.130
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	2.429
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	3.701
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	8.029
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	3.566
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	4.463
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	16.754
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	8.001
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	8.753
CATALUÐA	Group 0601 Alzheimer's disease  3310	Both sexes	1.779
CATALUÐA	Group 0601 Alzheimer's disease  3310	Men	594
CATALUÐA	Group 0601 Alzheimer's disease  3310	Women	1.185
CATALUÐA	Group 0602 Multiple sclerosis 340	Both sexes	191
CATALUÐA	Group 0602 Multiple sclerosis 340	Men	66
CATALUÐA	Group 0602 Multiple sclerosis 340	Women	124
CATALUÐA	Group 0603 Epilepsy  345	Both sexes	2.825
CATALUÐA	Group 0603 Epilepsy  345	Men	1.535
CATALUÐA	Group 0603 Epilepsy  345	Women	1.291
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Both sexes	2.085
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Men	1.060
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Women	1.025
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	9.874
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	4.746
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	5.128
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	5.005
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.473
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.532
CATALUÐA	Grupo 0701 Cataract  366	Both sexes	1.488
CATALUÐA	Grupo 0701 Cataract  366	Men	657
CATALUÐA	Grupo 0701 Cataract  366	Women	831
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.517
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.816
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.700
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	4.059
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.973
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	2.086
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	107.831
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	59.675
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	48.156
CATALUÐA	Group 0901 Hypertensive disease  401-405	Both sexes	4.348
CATALUÐA	Group 0901 Hypertensive disease  401-405	Men	1.805
CATALUÐA	Group 0901 Hypertensive disease  401-405	Women	2.543
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Both sexes	3.442
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Men	2.240
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Women	1.202
CATALUÐA	Group 0903 Acute myocardial infarction  410	Both sexes	9.726
CATALUÐA	Group 0903 Acute myocardial infarction  410	Men	6.830
CATALUÐA	Group 0903 Acute myocardial infarction  410	Women	2.896
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	7.121
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	5.473
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.648
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	3.119
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Men	1.446
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Women	1.673
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	13.487
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	7.127
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	6.360
CATALUÐA	Grupo 0907 Heart failure  428	Both sexes	26.107
CATALUÐA	Grupo 0907 Heart failure  428	Men	11.771
CATALUÐA	Grupo 0907 Heart failure  428	Women	14.336
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	19.479
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	10.395
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	9.084
CATALUÐA	Grupo 0909 Atherosclerosis  440	Both sexes	4.724
CATALUÐA	Grupo 0909 Atherosclerosis  440	Men	3.351
CATALUÐA	Grupo 0909 Atherosclerosis  440	Women	1.373
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.515
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Men	538
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Women	976
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	14.763
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	8.699
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	6.064
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	101.924
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	57.105
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	44.820
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	4.672
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	2.432
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	2.240
CATALUÐA	Group 1002 Pneumonia 480-486	Both sexes	20.265
CATALUÐA	Group 1002 Pneumonia 480-486	Men	11.841
CATALUÐA	Group 1002 Pneumonia 480-486	Women	8.424
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	14.696
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	6.689
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	8.007
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.105
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.697
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.408
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	6.660
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	4.056
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.604
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	18.943
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	13.939
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	5.004
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	3.678
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Men	883
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Women	2.795
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	29.906
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	15.568
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	14.338
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Both sexes	94.889
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Men	51.712
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Women	43.177
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.284
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	602
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	681
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.142
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	593
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	549
CATALUÐA	Group 1103 Diseases of the esophagus 530	Both sexes	1.582
CATALUÐA	Group 1103 Diseases of the esophagus 530	Men	931
CATALUÐA	Group 1103 Diseases of the esophagus 530	Women	651
CATALUÐA	Group 1104 Peptic ulcer 531-534	Both sexes	1.829
CATALUÐA	Group 1104 Peptic ulcer 531-534	Men	1.219
CATALUÐA	Group 1104 Peptic ulcer 531-534	Women	610
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	2.111
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	1.041
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	1.070
CATALUÐA	Group 1106 Appendicitis  540-543	Both sexes	7.837
CATALUÐA	Group 1106 Appendicitis  540-543	Men	4.381
CATALUÐA	Group 1106 Appendicitis  540-543	Women	3.456
CATALUÐA	Group 1107 Inguinal hernia  550	Both sexes	9.124
CATALUÐA	Group 1107 Inguinal hernia  550	Men	8.030
CATALUÐA	Group 1107 Inguinal hernia  550	Women	1.093
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Both sexes	8.630
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Men	3.835
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Women	4.795
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.594
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	814
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	780
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.860
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	2.249
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.611
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	4.478
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Men	2.352
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Women	2.126
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Both sexes	4.313
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Men	2.122
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Women	2.192
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	4.961
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.074
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.887
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	3.282
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.448
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.834
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.883
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.534
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Women	349
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	3.781
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Men	2.200
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Women	1.581
CATALUÐA	Group 1117 Cholelithiasis  574	Both sexes	18.092
CATALUÐA	Group 1117 Cholelithiasis  574	Men	7.542
CATALUÐA	Group 1117 Cholelithiasis  574	Women	10.550
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	5.134
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.769
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	2.365
CATALUÐA	Group 1119 Pancreatic diseases 577	Both sexes	5.164
CATALUÐA	Group 1119 Pancreatic diseases 577	Men	2.905
CATALUÐA	Group 1119 Pancreatic diseases 577	Women	2.258
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.808
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	2.070
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.738
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	9.068
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	4.678
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	4.390
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	5.709
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	3.210
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	2.499
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	316
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	158
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	158
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	3.043
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.311
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.732
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	66.814
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	31.001
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	35.813
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CATALUÐA	Group 1303 Internal derangement of knee 717	Both sexes	8.559
CATALUÐA	Group 1303 Internal derangement of knee 717	Men	5.542
CATALUÐA	Group 1303 Internal derangement of knee 717	Women	3.017
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	25.906
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	10.537
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	15.369
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	1.016
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	387
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	629
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.931
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.389
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.542
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	5.670
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	3.025
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.645
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.852
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	832
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	1.020
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	10.771
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	5.226
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	5.545
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	10.109
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	4.063
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	6.046
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	61.637
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	28.931
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	32.706
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	7.143
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	2.211
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	4.932
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	5.649
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Men	3.242
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Women	2.407
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	7.870
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Men	4.750
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Women	3.120
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	16.160
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	7.662
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	8.498
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Both sexes	5.343
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Men	5.343
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Women	..
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	5.267
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Men	5.267
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CATALUÐA	Group 1407 Disorders of breast  610-612	Both sexes	4.913
CATALUÐA	Group 1407 Disorders of breast  610-612	Men	281
CATALUÐA	Group 1407 Disorders of breast  610-612	Women	4.632
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.223
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.223
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	430
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	430
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	7.639
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	176
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	7.464
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	76.061
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	76.061
CATALUÐA	Group 1501 Legally induced abortion  635	Both sexes	656
CATALUÐA	Group 1501 Legally induced abortion  635	Men	..
CATALUÐA	Group 1501 Legally induced abortion  635	Women	656
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.250
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.250
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	39.513
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	39.513
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	19.082
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	19.082
CATALUÐA	Group 1505 Single spontaneous delivery  650	Both sexes	5.470
CATALUÐA	Group 1505 Single spontaneous delivery  650	Men	..
CATALUÐA	Group 1505 Single spontaneous delivery  650	Women	5.470
CATALUÐA	Group 1506 Other deliveries  6695-6697	Both sexes	1.789
CATALUÐA	Group 1506 Other deliveries  6695-6697	Men	..
CATALUÐA	Group 1506 Other deliveries  6695-6697	Women	1.789
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Both sexes	826
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Men	..
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Women	826
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	6.475
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	6.475
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	10.633
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	5.783
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	4.850
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	3.389
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.852
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.537
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	7.244
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	3.931
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	3.313
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.893
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Men	3.880
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Women	3.013
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	29.723
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	16.108
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	13.615
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.874
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Men	1.629
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Women	1.245
CATALUÐA	Group 1802 Abdominal pain   7890	Both sexes	3.449
CATALUÐA	Group 1802 Abdominal pain   7890	Men	1.326
CATALUÐA	Group 1802 Abdominal pain   7890	Women	2.123
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.486
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	676
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	810
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	21.914
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	12.477
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	9.437
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Both sexes	80.726
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Men	38.389
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Women	42.337
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	4.987
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	2.664
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	2.322
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.645
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.128
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	517
CATALUÐA	Group 1903 Radius and ulna fracture 813	Both sexes	4.192
CATALUÐA	Group 1903 Radius and ulna fracture 813	Men	1.920
CATALUÐA	Group 1903 Radius and ulna fracture 813	Women	2.272
CATALUÐA	Group 1904 Femur fracture  820-821	Both sexes	16.937
CATALUÐA	Group 1904 Femur fracture  820-821	Men	4.751
CATALUÐA	Group 1904 Femur fracture  820-821	Women	12.186
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	5.510
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Men	2.686
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Women	2.824
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	22.588
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	12.524
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	10.065
CATALUÐA	Group 1907 Burns  940-949	Both sexes	623
CATALUÐA	Group 1907 Burns  940-949	Men	407
CATALUÐA	Group 1907 Burns  940-949	Women	217
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	2.106
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	827
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	1.279
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	19.846
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	10.223
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	9.624
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	252
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	159
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	93
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	2.039
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	1.099
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	940
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	16.578
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	8.270
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	8.308
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	363
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	237
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	126
CATALUÐA	Group 2102 Contraceptive management  V25	Both sexes	207
CATALUÐA	Group 2102 Contraceptive management  V25	Men	12
CATALUÐA	Group 2102 Contraceptive management  V25	Women	195
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	4.146
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.517
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.629
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	11.862
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	5.503
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	6.358
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	647.244
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	305.763
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	341.480
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	12.640
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	7.021
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	5.620
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.975
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	976
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	999
Barcelona	Group 0102 Imprecise intestinal infections 009	Both sexes	1.438
Barcelona	Group 0102 Imprecise intestinal infections 009	Men	719
Barcelona	Group 0102 Imprecise intestinal infections 009	Women	719
Barcelona	Group 0103 Tuberculosis 010-018, 137	Both sexes	449
Barcelona	Group 0103 Tuberculosis 010-018, 137	Men	301
Barcelona	Group 0103 Tuberculosis 010-018, 137	Women	148
Barcelona	Group 0104 Septicaemia  038	Both sexes	4.240
Barcelona	Group 0104 Septicaemia  038	Men	2.346
Barcelona	Group 0104 Septicaemia  038	Women	1.894
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	461
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	349
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	112
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	4.077
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.330
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	1.747
Barcelona	Group 0200 Neoplasms  140-239	Both sexes	62.021
Barcelona	Group 0200 Neoplasms  140-239	Men	33.321
Barcelona	Group 0200 Neoplasms  140-239	Women	28.700
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	6.501
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.896
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.605
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	5.116
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.947
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.169
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	808
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	468
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	340
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	4.354
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Men	36
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Women	4.319
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.399
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.399
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	714
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Women	714
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	2.329
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Men	2.329
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	6.523
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Men	5.460
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Women	1.063
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	23.327
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	13.686
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	9.641
Barcelona	Group 0210 Carcinoma in situ  230-234	Both sexes	679
Barcelona	Group 0210 Carcinoma in situ  230-234	Men	275
Barcelona	Group 0210 Carcinoma in situ  230-234	Women	403
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	661
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	420
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	241
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	2.717
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Women	2.717
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	6.892
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	2.804
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	4.088
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	5.475
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.682
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	2.793
Barcelona	Group 0301 Anaemias 280-285	Both sexes	3.013
Barcelona	Group 0301 Anaemias 280-285	Men	1.393
Barcelona	Group 0301 Anaemias 280-285	Women	1.620
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.462
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.288
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.173
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	11.568
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.564
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	7.004
Barcelona	Group 0401 Diabetes mellitus  249-250	Both sexes	3.533
Barcelona	Group 0401 Diabetes mellitus  249-250	Men	2.062
Barcelona	Group 0401 Diabetes mellitus  249-250	Women	1.471
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	8.035
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.502
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	5.533
Barcelona	Group 0500 Mental disorders  290-319	Both sexes	21.590
Barcelona	Group 0500 Mental disorders  290-319	Men	11.201
Barcelona	Group 0500 Mental disorders  290-319	Women	10.390
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	1.588
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	680
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	908
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.454
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.071
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	383
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.276
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	924
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	352
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	6.486
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	4.009
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	2.478
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	4.690
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	1.866
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	2.824
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	6.097
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	2.652
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	3.445
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	13.764
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	6.547
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	7.217
Barcelona	Group 0601 Alzheimer's disease  3310	Both sexes	1.493
Barcelona	Group 0601 Alzheimer's disease  3310	Men	479
Barcelona	Group 0601 Alzheimer's disease  3310	Women	1.014
Barcelona	Group 0602 Multiple sclerosis 340	Both sexes	138
Barcelona	Group 0602 Multiple sclerosis 340	Men	46
Barcelona	Group 0602 Multiple sclerosis 340	Women	93
Barcelona	Group 0603 Epilepsy  345	Both sexes	2.380
Barcelona	Group 0603 Epilepsy  345	Men	1.308
Barcelona	Group 0603 Epilepsy  345	Women	1.071
Barcelona	Group 0604 Transient cerebral ischemia 435	Both sexes	1.672
Barcelona	Group 0604 Transient cerebral ischemia 435	Men	832
Barcelona	Group 0604 Transient cerebral ischemia 435	Women	839
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	8.081
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	3.881
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	4.200
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	3.932
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	1.943
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	1.990
Barcelona	Grupo 0701 Cataract  366	Both sexes	926
Barcelona	Grupo 0701 Cataract  366	Men	411
Barcelona	Grupo 0701 Cataract  366	Women	515
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.006
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.532
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.474
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.253
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.585
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.668
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	84.756
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	46.886
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	37.870
Barcelona	Group 0901 Hypertensive disease  401-405	Both sexes	3.832
Barcelona	Group 0901 Hypertensive disease  401-405	Men	1.583
Barcelona	Group 0901 Hypertensive disease  401-405	Women	2.249
Barcelona	Group 0902 Angina pectoris  4111, 413	Both sexes	2.523
Barcelona	Group 0902 Angina pectoris  4111, 413	Men	1.597
Barcelona	Group 0902 Angina pectoris  4111, 413	Women	926
Barcelona	Group 0903 Acute myocardial infarction  410	Both sexes	7.263
Barcelona	Group 0903 Acute myocardial infarction  410	Men	5.139
Barcelona	Group 0903 Acute myocardial infarction  410	Women	2.124
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	6.108
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	4.725
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.382
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.350
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Men	1.090
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Women	1.260
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	10.699
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	5.608
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	5.091
Barcelona	Grupo 0907 Heart failure  428	Both sexes	20.231
Barcelona	Grupo 0907 Heart failure  428	Men	9.034
Barcelona	Grupo 0907 Heart failure  428	Women	11.196
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	14.849
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	7.909
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	6.940
Barcelona	Grupo 0909 Atherosclerosis  440	Both sexes	3.897
Barcelona	Grupo 0909 Atherosclerosis  440	Men	2.763
Barcelona	Grupo 0909 Atherosclerosis  440	Women	1.134
Barcelona	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.050
Barcelona	Group 0910 Varicose veins of lower extremities 454	Men	370
Barcelona	Group 0910 Varicose veins of lower extremities 454	Women	680
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	11.953
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	7.066
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	4.886
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	77.879
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	43.511
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	34.368
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.902
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	2.026
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.876
Barcelona	Group 1002 Pneumonia 480-486	Both sexes	15.181
Barcelona	Group 1002 Pneumonia 480-486	Men	8.841
Barcelona	Group 1002 Pneumonia 480-486	Women	6.340
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	9.758
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	4.392
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	5.366
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.131
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.149
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	983
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	5.051
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.033
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.018
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	14.354
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	10.637
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	3.717
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	2.855
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Men	656
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Women	2.198
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	24.647
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	12.778
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	11.869
Barcelona	Group 1100 Diseases of the digestive system  520-579	Both sexes	72.325
Barcelona	Group 1100 Diseases of the digestive system  520-579	Men	39.016
Barcelona	Group 1100 Diseases of the digestive system  520-579	Women	33.309
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	955
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	447
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	507
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	942
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	473
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	469
Barcelona	Group 1103 Diseases of the esophagus 530	Both sexes	1.261
Barcelona	Group 1103 Diseases of the esophagus 530	Men	718
Barcelona	Group 1103 Diseases of the esophagus 530	Women	543
Barcelona	Group 1104 Peptic ulcer 531-534	Both sexes	1.384
Barcelona	Group 1104 Peptic ulcer 531-534	Men	912
Barcelona	Group 1104 Peptic ulcer 531-534	Women	472
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.665
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	801
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	864
Barcelona	Group 1106 Appendicitis  540-543	Both sexes	5.992
Barcelona	Group 1106 Appendicitis  540-543	Men	3.359
Barcelona	Group 1106 Appendicitis  540-543	Women	2.632
Barcelona	Group 1107 Inguinal hernia  550	Both sexes	6.788
Barcelona	Group 1107 Inguinal hernia  550	Men	5.972
Barcelona	Group 1107 Inguinal hernia  550	Women	816
Barcelona	Group 1108 Other abdominal hernia  551-553	Both sexes	6.446
Barcelona	Group 1108 Other abdominal hernia  551-553	Men	2.856
Barcelona	Group 1108 Other abdominal hernia  551-553	Women	3.591
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.225
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	624
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	601
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	3.772
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.712
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.061
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.425
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Men	1.756
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Women	1.669
Barcelona	Group 1112 Intestinal diverticulosis 562	Both sexes	3.434
Barcelona	Group 1112 Intestinal diverticulosis 562	Men	1.658
Barcelona	Group 1112 Intestinal diverticulosis 562	Women	1.775
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	3.605
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	2.215
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.389
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.607
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.135
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.471
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.461
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.187
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Women	274
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	3.060
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Men	1.768
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Women	1.292
Barcelona	Group 1117 Cholelithiasis  574	Both sexes	13.689
Barcelona	Group 1117 Cholelithiasis  574	Men	5.665
Barcelona	Group 1117 Cholelithiasis  574	Women	8.024
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.740
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.009
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.731
Barcelona	Group 1119 Pancreatic diseases 577	Both sexes	3.916
Barcelona	Group 1119 Pancreatic diseases 577	Men	2.173
Barcelona	Group 1119 Pancreatic diseases 577	Women	1.743
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	2.959
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.574
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.384
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	7.018
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.551
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	3.467
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	4.367
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	2.422
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.945
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	251
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	125
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	126
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.399
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.004
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.396
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	53.447
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	24.902
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	28.544
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Barcelona	Group 1303 Internal derangement of knee 717	Both sexes	7.326
Barcelona	Group 1303 Internal derangement of knee 717	Men	4.775
Barcelona	Group 1303 Internal derangement of knee 717	Women	2.551
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	19.883
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	8.034
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	11.849
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	833
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	299
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	535
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.431
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.152
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.279
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	4.812
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2.580
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.232
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.334
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	598
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	736
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	8.622
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	4.154
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	4.468
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	8.204
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	3.310
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	4.893
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	48.430
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	22.598
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	25.832
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	5.385
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.688
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	3.697
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	4.472
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Men	2.534
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Women	1.939
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	6.097
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Men	3.685
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Women	2.411
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	12.525
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	5.787
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	6.738
Barcelona	Group 1405 Prostatic hyperplasia  600	Both sexes	4.270
Barcelona	Group 1405 Prostatic hyperplasia  600	Men	4.270
Barcelona	Group 1405 Prostatic hyperplasia  600	Women	..
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	4.243
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Men	4.243
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Barcelona	Group 1407 Disorders of breast  610-612	Both sexes	4.397
Barcelona	Group 1407 Disorders of breast  610-612	Men	254
Barcelona	Group 1407 Disorders of breast  610-612	Women	4.143
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	924
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	924
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	265
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	265
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	5.853
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	137
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	5.715
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	56.579
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	56.579
Barcelona	Group 1501 Legally induced abortion  635	Both sexes	545
Barcelona	Group 1501 Legally induced abortion  635	Men	..
Barcelona	Group 1501 Legally induced abortion  635	Women	545
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.385
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.385
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	29.597
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	29.597
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	15.015
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	15.015
Barcelona	Group 1505 Single spontaneous delivery  650	Both sexes	3.215
Barcelona	Group 1505 Single spontaneous delivery  650	Men	..
Barcelona	Group 1505 Single spontaneous delivery  650	Women	3.215
Barcelona	Group 1506 Other deliveries  6695-6697	Both sexes	1.461
Barcelona	Group 1506 Other deliveries  6695-6697	Men	..
Barcelona	Group 1506 Other deliveries  6695-6697	Women	1.461
Barcelona	Group 1507 Complications related to the puerperium  670-676	Both sexes	570
Barcelona	Group 1507 Complications related to the puerperium  670-676	Men	..
Barcelona	Group 1507 Complications related to the puerperium  670-676	Women	570
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	4.791
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	4.791
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	8.234
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	4.450
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	3.783
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	2.697
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.465
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.232
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	5.537
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	2.985
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.551
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.119
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Men	3.423
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Women	2.695
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	22.186
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	11.979
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	10.207
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.095
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Men	1.197
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Women	898
Barcelona	Group 1802 Abdominal pain   7890	Both sexes	2.333
Barcelona	Group 1802 Abdominal pain   7890	Men	879
Barcelona	Group 1802 Abdominal pain   7890	Women	1.454
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.397
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	636
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	761
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	16.361
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	9.267
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	7.094
Barcelona	Group 1900 Injuries and poisoning  800-999	Both sexes	62.064
Barcelona	Group 1900 Injuries and poisoning  800-999	Men	29.705
Barcelona	Group 1900 Injuries and poisoning  800-999	Women	32.359
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	3.744
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.947
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.797
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.263
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	858
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	404
Barcelona	Group 1903 Radius and ulna fracture 813	Both sexes	3.112
Barcelona	Group 1903 Radius and ulna fracture 813	Men	1.425
Barcelona	Group 1903 Radius and ulna fracture 813	Women	1.688
Barcelona	Group 1904 Femur fracture  820-821	Both sexes	12.364
Barcelona	Group 1904 Femur fracture  820-821	Men	3.477
Barcelona	Group 1904 Femur fracture  820-821	Women	8.886
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	4.153
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Men	1.994
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Women	2.159
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	16.992
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	9.485
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	7.506
Barcelona	Group 1907 Burns  940-949	Both sexes	564
Barcelona	Group 1907 Burns  940-949	Men	371
Barcelona	Group 1907 Burns  940-949	Women	193
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.642
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	648
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	994
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	16.487
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	8.551
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	7.937
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	205
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	132
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	72
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.538
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	815
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	723
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	13.963
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	6.878
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	7.085
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	336
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	221
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	115
Barcelona	Group 2102 Contraceptive management  V25	Both sexes	135
Barcelona	Group 2102 Contraceptive management  V25	Men	9
Barcelona	Group 2102 Contraceptive management  V25	Women	126
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	3.518
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.101
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.418
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	9.974
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	4.548
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	5.426
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	68.954
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	32.215
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	36.739
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.273
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	738
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	536
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	137
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	79
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	59
Girona	Group 0102 Imprecise intestinal infections 009	Both sexes	221
Girona	Group 0102 Imprecise intestinal infections 009	Men	120
Girona	Group 0102 Imprecise intestinal infections 009	Women	102
Girona	Group 0103 Tuberculosis 010-018, 137	Both sexes	60
Girona	Group 0103 Tuberculosis 010-018, 137	Men	39
Girona	Group 0103 Tuberculosis 010-018, 137	Women	21
Girona	Group 0104 Septicaemia  038	Both sexes	365
Girona	Group 0104 Septicaemia  038	Men	206
Girona	Group 0104 Septicaemia  038	Women	160
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	40
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	29
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	10
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	450
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	266
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	184
Girona	Group 0200 Neoplasms  140-239	Both sexes	6.139
Girona	Group 0200 Neoplasms  140-239	Men	3.357
Girona	Group 0200 Neoplasms  140-239	Women	2.783
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	737
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	457
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	280
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	573
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	444
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	129
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	124
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	62
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	63
Girona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	517
Girona	Group 0204 Malignant neoplasm of breast  174-175	Men	6
Girona	Group 0204 Malignant neoplasm of breast  174-175	Women	511
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	105
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	105
Girona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	55
Girona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Girona	Group 0206 Malignant neoplasm of ovary  1830	Women	55
Girona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	180
Girona	Group 0207 Malignant neoplasm of prostate  185	Men	180
Girona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Girona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	654
Girona	Group 0208 Malignant neoplasm of bladder  188	Men	550
Girona	Group 0208 Malignant neoplasm of bladder  188	Women	104
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.194
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.359
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	835
Girona	Group 0210 Carcinoma in situ  230-234	Both sexes	40
Girona	Group 0210 Carcinoma in situ  230-234	Men	9
Girona	Group 0210 Carcinoma in situ  230-234	Women	30
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	31
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	22
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	9
Girona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	277
Girona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Girona	Grupo 0212 Leiomyoma of uterus  218	Women	277
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	652
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	268
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	384
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	526
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	251
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	275
Girona	Group 0301 Anaemias 280-285	Both sexes	319
Girona	Group 0301 Anaemias 280-285	Men	156
Girona	Group 0301 Anaemias 280-285	Women	162
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	208
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	95
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	113
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.004
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	381
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	623
Girona	Group 0401 Diabetes mellitus  249-250	Both sexes	322
Girona	Group 0401 Diabetes mellitus  249-250	Men	168
Girona	Group 0401 Diabetes mellitus  249-250	Women	154
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	681
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	213
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	469
Girona	Group 0500 Mental disorders  290-319	Both sexes	1.736
Girona	Group 0500 Mental disorders  290-319	Men	915
Girona	Group 0500 Mental disorders  290-319	Women	821
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	107
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	34
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	73
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	110
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	88
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	22
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	93
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	73
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	19
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	671
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	404
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	267
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	369
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	144
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	225
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	386
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	171
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	215
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.147
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	565
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	582
Girona	Group 0601 Alzheimer's disease  3310	Both sexes	82
Girona	Group 0601 Alzheimer's disease  3310	Men	28
Girona	Group 0601 Alzheimer's disease  3310	Women	53
Girona	Group 0602 Multiple sclerosis 340	Both sexes	19
Girona	Group 0602 Multiple sclerosis 340	Men	7
Girona	Group 0602 Multiple sclerosis 340	Women	11
Girona	Group 0603 Epilepsy  345	Both sexes	175
Girona	Group 0603 Epilepsy  345	Men	89
Girona	Group 0603 Epilepsy  345	Women	86
Girona	Group 0604 Transient cerebral ischemia 435	Both sexes	105
Girona	Group 0604 Transient cerebral ischemia 435	Men	61
Girona	Group 0604 Transient cerebral ischemia 435	Women	44
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	767
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	380
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	387
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	639
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	298
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	341
Girona	Grupo 0701 Cataract  366	Both sexes	381
Girona	Grupo 0701 Cataract  366	Men	168
Girona	Grupo 0701 Cataract  366	Women	213
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	258
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	130
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	128
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	233
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	121
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	112
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.684
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.765
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.919
Girona	Group 0901 Hypertensive disease  401-405	Both sexes	146
Girona	Group 0901 Hypertensive disease  401-405	Men	63
Girona	Group 0901 Hypertensive disease  401-405	Women	83
Girona	Group 0902 Angina pectoris  4111, 413	Both sexes	405
Girona	Group 0902 Angina pectoris  4111, 413	Men	287
Girona	Group 0902 Angina pectoris  4111, 413	Women	117
Girona	Group 0903 Acute myocardial infarction  410	Both sexes	906
Girona	Group 0903 Acute myocardial infarction  410	Men	575
Girona	Group 0903 Acute myocardial infarction  410	Women	331
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	360
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	243
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	117
Girona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	272
Girona	Group 0905 Diseases of the lungs circulation 415-417	Men	128
Girona	Group 0905 Diseases of the lungs circulation 415-417	Women	144
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.041
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	578
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	464
Girona	Grupo 0907 Heart failure  428	Both sexes	2.110
Girona	Grupo 0907 Heart failure  428	Men	971
Girona	Grupo 0907 Heart failure  428	Women	1.139
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.676
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	874
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	802
Girona	Grupo 0909 Atherosclerosis  440	Both sexes	290
Girona	Grupo 0909 Atherosclerosis  440	Men	213
Girona	Grupo 0909 Atherosclerosis  440	Women	77
Girona	Group 0910 Varicose veins of lower extremities 454	Both sexes	233
Girona	Group 0910 Varicose veins of lower extremities 454	Men	98
Girona	Group 0910 Varicose veins of lower extremities 454	Women	135
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.245
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	735
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	510
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	8.367
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.703
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.664
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	229
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	117
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	111
Girona	Group 1002 Pneumonia 480-486	Both sexes	1.795
Girona	Group 1002 Pneumonia 480-486	Men	1.068
Girona	Group 1002 Pneumonia 480-486	Women	727
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.558
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	714
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	845
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	460
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	252
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	208
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	703
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	435
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	269
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.386
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.005
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	381
Girona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	325
Girona	Group 1007 Asthma 4930-4931,4938-4939	Men	110
Girona	Group 1007 Asthma 4930-4931,4938-4939	Women	215
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.911
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.002
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	909
Girona	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.041
Girona	Group 1100 Diseases of the digestive system  520-579	Men	4.562
Girona	Group 1100 Diseases of the digestive system  520-579	Women	3.479
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	40
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	23
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	17
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	62
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	43
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	19
Girona	Group 1103 Diseases of the esophagus 530	Both sexes	108
Girona	Group 1103 Diseases of the esophagus 530	Men	66
Girona	Group 1103 Diseases of the esophagus 530	Women	42
Girona	Group 1104 Peptic ulcer 531-534	Both sexes	177
Girona	Group 1104 Peptic ulcer 531-534	Men	116
Girona	Group 1104 Peptic ulcer 531-534	Women	61
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	135
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	71
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	64
Girona	Group 1106 Appendicitis  540-543	Both sexes	710
Girona	Group 1106 Appendicitis  540-543	Men	403
Girona	Group 1106 Appendicitis  540-543	Women	306
Girona	Group 1107 Inguinal hernia  550	Both sexes	913
Girona	Group 1107 Inguinal hernia  550	Men	796
Girona	Group 1107 Inguinal hernia  550	Women	118
Girona	Group 1108 Other abdominal hernia  551-553	Both sexes	835
Girona	Group 1108 Other abdominal hernia  551-553	Men	390
Girona	Group 1108 Other abdominal hernia  551-553	Women	445
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	133
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	72
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	61
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	329
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	158
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	171
Girona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	363
Girona	Group 1111 Intestinal obstruction without hernia 560	Men	211
Girona	Group 1111 Intestinal obstruction without hernia 560	Women	152
Girona	Group 1112 Intestinal diverticulosis 562	Both sexes	300
Girona	Group 1112 Intestinal diverticulosis 562	Men	153
Girona	Group 1112 Intestinal diverticulosis 562	Women	147
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	536
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	344
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	192
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	220
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	103
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	117
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	131
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Men	95
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Women	36
Girona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	260
Girona	Group 1116 Other diseases of the liver 570,5714-573	Men	165
Girona	Group 1116 Other diseases of the liver 570,5714-573	Women	95
Girona	Group 1117 Cholelithiasis  574	Both sexes	1.550
Girona	Group 1117 Cholelithiasis  574	Men	638
Girona	Group 1117 Cholelithiasis  574	Women	912
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	500
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	270
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	231
Girona	Group 1119 Pancreatic diseases 577	Both sexes	403
Girona	Group 1119 Pancreatic diseases 577	Men	252
Girona	Group 1119 Pancreatic diseases 577	Women	151
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	337
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	193
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	143
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	875
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	500
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	375
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	588
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	365
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	223
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	22
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	8
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	265
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	127
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	138
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.781
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.655
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.125
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Girona	Group 1303 Internal derangement of knee 717	Both sexes	532
Girona	Group 1303 Internal derangement of knee 717	Men	322
Girona	Group 1303 Internal derangement of knee 717	Women	210
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.434
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.040
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.393
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	63
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	26
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	37
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	202
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	98
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	103
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	347
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	188
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	159
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	246
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	119
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	127
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.102
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	539
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	563
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	856
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	323
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	533
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.714
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.230
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.484
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	658
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	216
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	442
Girona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	483
Girona	Group 1402 Renal failure  5836-5837, 584-586	Men	295
Girona	Group 1402 Renal failure  5836-5837, 584-586	Women	188
Girona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	550
Girona	Group 1403 Urolithiasis  592, 594, 7880	Men	334
Girona	Group 1403 Urolithiasis  592, 594, 7880	Women	216
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.145
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	610
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	535
Girona	Group 1405 Prostatic hyperplasia  600	Both sexes	405
Girona	Group 1405 Prostatic hyperplasia  600	Men	405
Girona	Group 1405 Prostatic hyperplasia  600	Women	..
Girona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	332
Girona	Group 1406 Other diseases of the male genital organs    601-608	Men	332
Girona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Girona	Group 1407 Disorders of breast  610-612	Both sexes	254
Girona	Group 1407 Disorders of breast  610-612	Men	14
Girona	Group 1407 Disorders of breast  610-612	Women	240
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	116
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	116
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	59
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	59
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	712
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	24
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	687
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.469
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.469
Girona	Group 1501 Legally induced abortion  635	Both sexes	47
Girona	Group 1501 Legally induced abortion  635	Men	..
Girona	Group 1501 Legally induced abortion  635	Women	47
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	274
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	274
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.853
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.853
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.508
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.508
Girona	Group 1505 Single spontaneous delivery  650	Both sexes	906
Girona	Group 1505 Single spontaneous delivery  650	Men	..
Girona	Group 1505 Single spontaneous delivery  650	Women	906
Girona	Group 1506 Other deliveries  6695-6697	Both sexes	214
Girona	Group 1506 Other deliveries  6695-6697	Men	..
Girona	Group 1506 Other deliveries  6695-6697	Women	214
Girona	Group 1507 Complications related to the puerperium  670-676	Both sexes	69
Girona	Group 1507 Complications related to the puerperium  670-676	Men	..
Girona	Group 1507 Complications related to the puerperium  670-676	Women	69
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	597
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	597
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	883
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	499
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	384
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	309
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	165
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	144
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	574
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	334
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	240
Girona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	272
Girona	Grupo 1700 Congenital abnormalities  740-759	Men	177
Girona	Grupo 1700 Congenital abnormalities  740-759	Women	94
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.691
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.454
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.237
Girona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	280
Girona	Group 1801 Pain in throat and chest 7841, 7865	Men	162
Girona	Group 1801 Pain in throat and chest 7841, 7865	Women	119
Girona	Group 1802 Abdominal pain   7890	Both sexes	427
Girona	Group 1802 Abdominal pain   7890	Men	171
Girona	Group 1802 Abdominal pain   7890	Women	256
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	33
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	15
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	19
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.951
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.107
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	844
Girona	Group 1900 Injuries and poisoning  800-999	Both sexes	7.533
Girona	Group 1900 Injuries and poisoning  800-999	Men	3.526
Girona	Group 1900 Injuries and poisoning  800-999	Women	4.008
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	395
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	237
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	158
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	93
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	68
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	25
Girona	Group 1903 Radius and ulna fracture 813	Both sexes	509
Girona	Group 1903 Radius and ulna fracture 813	Men	231
Girona	Group 1903 Radius and ulna fracture 813	Women	278
Girona	Group 1904 Femur fracture  820-821	Both sexes	1.844
Girona	Group 1904 Femur fracture  820-821	Men	510
Girona	Group 1904 Femur fracture  820-821	Women	1.333
Girona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	601
Girona	Group 1905 Leg fracture, including the ankle 823-824	Men	304
Girona	Group 1905 Leg fracture, including the ankle 823-824	Women	298
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.236
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.261
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	975
Girona	Group 1907 Burns  940-949	Both sexes	32
Girona	Group 1907 Burns  940-949	Men	17
Girona	Group 1907 Burns  940-949	Women	16
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	207
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	77
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	130
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.420
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	708
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	711
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	25
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	17
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	8
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	170
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	95
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	75
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	948
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	520
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	428
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	4
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	3
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1
Girona	Group 2102 Contraceptive management  V25	Both sexes	16
Girona	Group 2102 Contraceptive management  V25	Men	3
Girona	Group 2102 Contraceptive management  V25	Women	13
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	218
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	147
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	71
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	710
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	366
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	343
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	39.241
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.795
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	20.446
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	649
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	391
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	258
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	80
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	36
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	44
Lleida	Group 0102 Imprecise intestinal infections 009	Both sexes	121
Lleida	Group 0102 Imprecise intestinal infections 009	Men	61
Lleida	Group 0102 Imprecise intestinal infections 009	Women	60
Lleida	Group 0103 Tuberculosis 010-018, 137	Both sexes	39
Lleida	Group 0103 Tuberculosis 010-018, 137	Men	31
Lleida	Group 0103 Tuberculosis 010-018, 137	Women	8
Lleida	Group 0104 Septicaemia  038	Both sexes	162
Lleida	Group 0104 Septicaemia  038	Men	99
Lleida	Group 0104 Septicaemia  038	Women	63
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	26
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	23
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	221
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	141
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	80
Lleida	Group 0200 Neoplasms  140-239	Both sexes	3.764
Lleida	Group 0200 Neoplasms  140-239	Men	2.223
Lleida	Group 0200 Neoplasms  140-239	Women	1.541
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	517
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	334
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	183
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	277
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	212
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	65
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	41
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	32
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	9
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	256
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Women	255
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	62
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	62
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	41
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Women	41
Lleida	Group 0207 Malignant neoplasm of prostate  185	Both sexes	157
Lleida	Group 0207 Malignant neoplasm of prostate  185	Men	157
Lleida	Group 0207 Malignant neoplasm of prostate  185	Women	..
Lleida	Group 0208 Malignant neoplasm of bladder  188	Both sexes	473
Lleida	Group 0208 Malignant neoplasm of bladder  188	Men	391
Lleida	Group 0208 Malignant neoplasm of bladder  188	Women	82
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.295
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	805
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	490
Lleida	Group 0210 Carcinoma in situ  230-234	Both sexes	22
Lleida	Group 0210 Carcinoma in situ  230-234	Men	12
Lleida	Group 0210 Carcinoma in situ  230-234	Women	10
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	99
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	69
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	30
Lleida	Grupo 0212 Leiomyoma of uterus  218	Both sexes	110
Lleida	Grupo 0212 Leiomyoma of uterus  218	Men	..
Lleida	Grupo 0212 Leiomyoma of uterus  218	Women	110
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	414
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	210
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	204
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	297
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	176
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	121
Lleida	Group 0301 Anaemias 280-285	Both sexes	175
Lleida	Group 0301 Anaemias 280-285	Men	89
Lleida	Group 0301 Anaemias 280-285	Women	86
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	122
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	87
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	35
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	542
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	237
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	305
Lleida	Group 0401 Diabetes mellitus  249-250	Both sexes	184
Lleida	Group 0401 Diabetes mellitus  249-250	Men	112
Lleida	Group 0401 Diabetes mellitus  249-250	Women	72
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	358
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	125
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	233
Lleida	Group 0500 Mental disorders  290-319	Both sexes	2.133
Lleida	Group 0500 Mental disorders  290-319	Men	1.050
Lleida	Group 0500 Mental disorders  290-319	Women	1.083
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	94
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	46
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	48
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	105
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	64
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	41
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	133
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	89
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	44
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	643
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	389
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	254
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	567
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	207
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	360
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	591
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	255
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	336
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	653
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	334
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	319
Lleida	Group 0601 Alzheimer's disease  3310	Both sexes	86
Lleida	Group 0601 Alzheimer's disease  3310	Men	45
Lleida	Group 0601 Alzheimer's disease  3310	Women	41
Lleida	Group 0602 Multiple sclerosis 340	Both sexes	5
Lleida	Group 0602 Multiple sclerosis 340	Men	4
Lleida	Group 0602 Multiple sclerosis 340	Women	1
Lleida	Group 0603 Epilepsy  345	Both sexes	92
Lleida	Group 0603 Epilepsy  345	Men	45
Lleida	Group 0603 Epilepsy  345	Women	47
Lleida	Group 0604 Transient cerebral ischemia 435	Both sexes	106
Lleida	Group 0604 Transient cerebral ischemia 435	Men	60
Lleida	Group 0604 Transient cerebral ischemia 435	Women	46
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	364
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	180
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	184
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	136
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	87
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	49
Lleida	Grupo 0701 Cataract  366	Both sexes	31
Lleida	Grupo 0701 Cataract  366	Men	17
Lleida	Grupo 0701 Cataract  366	Women	14
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	105
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	70
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	35
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	131
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Men	56
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Women	75
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.777
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.641
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.136
Lleida	Group 0901 Hypertensive disease  401-405	Both sexes	97
Lleida	Group 0901 Hypertensive disease  401-405	Men	52
Lleida	Group 0901 Hypertensive disease  401-405	Women	45
Lleida	Group 0902 Angina pectoris  4111, 413	Both sexes	77
Lleida	Group 0902 Angina pectoris  4111, 413	Men	52
Lleida	Group 0902 Angina pectoris  4111, 413	Women	25
Lleida	Group 0903 Acute myocardial infarction  410	Both sexes	367
Lleida	Group 0903 Acute myocardial infarction  410	Men	256
Lleida	Group 0903 Acute myocardial infarction  410	Women	111
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	301
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	243
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	58
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	178
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Men	84
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Women	94
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	637
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	321
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	316
Lleida	Grupo 0907 Heart failure  428	Both sexes	1.378
Lleida	Grupo 0907 Heart failure  428	Men	637
Lleida	Grupo 0907 Heart failure  428	Women	741
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.016
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	567
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	449
Lleida	Grupo 0909 Atherosclerosis  440	Both sexes	197
Lleida	Grupo 0909 Atherosclerosis  440	Men	124
Lleida	Grupo 0909 Atherosclerosis  440	Women	73
Lleida	Group 0910 Varicose veins of lower extremities 454	Both sexes	55
Lleida	Group 0910 Varicose veins of lower extremities 454	Men	17
Lleida	Group 0910 Varicose veins of lower extremities 454	Women	38
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	474
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	288
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	186
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.331
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.089
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.242
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	130
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	72
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	58
Lleida	Group 1002 Pneumonia 480-486	Both sexes	980
Lleida	Group 1002 Pneumonia 480-486	Men	581
Lleida	Group 1002 Pneumonia 480-486	Women	399
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.088
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Men	503
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Women	585
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	124
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	71
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	53
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	206
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	130
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	76
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.241
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	881
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	360
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	123
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Men	23
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Women	100
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.439
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	828
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	611
Lleida	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.866
Lleida	Group 1100 Diseases of the digestive system  520-579	Men	2.682
Lleida	Group 1100 Diseases of the digestive system  520-579	Women	2.184
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	38
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	21
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	17
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	33
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	16
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	17
Lleida	Group 1103 Diseases of the esophagus 530	Both sexes	85
Lleida	Group 1103 Diseases of the esophagus 530	Men	50
Lleida	Group 1103 Diseases of the esophagus 530	Women	35
Lleida	Group 1104 Peptic ulcer 531-534	Both sexes	103
Lleida	Group 1104 Peptic ulcer 531-534	Men	75
Lleida	Group 1104 Peptic ulcer 531-534	Women	28
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	102
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	57
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	45
Lleida	Group 1106 Appendicitis  540-543	Both sexes	402
Lleida	Group 1106 Appendicitis  540-543	Men	217
Lleida	Group 1106 Appendicitis  540-543	Women	185
Lleida	Group 1107 Inguinal hernia  550	Both sexes	368
Lleida	Group 1107 Inguinal hernia  550	Men	322
Lleida	Group 1107 Inguinal hernia  550	Women	46
Lleida	Group 1108 Other abdominal hernia  551-553	Both sexes	356
Lleida	Group 1108 Other abdominal hernia  551-553	Men	160
Lleida	Group 1108 Other abdominal hernia  551-553	Women	196
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	77
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	36
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	41
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	230
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	116
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	114
Lleida	Group 1111 Intestinal obstruction without hernia 560	Both sexes	260
Lleida	Group 1111 Intestinal obstruction without hernia 560	Men	148
Lleida	Group 1111 Intestinal obstruction without hernia 560	Women	112
Lleida	Group 1112 Intestinal diverticulosis 562	Both sexes	195
Lleida	Group 1112 Intestinal diverticulosis 562	Men	90
Lleida	Group 1112 Intestinal diverticulosis 562	Women	105
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	210
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	140
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	70
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	180
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	83
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	97
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	116
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Men	99
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Women	17
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	165
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Men	95
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Women	70
Lleida	Group 1117 Cholelithiasis  574	Both sexes	1.089
Lleida	Group 1117 Cholelithiasis  574	Men	472
Lleida	Group 1117 Cholelithiasis  574	Women	617
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	398
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	206
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	192
Lleida	Group 1119 Pancreatic diseases 577	Both sexes	253
Lleida	Group 1119 Pancreatic diseases 577	Men	155
Lleida	Group 1119 Pancreatic diseases 577	Women	98
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	206
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	124
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	82
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	361
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	194
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	167
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	227
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	136
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	91
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	8
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	3
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	5
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	126
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	55
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	71
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.271
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.022
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.249
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Lleida	Group 1303 Internal derangement of knee 717	Both sexes	118
Lleida	Group 1303 Internal derangement of knee 717	Men	75
Lleida	Group 1303 Internal derangement of knee 717	Women	43
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.141
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	477
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	664
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	61
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	34
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	27
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	110
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	54
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	56
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	181
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	103
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	78
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	103
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	38
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	65
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	271
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	125
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	146
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	286
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	116
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	170
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.903
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.467
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.436
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	409
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	100
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	309
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	238
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Men	143
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Women	95
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	466
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Men	289
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Women	177
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	824
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	453
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	371
Lleida	Group 1405 Prostatic hyperplasia  600	Both sexes	263
Lleida	Group 1405 Prostatic hyperplasia  600	Men	263
Lleida	Group 1405 Prostatic hyperplasia  600	Women	..
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	205
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Men	205
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Lleida	Group 1407 Disorders of breast  610-612	Both sexes	111
Lleida	Group 1407 Disorders of breast  610-612	Men	3
Lleida	Group 1407 Disorders of breast  610-612	Women	108
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	57
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	57
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	28
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	28
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	302
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	291
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	4.065
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	4.065
Lleida	Group 1501 Legally induced abortion  635	Both sexes	26
Lleida	Group 1501 Legally induced abortion  635	Men	..
Lleida	Group 1501 Legally induced abortion  635	Women	26
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	186
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	186
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.162
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.162
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	751
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	751
Lleida	Group 1505 Single spontaneous delivery  650	Both sexes	372
Lleida	Group 1505 Single spontaneous delivery  650	Men	..
Lleida	Group 1505 Single spontaneous delivery  650	Women	372
Lleida	Group 1506 Other deliveries  6695-6697	Both sexes	57
Lleida	Group 1506 Other deliveries  6695-6697	Men	..
Lleida	Group 1506 Other deliveries  6695-6697	Women	57
Lleida	Group 1507 Complications related to the puerperium  670-676	Both sexes	51
Lleida	Group 1507 Complications related to the puerperium  670-676	Men	..
Lleida	Group 1507 Complications related to the puerperium  670-676	Women	51
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	460
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	460
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	367
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Men	209
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Women	158
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	80
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	53
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	27
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	287
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	156
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	131
Lleida	Grupo 1700 Congenital abnormalities  740-759	Both sexes	79
Lleida	Grupo 1700 Congenital abnormalities  740-759	Men	45
Lleida	Grupo 1700 Congenital abnormalities  740-759	Women	34
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.749
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	935
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	814
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	144
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Men	83
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Women	61
Lleida	Group 1802 Abdominal pain   7890	Both sexes	306
Lleida	Group 1802 Abdominal pain   7890	Men	125
Lleida	Group 1802 Abdominal pain   7890	Women	181
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	34
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	17
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	17
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.265
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	710
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	555
Lleida	Group 1900 Injuries and poisoning  800-999	Both sexes	3.835
Lleida	Group 1900 Injuries and poisoning  800-999	Men	1.774
Lleida	Group 1900 Injuries and poisoning  800-999	Women	2.061
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	355
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	197
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	158
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	75
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	54
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	21
Lleida	Group 1903 Radius and ulna fracture 813	Both sexes	175
Lleida	Group 1903 Radius and ulna fracture 813	Men	70
Lleida	Group 1903 Radius and ulna fracture 813	Women	105
Lleida	Group 1904 Femur fracture  820-821	Both sexes	961
Lleida	Group 1904 Femur fracture  820-821	Men	268
Lleida	Group 1904 Femur fracture  820-821	Women	693
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	276
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Men	138
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Women	138
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.185
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	645
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	540
Lleida	Group 1907 Burns  940-949	Both sexes	9
Lleida	Group 1907 Burns  940-949	Men	8
Lleida	Group 1907 Burns  940-949	Women	1
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	112
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	49
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	63
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	570
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	276
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	294
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	108
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	66
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	42
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	332
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	183
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	149
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	18
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	9
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	9
Lleida	Group 2102 Contraceptive management  V25	Both sexes	7
Lleida	Group 2102 Contraceptive management  V25	Men	..
Lleida	Group 2102 Contraceptive management  V25	Women	7
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	144
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	92
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	52
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	163
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	82
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	81
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	77.314
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	36.741
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	40.573
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.296
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	694
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	602
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	177
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	100
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	76
Tarragona	Group 0102 Imprecise intestinal infections 009	Both sexes	173
Tarragona	Group 0102 Imprecise intestinal infections 009	Men	79
Tarragona	Group 0102 Imprecise intestinal infections 009	Women	94
Tarragona	Group 0103 Tuberculosis 010-018, 137	Both sexes	57
Tarragona	Group 0103 Tuberculosis 010-018, 137	Men	32
Tarragona	Group 0103 Tuberculosis 010-018, 137	Women	24
Tarragona	Group 0104 Septicaemia  038	Both sexes	331
Tarragona	Group 0104 Septicaemia  038	Men	171
Tarragona	Group 0104 Septicaemia  038	Women	160
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	92
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	69
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	22
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	468
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	243
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	225
Tarragona	Group 0200 Neoplasms  140-239	Both sexes	7.017
Tarragona	Group 0200 Neoplasms  140-239	Men	4.078
Tarragona	Group 0200 Neoplasms  140-239	Women	2.939
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	934
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	578
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	355
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	799
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	659
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	140
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	114
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	74
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	40
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	473
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Men	5
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Women	468
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	169
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	169
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	102
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Women	102
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	211
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Men	211
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.007
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Men	848
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Women	159
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.180
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.349
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	832
Tarragona	Group 0210 Carcinoma in situ  230-234	Both sexes	69
Tarragona	Group 0210 Carcinoma in situ  230-234	Men	27
Tarragona	Group 0210 Carcinoma in situ  230-234	Women	42
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	101
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	61
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	40
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	275
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Women	275
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	584
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	266
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	318
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	635
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	296
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	339
Tarragona	Group 0301 Anaemias 280-285	Both sexes	432
Tarragona	Group 0301 Anaemias 280-285	Men	193
Tarragona	Group 0301 Anaemias 280-285	Women	239
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	202
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	103
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	100
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.204
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	479
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	724
Tarragona	Group 0401 Diabetes mellitus  249-250	Both sexes	427
Tarragona	Group 0401 Diabetes mellitus  249-250	Men	241
Tarragona	Group 0401 Diabetes mellitus  249-250	Women	186
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	777
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	239
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	538
Tarragona	Group 0500 Mental disorders  290-319	Both sexes	2.649
Tarragona	Group 0500 Mental disorders  290-319	Men	1.481
Tarragona	Group 0500 Mental disorders  290-319	Women	1.168
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	190
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	89
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	101
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	174
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	117
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	57
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	155
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	132
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	23
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	671
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	443
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	227
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	504
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	212
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	292
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	954
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	488
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	467
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.190
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	555
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	635
Tarragona	Group 0601 Alzheimer's disease  3310	Both sexes	118
Tarragona	Group 0601 Alzheimer's disease  3310	Men	42
Tarragona	Group 0601 Alzheimer's disease  3310	Women	76
Tarragona	Group 0602 Multiple sclerosis 340	Both sexes	29
Tarragona	Group 0602 Multiple sclerosis 340	Men	9
Tarragona	Group 0602 Multiple sclerosis 340	Women	19
Tarragona	Group 0603 Epilepsy  345	Both sexes	179
Tarragona	Group 0603 Epilepsy  345	Men	93
Tarragona	Group 0603 Epilepsy  345	Women	86
Tarragona	Group 0604 Transient cerebral ischemia 435	Both sexes	202
Tarragona	Group 0604 Transient cerebral ischemia 435	Men	107
Tarragona	Group 0604 Transient cerebral ischemia 435	Women	96
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	662
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	305
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	357
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	298
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	145
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	152
Tarragona	Grupo 0701 Cataract  366	Both sexes	150
Tarragona	Grupo 0701 Cataract  366	Men	61
Tarragona	Grupo 0701 Cataract  366	Women	89
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	147
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	84
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	63
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	442
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	211
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	230
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.614
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.384
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.230
Tarragona	Group 0901 Hypertensive disease  401-405	Both sexes	272
Tarragona	Group 0901 Hypertensive disease  401-405	Men	107
Tarragona	Group 0901 Hypertensive disease  401-405	Women	165
Tarragona	Group 0902 Angina pectoris  4111, 413	Both sexes	437
Tarragona	Group 0902 Angina pectoris  4111, 413	Men	304
Tarragona	Group 0902 Angina pectoris  4111, 413	Women	133
Tarragona	Group 0903 Acute myocardial infarction  410	Both sexes	1.191
Tarragona	Group 0903 Acute myocardial infarction  410	Men	861
Tarragona	Group 0903 Acute myocardial infarction  410	Women	330
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	352
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	261
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	91
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	319
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Men	143
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Women	175
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.110
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	620
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	489
Tarragona	Grupo 0907 Heart failure  428	Both sexes	2.388
Tarragona	Grupo 0907 Heart failure  428	Men	1.129
Tarragona	Grupo 0907 Heart failure  428	Women	1.260
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.938
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.045
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	893
Tarragona	Grupo 0909 Atherosclerosis  440	Both sexes	340
Tarragona	Grupo 0909 Atherosclerosis  440	Men	251
Tarragona	Grupo 0909 Atherosclerosis  440	Women	89
Tarragona	Group 0910 Varicose veins of lower extremities 454	Both sexes	176
Tarragona	Group 0910 Varicose veins of lower extremities 454	Men	53
Tarragona	Group 0910 Varicose veins of lower extremities 454	Women	123
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.091
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	609
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	482
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.347
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.801
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.546
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	411
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	217
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	195
Tarragona	Group 1002 Pneumonia 480-486	Both sexes	2.308
Tarragona	Group 1002 Pneumonia 480-486	Men	1.351
Tarragona	Group 1002 Pneumonia 480-486	Women	958
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.291
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.080
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.211
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	390
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	225
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	164
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	699
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	458
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	241
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.963
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.416
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	547
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	375
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Men	93
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Women	282
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.909
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	960
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	948
Tarragona	Group 1100 Diseases of the digestive system  520-579	Both sexes	9.657
Tarragona	Group 1100 Diseases of the digestive system  520-579	Men	5.452
Tarragona	Group 1100 Diseases of the digestive system  520-579	Women	4.205
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	251
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	111
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	140
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	106
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	61
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	45
Tarragona	Group 1103 Diseases of the esophagus 530	Both sexes	128
Tarragona	Group 1103 Diseases of the esophagus 530	Men	96
Tarragona	Group 1103 Diseases of the esophagus 530	Women	31
Tarragona	Group 1104 Peptic ulcer 531-534	Both sexes	165
Tarragona	Group 1104 Peptic ulcer 531-534	Men	116
Tarragona	Group 1104 Peptic ulcer 531-534	Women	50
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	209
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	112
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	98
Tarragona	Group 1106 Appendicitis  540-543	Both sexes	734
Tarragona	Group 1106 Appendicitis  540-543	Men	402
Tarragona	Group 1106 Appendicitis  540-543	Women	332
Tarragona	Group 1107 Inguinal hernia  550	Both sexes	1.055
Tarragona	Group 1107 Inguinal hernia  550	Men	941
Tarragona	Group 1107 Inguinal hernia  550	Women	114
Tarragona	Group 1108 Other abdominal hernia  551-553	Both sexes	992
Tarragona	Group 1108 Other abdominal hernia  551-553	Men	429
Tarragona	Group 1108 Other abdominal hernia  551-553	Women	564
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	159
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	82
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	76
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	528
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	263
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	265
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	430
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Men	237
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Women	193
Tarragona	Group 1112 Intestinal diverticulosis 562	Both sexes	385
Tarragona	Group 1112 Intestinal diverticulosis 562	Men	220
Tarragona	Group 1112 Intestinal diverticulosis 562	Women	165
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	611
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	375
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	236
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	276
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	127
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	149
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	175
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Men	153
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Women	22
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	296
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Men	172
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Women	124
Tarragona	Group 1117 Cholelithiasis  574	Both sexes	1.765
Tarragona	Group 1117 Cholelithiasis  574	Men	768
Tarragona	Group 1117 Cholelithiasis  574	Women	997
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	496
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	284
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	211
Tarragona	Group 1119 Pancreatic diseases 577	Both sexes	592
Tarragona	Group 1119 Pancreatic diseases 577	Men	326
Tarragona	Group 1119 Pancreatic diseases 577	Women	266
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	306
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	178
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	128
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	815
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	433
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	382
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	527
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	287
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	240
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	36
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	21
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	14
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	252
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	125
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	127
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.316
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.421
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.894
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Tarragona	Group 1303 Internal derangement of knee 717	Both sexes	583
Tarragona	Group 1303 Internal derangement of knee 717	Men	370
Tarragona	Group 1303 Internal derangement of knee 717	Women	213
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.448
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	986
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.462
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	59
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	28
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	30
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	188
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	84
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	104
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	329
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	154
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	175
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	168
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	76
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	92
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	776
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	408
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	368
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	764
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	314
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	450
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.590
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.636
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.953
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	691
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	207
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	484
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	455
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Men	269
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Women	186
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	758
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Men	442
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Women	316
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.666
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	813
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	854
Tarragona	Group 1405 Prostatic hyperplasia  600	Both sexes	405
Tarragona	Group 1405 Prostatic hyperplasia  600	Men	405
Tarragona	Group 1405 Prostatic hyperplasia  600	Women	..
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	487
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Men	487
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Tarragona	Group 1407 Disorders of breast  610-612	Both sexes	151
Tarragona	Group 1407 Disorders of breast  610-612	Men	10
Tarragona	Group 1407 Disorders of breast  610-612	Women	141
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	126
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	126
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	78
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	78
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	773
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	770
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.948
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.948
Tarragona	Group 1501 Legally induced abortion  635	Both sexes	38
Tarragona	Group 1501 Legally induced abortion  635	Men	..
Tarragona	Group 1501 Legally induced abortion  635	Women	38
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	405
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	405
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.900
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.900
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.808
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.808
Tarragona	Group 1505 Single spontaneous delivery  650	Both sexes	977
Tarragona	Group 1505 Single spontaneous delivery  650	Men	..
Tarragona	Group 1505 Single spontaneous delivery  650	Women	977
Tarragona	Group 1506 Other deliveries  6695-6697	Both sexes	57
Tarragona	Group 1506 Other deliveries  6695-6697	Men	..
Tarragona	Group 1506 Other deliveries  6695-6697	Women	57
Tarragona	Group 1507 Complications related to the puerperium  670-676	Both sexes	136
Tarragona	Group 1507 Complications related to the puerperium  670-676	Men	..
Tarragona	Group 1507 Complications related to the puerperium  670-676	Women	136
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	627
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	627
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.150
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	625
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	525
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	303
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	169
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	134
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	846
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	456
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	391
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	424
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Men	235
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Women	189
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.096
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.740
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.357
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	354
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Men	187
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Women	168
Tarragona	Group 1802 Abdominal pain   7890	Both sexes	383
Tarragona	Group 1802 Abdominal pain   7890	Men	152
Tarragona	Group 1802 Abdominal pain   7890	Women	232
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	21
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	8
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	13
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.337
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.393
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	944
Tarragona	Group 1900 Injuries and poisoning  800-999	Both sexes	7.294
Tarragona	Group 1900 Injuries and poisoning  800-999	Men	3.385
Tarragona	Group 1900 Injuries and poisoning  800-999	Women	3.909
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	492
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	283
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	210
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	214
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	148
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	66
Tarragona	Group 1903 Radius and ulna fracture 813	Both sexes	396
Tarragona	Group 1903 Radius and ulna fracture 813	Men	195
Tarragona	Group 1903 Radius and ulna fracture 813	Women	201
Tarragona	Group 1904 Femur fracture  820-821	Both sexes	1.769
Tarragona	Group 1904 Femur fracture  820-821	Men	495
Tarragona	Group 1904 Femur fracture  820-821	Women	1.274
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	479
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Men	250
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Women	229
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.176
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.132
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.043
Tarragona	Group 1907 Burns  940-949	Both sexes	18
Tarragona	Group 1907 Burns  940-949	Men	11
Tarragona	Group 1907 Burns  940-949	Women	7
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	145
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	53
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	92
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.369
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	688
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	681
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	7
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	222
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	122
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	100
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.335
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	689
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	647
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	5
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	4
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1
Tarragona	Group 2102 Contraceptive management  V25	Both sexes	50
Tarragona	Group 2102 Contraceptive management  V25	Men	..
Tarragona	Group 2102 Contraceptive management  V25	Women	50
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	266
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	178
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	88
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.015
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	507
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	508
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	510.074
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	243.994
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	266.080
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	11.392
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	6.341
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	5.051
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.783
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	913
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	870
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Both sexes	1.047
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Men	516
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Women	531
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Both sexes	400
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Men	273
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Women	127
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Both sexes	4.077
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Men	2.269
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Women	1.808
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	488
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	343
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	145
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	3.597
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.027
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	1.570
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Both sexes	52.929
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Men	27.920
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Women	25.009
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	5.566
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.313
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.253
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.620
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.623
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	997
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	766
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	479
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	287
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	4.622
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Men	24
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Women	4.598
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.073
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.073
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	620
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Women	620
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.973
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Men	1.973
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Women	..
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	5.742
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Men	4.825
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Women	917
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	17.096
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	10.046
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	7.050
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Both sexes	680
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Men	215
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Women	465
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	641
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	396
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	245
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	2.670
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Men	..
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Women	2.670
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	6.860
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.026
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	3.834
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	4.305
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.127
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	2.178
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Both sexes	2.494
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Men	1.222
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Women	1.272
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	1.811
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	905
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	906
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	10.031
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.192
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	5.839
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Both sexes	3.332
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Men	1.983
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Women	1.349
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	6.699
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.209
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	4.490
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Both sexes	10.143
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Men	5.360
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Women	4.783
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	339
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	167
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	172
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	719
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	520
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	199
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	591
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	407
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	183
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	3.021
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	1.846
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.175
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	2.212
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	946
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.265
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	3.261
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	1.474
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.787
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	11.745
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	5.877
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	5.868
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Both sexes	212
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Men	71
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Women	141
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Both sexes	264
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Men	69
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Women	195
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Both sexes	2.546
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Men	1.377
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Women	1.169
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Both sexes	1.865
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Men	983
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Women	882
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	6.858
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	3.377
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	3.481
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	2.306
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	1.232
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	1.074
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Both sexes	298
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Men	158
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Women	140
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	2.008
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.074
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	934
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	2.407
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.177
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.230
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	66.297
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	38.037
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	28.260
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Both sexes	2.038
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Men	1.053
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Women	985
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Both sexes	3.678
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Men	2.341
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Women	1.337
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Both sexes	5.989
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Men	4.273
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Women	1.716
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	4.216
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	3.248
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	968
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.020
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Men	901
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Women	1.119
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	9.167
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	4.946
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.221
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Both sexes	13.391
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Men	6.347
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Women	7.044
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	12.151
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	6.736
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	5.415
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Both sexes	1.806
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Men	1.360
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Women	446
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.131
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Men	401
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Women	730
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	10.710
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	6.431
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	4.279
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	58.738
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	33.442
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	25.296
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.303
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.702
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.601
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Both sexes	14.518
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Men	8.479
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Women	6.039
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	5.844
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	2.823
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	3.021
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.489
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.887
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.602
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	3.527
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	2.129
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.398
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	9.193
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	6.929
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	2.264
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.767
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Men	490
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Women	1.277
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	17.097
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	9.003
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	8.094
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Both sexes	63.473
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Men	34.993
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Women	28.480
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.083
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	488
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	595
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	876
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	483
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	393
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Both sexes	1.296
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Men	791
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Women	505
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Both sexes	1.415
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Men	978
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Women	437
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.894
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	901
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	993
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Both sexes	5.624
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Men	3.131
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Women	2.493
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Both sexes	5.685
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Men	5.063
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Women	622
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Both sexes	5.087
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Men	2.336
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Women	2.751
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.439
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	722
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	717
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	3.802
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.784
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.018
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	2.795
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Men	1.432
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Women	1.363
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Both sexes	2.668
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Men	1.373
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Women	1.295
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	3.852
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	2.454
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.398
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.046
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	976
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.070
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.072
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Men	889
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Women	183
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.405
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Men	1.403
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Women	1.002
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Both sexes	10.244
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Men	4.197
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Women	6.047
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.297
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	1.813
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.484
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Both sexes	3.435
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Men	1.888
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Women	1.547
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.458
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.891
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.567
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	4.865
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	2.698
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	2.167
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.199
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.881
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.318
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	201
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	106
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	95
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	1.465
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	711
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	754
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	35.244
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	17.381
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	17.863
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Both sexes	5.325
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Men	3.756
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Women	1.569
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	12.229
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	5.218
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	7.011
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	682
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	232
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	450
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.020
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.049
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	971
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	3.051
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	1.621
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	1.430
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	898
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	428
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	470
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	5.438
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	2.933
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	2.505
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	5.601
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	2.144
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	3.457
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	36.050
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	16.272
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	19.778
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	3.735
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.374
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	2.361
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	3.232
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Men	1.887
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Women	1.345
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	4.746
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Men	2.920
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Women	1.826
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	10.223
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	5.037
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	5.186
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Both sexes	2.821
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Men	2.821
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Women	..
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.994
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Men	1.994
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Both sexes	2.794
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Men	185
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Women	2.609
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	995
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	995
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	398
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	398
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	5.112
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	54
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	5.058
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	50.289
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	50.289
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Both sexes	182
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Men	..
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Women	182
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.994
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.994
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	30.522
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	30.522
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	7.786
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	7.786
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Both sexes	3.343
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Men	..
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Women	3.343
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Both sexes	1.759
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Men	..
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Women	1.759
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Both sexes	384
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Men	..
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Women	384
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	3.319
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	3.319
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	7.103
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	3.919
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	3.184
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	1.923
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	999
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	924
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	5.180
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	2.920
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.260
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	3.773
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Men	2.099
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Women	1.674
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	24.265
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	13.401
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	10.864
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	3.316
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Men	1.896
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Women	1.420
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Both sexes	2.429
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Men	908
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Women	1.521
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	560
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	308
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	252
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	17.960
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	10.289
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	7.671
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Both sexes	45.036
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Men	22.807
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Women	22.229
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.492
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.438
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.054
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.060
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	733
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	327
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Both sexes	3.306
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Men	1.529
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Women	1.777
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Both sexes	7.237
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Men	2.157
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Women	5.080
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	3.527
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Men	1.779
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Women	1.748
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	13.723
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	8.163
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	5.560
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Both sexes	289
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Men	204
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Women	85
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.317
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	524
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	793
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	10.105
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	5.244
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	4.861
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	211
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	129
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	82
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.769
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	907
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	862
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	9.683
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	4.719
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	4.964
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	592
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	330
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	262
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Both sexes	126
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Men	5
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Women	121
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	3.060
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.841
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.219
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	5.905
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	2.543
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	3.362
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	198.794
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	95.121
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	103.673
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.715
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.615
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.100
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	705
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	347
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	358
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Both sexes	551
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Men	267
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Women	284
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Both sexes	130
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Men	89
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Women	41
Alicante/Alacant	Group 0104 Septicaemia  038	Both sexes	2.028
Alicante/Alacant	Group 0104 Septicaemia  038	Men	1.123
Alicante/Alacant	Group 0104 Septicaemia  038	Women	905
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	124
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	97
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	27
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.177
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	692
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	485
Alicante/Alacant	Group 0200 Neoplasms  140-239	Both sexes	17.529
Alicante/Alacant	Group 0200 Neoplasms  140-239	Men	9.167
Alicante/Alacant	Group 0200 Neoplasms  140-239	Women	8.362
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.955
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.176
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	779
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.602
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.227
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	375
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	211
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	135
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	76
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.326
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Men	11
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Women	1.315
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	298
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	298
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	188
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Women	188
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Both sexes	421
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Men	421
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Women	..
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.708
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Men	1.426
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Women	282
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.737
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.400
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.337
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Both sexes	203
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Men	49
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Women	154
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	334
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	200
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	134
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.082
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Men	..
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Women	1.082
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.464
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.122
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.342
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.876
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	906
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	970
Alicante/Alacant	Group 0301 Anaemias 280-285	Both sexes	1.129
Alicante/Alacant	Group 0301 Anaemias 280-285	Men	555
Alicante/Alacant	Group 0301 Anaemias 280-285	Women	574
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	747
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	351
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	396
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.713
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.651
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.062
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Both sexes	1.310
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Men	814
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Women	496
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.403
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	837
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.566
Alicante/Alacant	Group 0500 Mental disorders  290-319	Both sexes	4.106
Alicante/Alacant	Group 0500 Mental disorders  290-319	Men	2.137
Alicante/Alacant	Group 0500 Mental disorders  290-319	Women	1.969
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	165
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	86
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	79
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	300
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	209
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	91
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	216
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	143
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	72
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.174
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	709
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	465
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	839
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	348
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	490
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.412
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	642
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	770
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.299
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.618
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.681
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Both sexes	115
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Men	36
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Women	79
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Both sexes	108
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Men	24
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Women	84
Alicante/Alacant	Group 0603 Epilepsy  345	Both sexes	1.171
Alicante/Alacant	Group 0603 Epilepsy  345	Men	626
Alicante/Alacant	Group 0603 Epilepsy  345	Women	545
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Both sexes	889
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Men	452
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Women	437
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.016
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.480
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.536
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	929
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	497
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	432
Alicante/Alacant	Grupo 0701 Cataract  366	Both sexes	134
Alicante/Alacant	Grupo 0701 Cataract  366	Men	72
Alicante/Alacant	Grupo 0701 Cataract  366	Women	62
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	795
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	425
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	370
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	791
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Men	371
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Women	420
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	28.335
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	16.357
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	11.978
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Both sexes	1.178
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Men	626
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Women	552
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Both sexes	1.510
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Men	937
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Women	573
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Both sexes	2.592
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Men	1.877
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Women	715
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.856
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.422
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	434
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	839
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Men	378
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Women	461
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.552
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.510
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.042
Alicante/Alacant	Grupo 0907 Heart failure  428	Both sexes	5.556
Alicante/Alacant	Grupo 0907 Heart failure  428	Men	2.691
Alicante/Alacant	Grupo 0907 Heart failure  428	Women	2.865
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	4.945
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.766
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.179
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Both sexes	676
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Men	501
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Women	175
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Both sexes	446
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Men	174
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Women	272
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	4.185
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	2.475
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.710
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	22.769
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	12.847
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	9.922
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.335
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	664
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	671
Alicante/Alacant	Group 1002 Pneumonia 480-486	Both sexes	5.268
Alicante/Alacant	Group 1002 Pneumonia 480-486	Men	3.058
Alicante/Alacant	Group 1002 Pneumonia 480-486	Women	2.210
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.543
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.187
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.356
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.089
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	588
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	501
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.197
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	741
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	456
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.888
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.876
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.012
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	710
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Men	189
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Women	521
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	6.739
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.544
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.195
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Both sexes	25.802
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Men	14.260
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Women	11.542
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	339
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	138
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	201
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	283
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	151
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	132
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Both sexes	551
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Men	338
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Women	213
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Both sexes	682
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Men	454
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Women	228
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	926
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	415
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	511
Alicante/Alacant	Group 1106 Appendicitis  540-543	Both sexes	2.168
Alicante/Alacant	Group 1106 Appendicitis  540-543	Men	1.171
Alicante/Alacant	Group 1106 Appendicitis  540-543	Women	997
Alicante/Alacant	Group 1107 Inguinal hernia  550	Both sexes	2.355
Alicante/Alacant	Group 1107 Inguinal hernia  550	Men	2.109
Alicante/Alacant	Group 1107 Inguinal hernia  550	Women	246
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Both sexes	1.987
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Men	974
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Women	1.013
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	634
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	313
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	321
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.852
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	876
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	976
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.044
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Men	518
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Women	526
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Both sexes	1.329
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Men	662
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Women	667
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.374
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	873
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	501
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	927
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	466
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	461
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	533
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Men	433
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Women	100
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	895
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Men	529
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Women	366
Alicante/Alacant	Group 1117 Cholelithiasis  574	Both sexes	3.981
Alicante/Alacant	Group 1117 Cholelithiasis  574	Men	1.645
Alicante/Alacant	Group 1117 Cholelithiasis  574	Women	2.336
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.252
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	715
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	537
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Both sexes	1.470
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Men	807
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Women	663
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.220
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	673
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	547
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.086
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.175
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	911
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.397
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	823
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	574
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	100
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	53
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	47
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	589
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	299
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	290
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	12.549
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.968
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.581
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Both sexes	1.618
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Men	1.105
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Women	513
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.454
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.858
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.596
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	261
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	98
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	163
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	937
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	489
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	448
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.018
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	520
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	498
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	347
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	148
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	199
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.917
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.026
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	891
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.997
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	724
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.273
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	13.898
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	6.039
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	7.859
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.568
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	537
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	1.031
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.257
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Men	725
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Women	532
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.883
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Men	1.159
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Women	724
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.653
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.774
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.879
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Both sexes	1.005
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Men	1.005
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Women	..
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	744
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Men	744
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Both sexes	1.498
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Men	75
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Women	1.423
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	397
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	397
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	130
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	130
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.763
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	20
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.743
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.073
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.073
Alicante/Alacant	Group 1501 Legally induced abortion  635	Both sexes	39
Alicante/Alacant	Group 1501 Legally induced abortion  635	Men	..
Alicante/Alacant	Group 1501 Legally induced abortion  635	Women	39
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.867
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.867
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.180
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.180
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.835
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.835
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Both sexes	1.124
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Men	..
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Women	1.124
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Both sexes	792
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Men	..
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Women	792
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Both sexes	171
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Men	..
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Women	171
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.065
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.065
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.553
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.433
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.120
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	669
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	353
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	316
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.884
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.080
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	804
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Both sexes	963
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Men	584
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Women	379
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	11.295
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.216
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.079
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.709
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Men	981
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Women	728
Alicante/Alacant	Group 1802 Abdominal pain   7890	Both sexes	1.242
Alicante/Alacant	Group 1802 Abdominal pain   7890	Men	470
Alicante/Alacant	Group 1802 Abdominal pain   7890	Women	772
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	379
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	196
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	183
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	7.965
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.569
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.396
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Both sexes	17.213
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Men	8.623
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Women	8.590
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.025
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	624
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	401
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	429
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	292
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	137
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Both sexes	1.263
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Men	528
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Women	735
Alicante/Alacant	Group 1904 Femur fracture  820-821	Both sexes	2.668
Alicante/Alacant	Group 1904 Femur fracture  820-821	Men	809
Alicante/Alacant	Group 1904 Femur fracture  820-821	Women	1.859
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.388
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Men	644
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Women	744
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	5.197
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.062
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.135
Alicante/Alacant	Group 1907 Burns  940-949	Both sexes	122
Alicante/Alacant	Group 1907 Burns  940-949	Men	71
Alicante/Alacant	Group 1907 Burns  940-949	Women	51
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	563
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	230
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	333
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.819
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.994
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.825
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	79
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	43
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	36
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	660
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	326
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	334
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.300
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.657
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.643
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	315
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	167
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	148
Alicante/Alacant	Group 2102 Contraceptive management  V25	Both sexes	29
Alicante/Alacant	Group 2102 Contraceptive management  V25	Men	..
Alicante/Alacant	Group 2102 Contraceptive management  V25	Women	29
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	986
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	610
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	376
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.970
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	880
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.090
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	49.557
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	24.124
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	25.433
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.204
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	661
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	543
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	171
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	93
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	78
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Both sexes	162
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Men	85
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Women	77
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Both sexes	51
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Men	34
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Women	17
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Both sexes	404
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Men	224
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Women	180
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	9
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	5
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	407
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	220
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	187
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Both sexes	5.031
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Men	2.701
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Women	2.330
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	614
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	383
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	231
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	426
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	342
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	84
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	58
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	32
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	26
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	457
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Women	456
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	128
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	128
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	77
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Women	77
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Both sexes	204
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Men	204
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Women	..
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Both sexes	538
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Men	453
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Women	85
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.598
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	995
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	603
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Both sexes	69
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Men	28
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Women	41
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	89
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	60
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	29
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Both sexes	204
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Men	..
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Women	204
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	569
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	203
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	366
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	327
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	172
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	155
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Both sexes	201
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Men	104
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Women	97
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	126
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	68
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	58
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.000
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	443
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	557
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Both sexes	401
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Men	236
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Women	165
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	599
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	207
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	392
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Both sexes	781
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Men	441
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Women	340
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	25
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	12
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	13
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	72
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	52
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	20
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	80
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	57
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	23
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	224
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	140
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	84
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	190
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	90
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	100
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	190
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	90
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	100
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	879
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	492
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	387
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Both sexes	11
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Men	4
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Women	7
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Both sexes	29
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Men	6
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Women	23
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Both sexes	220
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Men	128
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Women	92
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Both sexes	159
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Men	97
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Women	62
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	460
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	257
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	203
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	219
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	106
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	113
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Both sexes	46
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Men	23
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Women	23
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	173
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	83
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	90
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	180
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Men	94
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Women	86
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.567
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.780
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.787
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Both sexes	229
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Men	122
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Women	107
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Both sexes	409
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Men	269
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Women	140
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Both sexes	562
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Men	405
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Women	157
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	295
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	216
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	79
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	146
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Men	77
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Women	69
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	862
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	472
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	390
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Both sexes	1.539
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Men	736
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Women	803
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.270
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	706
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	564
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Both sexes	128
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Men	103
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Women	25
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Both sexes	148
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Men	52
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Women	96
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	979
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	622
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	357
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.191
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.658
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.533
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	314
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	173
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	141
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Both sexes	1.571
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Men	945
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Women	626
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	841
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Men	415
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Women	426
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	468
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	249
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	219
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	196
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	122
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	74
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.243
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	984
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	259
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	201
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Men	56
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Women	145
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.357
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	714
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	643
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.383
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Men	3.575
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Women	2.808
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	38
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	19
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	19
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	63
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	40
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	23
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Both sexes	119
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Men	72
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Women	47
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Both sexes	149
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Men	104
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Women	45
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	166
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	99
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	67
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Both sexes	571
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Men	327
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Women	244
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Both sexes	602
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Men	539
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Women	63
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Both sexes	613
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Men	296
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Women	317
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	113
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	58
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	55
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	334
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	159
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	175
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Both sexes	283
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Men	166
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Women	117
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Both sexes	223
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Men	127
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Women	96
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	407
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	256
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	151
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	178
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	95
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	83
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	111
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Men	88
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Women	23
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	212
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Men	115
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Women	97
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Both sexes	1.260
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Men	524
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Women	736
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	314
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	151
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	163
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Both sexes	323
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Men	177
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Women	146
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	304
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	163
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	141
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	391
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	209
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	182
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	261
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	146
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	115
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	24
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	15
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	106
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	54
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	52
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.869
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.481
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.388
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Both sexes	464
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Men	352
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Women	112
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.014
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	450
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	564
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	52
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	19
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	33
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	135
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	72
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	63
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	225
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	115
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	110
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	84
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	66
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	18
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	381
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	205
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	176
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	514
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	202
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	312
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.496
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.642
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.854
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	413
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	153
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	260
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	237
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Men	146
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Women	91
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	485
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Men	307
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Women	178
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	915
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	451
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	464
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Both sexes	297
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Men	297
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Women	..
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	263
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Men	263
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Both sexes	171
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Men	16
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Women	155
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	107
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	107
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	44
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	44
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	564
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	9
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	555
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.471
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.471
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Both sexes	41
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Men	..
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Women	41
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	212
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	212
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.660
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.660
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	794
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	794
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Both sexes	175
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Men	..
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Women	175
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Both sexes	36
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Men	..
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Women	36
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Both sexes	33
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Men	..
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Women	33
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	520
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	520
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	953
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Men	519
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Women	434
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	228
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	107
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	121
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	725
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	412
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	313
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Both sexes	310
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Men	184
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Women	126
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.821
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.068
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	753
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	290
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Men	165
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Women	125
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Both sexes	189
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Men	81
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Women	108
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	45
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	28
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	17
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.297
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	794
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	503
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Both sexes	4.436
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Men	2.303
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Women	2.133
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	333
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	193
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	140
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	120
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	61
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	59
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Both sexes	329
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Men	164
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Women	165
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Both sexes	786
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Men	230
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Women	556
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	348
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Men	176
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Women	172
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.200
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	771
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	429
Castell¾n/Castell¾	Group 1907 Burns  940-949	Both sexes	3
Castell¾n/Castell¾	Group 1907 Burns  940-949	Men	2
Castell¾n/Castell¾	Group 1907 Burns  940-949	Women	1
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	107
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	44
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	63
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.004
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	542
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	462
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	5
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	197
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	115
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	82
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.048
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	595
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	453
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	61
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	32
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	29
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Both sexes	38
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Men	..
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Women	38
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	425
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	293
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	132
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	524
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	270
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	254
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	261.723
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	124.749
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	136.974
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	5.473
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	3.065
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.408
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	907
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	473
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	434
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Both sexes	334
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Men	164
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Women	170
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Both sexes	219
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Men	150
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Women	69
Valencia/ValÞncia	Group 0104 Septicaemia  038	Both sexes	1.645
Valencia/ValÞncia	Group 0104 Septicaemia  038	Men	922
Valencia/ValÞncia	Group 0104 Septicaemia  038	Women	723
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	355
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	241
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	114
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	2.013
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	1.115
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	898
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Both sexes	30.369
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Men	16.052
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Women	14.317
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	2.997
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.754
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.243
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	2.592
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	2.054
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	538
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	497
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	312
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	185
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	2.839
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Men	12
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Women	2.827
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	647
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	647
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	355
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Women	355
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.348
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Men	1.348
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	3.496
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Men	2.946
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Women	550
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	9.761
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	5.651
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	4.110
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Both sexes	408
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Men	138
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Women	270
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	218
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	136
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	82
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.384
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Women	1.384
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.827
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.701
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.126
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.102
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.049
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.053
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Both sexes	1.164
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Men	563
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Women	601
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	938
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	486
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	452
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	5.318
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	2.098
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	3.220
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Both sexes	1.621
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Men	933
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Women	688
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.697
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.165
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.532
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Both sexes	5.256
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Men	2.782
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Women	2.474
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	149
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	69
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	80
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	347
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	259
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	88
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	295
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	207
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	88
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.623
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	997
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	626
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.183
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	508
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	675
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.659
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	742
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	917
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.567
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.767
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.800
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Both sexes	86
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Men	31
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Women	55
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Both sexes	127
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Men	39
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Women	88
Valencia/ValÞncia	Group 0603 Epilepsy  345	Both sexes	1.155
Valencia/ValÞncia	Group 0603 Epilepsy  345	Men	623
Valencia/ValÞncia	Group 0603 Epilepsy  345	Women	532
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Both sexes	817
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Men	434
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Women	383
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.382
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.640
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.742
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.158
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	629
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	529
Valencia/ValÞncia	Grupo 0701 Cataract  366	Both sexes	118
Valencia/ValÞncia	Grupo 0701 Cataract  366	Men	63
Valencia/ValÞncia	Grupo 0701 Cataract  366	Women	55
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.040
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	566
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	474
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.436
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	712
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	724
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	31.395
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	17.900
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	13.495
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Both sexes	631
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Men	305
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Women	326
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Both sexes	1.759
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Men	1.135
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Women	624
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Both sexes	2.835
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Men	1.991
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Women	844
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.065
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.610
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	455
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.035
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Men	446
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Women	589
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	3.753
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.964
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.789
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Both sexes	6.296
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Men	2.920
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Women	3.376
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	5.936
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.264
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.672
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Both sexes	1.002
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Men	756
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Women	246
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Both sexes	537
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Men	175
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Women	362
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	5.546
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.334
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.212
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	29.778
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	16.937
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	12.841
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.654
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	865
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	789
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Both sexes	7.679
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Men	4.476
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Women	3.203
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.460
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.221
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.239
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.932
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.050
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	882
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.134
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.266
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	868
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	4.062
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	3.069
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	993
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	856
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Men	245
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Women	611
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	9.001
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	4.745
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	4.256
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Both sexes	31.288
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Men	17.158
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Women	14.130
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	706
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	331
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	375
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	530
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	292
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	238
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Both sexes	626
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Men	381
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Women	245
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Both sexes	584
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Men	420
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Women	164
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	802
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	387
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	415
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Both sexes	2.885
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Men	1.633
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Women	1.252
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Both sexes	2.728
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Men	2.415
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Women	313
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Both sexes	2.487
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Men	1.066
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Women	1.421
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	692
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	351
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	341
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.616
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	749
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	867
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.468
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Men	748
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Women	720
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Both sexes	1.116
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Men	584
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Women	532
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	2.071
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.325
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	746
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	941
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	415
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	526
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	428
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Men	368
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Women	60
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.298
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Men	759
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Women	539
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Both sexes	5.003
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Men	2.028
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Women	2.975
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.731
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	947
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	784
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Both sexes	1.642
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Men	904
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Women	738
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.934
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.055
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	879
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.388
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.314
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.074
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.541
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	912
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	629
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	77
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	44
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	33
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	770
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	358
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	412
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	19.826
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	9.932
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	9.894
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Both sexes	3.243
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Men	2.299
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Women	944
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	6.761
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	2.910
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.851
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	369
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	115
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	254
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	948
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	488
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	460
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.808
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	986
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	822
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	467
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	214
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	253
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	3.140
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.702
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.438
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	3.090
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.218
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.872
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	18.656
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.591
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	10.065
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.754
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	684
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	1.070
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.738
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Men	1.016
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Women	722
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.378
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Men	1.454
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Women	924
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.655
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.812
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.843
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Both sexes	1.519
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Men	1.519
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Women	..
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	987
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Men	987
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Both sexes	1.125
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Men	94
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Women	1.031
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	491
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	491
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	224
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	224
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.785
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	25
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.760
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	25.745
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	25.745
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Both sexes	102
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Men	..
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Women	102
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	915
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	915
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	15.682
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	15.682
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	4.157
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	4.157
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Both sexes	2.044
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Men	..
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Women	2.044
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Both sexes	931
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Men	..
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Women	931
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Both sexes	180
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Men	..
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Women	180
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.734
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.734
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	3.597
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.967
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.630
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	1.026
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	539
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	487
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.571
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.428
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	1.143
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	2.500
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Men	1.331
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Women	1.169
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	11.149
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.117
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.032
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.317
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Men	750
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Women	567
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Both sexes	998
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Men	357
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Women	641
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	136
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	84
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	52
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.698
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.926
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.772
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Both sexes	23.387
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Men	11.881
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Women	11.506
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.134
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	621
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	513
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	511
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	380
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	131
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Both sexes	1.714
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Men	837
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Women	877
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Both sexes	3.783
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Men	1.118
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Women	2.665
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.791
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Men	959
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Women	832
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	7.326
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	4.330
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.996
Valencia/ValÞncia	Group 1907 Burns  940-949	Both sexes	164
Valencia/ValÞncia	Group 1907 Burns  940-949	Men	131
Valencia/ValÞncia	Group 1907 Burns  940-949	Women	33
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	647
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	250
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	397
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	5.282
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.708
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.574
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	123
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	81
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	42
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	912
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	466
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	446
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	5.335
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	2.467
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.868
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	216
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	131
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	85
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Both sexes	59
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Men	5
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Women	54
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.649
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	938
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	711
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	3.411
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.393
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	2.018
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	113.053
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	54.226
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	58.827
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.000
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.098
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	902
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	398
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	204
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	194
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Both sexes	213
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Men	122
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Women	91
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Both sexes	72
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Men	48
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Women	24
EXTREMADURA	Group 0104 Septicaemia  038	Both sexes	446
EXTREMADURA	Group 0104 Septicaemia  038	Men	211
EXTREMADURA	Group 0104 Septicaemia  038	Women	235
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	53
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	46
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	818
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	467
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	351
EXTREMADURA	Group 0200 Neoplasms  140-239	Both sexes	10.240
EXTREMADURA	Group 0200 Neoplasms  140-239	Men	5.467
EXTREMADURA	Group 0200 Neoplasms  140-239	Women	4.773
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	961
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	561
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	400
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	829
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	715
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	114
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	528
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	307
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	221
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	800
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Men	7
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Women	793
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	214
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	214
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	107
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Women	107
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	273
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Men	273
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Women	..
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	749
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Men	651
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Women	98
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.832
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.771
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.061
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Both sexes	221
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Men	71
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Women	150
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	154
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	93
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	61
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	561
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Men	..
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Women	561
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.011
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.018
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	993
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.045
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	535
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	510
EXTREMADURA	Group 0301 Anaemias 280-285	Both sexes	676
EXTREMADURA	Group 0301 Anaemias 280-285	Men	328
EXTREMADURA	Group 0301 Anaemias 280-285	Women	348
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	369
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	207
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	162
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.653
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	720
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	933
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Both sexes	572
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Men	315
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Women	257
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.081
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	405
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	676
EXTREMADURA	Group 0500 Mental disorders  290-319	Both sexes	3.180
EXTREMADURA	Group 0500 Mental disorders  290-319	Men	1.783
EXTREMADURA	Group 0500 Mental disorders  290-319	Women	1.397
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	60
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	26
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	34
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	274
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	226
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	48
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	106
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	77
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	29
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	745
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	472
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	273
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	670
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	290
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	380
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.325
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	692
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	633
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.509
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.263
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.246
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Both sexes	49
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Men	25
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Women	24
EXTREMADURA	Group 0602 Multiple sclerosis 340	Both sexes	95
EXTREMADURA	Group 0602 Multiple sclerosis 340	Men	38
EXTREMADURA	Group 0602 Multiple sclerosis 340	Women	57
EXTREMADURA	Group 0603 Epilepsy  345	Both sexes	530
EXTREMADURA	Group 0603 Epilepsy  345	Men	284
EXTREMADURA	Group 0603 Epilepsy  345	Women	246
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Both sexes	550
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Men	282
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Women	268
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.285
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	634
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	651
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.646
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	868
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	778
EXTREMADURA	Grupo 0701 Cataract  366	Both sexes	500
EXTREMADURA	Grupo 0701 Cataract  366	Men	244
EXTREMADURA	Grupo 0701 Cataract  366	Women	256
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.146
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	624
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	522
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	542
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	252
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	290
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	15.605
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.532
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.073
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Both sexes	629
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Men	242
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Women	387
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Both sexes	892
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Men	524
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Women	368
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Both sexes	1.225
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Men	854
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Women	371
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	969
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	728
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	241
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	632
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Men	308
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Women	324
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.167
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.106
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.061
EXTREMADURA	Grupo 0907 Heart failure  428	Both sexes	3.374
EXTREMADURA	Grupo 0907 Heart failure  428	Men	1.488
EXTREMADURA	Grupo 0907 Heart failure  428	Women	1.886
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.837
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.598
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.239
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Both sexes	305
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Men	241
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Women	64
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Both sexes	302
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Men	113
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Women	189
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.273
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.330
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	943
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.003
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.844
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.159
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	655
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	361
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	294
EXTREMADURA	Group 1002 Pneumonia 480-486	Both sexes	3.162
EXTREMADURA	Group 1002 Pneumonia 480-486	Men	1.901
EXTREMADURA	Group 1002 Pneumonia 480-486	Women	1.261
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	973
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	496
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	477
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	945
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	506
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	439
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.026
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	662
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	364
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.632
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.419
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	213
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	278
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Men	92
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Women	186
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	6.332
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.407
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.925
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.733
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Men	7.828
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Women	5.905
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	208
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	75
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	133
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	189
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	106
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	83
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Both sexes	296
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Men	179
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Women	117
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Both sexes	209
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Men	138
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Women	71
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	314
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	165
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	149
EXTREMADURA	Group 1106 Appendicitis  540-543	Both sexes	1.026
EXTREMADURA	Group 1106 Appendicitis  540-543	Men	570
EXTREMADURA	Group 1106 Appendicitis  540-543	Women	456
EXTREMADURA	Group 1107 Inguinal hernia  550	Both sexes	1.321
EXTREMADURA	Group 1107 Inguinal hernia  550	Men	1.188
EXTREMADURA	Group 1107 Inguinal hernia  550	Women	133
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Both sexes	1.017
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Men	474
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Women	543
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	243
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	125
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	118
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.055
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	542
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	513
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	792
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Men	409
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Women	383
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Both sexes	433
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Men	210
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Women	223
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	978
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	650
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	328
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	445
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	219
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	226
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	236
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Men	206
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Women	30
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	445
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Men	286
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Women	159
EXTREMADURA	Group 1117 Cholelithiasis  574	Both sexes	2.072
EXTREMADURA	Group 1117 Cholelithiasis  574	Men	904
EXTREMADURA	Group 1117 Cholelithiasis  574	Women	1.168
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	920
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	507
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	413
EXTREMADURA	Group 1119 Pancreatic diseases 577	Both sexes	763
EXTREMADURA	Group 1119 Pancreatic diseases 577	Men	440
EXTREMADURA	Group 1119 Pancreatic diseases 577	Women	323
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	771
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	435
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	336
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.050
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	524
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	526
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	635
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	340
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	295
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	43
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	18
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	25
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	372
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	166
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	206
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.419
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.038
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.381
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
EXTREMADURA	Group 1303 Internal derangement of knee 717	Both sexes	956
EXTREMADURA	Group 1303 Internal derangement of knee 717	Men	678
EXTREMADURA	Group 1303 Internal derangement of knee 717	Women	278
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.179
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	880
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.299
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	115
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	53
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	62
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	374
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	178
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	196
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	637
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	331
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	306
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	144
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	67
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	77
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	773
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	446
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	327
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.241
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	405
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	836
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.926
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.357
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.569
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	649
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	285
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	364
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	875
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Men	453
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Women	422
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	791
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Men	450
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Women	341
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.694
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	783
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	911
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Both sexes	537
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Men	537
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Women	..
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	800
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Men	800
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
EXTREMADURA	Group 1407 Disorders of breast  610-612	Both sexes	344
EXTREMADURA	Group 1407 Disorders of breast  610-612	Men	31
EXTREMADURA	Group 1407 Disorders of breast  610-612	Women	313
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	298
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	298
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	291
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	291
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.647
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	18
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.629
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.338
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.338
EXTREMADURA	Group 1501 Legally induced abortion  635	Both sexes	3
EXTREMADURA	Group 1501 Legally induced abortion  635	Men	..
EXTREMADURA	Group 1501 Legally induced abortion  635	Women	3
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.155
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.155
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.939
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.939
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.549
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.549
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Both sexes	610
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Men	..
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Women	610
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Both sexes	501
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Men	..
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Women	501
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Both sexes	66
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Men	..
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Women	66
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	515
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	515
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.546
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	855
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	691
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	373
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	207
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	166
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.173
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	648
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	525
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	743
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Men	480
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Women	263
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.784
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.711
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.073
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	717
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Men	404
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Women	313
EXTREMADURA	Group 1802 Abdominal pain   7890	Both sexes	734
EXTREMADURA	Group 1802 Abdominal pain   7890	Men	297
EXTREMADURA	Group 1802 Abdominal pain   7890	Women	437
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	101
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	43
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	58
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.232
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.967
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.265
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Both sexes	8.234
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Men	4.082
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Women	4.152
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	365
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	195
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	170
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	235
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	167
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	68
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Both sexes	462
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Men	242
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Women	220
EXTREMADURA	Group 1904 Femur fracture  820-821	Both sexes	1.645
EXTREMADURA	Group 1904 Femur fracture  820-821	Men	458
EXTREMADURA	Group 1904 Femur fracture  820-821	Women	1.187
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	602
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Men	291
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Women	311
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.206
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.321
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	885
EXTREMADURA	Group 1907 Burns  940-949	Both sexes	83
EXTREMADURA	Group 1907 Burns  940-949	Men	45
EXTREMADURA	Group 1907 Burns  940-949	Women	38
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	260
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	128
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	132
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.059
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.068
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	991
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	25
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	14
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	11
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	292
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	153
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	139
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.857
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	989
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	868
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	268
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	172
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	96
EXTREMADURA	Group 2102 Contraceptive management  V25	Both sexes	53
EXTREMADURA	Group 2102 Contraceptive management  V25	Men	2
EXTREMADURA	Group 2102 Contraceptive management  V25	Women	51
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	676
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	396
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	280
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	860
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	419
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	441
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	73.113
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	34.934
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	38.179
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.461
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	793
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	668
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	231
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	108
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	123
Badajoz	Group 0102 Imprecise intestinal infections 009	Both sexes	177
Badajoz	Group 0102 Imprecise intestinal infections 009	Men	99
Badajoz	Group 0102 Imprecise intestinal infections 009	Women	78
Badajoz	Group 0103 Tuberculosis 010-018, 137	Both sexes	49
Badajoz	Group 0103 Tuberculosis 010-018, 137	Men	34
Badajoz	Group 0103 Tuberculosis 010-018, 137	Women	15
Badajoz	Group 0104 Septicaemia  038	Both sexes	365
Badajoz	Group 0104 Septicaemia  038	Men	168
Badajoz	Group 0104 Septicaemia  038	Women	197
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	44
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	37
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	595
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	347
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	248
Badajoz	Group 0200 Neoplasms  140-239	Both sexes	6.373
Badajoz	Group 0200 Neoplasms  140-239	Men	3.487
Badajoz	Group 0200 Neoplasms  140-239	Women	2.886
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	632
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	389
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	243
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	560
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	478
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	82
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	60
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	36
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	24
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	477
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Men	6
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Women	471
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	130
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	130
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	66
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Women	66
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Both sexes	178
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Men	178
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Women	..
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Both sexes	493
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Men	431
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Women	62
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.927
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.213
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	714
Badajoz	Group 0210 Carcinoma in situ  230-234	Both sexes	151
Badajoz	Group 0210 Carcinoma in situ  230-234	Men	52
Badajoz	Group 0210 Carcinoma in situ  230-234	Women	99
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	104
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	60
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	44
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Both sexes	328
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Men	..
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Women	328
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.267
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	644
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	623
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	717
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	361
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	356
Badajoz	Group 0301 Anaemias 280-285	Both sexes	489
Badajoz	Group 0301 Anaemias 280-285	Men	230
Badajoz	Group 0301 Anaemias 280-285	Women	259
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	228
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	131
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	97
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.040
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	470
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	570
Badajoz	Group 0401 Diabetes mellitus  249-250	Both sexes	408
Badajoz	Group 0401 Diabetes mellitus  249-250	Men	229
Badajoz	Group 0401 Diabetes mellitus  249-250	Women	179
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	632
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	241
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	391
Badajoz	Group 0500 Mental disorders  290-319	Both sexes	1.507
Badajoz	Group 0500 Mental disorders  290-319	Men	786
Badajoz	Group 0500 Mental disorders  290-319	Women	721
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	47
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	23
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	24
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	85
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	70
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	15
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	62
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	44
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	18
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	272
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	171
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	101
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	325
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	125
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	200
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	716
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	353
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	363
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.882
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	937
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	945
Badajoz	Group 0601 Alzheimer's disease  3310	Both sexes	39
Badajoz	Group 0601 Alzheimer's disease  3310	Men	18
Badajoz	Group 0601 Alzheimer's disease  3310	Women	21
Badajoz	Group 0602 Multiple sclerosis 340	Both sexes	84
Badajoz	Group 0602 Multiple sclerosis 340	Men	35
Badajoz	Group 0602 Multiple sclerosis 340	Women	49
Badajoz	Group 0603 Epilepsy  345	Both sexes	382
Badajoz	Group 0603 Epilepsy  345	Men	211
Badajoz	Group 0603 Epilepsy  345	Women	171
Badajoz	Group 0604 Transient cerebral ischemia 435	Both sexes	435
Badajoz	Group 0604 Transient cerebral ischemia 435	Men	219
Badajoz	Group 0604 Transient cerebral ischemia 435	Women	216
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	942
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	454
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	488
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	825
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	470
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	355
Badajoz	Grupo 0701 Cataract  366	Both sexes	107
Badajoz	Grupo 0701 Cataract  366	Men	55
Badajoz	Grupo 0701 Cataract  366	Women	52
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	718
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	415
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	303
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	333
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Men	152
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Women	181
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.109
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.541
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.568
Badajoz	Group 0901 Hypertensive disease  401-405	Both sexes	468
Badajoz	Group 0901 Hypertensive disease  401-405	Men	196
Badajoz	Group 0901 Hypertensive disease  401-405	Women	272
Badajoz	Group 0902 Angina pectoris  4111, 413	Both sexes	618
Badajoz	Group 0902 Angina pectoris  4111, 413	Men	368
Badajoz	Group 0902 Angina pectoris  4111, 413	Women	250
Badajoz	Group 0903 Acute myocardial infarction  410	Both sexes	728
Badajoz	Group 0903 Acute myocardial infarction  410	Men	505
Badajoz	Group 0903 Acute myocardial infarction  410	Women	223
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	570
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	420
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	150
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	406
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Men	198
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Women	208
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.557
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	797
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	760
Badajoz	Grupo 0907 Heart failure  428	Both sexes	2.187
Badajoz	Grupo 0907 Heart failure  428	Men	987
Badajoz	Grupo 0907 Heart failure  428	Women	1.200
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.799
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.019
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	780
Badajoz	Grupo 0909 Atherosclerosis  440	Both sexes	126
Badajoz	Grupo 0909 Atherosclerosis  440	Men	103
Badajoz	Grupo 0909 Atherosclerosis  440	Women	23
Badajoz	Group 0910 Varicose veins of lower extremities 454	Both sexes	152
Badajoz	Group 0910 Varicose veins of lower extremities 454	Men	71
Badajoz	Group 0910 Varicose veins of lower extremities 454	Women	81
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.498
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	877
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	621
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.099
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.926
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.173
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	378
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	198
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	180
Badajoz	Group 1002 Pneumonia 480-486	Both sexes	1.980
Badajoz	Group 1002 Pneumonia 480-486	Men	1.187
Badajoz	Group 1002 Pneumonia 480-486	Women	793
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	562
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Men	290
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Women	272
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	624
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	353
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	271
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	560
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	363
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	197
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.035
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	875
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	160
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	180
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Men	61
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Women	119
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.780
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.599
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.181
Badajoz	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.681
Badajoz	Group 1100 Diseases of the digestive system  520-579	Men	4.823
Badajoz	Group 1100 Diseases of the digestive system  520-579	Women	3.858
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	196
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	69
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	127
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	139
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	84
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	55
Badajoz	Group 1103 Diseases of the esophagus 530	Both sexes	207
Badajoz	Group 1103 Diseases of the esophagus 530	Men	123
Badajoz	Group 1103 Diseases of the esophagus 530	Women	84
Badajoz	Group 1104 Peptic ulcer 531-534	Both sexes	128
Badajoz	Group 1104 Peptic ulcer 531-534	Men	87
Badajoz	Group 1104 Peptic ulcer 531-534	Women	41
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	230
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	115
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	115
Badajoz	Group 1106 Appendicitis  540-543	Both sexes	751
Badajoz	Group 1106 Appendicitis  540-543	Men	411
Badajoz	Group 1106 Appendicitis  540-543	Women	340
Badajoz	Group 1107 Inguinal hernia  550	Both sexes	672
Badajoz	Group 1107 Inguinal hernia  550	Men	592
Badajoz	Group 1107 Inguinal hernia  550	Women	80
Badajoz	Group 1108 Other abdominal hernia  551-553	Both sexes	630
Badajoz	Group 1108 Other abdominal hernia  551-553	Men	270
Badajoz	Group 1108 Other abdominal hernia  551-553	Women	360
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	176
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	96
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	80
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	651
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	322
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	329
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Both sexes	496
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Men	260
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Women	236
Badajoz	Group 1112 Intestinal diverticulosis 562	Both sexes	292
Badajoz	Group 1112 Intestinal diverticulosis 562	Men	140
Badajoz	Group 1112 Intestinal diverticulosis 562	Women	152
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	573
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	398
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	175
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	302
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	142
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	160
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	184
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Men	162
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Women	22
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	287
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Men	178
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Women	109
Badajoz	Group 1117 Cholelithiasis  574	Both sexes	1.256
Badajoz	Group 1117 Cholelithiasis  574	Men	547
Badajoz	Group 1117 Cholelithiasis  574	Women	709
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	531
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	286
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	245
Badajoz	Group 1119 Pancreatic diseases 577	Both sexes	506
Badajoz	Group 1119 Pancreatic diseases 577	Men	290
Badajoz	Group 1119 Pancreatic diseases 577	Women	216
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	474
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	251
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	223
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	626
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	314
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	312
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	381
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	205
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	176
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	27
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	11
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	16
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	218
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	98
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	120
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.345
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.089
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.256
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Badajoz	Group 1303 Internal derangement of knee 717	Both sexes	689
Badajoz	Group 1303 Internal derangement of knee 717	Men	489
Badajoz	Group 1303 Internal derangement of knee 717	Women	200
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.444
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	577
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	867
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	96
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	45
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	51
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	261
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	128
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	133
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	450
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	238
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	212
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	77
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	33
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	44
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	534
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	309
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	225
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	794
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	270
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	524
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.001
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.117
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.884
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	456
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	199
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	257
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	641
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Men	328
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Women	313
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	546
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Men	325
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Women	221
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.028
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	461
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	567
Badajoz	Group 1405 Prostatic hyperplasia  600	Both sexes	277
Badajoz	Group 1405 Prostatic hyperplasia  600	Men	277
Badajoz	Group 1405 Prostatic hyperplasia  600	Women	..
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	494
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Men	494
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Badajoz	Group 1407 Disorders of breast  610-612	Both sexes	234
Badajoz	Group 1407 Disorders of breast  610-612	Men	18
Badajoz	Group 1407 Disorders of breast  610-612	Women	216
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	191
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	191
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	147
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	147
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	987
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	15
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	972
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.760
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.760
Badajoz	Group 1501 Legally induced abortion  635	Both sexes	1
Badajoz	Group 1501 Legally induced abortion  635	Men	..
Badajoz	Group 1501 Legally induced abortion  635	Women	1
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	764
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	764
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.144
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.144
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.711
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.711
Badajoz	Group 1505 Single spontaneous delivery  650	Both sexes	314
Badajoz	Group 1505 Single spontaneous delivery  650	Men	..
Badajoz	Group 1505 Single spontaneous delivery  650	Women	314
Badajoz	Group 1506 Other deliveries  6695-6697	Both sexes	406
Badajoz	Group 1506 Other deliveries  6695-6697	Men	..
Badajoz	Group 1506 Other deliveries  6695-6697	Women	406
Badajoz	Group 1507 Complications related to the puerperium  670-676	Both sexes	57
Badajoz	Group 1507 Complications related to the puerperium  670-676	Men	..
Badajoz	Group 1507 Complications related to the puerperium  670-676	Women	57
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	363
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	363
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	857
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Men	495
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Women	362
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	205
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	119
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	86
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	652
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	376
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	276
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Both sexes	561
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Men	376
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Women	185
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	4.781
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.601
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.180
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	459
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Men	248
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Women	211
Badajoz	Group 1802 Abdominal pain   7890	Both sexes	473
Badajoz	Group 1802 Abdominal pain   7890	Men	190
Badajoz	Group 1802 Abdominal pain   7890	Women	283
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	97
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	41
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	56
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.752
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.122
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.630
Badajoz	Group 1900 Injuries and poisoning  800-999	Both sexes	5.083
Badajoz	Group 1900 Injuries and poisoning  800-999	Men	2.582
Badajoz	Group 1900 Injuries and poisoning  800-999	Women	2.501
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	250
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	134
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	116
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	147
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	109
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	38
Badajoz	Group 1903 Radius and ulna fracture 813	Both sexes	255
Badajoz	Group 1903 Radius and ulna fracture 813	Men	143
Badajoz	Group 1903 Radius and ulna fracture 813	Women	112
Badajoz	Group 1904 Femur fracture  820-821	Both sexes	965
Badajoz	Group 1904 Femur fracture  820-821	Men	275
Badajoz	Group 1904 Femur fracture  820-821	Women	690
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	344
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Men	167
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Women	177
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.298
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	792
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	506
Badajoz	Group 1907 Burns  940-949	Both sexes	13
Badajoz	Group 1907 Burns  940-949	Men	9
Badajoz	Group 1907 Burns  940-949	Women	4
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	171
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	86
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	85
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.442
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	757
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	685
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	20
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	12
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	8
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	178
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	98
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	80
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.072
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	614
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	458
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	263
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	169
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	94
Badajoz	Group 2102 Contraceptive management  V25	Both sexes	24
Badajoz	Group 2102 Contraceptive management  V25	Men	..
Badajoz	Group 2102 Contraceptive management  V25	Women	24
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	318
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	203
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	115
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	467
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	242
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	225
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	39.940
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	19.292
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	20.648
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	539
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	305
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	234
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	167
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	96
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	71
Cßceres	Group 0102 Imprecise intestinal infections 009	Both sexes	36
Cßceres	Group 0102 Imprecise intestinal infections 009	Men	23
Cßceres	Group 0102 Imprecise intestinal infections 009	Women	13
Cßceres	Group 0103 Tuberculosis 010-018, 137	Both sexes	23
Cßceres	Group 0103 Tuberculosis 010-018, 137	Men	14
Cßceres	Group 0103 Tuberculosis 010-018, 137	Women	9
Cßceres	Group 0104 Septicaemia  038	Both sexes	81
Cßceres	Group 0104 Septicaemia  038	Men	43
Cßceres	Group 0104 Septicaemia  038	Women	38
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	9
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	9
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	223
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	120
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	103
Cßceres	Group 0200 Neoplasms  140-239	Both sexes	3.867
Cßceres	Group 0200 Neoplasms  140-239	Men	1.980
Cßceres	Group 0200 Neoplasms  140-239	Women	1.887
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	329
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	172
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	157
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	269
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	237
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	32
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	468
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	271
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	197
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	323
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Women	322
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	84
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	84
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	41
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Women	41
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Both sexes	95
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Men	95
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Both sexes	256
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Men	220
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Women	36
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	905
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	558
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	347
Cßceres	Group 0210 Carcinoma in situ  230-234	Both sexes	70
Cßceres	Group 0210 Carcinoma in situ  230-234	Men	19
Cßceres	Group 0210 Carcinoma in situ  230-234	Women	51
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	50
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	33
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	17
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Both sexes	233
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Women	233
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	744
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	374
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	370
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	328
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	174
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	154
Cßceres	Group 0301 Anaemias 280-285	Both sexes	187
Cßceres	Group 0301 Anaemias 280-285	Men	98
Cßceres	Group 0301 Anaemias 280-285	Women	89
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	141
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	76
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	65
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	613
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	250
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	363
Cßceres	Group 0401 Diabetes mellitus  249-250	Both sexes	164
Cßceres	Group 0401 Diabetes mellitus  249-250	Men	86
Cßceres	Group 0401 Diabetes mellitus  249-250	Women	78
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	449
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	164
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	285
Cßceres	Group 0500 Mental disorders  290-319	Both sexes	1.673
Cßceres	Group 0500 Mental disorders  290-319	Men	997
Cßceres	Group 0500 Mental disorders  290-319	Women	676
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	13
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	3
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	10
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	189
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	156
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	33
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	44
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	33
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	11
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	473
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	301
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	172
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	345
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	165
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	180
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	609
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	339
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	270
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	627
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	326
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	301
Cßceres	Group 0601 Alzheimer's disease  3310	Both sexes	10
Cßceres	Group 0601 Alzheimer's disease  3310	Men	7
Cßceres	Group 0601 Alzheimer's disease  3310	Women	3
Cßceres	Group 0602 Multiple sclerosis 340	Both sexes	11
Cßceres	Group 0602 Multiple sclerosis 340	Men	3
Cßceres	Group 0602 Multiple sclerosis 340	Women	8
Cßceres	Group 0603 Epilepsy  345	Both sexes	148
Cßceres	Group 0603 Epilepsy  345	Men	73
Cßceres	Group 0603 Epilepsy  345	Women	75
Cßceres	Group 0604 Transient cerebral ischemia 435	Both sexes	115
Cßceres	Group 0604 Transient cerebral ischemia 435	Men	63
Cßceres	Group 0604 Transient cerebral ischemia 435	Women	52
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	343
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	180
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	163
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	821
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	398
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	423
Cßceres	Grupo 0701 Cataract  366	Both sexes	393
Cßceres	Grupo 0701 Cataract  366	Men	189
Cßceres	Grupo 0701 Cataract  366	Women	204
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	428
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	209
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	219
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	209
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Men	100
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Women	109
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.496
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.991
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.505
Cßceres	Group 0901 Hypertensive disease  401-405	Both sexes	161
Cßceres	Group 0901 Hypertensive disease  401-405	Men	46
Cßceres	Group 0901 Hypertensive disease  401-405	Women	115
Cßceres	Group 0902 Angina pectoris  4111, 413	Both sexes	274
Cßceres	Group 0902 Angina pectoris  4111, 413	Men	156
Cßceres	Group 0902 Angina pectoris  4111, 413	Women	118
Cßceres	Group 0903 Acute myocardial infarction  410	Both sexes	497
Cßceres	Group 0903 Acute myocardial infarction  410	Men	349
Cßceres	Group 0903 Acute myocardial infarction  410	Women	148
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	399
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	308
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	91
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	226
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Men	110
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Women	116
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	610
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	309
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	301
Cßceres	Grupo 0907 Heart failure  428	Both sexes	1.187
Cßceres	Grupo 0907 Heart failure  428	Men	501
Cßceres	Grupo 0907 Heart failure  428	Women	686
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.038
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	579
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	459
Cßceres	Grupo 0909 Atherosclerosis  440	Both sexes	179
Cßceres	Grupo 0909 Atherosclerosis  440	Men	138
Cßceres	Grupo 0909 Atherosclerosis  440	Women	41
Cßceres	Group 0910 Varicose veins of lower extremities 454	Both sexes	150
Cßceres	Group 0910 Varicose veins of lower extremities 454	Men	42
Cßceres	Group 0910 Varicose veins of lower extremities 454	Women	108
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	775
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	453
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	322
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.904
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.918
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.986
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	277
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	163
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	114
Cßceres	Group 1002 Pneumonia 480-486	Both sexes	1.182
Cßceres	Group 1002 Pneumonia 480-486	Men	714
Cßceres	Group 1002 Pneumonia 480-486	Women	468
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	411
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Men	206
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Women	205
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	321
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	153
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	168
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	466
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	299
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	167
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	597
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	544
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	53
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	98
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Men	31
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Women	67
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.552
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	808
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	744
Cßceres	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.052
Cßceres	Group 1100 Diseases of the digestive system  520-579	Men	3.005
Cßceres	Group 1100 Diseases of the digestive system  520-579	Women	2.047
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	12
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	6
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	6
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	50
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	22
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	28
Cßceres	Group 1103 Diseases of the esophagus 530	Both sexes	89
Cßceres	Group 1103 Diseases of the esophagus 530	Men	56
Cßceres	Group 1103 Diseases of the esophagus 530	Women	33
Cßceres	Group 1104 Peptic ulcer 531-534	Both sexes	81
Cßceres	Group 1104 Peptic ulcer 531-534	Men	51
Cßceres	Group 1104 Peptic ulcer 531-534	Women	30
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	84
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	50
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	34
Cßceres	Group 1106 Appendicitis  540-543	Both sexes	275
Cßceres	Group 1106 Appendicitis  540-543	Men	159
Cßceres	Group 1106 Appendicitis  540-543	Women	116
Cßceres	Group 1107 Inguinal hernia  550	Both sexes	649
Cßceres	Group 1107 Inguinal hernia  550	Men	596
Cßceres	Group 1107 Inguinal hernia  550	Women	53
Cßceres	Group 1108 Other abdominal hernia  551-553	Both sexes	387
Cßceres	Group 1108 Other abdominal hernia  551-553	Men	204
Cßceres	Group 1108 Other abdominal hernia  551-553	Women	183
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	67
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	29
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	38
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	404
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	220
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	184
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Both sexes	296
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Men	149
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Women	147
Cßceres	Group 1112 Intestinal diverticulosis 562	Both sexes	141
Cßceres	Group 1112 Intestinal diverticulosis 562	Men	70
Cßceres	Group 1112 Intestinal diverticulosis 562	Women	71
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	405
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	252
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	153
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	143
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	77
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	66
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	52
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Men	44
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	158
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Men	108
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Women	50
Cßceres	Group 1117 Cholelithiasis  574	Both sexes	816
Cßceres	Group 1117 Cholelithiasis  574	Men	357
Cßceres	Group 1117 Cholelithiasis  574	Women	459
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	389
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	221
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	168
Cßceres	Group 1119 Pancreatic diseases 577	Both sexes	257
Cßceres	Group 1119 Pancreatic diseases 577	Men	150
Cßceres	Group 1119 Pancreatic diseases 577	Women	107
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	297
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	184
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	113
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	424
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	210
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	214
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	254
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	135
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	119
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	16
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	9
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	154
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	68
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	86
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.074
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	949
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.125
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cßceres	Group 1303 Internal derangement of knee 717	Both sexes	267
Cßceres	Group 1303 Internal derangement of knee 717	Men	189
Cßceres	Group 1303 Internal derangement of knee 717	Women	78
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	735
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	303
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	432
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	19
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	8
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	11
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	113
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	50
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	63
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	187
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	93
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	94
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	67
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	34
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	33
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	239
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	137
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	102
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	447
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	135
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	312
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.925
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.240
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.685
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	193
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	86
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	107
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	234
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Men	125
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Women	109
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	245
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Men	125
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Women	120
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	666
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	322
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	344
Cßceres	Group 1405 Prostatic hyperplasia  600	Both sexes	260
Cßceres	Group 1405 Prostatic hyperplasia  600	Men	260
Cßceres	Group 1405 Prostatic hyperplasia  600	Women	..
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	306
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Men	306
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cßceres	Group 1407 Disorders of breast  610-612	Both sexes	110
Cßceres	Group 1407 Disorders of breast  610-612	Men	13
Cßceres	Group 1407 Disorders of breast  610-612	Women	97
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	107
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	107
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	144
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	144
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	660
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	657
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.578
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.578
Cßceres	Group 1501 Legally induced abortion  635	Both sexes	2
Cßceres	Group 1501 Legally induced abortion  635	Men	..
Cßceres	Group 1501 Legally induced abortion  635	Women	2
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	391
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	391
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.795
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.795
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	838
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	838
Cßceres	Group 1505 Single spontaneous delivery  650	Both sexes	296
Cßceres	Group 1505 Single spontaneous delivery  650	Men	..
Cßceres	Group 1505 Single spontaneous delivery  650	Women	296
Cßceres	Group 1506 Other deliveries  6695-6697	Both sexes	95
Cßceres	Group 1506 Other deliveries  6695-6697	Men	..
Cßceres	Group 1506 Other deliveries  6695-6697	Women	95
Cßceres	Group 1507 Complications related to the puerperium  670-676	Both sexes	9
Cßceres	Group 1507 Complications related to the puerperium  670-676	Men	..
Cßceres	Group 1507 Complications related to the puerperium  670-676	Women	9
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	152
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	152
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	689
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Men	360
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Women	329
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	168
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	88
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	80
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	521
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	272
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	249
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Both sexes	182
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Men	104
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Women	78
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.003
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.110
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	893
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	258
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Men	156
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Women	102
Cßceres	Group 1802 Abdominal pain   7890	Both sexes	261
Cßceres	Group 1802 Abdominal pain   7890	Men	107
Cßceres	Group 1802 Abdominal pain   7890	Women	154
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	4
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.480
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	845
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	635
Cßceres	Group 1900 Injuries and poisoning  800-999	Both sexes	3.151
Cßceres	Group 1900 Injuries and poisoning  800-999	Men	1.500
Cßceres	Group 1900 Injuries and poisoning  800-999	Women	1.651
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	115
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	61
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	54
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	88
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	58
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	30
Cßceres	Group 1903 Radius and ulna fracture 813	Both sexes	207
Cßceres	Group 1903 Radius and ulna fracture 813	Men	99
Cßceres	Group 1903 Radius and ulna fracture 813	Women	108
Cßceres	Group 1904 Femur fracture  820-821	Both sexes	680
Cßceres	Group 1904 Femur fracture  820-821	Men	183
Cßceres	Group 1904 Femur fracture  820-821	Women	497
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	258
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Men	124
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Women	134
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	908
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	529
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	379
Cßceres	Group 1907 Burns  940-949	Both sexes	70
Cßceres	Group 1907 Burns  940-949	Men	36
Cßceres	Group 1907 Burns  940-949	Women	34
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	89
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	42
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	47
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	617
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	311
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	306
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	5
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	114
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	55
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	59
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	785
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	375
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	410
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	5
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	3
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
Cßceres	Group 2102 Contraceptive management  V25	Both sexes	29
Cßceres	Group 2102 Contraceptive management  V25	Men	2
Cßceres	Group 2102 Contraceptive management  V25	Women	27
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	358
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	193
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	165
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	393
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	177
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	216
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	293.807
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	142.684
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	151.123
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	6.045
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	3.363
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.682
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.075
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	567
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	508
GALICIA	Group 0102 Imprecise intestinal infections 009	Both sexes	199
GALICIA	Group 0102 Imprecise intestinal infections 009	Men	106
GALICIA	Group 0102 Imprecise intestinal infections 009	Women	93
GALICIA	Group 0103 Tuberculosis 010-018, 137	Both sexes	303
GALICIA	Group 0103 Tuberculosis 010-018, 137	Men	200
GALICIA	Group 0103 Tuberculosis 010-018, 137	Women	103
GALICIA	Group 0104 Septicaemia  038	Both sexes	2.115
GALICIA	Group 0104 Septicaemia  038	Men	1.115
GALICIA	Group 0104 Septicaemia  038	Women	1.000
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	190
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	143
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	47
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	2.163
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	1.232
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	931
GALICIA	Group 0200 Neoplasms  140-239	Both sexes	30.261
GALICIA	Group 0200 Neoplasms  140-239	Men	16.191
GALICIA	Group 0200 Neoplasms  140-239	Women	14.070
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	3.299
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.944
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.355
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	2.060
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.586
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	474
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	477
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	269
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	208
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	2.116
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Men	16
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Women	2.100
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	659
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	659
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	254
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Women	254
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.640
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Men	1.640
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Women	..
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.390
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Men	1.998
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Women	392
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	11.543
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	6.806
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	4.737
GALICIA	Group 0210 Carcinoma in situ  230-234	Both sexes	726
GALICIA	Group 0210 Carcinoma in situ  230-234	Men	330
GALICIA	Group 0210 Carcinoma in situ  230-234	Women	396
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	381
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	247
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	134
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.205
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Men	..
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Women	1.205
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.511
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.355
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.156
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.805
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.401
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.404
GALICIA	Group 0301 Anaemias 280-285	Both sexes	1.808
GALICIA	Group 0301 Anaemias 280-285	Men	897
GALICIA	Group 0301 Anaemias 280-285	Women	911
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	997
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	504
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	493
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	4.567
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.757
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.810
GALICIA	Group 0401 Diabetes mellitus  249-250	Both sexes	1.563
GALICIA	Group 0401 Diabetes mellitus  249-250	Men	821
GALICIA	Group 0401 Diabetes mellitus  249-250	Women	742
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.004
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	936
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.068
GALICIA	Group 0500 Mental disorders  290-319	Both sexes	5.556
GALICIA	Group 0500 Mental disorders  290-319	Men	2.878
GALICIA	Group 0500 Mental disorders  290-319	Women	2.678
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	206
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	77
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	129
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	474
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	385
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	89
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	262
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	205
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	57
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.567
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	874
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	693
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.221
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	477
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	744
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.826
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	860
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	966
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.568
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.718
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.850
GALICIA	Group 0601 Alzheimer's disease  3310	Both sexes	112
GALICIA	Group 0601 Alzheimer's disease  3310	Men	46
GALICIA	Group 0601 Alzheimer's disease  3310	Women	66
GALICIA	Group 0602 Multiple sclerosis 340	Both sexes	284
GALICIA	Group 0602 Multiple sclerosis 340	Men	108
GALICIA	Group 0602 Multiple sclerosis 340	Women	176
GALICIA	Group 0603 Epilepsy  345	Both sexes	967
GALICIA	Group 0603 Epilepsy  345	Men	473
GALICIA	Group 0603 Epilepsy  345	Women	494
GALICIA	Group 0604 Transient cerebral ischemia 435	Both sexes	963
GALICIA	Group 0604 Transient cerebral ischemia 435	Men	485
GALICIA	Group 0604 Transient cerebral ischemia 435	Women	478
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.242
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.606
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.636
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.394
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	705
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	689
GALICIA	Grupo 0701 Cataract  366	Both sexes	88
GALICIA	Grupo 0701 Cataract  366	Men	46
GALICIA	Grupo 0701 Cataract  366	Women	42
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.306
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	659
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	647
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.187
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	616
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	571
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	39.501
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	22.116
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	17.385
GALICIA	Group 0901 Hypertensive disease  401-405	Both sexes	2.342
GALICIA	Group 0901 Hypertensive disease  401-405	Men	1.110
GALICIA	Group 0901 Hypertensive disease  401-405	Women	1.232
GALICIA	Group 0902 Angina pectoris  4111, 413	Both sexes	1.413
GALICIA	Group 0902 Angina pectoris  4111, 413	Men	880
GALICIA	Group 0902 Angina pectoris  4111, 413	Women	533
GALICIA	Group 0903 Acute myocardial infarction  410	Both sexes	3.251
GALICIA	Group 0903 Acute myocardial infarction  410	Men	2.334
GALICIA	Group 0903 Acute myocardial infarction  410	Women	917
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.696
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	2.103
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	593
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.522
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Men	615
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Women	907
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.548
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.560
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.988
GALICIA	Grupo 0907 Heart failure  428	Both sexes	8.201
GALICIA	Grupo 0907 Heart failure  428	Men	4.060
GALICIA	Grupo 0907 Heart failure  428	Women	4.141
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	6.657
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.298
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	3.359
GALICIA	Grupo 0909 Atherosclerosis  440	Both sexes	1.503
GALICIA	Grupo 0909 Atherosclerosis  440	Men	1.095
GALICIA	Grupo 0909 Atherosclerosis  440	Women	408
GALICIA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.031
GALICIA	Group 0910 Varicose veins of lower extremities 454	Men	310
GALICIA	Group 0910 Varicose veins of lower extremities 454	Women	721
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	6.337
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.751
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.586
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	40.810
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	22.720
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	18.090
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.310
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	685
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	625
GALICIA	Group 1002 Pneumonia 480-486	Both sexes	9.112
GALICIA	Group 1002 Pneumonia 480-486	Men	5.261
GALICIA	Group 1002 Pneumonia 480-486	Women	3.851
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.491
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	821
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	670
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.811
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.002
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	809
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.715
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.706
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.009
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	6.364
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	4.771
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.593
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.607
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Men	430
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Women	1.177
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	16.400
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	8.044
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	8.356
GALICIA	Group 1100 Diseases of the digestive system  520-579	Both sexes	34.723
GALICIA	Group 1100 Diseases of the digestive system  520-579	Men	19.545
GALICIA	Group 1100 Diseases of the digestive system  520-579	Women	15.178
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	446
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	214
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	232
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	466
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	272
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	194
GALICIA	Group 1103 Diseases of the esophagus 530	Both sexes	558
GALICIA	Group 1103 Diseases of the esophagus 530	Men	353
GALICIA	Group 1103 Diseases of the esophagus 530	Women	205
GALICIA	Group 1104 Peptic ulcer 531-534	Both sexes	550
GALICIA	Group 1104 Peptic ulcer 531-534	Men	364
GALICIA	Group 1104 Peptic ulcer 531-534	Women	186
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	743
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	400
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	343
GALICIA	Group 1106 Appendicitis  540-543	Both sexes	2.989
GALICIA	Group 1106 Appendicitis  540-543	Men	1.709
GALICIA	Group 1106 Appendicitis  540-543	Women	1.280
GALICIA	Group 1107 Inguinal hernia  550	Both sexes	3.519
GALICIA	Group 1107 Inguinal hernia  550	Men	3.128
GALICIA	Group 1107 Inguinal hernia  550	Women	391
GALICIA	Group 1108 Other abdominal hernia  551-553	Both sexes	2.475
GALICIA	Group 1108 Other abdominal hernia  551-553	Men	1.235
GALICIA	Group 1108 Other abdominal hernia  551-553	Women	1.240
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	674
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	332
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	342
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.673
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	781
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	892
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.809
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Men	951
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Women	858
GALICIA	Group 1112 Intestinal diverticulosis 562	Both sexes	1.653
GALICIA	Group 1112 Intestinal diverticulosis 562	Men	789
GALICIA	Group 1112 Intestinal diverticulosis 562	Women	864
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.971
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.294
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	677
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.205
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	539
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	666
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	811
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Men	648
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Women	163
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.457
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Men	902
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Women	555
GALICIA	Group 1117 Cholelithiasis  574	Both sexes	6.716
GALICIA	Group 1117 Cholelithiasis  574	Men	2.887
GALICIA	Group 1117 Cholelithiasis  574	Women	3.829
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.549
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	868
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	681
GALICIA	Group 1119 Pancreatic diseases 577	Both sexes	2.022
GALICIA	Group 1119 Pancreatic diseases 577	Men	1.091
GALICIA	Group 1119 Pancreatic diseases 577	Women	931
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.437
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	788
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	649
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	3.548
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.925
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.623
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	2.389
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.351
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.038
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	220
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	119
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	101
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	939
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	455
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	484
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	21.798
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	9.946
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	11.852
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
GALICIA	Group 1303 Internal derangement of knee 717	Both sexes	2.750
GALICIA	Group 1303 Internal derangement of knee 717	Men	1.891
GALICIA	Group 1303 Internal derangement of knee 717	Women	859
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	8.798
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	3.514
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	5.284
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	484
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	178
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	306
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	734
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	372
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	362
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.550
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	876
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	674
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	321
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	152
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	169
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	3.497
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.801
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.696
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	3.664
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.162
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	2.502
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	17.689
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.492
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	9.197
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.488
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	579
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	909
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.573
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Men	896
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Women	677
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.009
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Men	1.224
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Women	785
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.510
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.562
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.948
GALICIA	Group 1405 Prostatic hyperplasia  600	Both sexes	1.770
GALICIA	Group 1405 Prostatic hyperplasia  600	Men	1.770
GALICIA	Group 1405 Prostatic hyperplasia  600	Women	..
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.361
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Men	1.361
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
GALICIA	Group 1407 Disorders of breast  610-612	Both sexes	735
GALICIA	Group 1407 Disorders of breast  610-612	Men	80
GALICIA	Group 1407 Disorders of breast  610-612	Women	655
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	490
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	490
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	250
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	250
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.503
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	20
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.483
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	25.055
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	25.055
GALICIA	Group 1501 Legally induced abortion  635	Both sexes	259
GALICIA	Group 1501 Legally induced abortion  635	Men	..
GALICIA	Group 1501 Legally induced abortion  635	Women	259
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.413
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.413
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	14.749
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	14.749
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	4.085
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	4.085
GALICIA	Group 1505 Single spontaneous delivery  650	Both sexes	1.161
GALICIA	Group 1505 Single spontaneous delivery  650	Men	..
GALICIA	Group 1505 Single spontaneous delivery  650	Women	1.161
GALICIA	Group 1506 Other deliveries  6695-6697	Both sexes	557
GALICIA	Group 1506 Other deliveries  6695-6697	Men	..
GALICIA	Group 1506 Other deliveries  6695-6697	Women	557
GALICIA	Group 1507 Complications related to the puerperium  670-676	Both sexes	212
GALICIA	Group 1507 Complications related to the puerperium  670-676	Men	..
GALICIA	Group 1507 Complications related to the puerperium  670-676	Women	212
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.619
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.619
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	3.486
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.927
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.559
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	776
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	414
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	362
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.710
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.513
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	1.197
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	2.083
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Men	1.285
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Women	798
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	12.547
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.795
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.752
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.251
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Men	689
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Women	562
GALICIA	Group 1802 Abdominal pain   7890	Both sexes	1.072
GALICIA	Group 1802 Abdominal pain   7890	Men	417
GALICIA	Group 1802 Abdominal pain   7890	Women	655
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.824
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	884
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	940
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.400
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.805
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.595
GALICIA	Group 1900 Injuries and poisoning  800-999	Both sexes	29.130
GALICIA	Group 1900 Injuries and poisoning  800-999	Men	15.040
GALICIA	Group 1900 Injuries and poisoning  800-999	Women	14.090
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.951
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.137
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	814
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	938
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	677
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	261
GALICIA	Group 1903 Radius and ulna fracture 813	Both sexes	1.682
GALICIA	Group 1903 Radius and ulna fracture 813	Men	741
GALICIA	Group 1903 Radius and ulna fracture 813	Women	941
GALICIA	Group 1904 Femur fracture  820-821	Both sexes	4.265
GALICIA	Group 1904 Femur fracture  820-821	Men	1.068
GALICIA	Group 1904 Femur fracture  820-821	Women	3.197
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	2.130
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Men	973
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Women	1.157
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	8.950
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	5.389
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	3.561
GALICIA	Group 1907 Burns  940-949	Both sexes	267
GALICIA	Group 1907 Burns  940-949	Men	170
GALICIA	Group 1907 Burns  940-949	Women	97
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	649
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	284
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	365
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	7.674
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	4.254
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	3.420
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	69
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	40
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	29
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	555
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	307
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	248
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	6.054
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	3.264
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.790
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	258
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	137
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	121
GALICIA	Group 2102 Contraceptive management  V25	Both sexes	80
GALICIA	Group 2102 Contraceptive management  V25	Men	3
GALICIA	Group 2102 Contraceptive management  V25	Women	77
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	2.893
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.782
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.111
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.823
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.342
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.481
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	125.291
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	61.033
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	64.258
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.503
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.416
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.087
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	364
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	188
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	176
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Both sexes	111
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Men	56
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Women	55
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Both sexes	145
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Men	104
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Women	41
Coru±a, A	Group 0104 Septicaemia  038	Both sexes	827
Coru±a, A	Group 0104 Septicaemia  038	Men	452
Coru±a, A	Group 0104 Septicaemia  038	Women	375
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	90
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	64
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	26
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	966
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	552
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	414
Coru±a, A	Group 0200 Neoplasms  140-239	Both sexes	14.456
Coru±a, A	Group 0200 Neoplasms  140-239	Men	7.724
Coru±a, A	Group 0200 Neoplasms  140-239	Women	6.732
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.486
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	884
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	602
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.119
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	857
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	262
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	298
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	156
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	142
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.014
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Men	6
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Women	1.008
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	350
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	350
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	152
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Women	152
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Both sexes	703
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Men	703
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Women	..
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Both sexes	923
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Men	778
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Women	145
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.442
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.244
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.198
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Both sexes	434
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Men	241
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Women	193
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	217
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	153
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	64
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Both sexes	588
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Men	..
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Women	588
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.730
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	702
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.028
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.097
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	526
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	571
Coru±a, A	Group 0301 Anaemias 280-285	Both sexes	666
Coru±a, A	Group 0301 Anaemias 280-285	Men	321
Coru±a, A	Group 0301 Anaemias 280-285	Women	345
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	431
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	205
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	226
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.790
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	672
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.118
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Both sexes	630
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Men	352
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Women	278
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.160
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	320
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	840
Coru±a, A	Group 0500 Mental disorders  290-319	Both sexes	2.224
Coru±a, A	Group 0500 Mental disorders  290-319	Men	1.175
Coru±a, A	Group 0500 Mental disorders  290-319	Women	1.049
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	81
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	33
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	48
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	217
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	176
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	41
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	141
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	100
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	41
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	598
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	346
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	252
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	472
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	191
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	281
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	715
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	329
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	386
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.294
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.141
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.153
Coru±a, A	Group 0601 Alzheimer's disease  3310	Both sexes	30
Coru±a, A	Group 0601 Alzheimer's disease  3310	Men	10
Coru±a, A	Group 0601 Alzheimer's disease  3310	Women	20
Coru±a, A	Group 0602 Multiple sclerosis 340	Both sexes	72
Coru±a, A	Group 0602 Multiple sclerosis 340	Men	35
Coru±a, A	Group 0602 Multiple sclerosis 340	Women	37
Coru±a, A	Group 0603 Epilepsy  345	Both sexes	367
Coru±a, A	Group 0603 Epilepsy  345	Men	176
Coru±a, A	Group 0603 Epilepsy  345	Women	191
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Both sexes	387
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Men	211
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Women	176
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.438
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	709
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	729
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	513
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	242
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	271
Coru±a, A	Grupo 0701 Cataract  366	Both sexes	19
Coru±a, A	Grupo 0701 Cataract  366	Men	12
Coru±a, A	Grupo 0701 Cataract  366	Women	7
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	494
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	230
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	264
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	484
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Men	259
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Women	225
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.608
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.123
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.485
Coru±a, A	Group 0901 Hypertensive disease  401-405	Both sexes	1.032
Coru±a, A	Group 0901 Hypertensive disease  401-405	Men	520
Coru±a, A	Group 0901 Hypertensive disease  401-405	Women	512
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Both sexes	576
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Men	341
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Women	235
Coru±a, A	Group 0903 Acute myocardial infarction  410	Both sexes	1.616
Coru±a, A	Group 0903 Acute myocardial infarction  410	Men	1.176
Coru±a, A	Group 0903 Acute myocardial infarction  410	Women	440
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.501
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.176
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	325
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	580
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Men	233
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Women	347
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.965
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.108
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	857
Coru±a, A	Grupo 0907 Heart failure  428	Both sexes	3.257
Coru±a, A	Grupo 0907 Heart failure  428	Men	1.675
Coru±a, A	Grupo 0907 Heart failure  428	Women	1.582
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.738
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.365
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.373
Coru±a, A	Grupo 0909 Atherosclerosis  440	Both sexes	614
Coru±a, A	Grupo 0909 Atherosclerosis  440	Men	468
Coru±a, A	Grupo 0909 Atherosclerosis  440	Women	146
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Both sexes	546
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Men	148
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Women	398
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.183
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.913
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.270
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.763
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	9.028
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.735
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	564
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	292
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	272
Coru±a, A	Group 1002 Pneumonia 480-486	Both sexes	3.416
Coru±a, A	Group 1002 Pneumonia 480-486	Men	2.001
Coru±a, A	Group 1002 Pneumonia 480-486	Women	1.415
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	492
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Men	270
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Women	222
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	716
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	386
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	330
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.140
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	721
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	419
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.758
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.190
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	568
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	726
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Men	161
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Women	565
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.951
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.007
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.944
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Both sexes	14.616
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Men	8.150
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Women	6.466
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	204
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	90
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	114
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	203
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	114
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	89
Coru±a, A	Group 1103 Diseases of the esophagus 530	Both sexes	239
Coru±a, A	Group 1103 Diseases of the esophagus 530	Men	150
Coru±a, A	Group 1103 Diseases of the esophagus 530	Women	89
Coru±a, A	Group 1104 Peptic ulcer 531-534	Both sexes	243
Coru±a, A	Group 1104 Peptic ulcer 531-534	Men	162
Coru±a, A	Group 1104 Peptic ulcer 531-534	Women	81
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	271
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	142
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	129
Coru±a, A	Group 1106 Appendicitis  540-543	Both sexes	1.276
Coru±a, A	Group 1106 Appendicitis  540-543	Men	722
Coru±a, A	Group 1106 Appendicitis  540-543	Women	554
Coru±a, A	Group 1107 Inguinal hernia  550	Both sexes	1.385
Coru±a, A	Group 1107 Inguinal hernia  550	Men	1.251
Coru±a, A	Group 1107 Inguinal hernia  550	Women	134
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Both sexes	1.074
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Men	536
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Women	538
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	322
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	156
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	166
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	599
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	291
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	308
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Both sexes	745
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Men	390
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Women	355
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Both sexes	681
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Men	311
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Women	370
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	888
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	594
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	294
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	458
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	217
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	241
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	373
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Men	305
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Women	68
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	572
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Men	319
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Women	253
Coru±a, A	Group 1117 Cholelithiasis  574	Both sexes	3.105
Coru±a, A	Group 1117 Cholelithiasis  574	Men	1.316
Coru±a, A	Group 1117 Cholelithiasis  574	Women	1.789
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	529
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	297
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	232
Coru±a, A	Group 1119 Pancreatic diseases 577	Both sexes	831
Coru±a, A	Group 1119 Pancreatic diseases 577	Men	438
Coru±a, A	Group 1119 Pancreatic diseases 577	Women	393
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	618
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	349
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	269
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.408
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	783
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	625
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	923
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	539
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	384
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	91
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	55
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	36
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	394
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	189
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	205
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.159
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.026
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.133
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Coru±a, A	Group 1303 Internal derangement of knee 717	Both sexes	882
Coru±a, A	Group 1303 Internal derangement of knee 717	Men	639
Coru±a, A	Group 1303 Internal derangement of knee 717	Women	243
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.540
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.383
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.157
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	254
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	75
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	179
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	280
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	142
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	138
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	713
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	395
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	318
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	136
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	69
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	67
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.536
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	772
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	764
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.818
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	551
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.267
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.166
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.470
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.696
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	592
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	250
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	342
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	651
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Men	381
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Women	270
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	799
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Men	464
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Women	335
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.088
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.047
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.041
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Both sexes	778
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Men	778
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Women	..
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	506
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Men	506
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Coru±a, A	Group 1407 Disorders of breast  610-612	Both sexes	378
Coru±a, A	Group 1407 Disorders of breast  610-612	Men	39
Coru±a, A	Group 1407 Disorders of breast  610-612	Women	339
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	170
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	170
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	98
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	98
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.106
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	5
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.101
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.336
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.336
Coru±a, A	Group 1501 Legally induced abortion  635	Both sexes	64
Coru±a, A	Group 1501 Legally induced abortion  635	Men	..
Coru±a, A	Group 1501 Legally induced abortion  635	Women	64
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.162
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.162
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	7.195
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	7.195
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.250
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.250
Coru±a, A	Group 1505 Single spontaneous delivery  650	Both sexes	575
Coru±a, A	Group 1505 Single spontaneous delivery  650	Men	..
Coru±a, A	Group 1505 Single spontaneous delivery  650	Women	575
Coru±a, A	Group 1506 Other deliveries  6695-6697	Both sexes	229
Coru±a, A	Group 1506 Other deliveries  6695-6697	Men	..
Coru±a, A	Group 1506 Other deliveries  6695-6697	Women	229
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Both sexes	78
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Men	..
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Women	78
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	783
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	783
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.844
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Men	999
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Women	845
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	324
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	162
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	162
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.520
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	837
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	683
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.251
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Men	767
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Women	484
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	4.603
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.511
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.092
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	624
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Men	339
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Women	285
Coru±a, A	Group 1802 Abdominal pain   7890	Both sexes	404
Coru±a, A	Group 1802 Abdominal pain   7890	Men	160
Coru±a, A	Group 1802 Abdominal pain   7890	Women	244
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	307
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	158
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	149
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.268
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.854
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.414
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Both sexes	12.166
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Men	6.402
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Women	5.764
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	602
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	360
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	242
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	478
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	352
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	126
Coru±a, A	Group 1903 Radius and ulna fracture 813	Both sexes	750
Coru±a, A	Group 1903 Radius and ulna fracture 813	Men	334
Coru±a, A	Group 1903 Radius and ulna fracture 813	Women	416
Coru±a, A	Group 1904 Femur fracture  820-821	Both sexes	1.734
Coru±a, A	Group 1904 Femur fracture  820-821	Men	416
Coru±a, A	Group 1904 Femur fracture  820-821	Women	1.318
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	858
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Men	384
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Women	474
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.396
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.101
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.295
Coru±a, A	Group 1907 Burns  940-949	Both sexes	142
Coru±a, A	Group 1907 Burns  940-949	Men	87
Coru±a, A	Group 1907 Burns  940-949	Women	55
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	210
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	100
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	110
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.718
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.116
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.602
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	56
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	33
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	23
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	222
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	119
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	103
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.010
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.619
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.391
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	132
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	71
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	61
Coru±a, A	Group 2102 Contraceptive management  V25	Both sexes	19
Coru±a, A	Group 2102 Contraceptive management  V25	Men	1
Coru±a, A	Group 2102 Contraceptive management  V25	Women	18
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.305
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	800
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	505
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.554
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	747
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	807
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	35.113
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	17.306
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	17.807
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	764
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	451
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	313
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	199
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	115
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	84
Lugo	Group 0102 Imprecise intestinal infections 009	Both sexes	27
Lugo	Group 0102 Imprecise intestinal infections 009	Men	19
Lugo	Group 0102 Imprecise intestinal infections 009	Women	8
Lugo	Group 0103 Tuberculosis 010-018, 137	Both sexes	24
Lugo	Group 0103 Tuberculosis 010-018, 137	Men	18
Lugo	Group 0103 Tuberculosis 010-018, 137	Women	6
Lugo	Group 0104 Septicaemia  038	Both sexes	158
Lugo	Group 0104 Septicaemia  038	Men	88
Lugo	Group 0104 Septicaemia  038	Women	70
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	16
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	14
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	340
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	197
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	143
Lugo	Group 0200 Neoplasms  140-239	Both sexes	2.906
Lugo	Group 0200 Neoplasms  140-239	Men	1.501
Lugo	Group 0200 Neoplasms  140-239	Women	1.405
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	418
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	268
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	150
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	125
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	101
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	24
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	31
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	24
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	7
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	229
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Women	229
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	87
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	87
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	30
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Women	30
Lugo	Group 0207 Malignant neoplasm of prostate  185	Both sexes	118
Lugo	Group 0207 Malignant neoplasm of prostate  185	Men	118
Lugo	Group 0207 Malignant neoplasm of prostate  185	Women	..
Lugo	Group 0208 Malignant neoplasm of bladder  188	Both sexes	273
Lugo	Group 0208 Malignant neoplasm of bladder  188	Men	217
Lugo	Group 0208 Malignant neoplasm of bladder  188	Women	56
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.038
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	632
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	406
Lugo	Group 0210 Carcinoma in situ  230-234	Both sexes	65
Lugo	Group 0210 Carcinoma in situ  230-234	Men	25
Lugo	Group 0210 Carcinoma in situ  230-234	Women	40
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	29
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	15
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	14
Lugo	Grupo 0212 Leiomyoma of uterus  218	Both sexes	133
Lugo	Grupo 0212 Leiomyoma of uterus  218	Men	..
Lugo	Grupo 0212 Leiomyoma of uterus  218	Women	133
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	330
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	101
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	229
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	442
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	223
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	219
Lugo	Group 0301 Anaemias 280-285	Both sexes	286
Lugo	Group 0301 Anaemias 280-285	Men	139
Lugo	Group 0301 Anaemias 280-285	Women	147
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	156
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	84
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	72
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	632
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	282
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	350
Lugo	Group 0401 Diabetes mellitus  249-250	Both sexes	220
Lugo	Group 0401 Diabetes mellitus  249-250	Men	129
Lugo	Group 0401 Diabetes mellitus  249-250	Women	91
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	412
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	153
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	259
Lugo	Group 0500 Mental disorders  290-319	Both sexes	684
Lugo	Group 0500 Mental disorders  290-319	Men	333
Lugo	Group 0500 Mental disorders  290-319	Women	351
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	49
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	20
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	29
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	63
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	53
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	10
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	31
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	27
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	4
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	185
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	84
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	101
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	139
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	56
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	83
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	217
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	93
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	124
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	753
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	385
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	368
Lugo	Group 0601 Alzheimer's disease  3310	Both sexes	24
Lugo	Group 0601 Alzheimer's disease  3310	Men	11
Lugo	Group 0601 Alzheimer's disease  3310	Women	13
Lugo	Group 0602 Multiple sclerosis 340	Both sexes	58
Lugo	Group 0602 Multiple sclerosis 340	Men	21
Lugo	Group 0602 Multiple sclerosis 340	Women	37
Lugo	Group 0603 Epilepsy  345	Both sexes	155
Lugo	Group 0603 Epilepsy  345	Men	75
Lugo	Group 0603 Epilepsy  345	Women	80
Lugo	Group 0604 Transient cerebral ischemia 435	Both sexes	82
Lugo	Group 0604 Transient cerebral ischemia 435	Men	41
Lugo	Group 0604 Transient cerebral ischemia 435	Women	41
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	434
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	237
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	197
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	246
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	140
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	106
Lugo	Grupo 0701 Cataract  366	Both sexes	35
Lugo	Grupo 0701 Cataract  366	Men	19
Lugo	Grupo 0701 Cataract  366	Women	16
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	211
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	121
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	90
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	118
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Men	64
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Women	54
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.648
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.643
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.005
Lugo	Group 0901 Hypertensive disease  401-405	Both sexes	383
Lugo	Group 0901 Hypertensive disease  401-405	Men	170
Lugo	Group 0901 Hypertensive disease  401-405	Women	213
Lugo	Group 0902 Angina pectoris  4111, 413	Both sexes	261
Lugo	Group 0902 Angina pectoris  4111, 413	Men	170
Lugo	Group 0902 Angina pectoris  4111, 413	Women	91
Lugo	Group 0903 Acute myocardial infarction  410	Both sexes	325
Lugo	Group 0903 Acute myocardial infarction  410	Men	236
Lugo	Group 0903 Acute myocardial infarction  410	Women	89
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	249
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	181
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	68
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	240
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Men	93
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Women	147
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	539
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	320
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	219
Lugo	Grupo 0907 Heart failure  428	Both sexes	816
Lugo	Grupo 0907 Heart failure  428	Men	451
Lugo	Grupo 0907 Heart failure  428	Women	365
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	898
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	466
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	432
Lugo	Grupo 0909 Atherosclerosis  440	Both sexes	224
Lugo	Grupo 0909 Atherosclerosis  440	Men	154
Lugo	Grupo 0909 Atherosclerosis  440	Women	70
Lugo	Group 0910 Varicose veins of lower extremities 454	Both sexes	26
Lugo	Group 0910 Varicose veins of lower extremities 454	Men	11
Lugo	Group 0910 Varicose veins of lower extremities 454	Women	15
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	687
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	391
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	296
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.449
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.615
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.834
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	198
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	100
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	98
Lugo	Group 1002 Pneumonia 480-486	Both sexes	1.123
Lugo	Group 1002 Pneumonia 480-486	Men	698
Lugo	Group 1002 Pneumonia 480-486	Women	425
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	134
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Men	86
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Women	48
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	108
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	58
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	50
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	247
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	148
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	99
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	604
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	460
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	144
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	155
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Men	73
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Women	82
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.880
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	992
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	888
Lugo	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.681
Lugo	Group 1100 Diseases of the digestive system  520-579	Men	2.681
Lugo	Group 1100 Diseases of the digestive system  520-579	Women	2.000
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	45
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	26
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	19
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	39
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	21
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	18
Lugo	Group 1103 Diseases of the esophagus 530	Both sexes	71
Lugo	Group 1103 Diseases of the esophagus 530	Men	44
Lugo	Group 1103 Diseases of the esophagus 530	Women	27
Lugo	Group 1104 Peptic ulcer 531-534	Both sexes	56
Lugo	Group 1104 Peptic ulcer 531-534	Men	26
Lugo	Group 1104 Peptic ulcer 531-534	Women	30
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	107
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	60
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	47
Lugo	Group 1106 Appendicitis  540-543	Both sexes	389
Lugo	Group 1106 Appendicitis  540-543	Men	226
Lugo	Group 1106 Appendicitis  540-543	Women	163
Lugo	Group 1107 Inguinal hernia  550	Both sexes	457
Lugo	Group 1107 Inguinal hernia  550	Men	413
Lugo	Group 1107 Inguinal hernia  550	Women	44
Lugo	Group 1108 Other abdominal hernia  551-553	Both sexes	338
Lugo	Group 1108 Other abdominal hernia  551-553	Men	171
Lugo	Group 1108 Other abdominal hernia  551-553	Women	167
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	59
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	27
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	32
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	267
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	118
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	149
Lugo	Group 1111 Intestinal obstruction without hernia 560	Both sexes	291
Lugo	Group 1111 Intestinal obstruction without hernia 560	Men	148
Lugo	Group 1111 Intestinal obstruction without hernia 560	Women	143
Lugo	Group 1112 Intestinal diverticulosis 562	Both sexes	285
Lugo	Group 1112 Intestinal diverticulosis 562	Men	142
Lugo	Group 1112 Intestinal diverticulosis 562	Women	143
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	205
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	141
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	64
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	187
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	85
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	102
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	113
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Men	88
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Women	25
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	138
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Men	89
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Women	49
Lugo	Group 1117 Cholelithiasis  574	Both sexes	837
Lugo	Group 1117 Cholelithiasis  574	Men	417
Lugo	Group 1117 Cholelithiasis  574	Women	420
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	301
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	167
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	134
Lugo	Group 1119 Pancreatic diseases 577	Both sexes	293
Lugo	Group 1119 Pancreatic diseases 577	Men	167
Lugo	Group 1119 Pancreatic diseases 577	Women	126
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	203
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	105
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	98
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	446
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	233
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	213
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	302
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	167
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	135
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	33
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	18
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	15
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	111
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	48
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	63
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.705
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.222
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.483
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Lugo	Group 1303 Internal derangement of knee 717	Both sexes	336
Lugo	Group 1303 Internal derangement of knee 717	Men	215
Lugo	Group 1303 Internal derangement of knee 717	Women	121
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.145
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	468
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	677
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	58
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	23
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	35
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	102
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	45
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	57
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	140
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	84
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	56
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	37
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	20
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	17
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	440
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	226
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	214
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	447
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	141
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	306
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.185
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.085
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.100
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	182
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	79
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	103
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	238
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Men	131
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Women	107
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	195
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Men	128
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Women	67
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	636
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	319
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	317
Lugo	Group 1405 Prostatic hyperplasia  600	Both sexes	206
Lugo	Group 1405 Prostatic hyperplasia  600	Men	206
Lugo	Group 1405 Prostatic hyperplasia  600	Women	..
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	208
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Men	208
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Lugo	Group 1407 Disorders of breast  610-612	Both sexes	58
Lugo	Group 1407 Disorders of breast  610-612	Men	13
Lugo	Group 1407 Disorders of breast  610-612	Women	45
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	58
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	58
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	50
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	50
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	354
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	353
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.846
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.846
Lugo	Group 1501 Legally induced abortion  635	Both sexes	26
Lugo	Group 1501 Legally induced abortion  635	Men	..
Lugo	Group 1501 Legally induced abortion  635	Women	26
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	288
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	288
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.474
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.474
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	720
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	720
Lugo	Group 1505 Single spontaneous delivery  650	Both sexes	85
Lugo	Group 1505 Single spontaneous delivery  650	Men	..
Lugo	Group 1505 Single spontaneous delivery  650	Women	85
Lugo	Group 1506 Other deliveries  6695-6697	Both sexes	64
Lugo	Group 1506 Other deliveries  6695-6697	Men	..
Lugo	Group 1506 Other deliveries  6695-6697	Women	64
Lugo	Group 1507 Complications related to the puerperium  670-676	Both sexes	21
Lugo	Group 1507 Complications related to the puerperium  670-676	Men	..
Lugo	Group 1507 Complications related to the puerperium  670-676	Women	21
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	168
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	168
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	391
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Men	197
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Women	194
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	99
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	50
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	49
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	292
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	147
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	145
Lugo	Grupo 1700 Congenital abnormalities  740-759	Both sexes	113
Lugo	Grupo 1700 Congenital abnormalities  740-759	Men	69
Lugo	Grupo 1700 Congenital abnormalities  740-759	Women	44
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.846
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.046
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	800
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	149
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Men	87
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Women	62
Lugo	Group 1802 Abdominal pain   7890	Both sexes	166
Lugo	Group 1802 Abdominal pain   7890	Men	66
Lugo	Group 1802 Abdominal pain   7890	Women	100
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	308
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	164
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	144
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.223
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	729
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	494
Lugo	Group 1900 Injuries and poisoning  800-999	Both sexes	3.617
Lugo	Group 1900 Injuries and poisoning  800-999	Men	1.815
Lugo	Group 1900 Injuries and poisoning  800-999	Women	1.802
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	301
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	178
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	123
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	91
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	75
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	16
Lugo	Group 1903 Radius and ulna fracture 813	Both sexes	143
Lugo	Group 1903 Radius and ulna fracture 813	Men	61
Lugo	Group 1903 Radius and ulna fracture 813	Women	82
Lugo	Group 1904 Femur fracture  820-821	Both sexes	682
Lugo	Group 1904 Femur fracture  820-821	Men	158
Lugo	Group 1904 Femur fracture  820-821	Women	524
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	231
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Men	95
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Women	136
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.018
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	634
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	384
Lugo	Group 1907 Burns  940-949	Both sexes	33
Lugo	Group 1907 Burns  940-949	Men	20
Lugo	Group 1907 Burns  940-949	Women	13
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	90
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	36
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	54
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	931
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	501
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	430
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	3
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	94
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	55
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	39
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	641
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	321
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	320
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	41
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	18
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	23
Lugo	Group 2102 Contraceptive management  V25	Both sexes	17
Lugo	Group 2102 Contraceptive management  V25	Men	1
Lugo	Group 2102 Contraceptive management  V25	Women	16
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	190
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	104
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	86
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	393
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	198
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	195
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	38.393
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	19.199
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	19.194
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	836
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	459
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	377
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	217
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	121
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	96
Ourense	Group 0102 Imprecise intestinal infections 009	Both sexes	13
Ourense	Group 0102 Imprecise intestinal infections 009	Men	7
Ourense	Group 0102 Imprecise intestinal infections 009	Women	6
Ourense	Group 0103 Tuberculosis 010-018, 137	Both sexes	22
Ourense	Group 0103 Tuberculosis 010-018, 137	Men	14
Ourense	Group 0103 Tuberculosis 010-018, 137	Women	8
Ourense	Group 0104 Septicaemia  038	Both sexes	376
Ourense	Group 0104 Septicaemia  038	Men	203
Ourense	Group 0104 Septicaemia  038	Women	173
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	2
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	206
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	112
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	94
Ourense	Group 0200 Neoplasms  140-239	Both sexes	3.477
Ourense	Group 0200 Neoplasms  140-239	Men	1.958
Ourense	Group 0200 Neoplasms  140-239	Women	1.519
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	483
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	288
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	195
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	191
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	148
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	43
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	32
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	16
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	16
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	235
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Women	232
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	78
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	78
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	22
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Women	22
Ourense	Group 0207 Malignant neoplasm of prostate  185	Both sexes	145
Ourense	Group 0207 Malignant neoplasm of prostate  185	Men	145
Ourense	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ourense	Group 0208 Malignant neoplasm of bladder  188	Both sexes	390
Ourense	Group 0208 Malignant neoplasm of bladder  188	Men	325
Ourense	Group 0208 Malignant neoplasm of bladder  188	Women	65
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.287
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	792
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	495
Ourense	Group 0210 Carcinoma in situ  230-234	Both sexes	42
Ourense	Group 0210 Carcinoma in situ  230-234	Men	6
Ourense	Group 0210 Carcinoma in situ  230-234	Women	36
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	55
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	33
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	22
Ourense	Grupo 0212 Leiomyoma of uterus  218	Both sexes	93
Ourense	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ourense	Grupo 0212 Leiomyoma of uterus  218	Women	93
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	424
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	202
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	222
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	326
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	158
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	168
Ourense	Group 0301 Anaemias 280-285	Both sexes	235
Ourense	Group 0301 Anaemias 280-285	Men	113
Ourense	Group 0301 Anaemias 280-285	Women	122
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	91
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	45
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	46
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	445
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	189
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	256
Ourense	Group 0401 Diabetes mellitus  249-250	Both sexes	197
Ourense	Group 0401 Diabetes mellitus  249-250	Men	98
Ourense	Group 0401 Diabetes mellitus  249-250	Women	99
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	248
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	91
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	157
Ourense	Group 0500 Mental disorders  290-319	Both sexes	606
Ourense	Group 0500 Mental disorders  290-319	Men	323
Ourense	Group 0500 Mental disorders  290-319	Women	283
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	21
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	8
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	13
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	57
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	49
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	8
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	20
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	20
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	..
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	195
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	107
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	88
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	111
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	41
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	70
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	202
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	98
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	104
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	745
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	339
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	406
Ourense	Group 0601 Alzheimer's disease  3310	Both sexes	14
Ourense	Group 0601 Alzheimer's disease  3310	Men	3
Ourense	Group 0601 Alzheimer's disease  3310	Women	11
Ourense	Group 0602 Multiple sclerosis 340	Both sexes	68
Ourense	Group 0602 Multiple sclerosis 340	Men	22
Ourense	Group 0602 Multiple sclerosis 340	Women	46
Ourense	Group 0603 Epilepsy  345	Both sexes	142
Ourense	Group 0603 Epilepsy  345	Men	69
Ourense	Group 0603 Epilepsy  345	Women	73
Ourense	Group 0604 Transient cerebral ischemia 435	Both sexes	182
Ourense	Group 0604 Transient cerebral ischemia 435	Men	84
Ourense	Group 0604 Transient cerebral ischemia 435	Women	98
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	339
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	161
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	178
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	123
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	63
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	60
Ourense	Grupo 0701 Cataract  366	Both sexes	5
Ourense	Grupo 0701 Cataract  366	Men	1
Ourense	Grupo 0701 Cataract  366	Women	4
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	118
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	62
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	56
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	146
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Men	74
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Women	72
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.867
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.665
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.202
Ourense	Group 0901 Hypertensive disease  401-405	Both sexes	189
Ourense	Group 0901 Hypertensive disease  401-405	Men	98
Ourense	Group 0901 Hypertensive disease  401-405	Women	91
Ourense	Group 0902 Angina pectoris  4111, 413	Both sexes	352
Ourense	Group 0902 Angina pectoris  4111, 413	Men	230
Ourense	Group 0902 Angina pectoris  4111, 413	Women	122
Ourense	Group 0903 Acute myocardial infarction  410	Both sexes	290
Ourense	Group 0903 Acute myocardial infarction  410	Men	202
Ourense	Group 0903 Acute myocardial infarction  410	Women	88
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	127
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	94
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	33
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	229
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Men	92
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Women	137
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	638
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	360
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	278
Ourense	Grupo 0907 Heart failure  428	Both sexes	1.079
Ourense	Grupo 0907 Heart failure  428	Men	530
Ourense	Grupo 0907 Heart failure  428	Women	549
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.042
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	521
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	521
Ourense	Grupo 0909 Atherosclerosis  440	Both sexes	169
Ourense	Grupo 0909 Atherosclerosis  440	Men	115
Ourense	Grupo 0909 Atherosclerosis  440	Women	54
Ourense	Group 0910 Varicose veins of lower extremities 454	Both sexes	48
Ourense	Group 0910 Varicose veins of lower extremities 454	Men	18
Ourense	Group 0910 Varicose veins of lower extremities 454	Women	30
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	704
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	405
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	299
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.264
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.405
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.859
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	209
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	117
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	92
Ourense	Group 1002 Pneumonia 480-486	Both sexes	1.543
Ourense	Group 1002 Pneumonia 480-486	Men	898
Ourense	Group 1002 Pneumonia 480-486	Women	645
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	230
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Men	128
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Women	102
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	200
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	98
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	102
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	318
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	192
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	126
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	800
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	586
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	214
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	214
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Men	42
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Women	172
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.750
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.344
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.406
Ourense	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.832
Ourense	Group 1100 Diseases of the digestive system  520-579	Men	2.827
Ourense	Group 1100 Diseases of the digestive system  520-579	Women	2.005
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	5
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	3
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	2
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	29
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	14
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	15
Ourense	Group 1103 Diseases of the esophagus 530	Both sexes	67
Ourense	Group 1103 Diseases of the esophagus 530	Men	42
Ourense	Group 1103 Diseases of the esophagus 530	Women	25
Ourense	Group 1104 Peptic ulcer 531-534	Both sexes	79
Ourense	Group 1104 Peptic ulcer 531-534	Men	53
Ourense	Group 1104 Peptic ulcer 531-534	Women	26
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	114
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	61
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	53
Ourense	Group 1106 Appendicitis  540-543	Both sexes	345
Ourense	Group 1106 Appendicitis  540-543	Men	199
Ourense	Group 1106 Appendicitis  540-543	Women	146
Ourense	Group 1107 Inguinal hernia  550	Both sexes	534
Ourense	Group 1107 Inguinal hernia  550	Men	485
Ourense	Group 1107 Inguinal hernia  550	Women	49
Ourense	Group 1108 Other abdominal hernia  551-553	Both sexes	294
Ourense	Group 1108 Other abdominal hernia  551-553	Men	150
Ourense	Group 1108 Other abdominal hernia  551-553	Women	144
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	64
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	36
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	28
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	310
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	143
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	167
Ourense	Group 1111 Intestinal obstruction without hernia 560	Both sexes	290
Ourense	Group 1111 Intestinal obstruction without hernia 560	Men	164
Ourense	Group 1111 Intestinal obstruction without hernia 560	Women	126
Ourense	Group 1112 Intestinal diverticulosis 562	Both sexes	211
Ourense	Group 1112 Intestinal diverticulosis 562	Men	101
Ourense	Group 1112 Intestinal diverticulosis 562	Women	110
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	247
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	158
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	89
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	182
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	81
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	101
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	112
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Men	96
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Women	16
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	245
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Men	176
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Women	69
Ourense	Group 1117 Cholelithiasis  574	Both sexes	913
Ourense	Group 1117 Cholelithiasis  574	Men	422
Ourense	Group 1117 Cholelithiasis  574	Women	491
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	242
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	154
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	88
Ourense	Group 1119 Pancreatic diseases 577	Both sexes	292
Ourense	Group 1119 Pancreatic diseases 577	Men	142
Ourense	Group 1119 Pancreatic diseases 577	Women	150
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	257
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	147
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	110
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	479
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	264
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	215
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	336
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	185
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	151
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	22
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	11
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	11
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	121
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	68
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	53
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.715
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.218
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.497
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ourense	Group 1303 Internal derangement of knee 717	Both sexes	345
Ourense	Group 1303 Internal derangement of knee 717	Men	222
Ourense	Group 1303 Internal derangement of knee 717	Women	123
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.322
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	528
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	794
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	46
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	24
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	22
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	89
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	47
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	42
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	133
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	83
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	50
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	44
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	21
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	23
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	404
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	200
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	204
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	332
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	93
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	239
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.234
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.047
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.187
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	166
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	72
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	94
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	183
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Men	102
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Women	81
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	283
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Men	173
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Women	110
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	881
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	383
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	498
Ourense	Group 1405 Prostatic hyperplasia  600	Both sexes	157
Ourense	Group 1405 Prostatic hyperplasia  600	Men	157
Ourense	Group 1405 Prostatic hyperplasia  600	Women	..
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	153
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Men	153
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ourense	Group 1407 Disorders of breast  610-612	Both sexes	56
Ourense	Group 1407 Disorders of breast  610-612	Men	5
Ourense	Group 1407 Disorders of breast  610-612	Women	51
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	45
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	45
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	32
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	32
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	278
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	276
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.071
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.071
Ourense	Group 1501 Legally induced abortion  635	Both sexes	3
Ourense	Group 1501 Legally induced abortion  635	Men	..
Ourense	Group 1501 Legally induced abortion  635	Women	3
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	57
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	57
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.234
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.234
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	532
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	532
Ourense	Group 1505 Single spontaneous delivery  650	Both sexes	88
Ourense	Group 1505 Single spontaneous delivery  650	Men	..
Ourense	Group 1505 Single spontaneous delivery  650	Women	88
Ourense	Group 1506 Other deliveries  6695-6697	Both sexes	32
Ourense	Group 1506 Other deliveries  6695-6697	Men	..
Ourense	Group 1506 Other deliveries  6695-6697	Women	32
Ourense	Group 1507 Complications related to the puerperium  670-676	Both sexes	8
Ourense	Group 1507 Complications related to the puerperium  670-676	Men	..
Ourense	Group 1507 Complications related to the puerperium  670-676	Women	8
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	117
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	117
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	355
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Men	206
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Women	149
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	84
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	43
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	41
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	271
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	163
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	108
Ourense	Grupo 1700 Congenital abnormalities  740-759	Both sexes	115
Ourense	Grupo 1700 Congenital abnormalities  740-759	Men	57
Ourense	Grupo 1700 Congenital abnormalities  740-759	Women	58
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.437
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.826
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.611
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	228
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Men	129
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Women	99
Ourense	Group 1802 Abdominal pain   7890	Both sexes	208
Ourense	Group 1802 Abdominal pain   7890	Men	82
Ourense	Group 1802 Abdominal pain   7890	Women	126
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.153
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	555
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	598
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.848
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.060
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	788
Ourense	Group 1900 Injuries and poisoning  800-999	Both sexes	3.723
Ourense	Group 1900 Injuries and poisoning  800-999	Men	1.746
Ourense	Group 1900 Injuries and poisoning  800-999	Women	1.977
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	302
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	167
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	135
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	55
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	36
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	19
Ourense	Group 1903 Radius and ulna fracture 813	Both sexes	229
Ourense	Group 1903 Radius and ulna fracture 813	Men	95
Ourense	Group 1903 Radius and ulna fracture 813	Women	134
Ourense	Group 1904 Femur fracture  820-821	Both sexes	691
Ourense	Group 1904 Femur fracture  820-821	Men	177
Ourense	Group 1904 Femur fracture  820-821	Women	514
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	274
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Men	134
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Women	140
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.319
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	727
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	592
Ourense	Group 1907 Burns  940-949	Both sexes	9
Ourense	Group 1907 Burns  940-949	Men	8
Ourense	Group 1907 Burns  940-949	Women	1
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	108
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	42
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	66
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	671
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	326
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	345
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	63
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	32
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	31
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	597
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	375
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	222
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	34
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	23
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	11
Ourense	Group 2102 Contraceptive management  V25	Both sexes	8
Ourense	Group 2102 Contraceptive management  V25	Men	..
Ourense	Group 2102 Contraceptive management  V25	Women	8
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	304
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	215
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	89
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	251
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	137
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	114
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	95.010
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	45.146
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	49.864
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.942
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.037
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	905
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	295
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	143
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	152
Pontevedra	Group 0102 Imprecise intestinal infections 009	Both sexes	48
Pontevedra	Group 0102 Imprecise intestinal infections 009	Men	24
Pontevedra	Group 0102 Imprecise intestinal infections 009	Women	24
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Both sexes	112
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Men	64
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Women	48
Pontevedra	Group 0104 Septicaemia  038	Both sexes	754
Pontevedra	Group 0104 Septicaemia  038	Men	372
Pontevedra	Group 0104 Septicaemia  038	Women	382
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	82
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	63
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	19
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	651
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	371
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	280
Pontevedra	Group 0200 Neoplasms  140-239	Both sexes	9.422
Pontevedra	Group 0200 Neoplasms  140-239	Men	5.008
Pontevedra	Group 0200 Neoplasms  140-239	Women	4.414
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	912
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	504
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	408
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	625
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	480
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	145
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	116
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	73
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	43
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	638
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Men	7
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Women	631
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	144
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	144
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	50
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Women	50
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Both sexes	674
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Men	674
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Women	..
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Both sexes	804
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Men	678
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Women	126
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.776
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.138
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.638
Pontevedra	Group 0210 Carcinoma in situ  230-234	Both sexes	185
Pontevedra	Group 0210 Carcinoma in situ  230-234	Men	58
Pontevedra	Group 0210 Carcinoma in situ  230-234	Women	127
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	80
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	46
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	34
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Both sexes	391
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Men	..
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Women	391
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.027
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	350
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	677
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	940
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	494
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	446
Pontevedra	Group 0301 Anaemias 280-285	Both sexes	621
Pontevedra	Group 0301 Anaemias 280-285	Men	324
Pontevedra	Group 0301 Anaemias 280-285	Women	297
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	319
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	170
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	149
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.700
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	614
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.086
Pontevedra	Group 0401 Diabetes mellitus  249-250	Both sexes	516
Pontevedra	Group 0401 Diabetes mellitus  249-250	Men	242
Pontevedra	Group 0401 Diabetes mellitus  249-250	Women	274
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.184
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	372
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	812
Pontevedra	Group 0500 Mental disorders  290-319	Both sexes	2.042
Pontevedra	Group 0500 Mental disorders  290-319	Men	1.047
Pontevedra	Group 0500 Mental disorders  290-319	Women	995
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	55
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	16
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	39
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	137
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	107
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	30
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	70
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	58
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	12
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	589
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	337
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	252
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	499
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	189
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	310
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	692
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	340
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	352
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.776
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	853
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	923
Pontevedra	Group 0601 Alzheimer's disease  3310	Both sexes	44
Pontevedra	Group 0601 Alzheimer's disease  3310	Men	22
Pontevedra	Group 0601 Alzheimer's disease  3310	Women	22
Pontevedra	Group 0602 Multiple sclerosis 340	Both sexes	86
Pontevedra	Group 0602 Multiple sclerosis 340	Men	30
Pontevedra	Group 0602 Multiple sclerosis 340	Women	56
Pontevedra	Group 0603 Epilepsy  345	Both sexes	303
Pontevedra	Group 0603 Epilepsy  345	Men	153
Pontevedra	Group 0603 Epilepsy  345	Women	150
Pontevedra	Group 0604 Transient cerebral ischemia 435	Both sexes	312
Pontevedra	Group 0604 Transient cerebral ischemia 435	Men	149
Pontevedra	Group 0604 Transient cerebral ischemia 435	Women	163
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.031
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	499
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	532
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	512
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	260
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	252
Pontevedra	Grupo 0701 Cataract  366	Both sexes	29
Pontevedra	Grupo 0701 Cataract  366	Men	14
Pontevedra	Grupo 0701 Cataract  366	Women	15
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	483
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	246
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	237
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	439
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Men	219
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Women	220
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	12.378
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.685
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	5.693
Pontevedra	Group 0901 Hypertensive disease  401-405	Both sexes	738
Pontevedra	Group 0901 Hypertensive disease  401-405	Men	322
Pontevedra	Group 0901 Hypertensive disease  401-405	Women	416
Pontevedra	Group 0902 Angina pectoris  4111, 413	Both sexes	224
Pontevedra	Group 0902 Angina pectoris  4111, 413	Men	139
Pontevedra	Group 0902 Angina pectoris  4111, 413	Women	85
Pontevedra	Group 0903 Acute myocardial infarction  410	Both sexes	1.020
Pontevedra	Group 0903 Acute myocardial infarction  410	Men	720
Pontevedra	Group 0903 Acute myocardial infarction  410	Women	300
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	819
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	652
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	167
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	473
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Men	197
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Women	276
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.406
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	772
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	634
Pontevedra	Grupo 0907 Heart failure  428	Both sexes	3.049
Pontevedra	Grupo 0907 Heart failure  428	Men	1.404
Pontevedra	Grupo 0907 Heart failure  428	Women	1.645
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.979
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	946
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.033
Pontevedra	Grupo 0909 Atherosclerosis  440	Both sexes	496
Pontevedra	Grupo 0909 Atherosclerosis  440	Men	358
Pontevedra	Grupo 0909 Atherosclerosis  440	Women	138
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Both sexes	411
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Men	133
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Women	278
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.763
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.042
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	721
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	14.334
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.672
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.662
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	339
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	176
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	163
Pontevedra	Group 1002 Pneumonia 480-486	Both sexes	3.030
Pontevedra	Group 1002 Pneumonia 480-486	Men	1.664
Pontevedra	Group 1002 Pneumonia 480-486	Women	1.366
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	635
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Men	337
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Women	298
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	787
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	460
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	327
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.010
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	645
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	365
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.202
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.535
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	667
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	512
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Men	154
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Women	358
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.819
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.701
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.118
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.594
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Men	5.887
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Women	4.707
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	192
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	95
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	97
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	195
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	123
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	72
Pontevedra	Group 1103 Diseases of the esophagus 530	Both sexes	181
Pontevedra	Group 1103 Diseases of the esophagus 530	Men	117
Pontevedra	Group 1103 Diseases of the esophagus 530	Women	64
Pontevedra	Group 1104 Peptic ulcer 531-534	Both sexes	172
Pontevedra	Group 1104 Peptic ulcer 531-534	Men	123
Pontevedra	Group 1104 Peptic ulcer 531-534	Women	49
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	251
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	137
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	114
Pontevedra	Group 1106 Appendicitis  540-543	Both sexes	979
Pontevedra	Group 1106 Appendicitis  540-543	Men	562
Pontevedra	Group 1106 Appendicitis  540-543	Women	417
Pontevedra	Group 1107 Inguinal hernia  550	Both sexes	1.143
Pontevedra	Group 1107 Inguinal hernia  550	Men	979
Pontevedra	Group 1107 Inguinal hernia  550	Women	164
Pontevedra	Group 1108 Other abdominal hernia  551-553	Both sexes	769
Pontevedra	Group 1108 Other abdominal hernia  551-553	Men	378
Pontevedra	Group 1108 Other abdominal hernia  551-553	Women	391
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	229
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	113
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	116
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	497
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	229
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	268
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Both sexes	483
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Men	249
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Women	234
Pontevedra	Group 1112 Intestinal diverticulosis 562	Both sexes	476
Pontevedra	Group 1112 Intestinal diverticulosis 562	Men	235
Pontevedra	Group 1112 Intestinal diverticulosis 562	Women	241
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	631
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	401
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	230
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	378
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	156
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	222
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	213
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Men	159
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Women	54
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	502
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Men	318
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Women	184
Pontevedra	Group 1117 Cholelithiasis  574	Both sexes	1.861
Pontevedra	Group 1117 Cholelithiasis  574	Men	732
Pontevedra	Group 1117 Cholelithiasis  574	Women	1.129
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	477
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	250
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	227
Pontevedra	Group 1119 Pancreatic diseases 577	Both sexes	606
Pontevedra	Group 1119 Pancreatic diseases 577	Men	344
Pontevedra	Group 1119 Pancreatic diseases 577	Women	262
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	359
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	187
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	172
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.215
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	645
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	570
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	828
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	460
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	368
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	74
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	35
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	39
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	313
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	150
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	163
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	7.219
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.480
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.739
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Pontevedra	Group 1303 Internal derangement of knee 717	Both sexes	1.187
Pontevedra	Group 1303 Internal derangement of knee 717	Men	815
Pontevedra	Group 1303 Internal derangement of knee 717	Women	372
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.791
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.135
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.656
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	126
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	56
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	70
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	263
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	138
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	125
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	564
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	314
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	250
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	104
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	42
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	62
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.117
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	603
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	514
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.067
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	377
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	690
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	6.104
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.890
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.214
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	548
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	178
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	370
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	501
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Men	282
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Women	219
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	732
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Men	459
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Women	273
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.905
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	813
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.092
Pontevedra	Group 1405 Prostatic hyperplasia  600	Both sexes	629
Pontevedra	Group 1405 Prostatic hyperplasia  600	Men	629
Pontevedra	Group 1405 Prostatic hyperplasia  600	Women	..
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	494
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Men	494
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Pontevedra	Group 1407 Disorders of breast  610-612	Both sexes	243
Pontevedra	Group 1407 Disorders of breast  610-612	Men	23
Pontevedra	Group 1407 Disorders of breast  610-612	Women	220
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	217
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	217
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	70
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	70
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	765
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	12
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	753
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.802
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.802
Pontevedra	Group 1501 Legally induced abortion  635	Both sexes	166
Pontevedra	Group 1501 Legally induced abortion  635	Men	..
Pontevedra	Group 1501 Legally induced abortion  635	Women	166
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	906
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	906
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.846
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.846
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.583
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.583
Pontevedra	Group 1505 Single spontaneous delivery  650	Both sexes	413
Pontevedra	Group 1505 Single spontaneous delivery  650	Men	..
Pontevedra	Group 1505 Single spontaneous delivery  650	Women	413
Pontevedra	Group 1506 Other deliveries  6695-6697	Both sexes	232
Pontevedra	Group 1506 Other deliveries  6695-6697	Men	..
Pontevedra	Group 1506 Other deliveries  6695-6697	Women	232
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Both sexes	105
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Men	..
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Women	105
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	551
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	551
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	896
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Men	525
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Women	371
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	269
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	159
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	110
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	627
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	366
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	261
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Both sexes	604
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Men	392
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Women	212
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.661
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.412
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.249
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	250
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Men	134
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Women	116
Pontevedra	Group 1802 Abdominal pain   7890	Both sexes	294
Pontevedra	Group 1802 Abdominal pain   7890	Men	109
Pontevedra	Group 1802 Abdominal pain   7890	Women	185
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	56
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	7
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	49
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.061
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.162
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	899
Pontevedra	Group 1900 Injuries and poisoning  800-999	Both sexes	9.624
Pontevedra	Group 1900 Injuries and poisoning  800-999	Men	5.077
Pontevedra	Group 1900 Injuries and poisoning  800-999	Women	4.547
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	746
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	432
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	314
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	314
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	214
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	100
Pontevedra	Group 1903 Radius and ulna fracture 813	Both sexes	560
Pontevedra	Group 1903 Radius and ulna fracture 813	Men	251
Pontevedra	Group 1903 Radius and ulna fracture 813	Women	309
Pontevedra	Group 1904 Femur fracture  820-821	Both sexes	1.158
Pontevedra	Group 1904 Femur fracture  820-821	Men	317
Pontevedra	Group 1904 Femur fracture  820-821	Women	841
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	767
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Men	360
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Women	407
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.217
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.927
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.290
Pontevedra	Group 1907 Burns  940-949	Both sexes	83
Pontevedra	Group 1907 Burns  940-949	Men	55
Pontevedra	Group 1907 Burns  940-949	Women	28
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	241
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	106
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	135
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.354
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.311
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.043
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	8
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	176
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	101
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	75
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.806
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	949
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	857
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	51
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	25
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	26
Pontevedra	Group 2102 Contraceptive management  V25	Both sexes	36
Pontevedra	Group 2102 Contraceptive management  V25	Men	1
Pontevedra	Group 2102 Contraceptive management  V25	Women	35
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.094
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	663
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	431
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	625
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	260
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	365
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	704.396
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	322.316
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	382.080
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	18.822
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	10.312
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	8.510
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	3.082
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.510
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	1.572
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Both sexes	952
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Men	466
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Women	486
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	547
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Men	331
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Women	216
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Both sexes	8.440
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Men	4.478
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Women	3.963
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	323
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	273
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	50
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	5.478
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	3.255
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	2.223
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Both sexes	70.224
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Men	35.155
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Women	35.069
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	6.179
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.594
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.585
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.730
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.490
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.239
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.081
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	625
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	456
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.162
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Men	31
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Women	5.131
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.247
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.247
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	737
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Women	737
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	2.771
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Men	2.771
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	6.382
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Men	5.239
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Women	1.142
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	26.417
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	14.430
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	11.987
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Both sexes	1.088
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Men	366
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Women	722
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	1.101
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	622
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	479
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.504
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Women	3.504
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	9.825
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.986
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	5.839
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.063
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.842
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.220
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Both sexes	3.474
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Men	1.574
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Women	1.900
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.589
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.268
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.320
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	13.348
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.856
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	8.493
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Both sexes	2.739
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Men	1.582
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Women	1.157
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	10.609
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	3.274
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	7.335
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Both sexes	17.530
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Men	8.495
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Women	9.035
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	327
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	135
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	191
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.558
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.111
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	447
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.175
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	831
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	344
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	4.456
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	2.582
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.875
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	4.136
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	1.532
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	2.604
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	5.878
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	2.304
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	3.574
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	17.559
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	9.047
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	8.512
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Both sexes	297
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Men	116
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Women	181
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Both sexes	211
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Men	79
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Women	132
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Both sexes	3.383
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Men	1.712
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Women	1.671
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Both sexes	2.018
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Men	987
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Women	1.031
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	11.649
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	6.153
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	5.496
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	4.093
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.066
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.027
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Both sexes	473
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Men	215
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Women	258
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.620
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.851
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.770
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.604
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.725
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.879
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	79.809
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	43.097
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	36.711
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Both sexes	4.371
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Men	1.742
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Women	2.629
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Both sexes	1.985
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Men	1.215
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Women	770
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Both sexes	5.580
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Men	3.969
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Women	1.611
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	5.815
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	4.531
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.284
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	3.147
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Men	1.407
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Women	1.740
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	10.662
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	5.678
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.984
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Both sexes	17.690
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Men	7.767
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Women	9.923
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	12.032
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	6.169
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	5.863
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Both sexes	2.477
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Men	1.863
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Women	614
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.719
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Men	656
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Women	1.062
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	14.331
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	8.100
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	6.231
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	86.986
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	46.796
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	40.190
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.869
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.960
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.910
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Both sexes	20.102
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Men	11.205
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Women	8.897
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	7.265
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	3.506
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	3.759
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.680
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.949
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.731
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	6.432
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.761
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.672
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	14.176
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	10.146
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	4.030
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	4.024
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Men	1.324
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Women	2.700
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	27.436
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	12.945
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	14.491
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	82.160
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Men	44.442
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Women	37.718
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	2.402
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	1.033
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	1.369
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.462
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	821
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	641
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Both sexes	1.866
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Men	1.093
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Women	773
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Both sexes	1.234
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Men	848
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Women	387
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.695
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	774
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	922
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Both sexes	7.092
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Men	3.897
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Women	3.194
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Both sexes	8.486
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Men	7.457
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Women	1.028
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Both sexes	7.031
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Men	3.319
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Women	3.712
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.262
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	648
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	614
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.464
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	2.057
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.407
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.306
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Men	1.558
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Women	1.748
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Both sexes	3.661
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Men	1.786
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Women	1.875
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	4.969
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.190
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.780
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.659
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.152
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.507
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.161
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	984
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	177
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.754
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Men	1.654
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Women	1.100
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Both sexes	15.383
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Men	6.204
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Women	9.179
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.894
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.018
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.876
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Both sexes	4.422
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Men	2.403
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Women	2.019
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	2.957
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.546
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.411
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	6.522
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.281
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	3.241
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.528
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.921
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.607
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	345
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	157
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	187
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.650
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.203
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.447
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	60.345
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	28.393
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	31.952
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Both sexes	9.828
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Men	6.599
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Women	3.229
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	19.206
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	8.013
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	11.193
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	986
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	300
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	686
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	3.773
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.690
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	2.083
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	6.829
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	3.558
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	3.272
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	808
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	341
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	467
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	8.745
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	4.320
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	4.425
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	10.171
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	3.573
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	6.598
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	47.424
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	22.840
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	24.584
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	4.842
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.688
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	3.154
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	4.215
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Men	2.402
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Women	1.814
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	5.987
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Men	3.620
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Women	2.367
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	14.461
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	7.245
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	7.216
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Both sexes	4.748
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Men	4.748
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Women	..
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	2.748
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Men	2.748
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Both sexes	2.837
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Men	246
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Women	2.592
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.111
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.111
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	343
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	343
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	6.132
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	144
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	5.987
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	74.063
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	74.063
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Both sexes	121
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Men	..
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Women	121
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.583
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.583
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	48.703
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	48.703
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	11.313
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	11.313
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Both sexes	3.404
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Men	..
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Women	3.404
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Both sexes	1.910
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Men	..
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Women	1.910
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	580
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Men	..
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Women	580
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	5.448
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	5.448
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	10.634
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	5.947
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	4.687
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	2.484
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.340
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.144
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	8.150
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	4.607
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	3.543
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	7.219
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Men	3.768
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Women	3.451
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	23.930
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	12.660
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	11.270
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.456
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Men	1.348
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Women	1.108
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Both sexes	2.635
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Men	1.018
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Women	1.617
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.150
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	655
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	495
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	17.689
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	9.638
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	8.051
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Both sexes	55.232
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Men	28.430
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Women	26.802
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.448
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.344
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.104
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.457
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.023
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	434
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Both sexes	3.152
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Men	1.600
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Women	1.552
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Both sexes	7.488
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Men	1.996
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Women	5.492
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	3.724
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Men	1.908
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Women	1.816
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	14.449
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	8.756
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	5.694
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Both sexes	503
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Men	305
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Women	198
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.505
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	658
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	847
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	18.344
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	9.760
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	8.584
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	94
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	52
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	42
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	2.069
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	1.029
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	1.040
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	18.830
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	8.166
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	10.664
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	445
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	228
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	216
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Both sexes	134
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Men	11
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Women	123
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	5.864
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	3.229
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	2.634
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	12.387
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	4.697
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	7.690
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	149.343
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	69.584
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	79.759
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.495
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.936
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.559
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	555
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	293
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	262
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Both sexes	107
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Men	56
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Women	51
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	141
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Men	84
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Women	57
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Both sexes	1.553
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Men	830
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Women	723
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	96
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	78
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	18
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.043
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	595
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	448
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Both sexes	11.929
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Men	6.275
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Women	5.654
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.012
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	629
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	383
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	880
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	713
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	167
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	145
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	82
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	63
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	975
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Men	10
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Women	965
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	251
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	251
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	118
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Women	118
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	400
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Men	400
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.161
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Men	986
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Women	175
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.216
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.483
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.733
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Both sexes	219
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Men	100
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Women	119
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	125
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	72
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	53
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	617
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Women	617
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.809
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	799
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.010
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.377
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	674
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	703
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Both sexes	740
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Men	358
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Women	382
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	637
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	316
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	321
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.075
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.309
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.765
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Both sexes	1.033
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Men	647
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Women	386
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.042
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	662
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.379
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Both sexes	3.577
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Men	2.014
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Women	1.563
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	98
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	41
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	56
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	212
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	161
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	50
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	272
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	211
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	61
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.092
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	689
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	403
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	668
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	332
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	336
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.236
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	579
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	657
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.614
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.867
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.748
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Both sexes	108
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Men	33
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Women	75
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Both sexes	79
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Men	26
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Women	53
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Both sexes	720
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Men	405
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Women	315
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Both sexes	619
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Men	340
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Women	279
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.088
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.062
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.025
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	497
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	252
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	245
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Both sexes	63
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Men	31
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Women	32
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	434
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	221
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	213
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	664
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	340
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	324
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	18.528
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.473
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	8.055
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Both sexes	823
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Men	355
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Women	468
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Both sexes	997
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Men	597
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Women	400
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Both sexes	1.839
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Men	1.347
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Women	492
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.447
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.102
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	345
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	445
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Men	194
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Women	251
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.454
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.276
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.178
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Both sexes	3.276
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Men	1.495
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Women	1.781
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.333
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.863
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.470
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Both sexes	262
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Men	203
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Women	59
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	645
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Men	223
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Women	422
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.007
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.816
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.190
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	17.584
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	9.972
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	7.611
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	932
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	481
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	451
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Both sexes	4.092
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Men	2.347
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Women	1.746
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.660
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	823
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	837
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	764
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	404
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	360
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.199
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	721
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	478
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.332
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.922
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	410
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	798
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Men	251
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Women	547
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.806
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.023
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.782
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	18.102
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Men	9.981
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Women	8.122
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	304
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	151
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	153
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	293
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	161
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	132
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Both sexes	319
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Men	192
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Women	127
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Both sexes	301
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Men	194
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Women	107
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	479
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	235
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	244
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Both sexes	1.619
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Men	947
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Women	672
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Both sexes	1.577
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Men	1.407
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Women	169
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Both sexes	1.626
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Men	797
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Women	828
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	393
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	204
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	189
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.126
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	534
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	592
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	761
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Men	373
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Women	388
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Both sexes	760
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Men	427
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Women	333
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.130
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	765
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	364
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	585
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	277
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	308
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	214
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	186
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	28
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	662
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Men	411
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Women	251
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Both sexes	3.399
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Men	1.306
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Women	2.092
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	839
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	450
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	389
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Both sexes	937
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Men	540
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Women	397
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	779
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	422
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	357
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.553
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	840
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	713
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.017
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	599
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	418
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	74
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	31
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	43
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	462
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	210
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	252
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	10.321
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.003
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.318
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Both sexes	1.382
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Men	997
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Women	384
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.761
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.589
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.172
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	196
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	85
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	111
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	354
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	164
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	190
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.248
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	676
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	572
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	308
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	137
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	171
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.411
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	726
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	684
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.661
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	628
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.033
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.686
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.949
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.738
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.200
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	431
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	769
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	987
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Men	557
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Women	430
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.629
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Men	1.014
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Women	615
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.150
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.499
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.651
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Both sexes	723
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Men	723
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Women	..
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	668
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Men	668
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Both sexes	738
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Men	46
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Women	692
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	268
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	268
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	109
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	109
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.214
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	10
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.204
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	18.595
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	18.595
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Both sexes	4
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Men	..
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Women	4
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	964
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	964
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.536
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.536
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.214
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.214
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Both sexes	583
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Men	..
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Women	583
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Both sexes	792
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Men	..
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Women	792
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	135
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Men	..
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Women	135
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.367
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.367
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.692
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	955
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	737
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	599
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	342
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	257
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.093
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	613
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	480
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.086
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Men	576
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Women	510
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.768
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.341
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.427
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.069
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Men	626
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Women	443
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Both sexes	705
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Men	286
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Women	419
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	614
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	346
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	268
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.380
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	3.083
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.296
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Both sexes	12.241
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Men	6.612
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Women	5.629
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	739
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	445
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	294
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	311
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	219
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	92
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Both sexes	762
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Men	376
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Women	386
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Both sexes	1.739
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Men	595
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Women	1.144
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	844
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Men	453
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Women	391
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.676
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.327
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.349
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Both sexes	82
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Men	47
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Women	35
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	362
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	174
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	188
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.249
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.715
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.534
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	12
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	6
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	464
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	254
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	210
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.958
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.216
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.742
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	53
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	27
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	26
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Both sexes	76
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Men	9
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Women	67
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	885
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	596
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	289
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.944
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	584
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.360
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	68.553
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.380
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	35.173
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.265
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	733
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	532
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	203
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	117
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	86
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Both sexes	86
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Men	44
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Women	42
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	42
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Men	24
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Women	18
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Both sexes	496
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Men	285
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Women	211
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	31
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	20
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	11
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	407
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	243
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	164
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Both sexes	7.833
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Men	4.148
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Women	3.685
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	809
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	544
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	265
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	615
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	472
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	143
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	132
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	73
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	59
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	605
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Men	10
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Women	595
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	177
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	177
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	98
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Women	98
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	310
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Men	310
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	509
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Men	400
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Women	109
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.041
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.803
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.238
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Both sexes	120
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Men	39
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Women	81
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	109
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	62
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	47
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	312
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Women	312
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	996
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	435
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	561
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	691
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	375
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	316
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Both sexes	436
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Men	253
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Women	183
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	255
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	122
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	133
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.242
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	538
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	704
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Both sexes	390
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Men	246
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Women	144
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	852
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	292
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	560
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Both sexes	1.769
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Men	909
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Women	860
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	77
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	45
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	32
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	118
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	91
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	27
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	108
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	64
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	44
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	506
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	306
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	200
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	453
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	190
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	263
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	507
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	213
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	294
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.958
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.036
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	922
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Both sexes	203
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Men	83
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Women	120
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Both sexes	11
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Men	3
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Women	8
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Both sexes	183
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Men	90
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Women	93
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Both sexes	165
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Men	81
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Women	84
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.396
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	779
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	617
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	377
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	174
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	203
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Both sexes	43
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Men	19
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Women	24
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	334
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	155
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	179
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	426
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	222
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	204
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.320
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.821
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.499
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Both sexes	718
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Men	327
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Women	391
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Both sexes	209
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Men	122
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Women	87
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Both sexes	622
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Men	455
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Women	167
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	649
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	514
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	135
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	405
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Men	185
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Women	220
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.120
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	639
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	481
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Both sexes	1.265
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Men	648
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Women	617
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.411
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	738
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	673
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Both sexes	353
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Men	283
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Women	70
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	96
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Men	41
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Women	55
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.472
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	869
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	603
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	8.082
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.638
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.444
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	345
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	184
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	161
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Both sexes	1.748
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Men	979
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Women	769
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	486
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	265
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	221
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	713
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	402
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	311
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	835
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	529
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	306
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.173
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	863
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	310
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	250
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Men	94
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Women	156
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.532
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.322
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.210
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.440
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Men	4.830
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Women	3.610
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	158
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	83
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	75
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	159
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	97
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	62
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Both sexes	166
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Men	95
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Women	71
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Both sexes	130
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Men	92
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Women	38
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	222
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	101
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	121
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Both sexes	744
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Men	430
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Women	314
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Both sexes	702
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Men	616
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Women	86
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Both sexes	628
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Men	317
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Women	311
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	187
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	107
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	80
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	430
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	205
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	225
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	405
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Men	211
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Women	194
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Both sexes	352
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Men	154
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Women	198
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	551
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	379
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	172
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	375
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	177
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	198
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	209
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	182
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	27
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	282
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Men	162
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Women	120
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Both sexes	1.502
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Men	676
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Women	826
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	412
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	240
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	172
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Both sexes	383
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Men	241
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Women	142
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	443
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	265
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	178
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	665
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	378
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	287
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	371
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	229
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	142
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	33
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	20
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	261
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	129
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	132
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.415
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.239
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.176
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Both sexes	868
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Men	608
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Women	260
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.009
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.029
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	980
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	186
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	53
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	133
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	290
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	159
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	131
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	492
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	293
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	199
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	233
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	95
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	138
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.176
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	586
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	590
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.161
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	416
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	745
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.316
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.520
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.796
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	296
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	117
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	179
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	365
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Men	226
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Women	139
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	260
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Men	160
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Women	100
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	985
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	486
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	499
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Both sexes	343
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Men	343
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	160
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Men	160
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Both sexes	227
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Men	26
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Women	201
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	77
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	77
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	39
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	39
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	564
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	562
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	6.794
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	6.794
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Both sexes	1
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Women	1
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	420
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	420
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.252
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.252
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.303
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.303
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Both sexes	98
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Women	98
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Both sexes	229
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Women	229
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	37
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Women	37
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	454
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	454
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	659
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	373
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	286
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	160
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	84
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	76
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	499
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	289
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	210
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	535
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Men	294
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Women	241
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.586
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.373
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.213
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	146
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Men	88
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Women	58
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Both sexes	337
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Men	119
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Women	218
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	315
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	182
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	133
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.788
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	984
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	804
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Both sexes	5.715
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Men	2.994
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Women	2.721
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	385
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	216
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	169
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	169
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	118
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	51
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Both sexes	362
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Men	176
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Women	186
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Both sexes	827
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Men	217
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Women	610
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	386
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Men	194
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Women	192
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.706
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.039
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	667
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Both sexes	41
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Men	26
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Women	15
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	94
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	34
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	60
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.532
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	872
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	660
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	15
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	9
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	198
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	93
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	105
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.465
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	785
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	680
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	43
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	20
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	23
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Both sexes	8
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Women	8
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	800
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	475
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	325
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	614
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	290
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	324
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	246.170
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	122.390
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	123.780
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.937
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.766
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.171
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	591
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	306
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	286
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Both sexes	270
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Men	127
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Women	142
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Both sexes	174
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Men	99
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Women	75
PA═S VASCO	Group 0104 Septicaemia  038	Both sexes	2.359
PA═S VASCO	Group 0104 Septicaemia  038	Men	1.320
PA═S VASCO	Group 0104 Septicaemia  038	Women	1.039
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	233
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	169
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	64
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.310
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	745
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	565
PA═S VASCO	Group 0200 Neoplasms  140-239	Both sexes	23.712
PA═S VASCO	Group 0200 Neoplasms  140-239	Men	12.798
PA═S VASCO	Group 0200 Neoplasms  140-239	Women	10.913
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	2.399
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.483
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	915
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.646
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.224
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	422
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	404
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	217
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	188
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.759
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Men	16
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Women	1.743
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	466
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	466
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	232
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Men	..
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Women	232
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.226
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Men	1.226
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Women	..
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.197
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Men	1.783
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Women	414
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	8.753
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	5.216
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	3.537
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Both sexes	301
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Men	108
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Women	193
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	355
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	214
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	140
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Both sexes	936
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Men	..
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Women	936
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.038
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.311
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.727
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.799
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.364
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.435
PA═S VASCO	Group 0301 Anaemias 280-285	Both sexes	1.890
PA═S VASCO	Group 0301 Anaemias 280-285	Men	910
PA═S VASCO	Group 0301 Anaemias 280-285	Women	980
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	909
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	454
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	454
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.984
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.716
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.268
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Both sexes	1.394
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Men	855
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Women	539
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.590
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	861
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.729
PA═S VASCO	Group 0500 Mental disorders  290-319	Both sexes	7.417
PA═S VASCO	Group 0500 Mental disorders  290-319	Men	3.928
PA═S VASCO	Group 0500 Mental disorders  290-319	Women	3.488
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	169
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	83
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	86
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	618
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	428
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	190
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	547
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	399
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	147
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	2.474
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	1.516
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	958
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.748
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	671
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.076
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.861
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	831
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.030
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.297
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.818
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.479
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Both sexes	110
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Men	49
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Women	61
PA═S VASCO	Group 0602 Multiple sclerosis 340	Both sexes	76
PA═S VASCO	Group 0602 Multiple sclerosis 340	Men	19
PA═S VASCO	Group 0602 Multiple sclerosis 340	Women	57
PA═S VASCO	Group 0603 Epilepsy  345	Both sexes	851
PA═S VASCO	Group 0603 Epilepsy  345	Men	481
PA═S VASCO	Group 0603 Epilepsy  345	Women	370
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Both sexes	741
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Men	368
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Women	373
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.518
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.901
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.618
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	792
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	364
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	428
PA═S VASCO	Grupo 0701 Cataract  366	Both sexes	45
PA═S VASCO	Grupo 0701 Cataract  366	Men	19
PA═S VASCO	Grupo 0701 Cataract  366	Women	26
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	747
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	345
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	402
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.221
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Men	611
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Women	609
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	32.516
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	18.703
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	13.813
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Both sexes	1.687
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Men	757
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Women	930
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Both sexes	757
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Men	467
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Women	290
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Both sexes	2.131
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Men	1.495
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Women	637
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.305
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.816
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	489
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.154
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Men	528
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Women	626
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.884
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.814
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.070
PA═S VASCO	Grupo 0907 Heart failure  428	Both sexes	6.863
PA═S VASCO	Grupo 0907 Heart failure  428	Men	3.520
PA═S VASCO	Grupo 0907 Heart failure  428	Women	3.343
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	5.333
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.808
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.525
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Both sexes	1.562
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Men	1.176
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Women	386
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Both sexes	811
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Men	334
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Women	478
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	5.028
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	2.988
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.041
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	30.723
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	17.326
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	13.397
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.296
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	674
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	622
PA═S VASCO	Group 1002 Pneumonia 480-486	Both sexes	6.336
PA═S VASCO	Group 1002 Pneumonia 480-486	Men	3.748
PA═S VASCO	Group 1002 Pneumonia 480-486	Women	2.588
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	3.163
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.390
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.773
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.418
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	779
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	639
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.482
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.561
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	921
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	5.335
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	3.923
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.412
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.887
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Men	600
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Women	1.287
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	8.807
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	4.652
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	4.155
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Both sexes	29.582
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Men	16.985
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Women	12.597
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	351
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	176
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	175
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	410
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	237
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	173
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Both sexes	579
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Men	352
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Women	227
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Both sexes	595
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Men	421
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Women	174
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	575
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	312
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	263
PA═S VASCO	Group 1106 Appendicitis  540-543	Both sexes	2.648
PA═S VASCO	Group 1106 Appendicitis  540-543	Men	1.468
PA═S VASCO	Group 1106 Appendicitis  540-543	Women	1.179
PA═S VASCO	Group 1107 Inguinal hernia  550	Both sexes	3.416
PA═S VASCO	Group 1107 Inguinal hernia  550	Men	3.008
PA═S VASCO	Group 1107 Inguinal hernia  550	Women	408
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Both sexes	2.447
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Men	1.196
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Women	1.252
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	634
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	331
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	303
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.198
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	557
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	640
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.685
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Men	904
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Women	781
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Both sexes	1.436
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Men	655
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Women	781
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.985
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.301
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	684
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.110
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	518
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	593
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	574
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Men	453
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Women	120
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.040
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Men	627
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Women	413
PA═S VASCO	Group 1117 Cholelithiasis  574	Both sexes	4.778
PA═S VASCO	Group 1117 Cholelithiasis  574	Men	2.097
PA═S VASCO	Group 1117 Cholelithiasis  574	Women	2.681
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.403
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	802
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	601
PA═S VASCO	Group 1119 Pancreatic diseases 577	Both sexes	1.346
PA═S VASCO	Group 1119 Pancreatic diseases 577	Men	793
PA═S VASCO	Group 1119 Pancreatic diseases 577	Women	553
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.374
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	779
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	595
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.550
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.425
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.125
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.775
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.088
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	688
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	112
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	56
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	56
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	662
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	282
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	381
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	19.469
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	9.887
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	9.582
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
PA═S VASCO	Group 1303 Internal derangement of knee 717	Both sexes	2.535
PA═S VASCO	Group 1303 Internal derangement of knee 717	Men	1.674
PA═S VASCO	Group 1303 Internal derangement of knee 717	Women	862
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	7.594
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	3.676
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.918
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	289
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	120
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	169
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	1.121
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	583
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	538
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.330
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	733
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	597
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	626
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	295
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	331
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	3.031
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.730
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.301
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.943
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.076
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.867
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	16.110
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	7.943
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	8.167
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.430
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	545
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	886
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.394
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Men	809
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Women	585
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.433
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Men	1.529
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Women	904
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	4.787
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.419
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.368
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Both sexes	1.577
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Men	1.577
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Women	..
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	922
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Men	922
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Women	..
PA═S VASCO	Group 1407 Disorders of breast  610-612	Both sexes	1.136
PA═S VASCO	Group 1407 Disorders of breast  610-612	Men	85
PA═S VASCO	Group 1407 Disorders of breast  610-612	Women	1.051
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	378
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	378
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	98
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	98
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.955
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	57
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.898
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	20.675
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	20.675
PA═S VASCO	Group 1501 Legally induced abortion  635	Both sexes	166
PA═S VASCO	Group 1501 Legally induced abortion  635	Men	..
PA═S VASCO	Group 1501 Legally induced abortion  635	Women	166
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	499
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	499
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.657
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.657
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.851
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.851
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Both sexes	1.572
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Men	..
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Women	1.572
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Both sexes	314
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Men	..
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Women	314
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Both sexes	163
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Men	..
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Women	163
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.452
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.452
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.178
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.200
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Women	978
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	617
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	303
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	314
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.562
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	897
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	665
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.212
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Men	681
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Women	531
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	13.569
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	7.468
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	6.101
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.267
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Men	1.311
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Women	956
PA═S VASCO	Group 1802 Abdominal pain   7890	Both sexes	1.378
PA═S VASCO	Group 1802 Abdominal pain   7890	Men	560
PA═S VASCO	Group 1802 Abdominal pain   7890	Women	818
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.590
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	883
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	707
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.333
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.713
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.620
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Both sexes	21.215
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Men	11.347
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Women	9.868
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.274
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	719
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	555
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	534
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	369
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	165
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Both sexes	1.400
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Men	586
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Women	814
PA═S VASCO	Group 1904 Femur fracture  820-821	Both sexes	2.986
PA═S VASCO	Group 1904 Femur fracture  820-821	Men	843
PA═S VASCO	Group 1904 Femur fracture  820-821	Women	2.143
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.478
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Men	713
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Women	766
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	6.514
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	4.119
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.396
PA═S VASCO	Group 1907 Burns  940-949	Both sexes	123
PA═S VASCO	Group 1907 Burns  940-949	Men	86
PA═S VASCO	Group 1907 Burns  940-949	Women	37
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	554
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	242
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	313
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	5.553
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	3.250
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.302
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	61
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	42
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	19
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	736
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	379
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	358
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	6.212
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	3.058
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	3.154
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	247
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	120
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	126
PA═S VASCO	Group 2102 Contraceptive management  V25	Both sexes	95
PA═S VASCO	Group 2102 Contraceptive management  V25	Men	9
PA═S VASCO	Group 2102 Contraceptive management  V25	Women	86
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.645
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	999
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	647
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	4.225
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.930
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	2.295
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	36.721
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.648
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	18.073
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	611
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	342
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	269
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	79
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	41
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	38
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Both sexes	15
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Men	10
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Women	5
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Both sexes	28
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Men	16
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Women	12
Araba/┴lava	Group 0104 Septicaemia  038	Both sexes	269
Araba/┴lava	Group 0104 Septicaemia  038	Men	143
Araba/┴lava	Group 0104 Septicaemia  038	Women	126
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	12
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	208
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	125
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	83
Araba/┴lava	Group 0200 Neoplasms  140-239	Both sexes	3.183
Araba/┴lava	Group 0200 Neoplasms  140-239	Men	1.798
Araba/┴lava	Group 0200 Neoplasms  140-239	Women	1.385
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	297
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	179
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	118
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	164
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	126
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	38
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	13
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	9
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	4
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	241
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Women	237
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	59
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	59
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	36
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Women	36
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Both sexes	233
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Men	233
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Women	..
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Both sexes	400
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Men	330
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Women	70
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.184
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	703
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	481
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Both sexes	39
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Men	21
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Women	18
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	61
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	30
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	31
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Both sexes	82
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Men	..
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Women	82
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	374
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	163
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	211
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	466
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	196
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	270
Araba/┴lava	Group 0301 Anaemias 280-285	Both sexes	271
Araba/┴lava	Group 0301 Anaemias 280-285	Men	116
Araba/┴lava	Group 0301 Anaemias 280-285	Women	155
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	195
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	80
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	115
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	624
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	281
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	343
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Both sexes	254
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Men	149
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Women	105
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	370
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	132
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	238
Araba/┴lava	Group 0500 Mental disorders  290-319	Both sexes	1.007
Araba/┴lava	Group 0500 Mental disorders  290-319	Men	528
Araba/┴lava	Group 0500 Mental disorders  290-319	Women	479
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	24
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	10
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	14
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	112
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	72
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	40
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	36
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	23
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	13
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	318
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	197
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	121
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	203
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	86
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	117
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	314
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	140
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	174
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	819
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	446
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	373
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Both sexes	9
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Men	3
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Women	6
Araba/┴lava	Group 0602 Multiple sclerosis 340	Both sexes	15
Araba/┴lava	Group 0602 Multiple sclerosis 340	Men	3
Araba/┴lava	Group 0602 Multiple sclerosis 340	Women	12
Araba/┴lava	Group 0603 Epilepsy  345	Both sexes	177
Araba/┴lava	Group 0603 Epilepsy  345	Men	114
Araba/┴lava	Group 0603 Epilepsy  345	Women	63
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Both sexes	130
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Men	68
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Women	62
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	488
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	258
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	230
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	125
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	63
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	62
Araba/┴lava	Grupo 0701 Cataract  366	Both sexes	7
Araba/┴lava	Grupo 0701 Cataract  366	Men	4
Araba/┴lava	Grupo 0701 Cataract  366	Women	3
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	118
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	59
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	59
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	175
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Men	80
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Women	95
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.628
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.680
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.948
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Both sexes	282
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Men	114
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Women	168
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Both sexes	106
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Men	69
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Women	37
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Both sexes	460
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Men	318
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Women	142
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	187
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	152
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	35
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	198
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Men	105
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Women	93
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	557
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	340
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	217
Araba/┴lava	Grupo 0907 Heart failure  428	Both sexes	903
Araba/┴lava	Grupo 0907 Heart failure  428	Men	481
Araba/┴lava	Grupo 0907 Heart failure  428	Women	422
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	734
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	415
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	319
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Both sexes	240
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Men	183
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Women	57
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Both sexes	270
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Men	92
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Women	178
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	691
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	411
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	280
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.620
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.666
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.954
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	217
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	108
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	109
Araba/┴lava	Group 1002 Pneumonia 480-486	Both sexes	1.057
Araba/┴lava	Group 1002 Pneumonia 480-486	Men	667
Araba/┴lava	Group 1002 Pneumonia 480-486	Women	390
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	589
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Men	279
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Women	310
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	169
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	88
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	81
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	299
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	192
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	107
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	799
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	619
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	180
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	277
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Men	82
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Women	195
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.213
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	631
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	582
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.415
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Men	2.557
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Women	1.858
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	57
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	25
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	32
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	65
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	41
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	24
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Both sexes	128
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Men	74
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Women	54
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Both sexes	90
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Men	69
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Women	21
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	106
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	64
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	42
Araba/┴lava	Group 1106 Appendicitis  540-543	Both sexes	344
Araba/┴lava	Group 1106 Appendicitis  540-543	Men	197
Araba/┴lava	Group 1106 Appendicitis  540-543	Women	147
Araba/┴lava	Group 1107 Inguinal hernia  550	Both sexes	452
Araba/┴lava	Group 1107 Inguinal hernia  550	Men	399
Araba/┴lava	Group 1107 Inguinal hernia  550	Women	53
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Both sexes	327
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Men	145
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Women	182
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	132
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	68
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	64
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	241
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	120
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	121
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Both sexes	293
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Men	163
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Women	130
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Both sexes	190
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Men	106
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Women	84
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	231
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	140
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	91
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	149
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	84
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	65
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	86
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Men	67
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Women	19
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	165
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Men	89
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Women	76
Araba/┴lava	Group 1117 Cholelithiasis  574	Both sexes	674
Araba/┴lava	Group 1117 Cholelithiasis  574	Men	322
Araba/┴lava	Group 1117 Cholelithiasis  574	Women	352
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	237
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	133
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	104
Araba/┴lava	Group 1119 Pancreatic diseases 577	Both sexes	200
Araba/┴lava	Group 1119 Pancreatic diseases 577	Men	124
Araba/┴lava	Group 1119 Pancreatic diseases 577	Women	76
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	248
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	127
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	121
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	336
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	189
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	147
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	233
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	136
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	97
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	17
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	10
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	7
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	86
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	43
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	43
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.604
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.889
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.715
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Araba/┴lava	Group 1303 Internal derangement of knee 717	Both sexes	614
Araba/┴lava	Group 1303 Internal derangement of knee 717	Men	436
Araba/┴lava	Group 1303 Internal derangement of knee 717	Women	178
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.330
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	704
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	626
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	29
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	13
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	16
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	182
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	92
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	90
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	209
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	117
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	92
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	158
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	72
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	86
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	504
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	257
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	247
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	578
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	198
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	380
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.523
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.437
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.086
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	231
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	103
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	128
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	221
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Men	133
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Women	88
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	477
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Men	306
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Women	171
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	826
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	447
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	379
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Both sexes	271
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Men	271
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Women	..
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	168
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Men	168
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Araba/┴lava	Group 1407 Disorders of breast  610-612	Both sexes	90
Araba/┴lava	Group 1407 Disorders of breast  610-612	Men	4
Araba/┴lava	Group 1407 Disorders of breast  610-612	Women	86
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	47
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	47
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	13
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	13
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	179
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	5
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	174
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.996
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.996
Araba/┴lava	Group 1501 Legally induced abortion  635	Both sexes	20
Araba/┴lava	Group 1501 Legally induced abortion  635	Men	..
Araba/┴lava	Group 1501 Legally induced abortion  635	Women	20
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	64
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	64
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.074
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.074
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	561
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	561
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Both sexes	100
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Men	..
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Women	100
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Both sexes	2
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Men	..
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Women	2
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Both sexes	14
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Men	..
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Women	14
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	161
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	161
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	341
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Men	181
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Women	160
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	86
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	33
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	53
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	255
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	148
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	107
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Both sexes	144
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Men	86
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Women	58
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.136
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.182
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	954
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	244
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Men	133
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Women	111
Araba/┴lava	Group 1802 Abdominal pain   7890	Both sexes	274
Araba/┴lava	Group 1802 Abdominal pain   7890	Men	109
Araba/┴lava	Group 1802 Abdominal pain   7890	Women	165
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	3
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.615
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	938
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	677
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Both sexes	3.282
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Men	1.650
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Women	1.632
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	422
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	233
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	189
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	81
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	57
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	24
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Both sexes	191
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Men	70
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Women	121
Araba/┴lava	Group 1904 Femur fracture  820-821	Both sexes	352
Araba/┴lava	Group 1904 Femur fracture  820-821	Men	93
Araba/┴lava	Group 1904 Femur fracture  820-821	Women	259
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	205
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Men	97
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Women	108
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	844
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	481
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	363
Araba/┴lava	Group 1907 Burns  940-949	Both sexes	4
Araba/┴lava	Group 1907 Burns  940-949	Men	2
Araba/┴lava	Group 1907 Burns  940-949	Women	2
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	166
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	60
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	106
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	907
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	494
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	413
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	5
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	4
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	105
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	59
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	46
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	686
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	397
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	289
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	11
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	8
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	3
Araba/┴lava	Group 2102 Contraceptive management  V25	Both sexes	9
Araba/┴lava	Group 2102 Contraceptive management  V25	Men	1
Araba/┴lava	Group 2102 Contraceptive management  V25	Women	8
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	199
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	119
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	80
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	467
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	269
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	198
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	126.486
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	62.695
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	63.791
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.604
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.440
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.164
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	255
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	129
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	127
Bizkaia	Group 0102 Imprecise intestinal infections 009	Both sexes	166
Bizkaia	Group 0102 Imprecise intestinal infections 009	Men	73
Bizkaia	Group 0102 Imprecise intestinal infections 009	Women	92
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Both sexes	84
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Men	52
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Women	32
Bizkaia	Group 0104 Septicaemia  038	Both sexes	1.258
Bizkaia	Group 0104 Septicaemia  038	Men	679
Bizkaia	Group 0104 Septicaemia  038	Women	579
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	164
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	115
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	49
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	677
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	392
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	285
Bizkaia	Group 0200 Neoplasms  140-239	Both sexes	12.800
Bizkaia	Group 0200 Neoplasms  140-239	Men	6.888
Bizkaia	Group 0200 Neoplasms  140-239	Women	5.911
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.340
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	847
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	492
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	863
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	637
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	226
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	240
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	124
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	117
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	897
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Men	9
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Women	888
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	239
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	239
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	103
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Women	103
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	584
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Men	584
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.203
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Men	988
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Women	215
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.826
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.848
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.978
Bizkaia	Group 0210 Carcinoma in situ  230-234	Both sexes	163
Bizkaia	Group 0210 Carcinoma in situ  230-234	Men	54
Bizkaia	Group 0210 Carcinoma in situ  230-234	Women	109
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	123
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	78
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	44
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	520
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Women	520
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.699
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	719
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	980
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.449
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	736
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	713
Bizkaia	Group 0301 Anaemias 280-285	Both sexes	951
Bizkaia	Group 0301 Anaemias 280-285	Men	480
Bizkaia	Group 0301 Anaemias 280-285	Women	471
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	498
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	256
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	241
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.013
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	819
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.194
Bizkaia	Group 0401 Diabetes mellitus  249-250	Both sexes	638
Bizkaia	Group 0401 Diabetes mellitus  249-250	Men	378
Bizkaia	Group 0401 Diabetes mellitus  249-250	Women	260
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.375
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	441
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	934
Bizkaia	Group 0500 Mental disorders  290-319	Both sexes	4.404
Bizkaia	Group 0500 Mental disorders  290-319	Men	2.303
Bizkaia	Group 0500 Mental disorders  290-319	Women	2.100
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	51
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	24
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	27
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	319
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	229
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	90
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	398
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	291
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	106
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.519
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	893
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	626
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.126
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	424
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	701
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	991
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	442
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	549
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.843
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.487
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.356
Bizkaia	Group 0601 Alzheimer's disease  3310	Both sexes	49
Bizkaia	Group 0601 Alzheimer's disease  3310	Men	22
Bizkaia	Group 0601 Alzheimer's disease  3310	Women	27
Bizkaia	Group 0602 Multiple sclerosis 340	Both sexes	37
Bizkaia	Group 0602 Multiple sclerosis 340	Men	13
Bizkaia	Group 0602 Multiple sclerosis 340	Women	24
Bizkaia	Group 0603 Epilepsy  345	Both sexes	401
Bizkaia	Group 0603 Epilepsy  345	Men	209
Bizkaia	Group 0603 Epilepsy  345	Women	192
Bizkaia	Group 0604 Transient cerebral ischemia 435	Both sexes	356
Bizkaia	Group 0604 Transient cerebral ischemia 435	Men	179
Bizkaia	Group 0604 Transient cerebral ischemia 435	Women	177
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.999
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.064
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	936
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	434
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	193
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	241
Bizkaia	Grupo 0701 Cataract  366	Both sexes	27
Bizkaia	Grupo 0701 Cataract  366	Men	9
Bizkaia	Grupo 0701 Cataract  366	Women	18
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	407
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	184
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	223
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	484
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	260
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	223
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.408
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	9.922
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.486
Bizkaia	Group 0901 Hypertensive disease  401-405	Both sexes	948
Bizkaia	Group 0901 Hypertensive disease  401-405	Men	436
Bizkaia	Group 0901 Hypertensive disease  401-405	Women	512
Bizkaia	Group 0902 Angina pectoris  4111, 413	Both sexes	364
Bizkaia	Group 0902 Angina pectoris  4111, 413	Men	202
Bizkaia	Group 0902 Angina pectoris  4111, 413	Women	162
Bizkaia	Group 0903 Acute myocardial infarction  410	Both sexes	1.028
Bizkaia	Group 0903 Acute myocardial infarction  410	Men	704
Bizkaia	Group 0903 Acute myocardial infarction  410	Women	325
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.407
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.089
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	318
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	659
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Men	288
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Women	371
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.666
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.536
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.130
Bizkaia	Grupo 0907 Heart failure  428	Both sexes	3.804
Bizkaia	Grupo 0907 Heart failure  428	Men	1.904
Bizkaia	Grupo 0907 Heart failure  428	Women	1.900
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.760
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.432
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.328
Bizkaia	Grupo 0909 Atherosclerosis  440	Both sexes	788
Bizkaia	Grupo 0909 Atherosclerosis  440	Men	591
Bizkaia	Grupo 0909 Atherosclerosis  440	Women	197
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Both sexes	236
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Men	111
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Women	126
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.747
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.629
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.119
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.542
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.653
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.889
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	569
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	314
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	255
Bizkaia	Group 1002 Pneumonia 480-486	Both sexes	2.716
Bizkaia	Group 1002 Pneumonia 480-486	Men	1.533
Bizkaia	Group 1002 Pneumonia 480-486	Women	1.183
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.036
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	830
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.206
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	685
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	371
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	314
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.297
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	782
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	515
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.920
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.145
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	775
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.120
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Men	327
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Women	793
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.200
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.352
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.848
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Both sexes	15.900
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Men	9.099
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Women	6.801
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	183
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	102
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	81
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	197
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	107
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	90
Bizkaia	Group 1103 Diseases of the esophagus 530	Both sexes	297
Bizkaia	Group 1103 Diseases of the esophagus 530	Men	174
Bizkaia	Group 1103 Diseases of the esophagus 530	Women	123
Bizkaia	Group 1104 Peptic ulcer 531-534	Both sexes	330
Bizkaia	Group 1104 Peptic ulcer 531-534	Men	228
Bizkaia	Group 1104 Peptic ulcer 531-534	Women	102
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	292
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	150
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	142
Bizkaia	Group 1106 Appendicitis  540-543	Both sexes	1.402
Bizkaia	Group 1106 Appendicitis  540-543	Men	770
Bizkaia	Group 1106 Appendicitis  540-543	Women	631
Bizkaia	Group 1107 Inguinal hernia  550	Both sexes	2.063
Bizkaia	Group 1107 Inguinal hernia  550	Men	1.833
Bizkaia	Group 1107 Inguinal hernia  550	Women	230
Bizkaia	Group 1108 Other abdominal hernia  551-553	Both sexes	1.386
Bizkaia	Group 1108 Other abdominal hernia  551-553	Men	686
Bizkaia	Group 1108 Other abdominal hernia  551-553	Women	701
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	302
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	153
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	149
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	520
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	238
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	281
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	749
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Men	392
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Women	357
Bizkaia	Group 1112 Intestinal diverticulosis 562	Both sexes	779
Bizkaia	Group 1112 Intestinal diverticulosis 562	Men	353
Bizkaia	Group 1112 Intestinal diverticulosis 562	Women	426
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.067
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	688
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	379
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	667
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	295
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	373
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	335
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Men	270
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Women	64
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	615
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Men	379
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Women	236
Bizkaia	Group 1117 Cholelithiasis  574	Both sexes	2.659
Bizkaia	Group 1117 Cholelithiasis  574	Men	1.139
Bizkaia	Group 1117 Cholelithiasis  574	Women	1.520
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	774
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	416
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	358
Bizkaia	Group 1119 Pancreatic diseases 577	Both sexes	695
Bizkaia	Group 1119 Pancreatic diseases 577	Men	405
Bizkaia	Group 1119 Pancreatic diseases 577	Women	290
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	590
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	323
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	267
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.183
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	665
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	518
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	813
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	511
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	303
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	63
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	30
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	33
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	306
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	125
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	182
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.083
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.505
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.578
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Bizkaia	Group 1303 Internal derangement of knee 717	Both sexes	903
Bizkaia	Group 1303 Internal derangement of knee 717	Men	589
Bizkaia	Group 1303 Internal derangement of knee 717	Women	315
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.781
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.708
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.073
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	189
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	77
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	112
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	444
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	227
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	217
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	542
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	314
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	228
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	230
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	116
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	114
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.522
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	936
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	586
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.472
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	538
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	934
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	8.469
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.029
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.440
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	812
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	293
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	520
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	812
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Men	474
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Women	338
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.105
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Men	688
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Women	417
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.321
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.169
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.152
Bizkaia	Group 1405 Prostatic hyperplasia  600	Both sexes	768
Bizkaia	Group 1405 Prostatic hyperplasia  600	Men	768
Bizkaia	Group 1405 Prostatic hyperplasia  600	Women	..
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	546
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Men	546
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Bizkaia	Group 1407 Disorders of breast  610-612	Both sexes	720
Bizkaia	Group 1407 Disorders of breast  610-612	Men	49
Bizkaia	Group 1407 Disorders of breast  610-612	Women	671
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	200
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	200
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	41
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	41
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.144
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	42
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.102
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	10.217
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	10.217
Bizkaia	Group 1501 Legally induced abortion  635	Both sexes	74
Bizkaia	Group 1501 Legally induced abortion  635	Men	..
Bizkaia	Group 1501 Legally induced abortion  635	Women	74
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	223
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	223
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.736
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.736
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.100
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.100
Bizkaia	Group 1505 Single spontaneous delivery  650	Both sexes	809
Bizkaia	Group 1505 Single spontaneous delivery  650	Men	..
Bizkaia	Group 1505 Single spontaneous delivery  650	Women	809
Bizkaia	Group 1506 Other deliveries  6695-6697	Both sexes	174
Bizkaia	Group 1506 Other deliveries  6695-6697	Men	..
Bizkaia	Group 1506 Other deliveries  6695-6697	Women	174
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Both sexes	107
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Men	..
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Women	107
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	993
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	993
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	969
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	529
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	440
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	287
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	134
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	153
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	683
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	395
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	288
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	797
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Men	456
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Women	341
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	5.908
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.189
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.719
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.151
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Men	643
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Women	508
Bizkaia	Group 1802 Abdominal pain   7890	Both sexes	582
Bizkaia	Group 1802 Abdominal pain   7890	Men	240
Bizkaia	Group 1802 Abdominal pain   7890	Women	342
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	36
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	16
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	20
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.138
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.289
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.849
Bizkaia	Group 1900 Injuries and poisoning  800-999	Both sexes	11.255
Bizkaia	Group 1900 Injuries and poisoning  800-999	Men	6.183
Bizkaia	Group 1900 Injuries and poisoning  800-999	Women	5.072
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	393
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	228
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	165
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	198
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	133
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	65
Bizkaia	Group 1903 Radius and ulna fracture 813	Both sexes	773
Bizkaia	Group 1903 Radius and ulna fracture 813	Men	349
Bizkaia	Group 1903 Radius and ulna fracture 813	Women	424
Bizkaia	Group 1904 Femur fracture  820-821	Both sexes	1.694
Bizkaia	Group 1904 Femur fracture  820-821	Men	500
Bizkaia	Group 1904 Femur fracture  820-821	Women	1.194
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	804
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Men	394
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Women	411
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.713
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.435
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.279
Bizkaia	Group 1907 Burns  940-949	Both sexes	73
Bizkaia	Group 1907 Burns  940-949	Men	49
Bizkaia	Group 1907 Burns  940-949	Women	24
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	233
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	107
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	127
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.998
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.799
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.198
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	36
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	23
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	13
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	338
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	167
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	172
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.724
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.337
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.387
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	169
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	80
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	88
Bizkaia	Group 2102 Contraceptive management  V25	Both sexes	60
Bizkaia	Group 2102 Contraceptive management  V25	Men	4
Bizkaia	Group 2102 Contraceptive management  V25	Women	56
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	816
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	516
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	301
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.679
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	737
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	942
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	82.963
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	41.047
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	41.916
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.722
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	984
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	738
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	257
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	136
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	121
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Both sexes	89
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Men	44
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Women	45
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Both sexes	62
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Men	31
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Women	31
Gipuzkoa	Group 0104 Septicaemia  038	Both sexes	832
Gipuzkoa	Group 0104 Septicaemia  038	Men	498
Gipuzkoa	Group 0104 Septicaemia  038	Women	334
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	57
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	47
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	10
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	425
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	228
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	197
Gipuzkoa	Group 0200 Neoplasms  140-239	Both sexes	7.729
Gipuzkoa	Group 0200 Neoplasms  140-239	Men	4.112
Gipuzkoa	Group 0200 Neoplasms  140-239	Women	3.617
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	762
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	457
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	305
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	619
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	461
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	158
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	151
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	84
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	67
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	621
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Women	618
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	168
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	168
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	93
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Women	93
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Both sexes	409
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Men	409
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Women	..
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Both sexes	594
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Men	465
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Women	129
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.743
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.665
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.078
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Both sexes	99
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Men	33
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Women	66
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	171
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	106
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	65
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Both sexes	334
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Men	..
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Women	334
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	965
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	429
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	536
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	884
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	432
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	452
Gipuzkoa	Group 0301 Anaemias 280-285	Both sexes	668
Gipuzkoa	Group 0301 Anaemias 280-285	Men	314
Gipuzkoa	Group 0301 Anaemias 280-285	Women	354
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	216
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	118
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	98
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.347
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	616
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	731
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Both sexes	502
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Men	328
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Women	174
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	845
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	288
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	557
Gipuzkoa	Group 0500 Mental disorders  290-319	Both sexes	2.006
Gipuzkoa	Group 0500 Mental disorders  290-319	Men	1.097
Gipuzkoa	Group 0500 Mental disorders  290-319	Women	909
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	94
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	49
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	45
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	187
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	127
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	60
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	113
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	85
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	28
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	637
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	426
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	211
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	419
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	161
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	258
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	556
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	249
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	307
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.635
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	885
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	750
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Both sexes	52
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Men	24
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Women	28
Gipuzkoa	Group 0602 Multiple sclerosis 340	Both sexes	24
Gipuzkoa	Group 0602 Multiple sclerosis 340	Men	3
Gipuzkoa	Group 0602 Multiple sclerosis 340	Women	21
Gipuzkoa	Group 0603 Epilepsy  345	Both sexes	273
Gipuzkoa	Group 0603 Epilepsy  345	Men	158
Gipuzkoa	Group 0603 Epilepsy  345	Women	115
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Both sexes	255
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Men	121
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Women	134
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.031
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	579
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	452
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	233
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	108
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	125
Gipuzkoa	Grupo 0701 Cataract  366	Both sexes	11
Gipuzkoa	Grupo 0701 Cataract  366	Men	6
Gipuzkoa	Grupo 0701 Cataract  366	Women	5
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	222
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	102
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	120
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	562
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Men	271
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Women	291
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.480
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.101
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.379
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Both sexes	457
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Men	207
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Women	250
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Both sexes	287
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Men	196
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Women	91
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Both sexes	643
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Men	473
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Women	170
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	711
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	575
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	136
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	297
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Men	135
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Women	162
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.661
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	938
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	723
Gipuzkoa	Grupo 0907 Heart failure  428	Both sexes	2.156
Gipuzkoa	Grupo 0907 Heart failure  428	Men	1.135
Gipuzkoa	Grupo 0907 Heart failure  428	Women	1.021
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.839
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	961
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	878
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Both sexes	534
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Men	402
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Women	132
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Both sexes	305
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Men	131
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Women	174
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.590
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	948
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	642
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.561
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	6.007
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.554
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	510
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	252
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	258
Gipuzkoa	Group 1002 Pneumonia 480-486	Both sexes	2.563
Gipuzkoa	Group 1002 Pneumonia 480-486	Men	1.548
Gipuzkoa	Group 1002 Pneumonia 480-486	Women	1.015
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	538
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Men	281
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Women	257
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	564
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	320
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	244
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	886
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	587
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	299
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.616
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.159
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	457
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	490
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Men	191
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Women	299
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.394
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.669
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.725
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Both sexes	9.267
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Men	5.329
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Women	3.938
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	111
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	49
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	62
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	148
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	89
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	59
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Both sexes	154
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Men	104
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Women	50
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Both sexes	175
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Men	124
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Women	51
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	177
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	98
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	79
Gipuzkoa	Group 1106 Appendicitis  540-543	Both sexes	902
Gipuzkoa	Group 1106 Appendicitis  540-543	Men	501
Gipuzkoa	Group 1106 Appendicitis  540-543	Women	401
Gipuzkoa	Group 1107 Inguinal hernia  550	Both sexes	901
Gipuzkoa	Group 1107 Inguinal hernia  550	Men	776
Gipuzkoa	Group 1107 Inguinal hernia  550	Women	125
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Both sexes	734
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Men	365
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Women	369
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	200
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	110
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	90
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	437
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	199
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	238
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Both sexes	643
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Men	349
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Women	294
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Both sexes	467
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Men	196
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Women	271
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	687
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	473
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	214
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	294
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	139
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	155
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	153
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Men	116
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Women	37
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	260
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Men	159
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Women	101
Gipuzkoa	Group 1117 Cholelithiasis  574	Both sexes	1.445
Gipuzkoa	Group 1117 Cholelithiasis  574	Men	636
Gipuzkoa	Group 1117 Cholelithiasis  574	Women	809
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	392
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	253
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	139
Gipuzkoa	Group 1119 Pancreatic diseases 577	Both sexes	451
Gipuzkoa	Group 1119 Pancreatic diseases 577	Men	264
Gipuzkoa	Group 1119 Pancreatic diseases 577	Women	187
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	536
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	329
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	207
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.031
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	571
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	460
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	729
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	441
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	288
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	32
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	16
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	16
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	270
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	114
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	156
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.782
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.493
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.289
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Gipuzkoa	Group 1303 Internal derangement of knee 717	Both sexes	1.018
Gipuzkoa	Group 1303 Internal derangement of knee 717	Men	649
Gipuzkoa	Group 1303 Internal derangement of knee 717	Women	369
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.483
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.264
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.219
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	71
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	30
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	41
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	495
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	264
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	231
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	579
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	302
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	277
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	238
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	107
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	131
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.005
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	537
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	468
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	893
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	340
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	553
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.118
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.477
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.641
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	387
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	149
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	238
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	361
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Men	202
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Women	159
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	851
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Men	535
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Women	316
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.640
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	803
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	837
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Both sexes	538
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Men	538
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Women	..
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	208
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Men	208
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Gipuzkoa	Group 1407 Disorders of breast  610-612	Both sexes	326
Gipuzkoa	Group 1407 Disorders of breast  610-612	Men	32
Gipuzkoa	Group 1407 Disorders of breast  610-612	Women	294
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	131
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	131
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	44
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	44
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	632
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	10
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	622
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.462
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.462
Gipuzkoa	Group 1501 Legally induced abortion  635	Both sexes	72
Gipuzkoa	Group 1501 Legally induced abortion  635	Men	..
Gipuzkoa	Group 1501 Legally induced abortion  635	Women	72
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	212
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	212
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.847
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.847
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.190
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.190
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Both sexes	663
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Men	..
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Women	663
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Both sexes	138
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Men	..
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Women	138
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Both sexes	42
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Men	..
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Women	42
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	298
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	298
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	868
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Men	490
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Women	378
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	244
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	136
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	108
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	624
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	354
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	270
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Both sexes	271
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Men	139
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Women	132
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	5.525
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.097
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.428
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	872
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Men	535
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Women	337
Gipuzkoa	Group 1802 Abdominal pain   7890	Both sexes	522
Gipuzkoa	Group 1802 Abdominal pain   7890	Men	211
Gipuzkoa	Group 1802 Abdominal pain   7890	Women	311
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.551
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	865
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	686
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.580
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.486
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.094
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Both sexes	6.678
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Men	3.514
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Women	3.164
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	459
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	258
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	201
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	255
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	179
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	76
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Both sexes	436
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Men	167
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Women	269
Gipuzkoa	Group 1904 Femur fracture  820-821	Both sexes	940
Gipuzkoa	Group 1904 Femur fracture  820-821	Men	250
Gipuzkoa	Group 1904 Femur fracture  820-821	Women	690
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	469
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Men	222
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Women	247
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.957
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.203
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	754
Gipuzkoa	Group 1907 Burns  940-949	Both sexes	46
Gipuzkoa	Group 1907 Burns  940-949	Men	35
Gipuzkoa	Group 1907 Burns  940-949	Women	11
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	155
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	75
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	80
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.648
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	957
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	691
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	20
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	15
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	293
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	153
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	140
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.802
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.324
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.478
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	67
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	32
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	35
Gipuzkoa	Group 2102 Contraceptive management  V25	Both sexes	26
Gipuzkoa	Group 2102 Contraceptive management  V25	Men	4
Gipuzkoa	Group 2102 Contraceptive management  V25	Women	22
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	630
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	364
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	266
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.079
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	924
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.155
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	34.988
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	17.097
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	17.891
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	767
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	418
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	349
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	142
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	74
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	68
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Both sexes	25
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Men	15
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Women	10
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Both sexes	22
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Men	11
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Women	11
RIOJA, LA	Group 0104 Septicaemia  038	Both sexes	318
RIOJA, LA	Group 0104 Septicaemia  038	Men	164
RIOJA, LA	Group 0104 Septicaemia  038	Women	154
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	10
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	250
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	147
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	103
RIOJA, LA	Group 0200 Neoplasms  140-239	Both sexes	2.929
RIOJA, LA	Group 0200 Neoplasms  140-239	Men	1.534
RIOJA, LA	Group 0200 Neoplasms  140-239	Women	1.395
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	248
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	160
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	88
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	212
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	171
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	41
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	101
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	60
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	41
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	268
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Men	2
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Women	266
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	62
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	62
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	26
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Women	26
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	77
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Men	77
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Women	..
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	253
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Men	201
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Women	52
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.039
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	626
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	413
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Both sexes	44
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Men	7
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Women	37
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	38
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	23
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	15
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	151
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Men	..
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Women	151
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	410
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	207
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	203
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	524
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	265
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	259
RIOJA, LA	Group 0301 Anaemias 280-285	Both sexes	387
RIOJA, LA	Group 0301 Anaemias 280-285	Men	193
RIOJA, LA	Group 0301 Anaemias 280-285	Women	194
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	137
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	72
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	65
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	645
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	310
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	335
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Both sexes	316
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Men	184
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Women	132
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	329
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	126
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	203
RIOJA, LA	Group 0500 Mental disorders  290-319	Both sexes	730
RIOJA, LA	Group 0500 Mental disorders  290-319	Men	418
RIOJA, LA	Group 0500 Mental disorders  290-319	Women	312
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	28
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	13
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	15
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	41
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	23
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	18
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	45
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	34
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	11
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	211
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	131
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	80
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	122
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	46
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	76
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	283
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	171
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	112
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	596
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	304
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	292
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Both sexes	20
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Men	1
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Women	19
RIOJA, LA	Group 0602 Multiple sclerosis 340	Both sexes	9
RIOJA, LA	Group 0602 Multiple sclerosis 340	Men	1
RIOJA, LA	Group 0602 Multiple sclerosis 340	Women	8
RIOJA, LA	Group 0603 Epilepsy  345	Both sexes	102
RIOJA, LA	Group 0603 Epilepsy  345	Men	57
RIOJA, LA	Group 0603 Epilepsy  345	Women	45
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Both sexes	118
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Men	59
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Women	59
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	347
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	186
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	161
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	261
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	140
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	121
RIOJA, LA	Grupo 0701 Cataract  366	Both sexes	18
RIOJA, LA	Grupo 0701 Cataract  366	Men	9
RIOJA, LA	Grupo 0701 Cataract  366	Women	9
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	243
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	131
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	112
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	147
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	72
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	75
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.954
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.783
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.171
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Both sexes	333
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Men	154
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Women	179
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Both sexes	116
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Men	80
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Women	36
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Both sexes	404
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Men	290
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Women	114
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	216
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	176
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	40
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	194
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Men	94
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Women	100
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	601
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	327
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	274
RIOJA, LA	Grupo 0907 Heart failure  428	Both sexes	1.103
RIOJA, LA	Grupo 0907 Heart failure  428	Men	553
RIOJA, LA	Grupo 0907 Heart failure  428	Women	550
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	799
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	419
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	380
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Both sexes	137
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Men	103
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Women	34
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Both sexes	266
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Men	87
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Women	179
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	785
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	500
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	285
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.529
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.533
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.996
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	150
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	93
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	57
RIOJA, LA	Group 1002 Pneumonia 480-486	Both sexes	884
RIOJA, LA	Group 1002 Pneumonia 480-486	Men	509
RIOJA, LA	Group 1002 Pneumonia 480-486	Women	375
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	229
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	120
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	109
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	216
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	102
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	114
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	216
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	136
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	80
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	857
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	657
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	200
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	208
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Men	53
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Women	155
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.769
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	863
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	906
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.751
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Men	2.737
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Women	2.014
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	33
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	18
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	15
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	65
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	32
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	33
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Both sexes	77
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Men	54
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Women	23
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Both sexes	106
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Men	72
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Women	34
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	106
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	54
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	52
RIOJA, LA	Group 1106 Appendicitis  540-543	Both sexes	329
RIOJA, LA	Group 1106 Appendicitis  540-543	Men	191
RIOJA, LA	Group 1106 Appendicitis  540-543	Women	138
RIOJA, LA	Group 1107 Inguinal hernia  550	Both sexes	512
RIOJA, LA	Group 1107 Inguinal hernia  550	Men	455
RIOJA, LA	Group 1107 Inguinal hernia  550	Women	57
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Both sexes	329
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Men	147
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Women	182
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	64
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	25
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	39
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	417
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	207
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	210
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	289
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Men	174
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Women	115
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Both sexes	312
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Men	144
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Women	168
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	211
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	130
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	81
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	184
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	83
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	101
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	73
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Men	65
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	135
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Men	75
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Women	60
RIOJA, LA	Group 1117 Cholelithiasis  574	Both sexes	683
RIOJA, LA	Group 1117 Cholelithiasis  574	Men	325
RIOJA, LA	Group 1117 Cholelithiasis  574	Women	358
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	281
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	166
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	115
RIOJA, LA	Group 1119 Pancreatic diseases 577	Both sexes	322
RIOJA, LA	Group 1119 Pancreatic diseases 577	Men	189
RIOJA, LA	Group 1119 Pancreatic diseases 577	Women	133
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	223
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	131
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	92
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	345
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	179
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	166
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	200
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	108
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	92
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	18
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	11
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	127
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	64
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	63
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.652
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.346
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.306
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
RIOJA, LA	Group 1303 Internal derangement of knee 717	Both sexes	390
RIOJA, LA	Group 1303 Internal derangement of knee 717	Men	262
RIOJA, LA	Group 1303 Internal derangement of knee 717	Women	128
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	970
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	471
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	499
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	40
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	19
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	21
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	55
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	35
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	20
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	339
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	195
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	144
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	65
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	35
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	30
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	392
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	195
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	197
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	401
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	134
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	267
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.127
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.005
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.122
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	199
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	59
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	140
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	127
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Men	88
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Women	39
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	277
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Men	154
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Women	123
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	726
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	307
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	419
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Both sexes	188
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Men	188
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Women	..
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	184
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Men	184
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
RIOJA, LA	Group 1407 Disorders of breast  610-612	Both sexes	76
RIOJA, LA	Group 1407 Disorders of breast  610-612	Men	7
RIOJA, LA	Group 1407 Disorders of breast  610-612	Women	69
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	75
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	75
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	14
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	14
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	261
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	18
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	243
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.151
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.151
RIOJA, LA	Group 1501 Legally induced abortion  635	Both sexes	26
RIOJA, LA	Group 1501 Legally induced abortion  635	Men	..
RIOJA, LA	Group 1501 Legally induced abortion  635	Women	26
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	141
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	141
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.935
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.935
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	771
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	771
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Both sexes	71
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Men	..
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Women	71
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Both sexes	6
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Men	..
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Women	6
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Both sexes	13
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Men	..
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Women	13
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	188
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	188
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	229
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	133
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	96
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	97
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	56
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	41
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	132
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	77
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	55
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	130
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Men	88
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Women	42
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.667
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	933
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	734
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	162
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Men	106
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Women	56
RIOJA, LA	Group 1802 Abdominal pain   7890	Both sexes	253
RIOJA, LA	Group 1802 Abdominal pain   7890	Men	106
RIOJA, LA	Group 1802 Abdominal pain   7890	Women	147
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	6
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	4
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.246
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	719
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	527
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Both sexes	2.916
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Men	1.447
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Women	1.469
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	436
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	217
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	219
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	100
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	60
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	40
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Both sexes	109
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Men	55
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Women	54
RIOJA, LA	Group 1904 Femur fracture  820-821	Both sexes	513
RIOJA, LA	Group 1904 Femur fracture  820-821	Men	135
RIOJA, LA	Group 1904 Femur fracture  820-821	Women	378
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	161
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Men	81
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Women	80
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	667
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	377
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	290
RIOJA, LA	Group 1907 Burns  940-949	Both sexes	20
RIOJA, LA	Group 1907 Burns  940-949	Men	8
RIOJA, LA	Group 1907 Burns  940-949	Women	12
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	72
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	31
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	41
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	718
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	418
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	300
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	118
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	65
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	53
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	938
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	452
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	486
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	21
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	9
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	12
RIOJA, LA	Group 2102 Contraceptive management  V25	Both sexes	5
RIOJA, LA	Group 2102 Contraceptive management  V25	Men	2
RIOJA, LA	Group 2102 Contraceptive management  V25	Women	3
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	212
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	120
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	92
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	700
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	321
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	379
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	6.701
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.496
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	4.205
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	199
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	123
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	76
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	83
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	50
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	33
Ceuta	Group 0102 Imprecise intestinal infections 009	Both sexes	8
Ceuta	Group 0102 Imprecise intestinal infections 009	Men	4
Ceuta	Group 0102 Imprecise intestinal infections 009	Women	4
Ceuta	Group 0103 Tuberculosis 010-018, 137	Both sexes	37
Ceuta	Group 0103 Tuberculosis 010-018, 137	Men	32
Ceuta	Group 0103 Tuberculosis 010-018, 137	Women	5
Ceuta	Group 0104 Septicaemia  038	Both sexes	42
Ceuta	Group 0104 Septicaemia  038	Men	21
Ceuta	Group 0104 Septicaemia  038	Women	21
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	1
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	..
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	28
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	16
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	12
Ceuta	Group 0200 Neoplasms  140-239	Both sexes	294
Ceuta	Group 0200 Neoplasms  140-239	Men	150
Ceuta	Group 0200 Neoplasms  140-239	Women	144
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	43
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	20
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	23
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	27
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	20
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	3
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	1
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	2
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	12
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Women	12
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	7
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	7
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	5
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Women	5
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Both sexes	8
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Men	8
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Both sexes	17
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Men	13
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Women	4
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	69
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	40
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	29
Ceuta	Group 0210 Carcinoma in situ  230-234	Both sexes	4
Ceuta	Group 0210 Carcinoma in situ  230-234	Men	1
Ceuta	Group 0210 Carcinoma in situ  230-234	Women	3
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	4
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	4
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	..
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Both sexes	14
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Women	14
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	81
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	43
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	38
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	69
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	36
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	33
Ceuta	Group 0301 Anaemias 280-285	Both sexes	38
Ceuta	Group 0301 Anaemias 280-285	Men	17
Ceuta	Group 0301 Anaemias 280-285	Women	21
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	31
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	19
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	12
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	149
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	66
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	83
Ceuta	Group 0401 Diabetes mellitus  249-250	Both sexes	82
Ceuta	Group 0401 Diabetes mellitus  249-250	Men	50
Ceuta	Group 0401 Diabetes mellitus  249-250	Women	32
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	67
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	16
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	51
Ceuta	Group 0500 Mental disorders  290-319	Both sexes	171
Ceuta	Group 0500 Mental disorders  290-319	Men	90
Ceuta	Group 0500 Mental disorders  290-319	Women	81
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	4
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	2
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	2
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	7
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	5
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	2
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	7
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	6
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	46
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	39
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	7
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	39
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	13
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	26
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	68
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	25
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	43
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	171
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	72
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	99
Ceuta	Group 0601 Alzheimer's disease  3310	Both sexes	2
Ceuta	Group 0601 Alzheimer's disease  3310	Men	..
Ceuta	Group 0601 Alzheimer's disease  3310	Women	2
Ceuta	Group 0602 Multiple sclerosis 340	Both sexes	13
Ceuta	Group 0602 Multiple sclerosis 340	Men	1
Ceuta	Group 0602 Multiple sclerosis 340	Women	12
Ceuta	Group 0603 Epilepsy  345	Both sexes	49
Ceuta	Group 0603 Epilepsy  345	Men	31
Ceuta	Group 0603 Epilepsy  345	Women	18
Ceuta	Group 0604 Transient cerebral ischemia 435	Both sexes	18
Ceuta	Group 0604 Transient cerebral ischemia 435	Men	4
Ceuta	Group 0604 Transient cerebral ischemia 435	Women	14
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	89
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	36
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	53
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	64
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	37
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	27
Ceuta	Grupo 0701 Cataract  366	Both sexes	9
Ceuta	Grupo 0701 Cataract  366	Men	6
Ceuta	Grupo 0701 Cataract  366	Women	3
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	55
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	31
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	24
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	18
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Men	8
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Women	10
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	653
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	341
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	312
Ceuta	Group 0901 Hypertensive disease  401-405	Both sexes	55
Ceuta	Group 0901 Hypertensive disease  401-405	Men	16
Ceuta	Group 0901 Hypertensive disease  401-405	Women	39
Ceuta	Group 0902 Angina pectoris  4111, 413	Both sexes	101
Ceuta	Group 0902 Angina pectoris  4111, 413	Men	59
Ceuta	Group 0902 Angina pectoris  4111, 413	Women	42
Ceuta	Group 0903 Acute myocardial infarction  410	Both sexes	67
Ceuta	Group 0903 Acute myocardial infarction  410	Men	53
Ceuta	Group 0903 Acute myocardial infarction  410	Women	14
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	8
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	7
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	7
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Men	3
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Women	4
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	74
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	40
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	34
Ceuta	Grupo 0907 Heart failure  428	Both sexes	142
Ceuta	Grupo 0907 Heart failure  428	Men	59
Ceuta	Grupo 0907 Heart failure  428	Women	83
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	117
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	66
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	51
Ceuta	Grupo 0909 Atherosclerosis  440	Both sexes	6
Ceuta	Grupo 0909 Atherosclerosis  440	Men	3
Ceuta	Grupo 0909 Atherosclerosis  440	Women	3
Ceuta	Group 0910 Varicose veins of lower extremities 454	Both sexes	8
Ceuta	Group 0910 Varicose veins of lower extremities 454	Men	3
Ceuta	Group 0910 Varicose veins of lower extremities 454	Women	5
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	68
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	32
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	36
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	580
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	323
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	257
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	33
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	16
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	17
Ceuta	Group 1002 Pneumonia 480-486	Both sexes	176
Ceuta	Group 1002 Pneumonia 480-486	Men	99
Ceuta	Group 1002 Pneumonia 480-486	Women	77
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	83
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Men	38
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Women	45
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	7
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	4
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	3
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	27
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	21
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	6
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	55
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	49
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	6
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	9
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Men	3
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Women	6
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	190
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	93
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	97
Ceuta	Group 1100 Diseases of the digestive system  520-579	Both sexes	668
Ceuta	Group 1100 Diseases of the digestive system  520-579	Men	336
Ceuta	Group 1100 Diseases of the digestive system  520-579	Women	332
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	8
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	3
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	5
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	4
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	3
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	1
Ceuta	Group 1103 Diseases of the esophagus 530	Both sexes	7
Ceuta	Group 1103 Diseases of the esophagus 530	Men	7
Ceuta	Group 1103 Diseases of the esophagus 530	Women	..
Ceuta	Group 1104 Peptic ulcer 531-534	Both sexes	6
Ceuta	Group 1104 Peptic ulcer 531-534	Men	6
Ceuta	Group 1104 Peptic ulcer 531-534	Women	..
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	13
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	9
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	4
Ceuta	Group 1106 Appendicitis  540-543	Both sexes	80
Ceuta	Group 1106 Appendicitis  540-543	Men	52
Ceuta	Group 1106 Appendicitis  540-543	Women	28
Ceuta	Group 1107 Inguinal hernia  550	Both sexes	18
Ceuta	Group 1107 Inguinal hernia  550	Men	18
Ceuta	Group 1107 Inguinal hernia  550	Women	..
Ceuta	Group 1108 Other abdominal hernia  551-553	Both sexes	43
Ceuta	Group 1108 Other abdominal hernia  551-553	Men	16
Ceuta	Group 1108 Other abdominal hernia  551-553	Women	27
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	11
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	8
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	3
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	109
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	53
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	56
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Both sexes	16
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Men	5
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Women	11
Ceuta	Group 1112 Intestinal diverticulosis 562	Both sexes	18
Ceuta	Group 1112 Intestinal diverticulosis 562	Men	11
Ceuta	Group 1112 Intestinal diverticulosis 562	Women	7
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	22
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	17
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	5
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	28
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	12
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	16
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	9
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Men	8
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Women	1
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	20
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Men	10
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Women	10
Ceuta	Group 1117 Cholelithiasis  574	Both sexes	128
Ceuta	Group 1117 Cholelithiasis  574	Men	40
Ceuta	Group 1117 Cholelithiasis  574	Women	88
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	53
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	23
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	30
Ceuta	Group 1119 Pancreatic diseases 577	Both sexes	49
Ceuta	Group 1119 Pancreatic diseases 577	Men	23
Ceuta	Group 1119 Pancreatic diseases 577	Women	26
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	26
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	12
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	14
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	73
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	29
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	44
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	57
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	23
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	34
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	..
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	..
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	..
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	16
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	6
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	10
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	162
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	59
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	103
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ceuta	Group 1303 Internal derangement of knee 717	Both sexes	11
Ceuta	Group 1303 Internal derangement of knee 717	Men	7
Ceuta	Group 1303 Internal derangement of knee 717	Women	4
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	38
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	14
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	24
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	8
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	1
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	7
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	9
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	2
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	7
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	12
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	3
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	9
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	9
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	6
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	3
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	35
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	14
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	21
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	40
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	12
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	28
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	305
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	134
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	171
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	30
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	15
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	15
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	38
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Men	21
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Women	17
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	42
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Men	26
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Women	16
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	77
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	32
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	45
Ceuta	Group 1405 Prostatic hyperplasia  600	Both sexes	22
Ceuta	Group 1405 Prostatic hyperplasia  600	Men	22
Ceuta	Group 1405 Prostatic hyperplasia  600	Women	..
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	17
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Men	17
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ceuta	Group 1407 Disorders of breast  610-612	Both sexes	11
Ceuta	Group 1407 Disorders of breast  610-612	Men	1
Ceuta	Group 1407 Disorders of breast  610-612	Women	10
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	10
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	10
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	18
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	18
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	40
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	40
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.909
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.909
Ceuta	Group 1501 Legally induced abortion  635	Both sexes	1
Ceuta	Group 1501 Legally induced abortion  635	Men	..
Ceuta	Group 1501 Legally induced abortion  635	Women	1
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	181
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	181
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.236
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.236
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	284
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	284
Ceuta	Group 1505 Single spontaneous delivery  650	Both sexes	85
Ceuta	Group 1505 Single spontaneous delivery  650	Men	..
Ceuta	Group 1505 Single spontaneous delivery  650	Women	85
Ceuta	Group 1506 Other deliveries  6695-6697	Both sexes	19
Ceuta	Group 1506 Other deliveries  6695-6697	Men	..
Ceuta	Group 1506 Other deliveries  6695-6697	Women	19
Ceuta	Group 1507 Complications related to the puerperium  670-676	Both sexes	2
Ceuta	Group 1507 Complications related to the puerperium  670-676	Men	..
Ceuta	Group 1507 Complications related to the puerperium  670-676	Women	2
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	101
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	101
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	131
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Men	84
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Women	47
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	29
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	20
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	9
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	102
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	64
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	38
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Both sexes	38
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Men	24
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Women	14
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	375
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	198
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	177
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	18
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Men	11
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Women	7
Ceuta	Group 1802 Abdominal pain   7890	Both sexes	49
Ceuta	Group 1802 Abdominal pain   7890	Men	15
Ceuta	Group 1802 Abdominal pain   7890	Women	34
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	306
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	171
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	135
Ceuta	Group 1900 Injuries and poisoning  800-999	Both sexes	523
Ceuta	Group 1900 Injuries and poisoning  800-999	Men	297
Ceuta	Group 1900 Injuries and poisoning  800-999	Women	226
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	43
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	28
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	15
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	20
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	15
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	5
Ceuta	Group 1903 Radius and ulna fracture 813	Both sexes	61
Ceuta	Group 1903 Radius and ulna fracture 813	Men	47
Ceuta	Group 1903 Radius and ulna fracture 813	Women	14
Ceuta	Group 1904 Femur fracture  820-821	Both sexes	91
Ceuta	Group 1904 Femur fracture  820-821	Men	30
Ceuta	Group 1904 Femur fracture  820-821	Women	61
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	62
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Men	35
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Women	27
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	138
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	89
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	49
Ceuta	Group 1907 Burns  940-949	Both sexes	5
Ceuta	Group 1907 Burns  940-949	Men	2
Ceuta	Group 1907 Burns  940-949	Women	3
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	11
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	6
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	5
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	78
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	37
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	41
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	13
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	8
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	5
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	149
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	89
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	60
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	1
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	..
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1
Ceuta	Group 2102 Contraceptive management  V25	Both sexes	1
Ceuta	Group 2102 Contraceptive management  V25	Men	..
Ceuta	Group 2102 Contraceptive management  V25	Women	1
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	100
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	59
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	41
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	47
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	30
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	17
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	7.353
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.037
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	5.316
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	154
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	90
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	64
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	47
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	30
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	17
Melilla	Group 0102 Imprecise intestinal infections 009	Both sexes	2
Melilla	Group 0102 Imprecise intestinal infections 009	Men	1
Melilla	Group 0102 Imprecise intestinal infections 009	Women	1
Melilla	Group 0103 Tuberculosis 010-018, 137	Both sexes	16
Melilla	Group 0103 Tuberculosis 010-018, 137	Men	10
Melilla	Group 0103 Tuberculosis 010-018, 137	Women	6
Melilla	Group 0104 Septicaemia  038	Both sexes	29
Melilla	Group 0104 Septicaemia  038	Men	11
Melilla	Group 0104 Septicaemia  038	Women	18
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	8
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	52
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	31
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	21
Melilla	Group 0200 Neoplasms  140-239	Both sexes	286
Melilla	Group 0200 Neoplasms  140-239	Men	135
Melilla	Group 0200 Neoplasms  140-239	Women	151
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	30
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	16
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	14
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	26
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	19
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	..
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	1
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	25
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Women	25
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	3
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	3
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	..
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Women	..
Melilla	Group 0207 Malignant neoplasm of prostate  185	Both sexes	4
Melilla	Group 0207 Malignant neoplasm of prostate  185	Men	4
Melilla	Group 0207 Malignant neoplasm of prostate  185	Women	..
Melilla	Group 0208 Malignant neoplasm of bladder  188	Both sexes	32
Melilla	Group 0208 Malignant neoplasm of bladder  188	Men	32
Melilla	Group 0208 Malignant neoplasm of bladder  188	Women	..
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	92
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	41
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	51
Melilla	Group 0210 Carcinoma in situ  230-234	Both sexes	4
Melilla	Group 0210 Carcinoma in situ  230-234	Men	1
Melilla	Group 0210 Carcinoma in situ  230-234	Women	3
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	4
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	3
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	1
Melilla	Grupo 0212 Leiomyoma of uterus  218	Both sexes	21
Melilla	Grupo 0212 Leiomyoma of uterus  218	Men	..
Melilla	Grupo 0212 Leiomyoma of uterus  218	Women	21
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	44
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	19
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	25
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	58
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	34
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	24
Melilla	Group 0301 Anaemias 280-285	Both sexes	23
Melilla	Group 0301 Anaemias 280-285	Men	13
Melilla	Group 0301 Anaemias 280-285	Women	10
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	35
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	21
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	14
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	168
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	84
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	84
Melilla	Group 0401 Diabetes mellitus  249-250	Both sexes	88
Melilla	Group 0401 Diabetes mellitus  249-250	Men	55
Melilla	Group 0401 Diabetes mellitus  249-250	Women	33
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	80
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	29
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	51
Melilla	Group 0500 Mental disorders  290-319	Both sexes	125
Melilla	Group 0500 Mental disorders  290-319	Men	81
Melilla	Group 0500 Mental disorders  290-319	Women	44
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	1
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	..
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	5
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	5
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	..
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	24
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	21
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	32
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	22
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	10
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	21
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	8
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	13
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	42
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	25
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	17
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	63
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	31
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	32
Melilla	Group 0601 Alzheimer's disease  3310	Both sexes	..
Melilla	Group 0601 Alzheimer's disease  3310	Men	..
Melilla	Group 0601 Alzheimer's disease  3310	Women	..
Melilla	Group 0602 Multiple sclerosis 340	Both sexes	3
Melilla	Group 0602 Multiple sclerosis 340	Men	..
Melilla	Group 0602 Multiple sclerosis 340	Women	3
Melilla	Group 0603 Epilepsy  345	Both sexes	27
Melilla	Group 0603 Epilepsy  345	Men	18
Melilla	Group 0603 Epilepsy  345	Women	9
Melilla	Group 0604 Transient cerebral ischemia 435	Both sexes	7
Melilla	Group 0604 Transient cerebral ischemia 435	Men	2
Melilla	Group 0604 Transient cerebral ischemia 435	Women	5
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	26
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	11
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	15
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	31
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	15
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	16
Melilla	Grupo 0701 Cataract  366	Both sexes	5
Melilla	Grupo 0701 Cataract  366	Men	3
Melilla	Grupo 0701 Cataract  366	Women	2
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	26
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	12
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	14
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	16
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Men	8
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Women	8
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	510
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	262
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	248
Melilla	Group 0901 Hypertensive disease  401-405	Both sexes	8
Melilla	Group 0901 Hypertensive disease  401-405	Men	5
Melilla	Group 0901 Hypertensive disease  401-405	Women	3
Melilla	Group 0902 Angina pectoris  4111, 413	Both sexes	59
Melilla	Group 0902 Angina pectoris  4111, 413	Men	29
Melilla	Group 0902 Angina pectoris  4111, 413	Women	30
Melilla	Group 0903 Acute myocardial infarction  410	Both sexes	68
Melilla	Group 0903 Acute myocardial infarction  410	Men	42
Melilla	Group 0903 Acute myocardial infarction  410	Women	26
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	10
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	6
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	4
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	4
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Men	1
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Women	3
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	58
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	31
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	27
Melilla	Grupo 0907 Heart failure  428	Both sexes	129
Melilla	Grupo 0907 Heart failure  428	Men	64
Melilla	Grupo 0907 Heart failure  428	Women	65
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	109
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	49
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	60
Melilla	Grupo 0909 Atherosclerosis  440	Both sexes	2
Melilla	Grupo 0909 Atherosclerosis  440	Men	..
Melilla	Grupo 0909 Atherosclerosis  440	Women	2
Melilla	Group 0910 Varicose veins of lower extremities 454	Both sexes	8
Melilla	Group 0910 Varicose veins of lower extremities 454	Men	2
Melilla	Group 0910 Varicose veins of lower extremities 454	Women	6
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	55
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	33
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	22
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	500
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	299
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	201
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	12
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	6
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	6
Melilla	Group 1002 Pneumonia 480-486	Both sexes	166
Melilla	Group 1002 Pneumonia 480-486	Men	97
Melilla	Group 1002 Pneumonia 480-486	Women	69
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	77
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Men	49
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Women	28
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	..
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	..
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	..
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	9
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	4
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	5
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	44
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	37
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	7
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	24
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Men	10
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Women	14
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	168
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	96
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	72
Melilla	Group 1100 Diseases of the digestive system  520-579	Both sexes	698
Melilla	Group 1100 Diseases of the digestive system  520-579	Men	388
Melilla	Group 1100 Diseases of the digestive system  520-579	Women	310
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	8
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	4
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	4
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	..
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	1
Melilla	Group 1103 Diseases of the esophagus 530	Both sexes	7
Melilla	Group 1103 Diseases of the esophagus 530	Men	4
Melilla	Group 1103 Diseases of the esophagus 530	Women	3
Melilla	Group 1104 Peptic ulcer 531-534	Both sexes	28
Melilla	Group 1104 Peptic ulcer 531-534	Men	21
Melilla	Group 1104 Peptic ulcer 531-534	Women	7
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	12
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	9
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	3
Melilla	Group 1106 Appendicitis  540-543	Both sexes	80
Melilla	Group 1106 Appendicitis  540-543	Men	46
Melilla	Group 1106 Appendicitis  540-543	Women	34
Melilla	Group 1107 Inguinal hernia  550	Both sexes	75
Melilla	Group 1107 Inguinal hernia  550	Men	73
Melilla	Group 1107 Inguinal hernia  550	Women	2
Melilla	Group 1108 Other abdominal hernia  551-553	Both sexes	52
Melilla	Group 1108 Other abdominal hernia  551-553	Men	18
Melilla	Group 1108 Other abdominal hernia  551-553	Women	34
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	9
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	6
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	3
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	39
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	18
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	21
Melilla	Group 1111 Intestinal obstruction without hernia 560	Both sexes	29
Melilla	Group 1111 Intestinal obstruction without hernia 560	Men	16
Melilla	Group 1111 Intestinal obstruction without hernia 560	Women	13
Melilla	Group 1112 Intestinal diverticulosis 562	Both sexes	11
Melilla	Group 1112 Intestinal diverticulosis 562	Men	7
Melilla	Group 1112 Intestinal diverticulosis 562	Women	4
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	34
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	19
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	15
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	15
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	8
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	7
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	13
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Men	11
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	41
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Men	23
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Women	18
Melilla	Group 1117 Cholelithiasis  574	Both sexes	134
Melilla	Group 1117 Cholelithiasis  574	Men	50
Melilla	Group 1117 Cholelithiasis  574	Women	84
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	35
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	19
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	16
Melilla	Group 1119 Pancreatic diseases 577	Both sexes	49
Melilla	Group 1119 Pancreatic diseases 577	Men	21
Melilla	Group 1119 Pancreatic diseases 577	Women	28
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	26
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	15
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	11
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	33
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	18
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	15
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	21
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	13
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	8
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	..
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	..
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	..
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	12
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	5
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	7
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	100
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	50
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	50
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Melilla	Group 1303 Internal derangement of knee 717	Both sexes	7
Melilla	Group 1303 Internal derangement of knee 717	Men	6
Melilla	Group 1303 Internal derangement of knee 717	Women	1
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	34
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	10
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	24
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	6
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	3
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	3
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	7
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	4
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	3
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	19
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	11
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	8
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	2
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	..
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	2
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	15
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	11
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	4
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	10
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	5
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	5
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	299
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	106
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	193
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	15
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	7
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	8
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	45
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Men	22
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Women	23
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	28
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Men	13
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Women	15
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	58
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	32
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	26
Melilla	Group 1405 Prostatic hyperplasia  600	Both sexes	11
Melilla	Group 1405 Prostatic hyperplasia  600	Men	11
Melilla	Group 1405 Prostatic hyperplasia  600	Women	..
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	16
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Men	16
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Melilla	Group 1407 Disorders of breast  610-612	Both sexes	7
Melilla	Group 1407 Disorders of breast  610-612	Men	4
Melilla	Group 1407 Disorders of breast  610-612	Women	3
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	21
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	21
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	34
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	34
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	64
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	63
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.516
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.516
Melilla	Group 1501 Legally induced abortion  635	Both sexes	..
Melilla	Group 1501 Legally induced abortion  635	Men	..
Melilla	Group 1501 Legally induced abortion  635	Women	..
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	261
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	261
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.550
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.550
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.031
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.031
Melilla	Group 1505 Single spontaneous delivery  650	Both sexes	220
Melilla	Group 1505 Single spontaneous delivery  650	Men	..
Melilla	Group 1505 Single spontaneous delivery  650	Women	220
Melilla	Group 1506 Other deliveries  6695-6697	Both sexes	32
Melilla	Group 1506 Other deliveries  6695-6697	Men	..
Melilla	Group 1506 Other deliveries  6695-6697	Women	32
Melilla	Group 1507 Complications related to the puerperium  670-676	Both sexes	15
Melilla	Group 1507 Complications related to the puerperium  670-676	Men	..
Melilla	Group 1507 Complications related to the puerperium  670-676	Women	15
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	407
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	407
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	200
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Men	98
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Women	102
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	48
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	22
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	26
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	152
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	76
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	76
Melilla	Grupo 1700 Congenital abnormalities  740-759	Both sexes	55
Melilla	Grupo 1700 Congenital abnormalities  740-759	Men	35
Melilla	Grupo 1700 Congenital abnormalities  740-759	Women	20
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	135
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	63
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	72
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Men	1
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Women	..
Melilla	Group 1802 Abdominal pain   7890	Both sexes	21
Melilla	Group 1802 Abdominal pain   7890	Men	7
Melilla	Group 1802 Abdominal pain   7890	Women	14
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	9
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	7
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	104
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	53
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	51
Melilla	Group 1900 Injuries and poisoning  800-999	Both sexes	379
Melilla	Group 1900 Injuries and poisoning  800-999	Men	229
Melilla	Group 1900 Injuries and poisoning  800-999	Women	150
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	17
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	14
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	3
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	19
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	16
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3
Melilla	Group 1903 Radius and ulna fracture 813	Both sexes	30
Melilla	Group 1903 Radius and ulna fracture 813	Men	21
Melilla	Group 1903 Radius and ulna fracture 813	Women	9
Melilla	Group 1904 Femur fracture  820-821	Both sexes	72
Melilla	Group 1904 Femur fracture  820-821	Men	24
Melilla	Group 1904 Femur fracture  820-821	Women	48
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	49
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Men	36
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Women	13
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	106
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	72
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	34
Melilla	Group 1907 Burns  940-949	Both sexes	14
Melilla	Group 1907 Burns  940-949	Men	7
Melilla	Group 1907 Burns  940-949	Women	7
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	12
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	6
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	6
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	53
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	30
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	23
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	5
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	2
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	3
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	27
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	11
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	16
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	..
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	..
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	..
Melilla	Group 2102 Contraceptive management  V25	Both sexes	9
Melilla	Group 2102 Contraceptive management  V25	Men	..
Melilla	Group 2102 Contraceptive management  V25	Women	9
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	..
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	17
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	10
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	7